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Abstract 
 
This thesis examines the issues of acyclic stereocontrol in the Claisen rearrangement, 
with particular emphasis on the effects of exopericyclic stereocentres – i.e. those 
adjacent to the array of atoms directly involved in the sigmatropic process.  It is 
divided into three main parts: 
The first section provides a review of the field of acyclic stereocontrol. The models 
used to explain the development of relationships between stereocenters in systems 
lacking well-defined conformational constraints are discussed.  This is an established 
field and particular emphasis is given to recent developments in the modelling of such 
systems. 
The second section discusses the results of our studies. Previous examples of 
exopericyclic stereocontrol in sigmatropic rearrangements are shown. Studies are 
presented that explore the importance of heteroatom-bearing stereocenters and effects 
of olefin substitution pattern on the manner and extent of stereoselectivity. Our efforts 
to exploit these stereochemical effects in the synthesis of small molecules are then 
presented. A novel reaction sequence is presented in which equilibrating mixtures of 
allylic azides undergo stereoselective Claisen rearrangements and further chemistry of 
the products of this transformation is then explored.  These studies, and attempts to 
deploy them in synthesis allow us to draw conclusions on the nature of acyclic 
stereocontrol in the Claisen rearrangement. 
The third section contains experimental procedures and characterisation data for all 
compounds prepared. 
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Ac  acetyl 
aq  aqueous 
Ar  aryl 
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EWG  electron withdrawing group 
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HMBC heteronuclear multiple bond correlation 
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HOMO highest occupied molecular orbital 
i-  ipso 
  
IPA  isopropanol 
Ka  acid dissociation constant 
LDA  lithium diisopropylamide 
LHMDS lithium bis(trimethylsilyl)amide 
Lig  ligand 
LUMO lowest occupied molecular orbital 
m  multiplet 
M  mol dm-3 
m-  meta 
m/w  microwave 
MCPBA meta-chloroperbenzoic acid 
Me  methyl 
Met  metal 
min  minutes 
MOM  methoxymethyl 
mp  melting point 
MS  mass spectroscopy 
NBSH  ortho-nitrobenzenesulfonylhydrazide 
NMO  N-methylmorpholine N-oxide 
NMR  nuclear magnetic resonance 
NOESY nuclear Overhauser effect spectroscopy 
Nu  nucleophile 
o-  ortho 
  
p-  para 
PDC  pyridinium dichromate 
Ph  phenyl 
PNB  para-nitrobenzyl 
ppm  parts per million 
PPTS  pyridinium para-toluenesulfonate 
Pr  propyl 
py  polystyrene 
q  quartet 
RHF  restricted Hartree–Fock 
rt  room temperature 
s  singlet 
SCX  silica cation exchange 
sept  septet 
t  triplet 
TBAF  tetra-n-butylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
TBDPS tert-butyldiphenylsilyl 
TBME  tert-butylmethyl ether 
TEA  triethylamine 
TES  triethylsilyl 
TFAA  trifluoroacetic anhydride 
THF  tetrahydrofuran 
  
THP  tetrahydropyran 
TLC  thin-layer chromatography 
TMEDA tetramethylethylenediamine 
TMS  trimethylsilyl 
Ts  para-toluenesulfonyl 
TS  transition state 
v  volume 
w  weight
  
Stereochemical notation 
 
The Maehr convention for indicating relative and absolute stereochemistry has been 
used throughout this thesis.1  Solid and broken lines are used to denote racemates, 
while solid and broken wedges denote absolute configuration. Narrowing of the 
wedges implies increasing distance from the reader in the latter case. 
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1.1 Introduction 
 
1.1.1 Background and scope of the review 
The issue of stereochemical control is central to the development of organic synthesis; 
in particular, the influence of a pre-existing stereocentre upon the new stereocentres 
established during a reaction is of key importance. Control of the relationship between 
two or more stereocentres is readily achieved in cyclic systems in which rigorous 
conformational constraints are imposed; while control of the relationship between 
stereocentres is more difficult to achieve in acyclic systems that lack such 
conformational rigidity. Nevertheless, in the 115 years since Fischer’s original report 
on the stereoselective addition of hydrogen cyanide to aldoses,2 the patterns 
governing acyclic stereocontrol have been intensely investigated and modelled. As a 
consequence of the continuing development of new stereoselective reactions and 
advances in computational techniques this remains an active area of interest in 
organic synthesis, with direct relevance to both the synthesis of small molecules and 
complex biologically active targets. 
Although the work presented in this thesis concentrates on particular aspects of 
acyclic stereocontrol in the Claisen rearrangement, it is appropriate to give a review 
of the state of the art in this whole field. This review concentrates on the development 
of models for predicting the sense of acyclic stereocontrol, particularly over the last 
10 years. Three major classes of reaction have been reviewed: addition of 
nucleophiles to carbonyls, addition of both electrophiles and nucleophiles to C=C 
double bonds, and pericyclic reactions. A brief account of acyclic stereocontrol in 
reactions of functional groups adjacent to organometallic complexes is given. We 
concentrate only on the relationships between adjacent stereocentres. Remote acyclic 
stereocontrol is beyond the scope of this review. Reactions involving chiral 
auxiliaries, and strategies for establishing absolute asymmetric induction are not 
covered. Individual examples of acyclic stereocontrol in the Claisen rearrangement 
are given a more detailed treatment in Chapter 2 of this thesis. 
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1.1.2 Stereochemical definitions 
The term ‘acyclic stereocontrol’ appears to have a somewhat flexible definition in the 
literature, and below is an attempt to define the term. While a particular reaction may 
establish a relationship between stereocentres in an acyclic molecule, this can be a 
result of highly ordered cyclic transition states.  As an example, the relationships 
between pseudoequatorial and pseudoaxial substituents in cyclic Zimmerman–Traxler 
transition states that determine stereoselectivity in the aldol reaction are an example 
of cyclic stereocontrol;3 while the stereoselectivity of nucleophilic addition to a 
carbonyl adjacent to a stereocentre is an example of acyclic stereocontrol (Scheme 1). 
 
Scheme 1             
A similar dichotomy is shown in the two Claisen rearrangements below (Scheme 2). 
Although both cases result in acyclic products, in the Ireland–Claisen rearrangement 
the relative configuration of the two new stereocentres formed during the sigmatropic 
process is controlled by the relative geometries of the vinylic and allylic portions of 
the ketene acetal, because the reaction occurs via a cyclic transition state.87a 
Conversely, as will be discussed in depth in this thesis, the relationship between a 
stereocentre outside the pericyclic array and the new C—C bond formed during a 
Claisen rearrangement 3→4 is a function of acyclic stereocontrol. 
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Scheme 2 
Therefore, acyclic stereocontrol refers to reactions where the reacting moiety is free to 
undergo rotation relative to a pre-existing stereocentre but adopts a preferred reactive 
conformation. Reaction can then occur from either one of two diastereotopic faces as 
determined by transition state interactions. 
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1.2 Nucleophilic addition to carbonyls with an adjacent stereocentre 
 
1.2.1 Historical basis of models 
Although the historical development of this area has been comprehensively 
reviewed,4 a brief overview is given here to aid further discussion, particularly as 
recent discussions of stereocontrol remain based on these models. In 1952, Cram 
reported an analysis of 1,2-asymmetric induction in the addition of nucleophiles to 
carbonyl compounds bearing an adjacent stereocentre 5.5 In this case, the largest (L) 
group adopts a conformation anti to the carbonyl group for steric reasons. The 
nucleophile then attacks preferentially from the side of the small (S) substituent. The 
outcome of the reaction is modified if chelation (usually mediated by a metal) 
between the carbonyl oxygen and one of the substituents on the adjacent stereocentre 
is possible. The large (L) substituent now eclipses the carbonyl group, yet attack still 
preferentially occurs from the side of the small (S) substituent (Scheme 3). 
 
Scheme 3 
The Cram model is generally reliable in its explanation for the diastereoselectivity of 
carbonyl addition reactions unless polar substituents are present on the adjacent 
stereocentre. Cornforth, studying the reaction of Grignard reagents and alkyllithiums 
with α-chloroketones 7 noted that the α-chloro group took the role of the large 
substituent, even if more sterically demanding substituents were also present.6 In a 
Cram-type model, this represents a nearly eclipsing arrangement between the 
carbonyl dipole and the C—Cl bond. The conformation with antiparallel alignment of 
the C=O and C—Cl dipoles was suggested. In the same fashion as the Cram model, 
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attack of the nucleophile then occurs from the side of the smaller substituent (Scheme 
4). 
 
Scheme 4 
Karabatsos suggested a transition state model 10 and highlighted the importance of 
the nucleophile attacking along the less hindered trajectory.7 An alternative 
interpretation was given by Felkin,8 who suggested that if a either Karabatsos or 
Cram-type transition state was assumed, increasing the size of the large group would 
lead to a reduction in stereoselectivity due to strain between the L and R substituents. 
This is not born out experimentally and an investigation into lithium aluminium 
hydride reduction of ketones adjacent to a stereocentre, in combination with an 
examination of polar effects suggested the reaction was best described by a staggered 
transition state 11. In this case, the largest, or most electronegative group lies 
perpendicular to the plane of the carbonyl, antiparallel to the approach of the 
nucleophile. Additionally, the staggered Felkin transition state 11 is preferable to the 
analogous Cram transition state 9 in that it leads directly to the more stable staggered 
conformation of the product (Scheme 5). 
 
Scheme 5 
Refinements to the model were made by Anh and Eisenstein,9 who investigated the 
individual factors involved in attack of the nucleophile antiperiplanar to the largest or 
most donating group.  Arrangement of the C2—L bond perpendicular to the carbonyl 
group results in overlap of the C2—L σ* and C=O π*orbitals, lowering the energy of 
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the LUMO. Antiperiplanar attack of the nucleophile then gives a more favourable 
overlap with the combination of orbitals than synperiplanar attack (Scheme 6). 
 
Scheme 6 
Computational evidence suggested that the Bürgi–Dunitz angle10 should be taken into 
account (Scheme 7) in agreement with approach of the nucleophile along the least 
hindered trajectory, reconciling the model with those of Cram and Karabatsos. The 
combination of the above refinements is now referred to as the polar Felkin–Anh 
model, and it persists as a widely accepted explanation for acyclic stereocontrol in 
addition of nucleophiles to carbonyls with adjacent stereocenters. 
 
Scheme 7 
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adjacent stereocentre, and aldol reactions of boron enolates derived from ketones with 
aldehydes bearing an adjacent stereocentre. Mengel and Reiser have reviewed earlier 
work in this area.4d In these reactions, stereoselectivity has been rationalised using a 
combination of the Zimmerman–Traxler and Felkin–Anh models. This is an example 
of acyclic stereocontrol occurring adjacent to a well-defined, cyclic transition state. 
Parallels can be drawn with exopericyclic stereocontrol in sigmatropic 
rearrangements, for which similar transition states are proposed; therefore a 
discussion of the literature in this area is highly relevant to our studies.  
Both Roush11 and Gennari12 have discussed this area. A transition state analysis is 
presented in Scheme 8. For each reaction with E- or Z-enolates, Zimmerman–Traxler 
transition states establish the relationship between C2 and C3 in line with the 
prediction. The relationship between C3 and C4 is a determined by acyclic 
stereocontrol. While reactions of E-enolates give the product predicted by the Felkin–
Anh model, the opposite ‘anti Felkin’ diastereomer is the major product of reaction of 
Z-enolates. According to Roush, the dominant stereocontrol element determining 
aldehyde diastereofacial selectivity is the minimisation of gauche-pentane interactions 
in the competing transition states. For Z-enolates the Felkin–Anh transition state 14 
contains an unfavourable syn-pentane interaction. A rotation of the aldehyde bond to 
the adjacent stereocentre of 120° partially relieves this interaction (transition state 15), 
but this is still destabilised relative to the anti Felkin transition state 16 by a gauche 
pentane interaction. The case for E-enolates is somewhat simpler, since the Felkin–
Anh transition state 17 contains the fewest gauche pentane interactions and also 
benefits stereoelectronically from the antiperiplanar alignment of the forming C—C 
and aldehyde C—R bonds. Hoffmann and Roush have reported similar 
diastereoselectivity patterns in allylation reactions.13 
There have been recent reports of additions of nucleophiles to carbonyls adjacent to a 
polar stereocentre, where the stereoselectivity is also poorly rationalised by the polar 
Felkin–Anh model. Indeed, numerous authors have suggested that Cornforth-type 
transition states, where the polar substituent is orientated antiparallel to the carbonyl 
group, minimising dipolar interactions might better explain such reactions.14 
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Scheme 8 
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1.2.3 Recent evidence for the Cornforth model 
The dichotomy between Felkin–Anh and Cornforth transition states in the context of 
allylation reactions was investigated by Gung in 2001 using ab initio computational 
methods.15 For the reaction of allylboronic acid 20 with 2-methoxypropanal 19, the 
relative energies of the Felkin–Anh 22 and Cornforth 21 transition states (which both 
lead to the same product 23) were calculated, with the former being higher in energy 
by 1.27 kcal/mol (Scheme 9). The criterion for the Felkin–Anh model, that the 
nucleophile approaches antiperiplanar to the αC—O bond is poorly satisfied in this 
case. This deviation is attributed to conformational factors, particularly a syn-pentane 
interaction between the axial vinyl protons of the allylboron moiety and the α-methyl 
group of the aldehyde. In light of these results the authors calculated the energies of 
individual fragments of the transition states with frozen geometry. However, they did 
not find any evidence of charge separation between the αC—O and carbonyl groups 
that would be expected for a Cornforth transition state. They concluded that the 
relative energies of the Felkin–Anh and Cornforth transition states were a function of 
conformational constraints only. 
 
Scheme 9 
Cornforth transition state models have found continued use in the study of 
diastereoselective allylation and crotylation reactions. In 2003, Batey reported the 
diastereoselective allylation and crotylation of α- and β-siloxy substituted aldehydes 
under phase transfer conditions, which was used in a total synthesis of the anti-obesity 
drug tetrahydrolipstatin.16 Both E- and Z- potassium allyl- and crotyltrifluoroborates 
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25 reacted with α-tert-butyldimethylsiloxy aldehydes 24 to give, in all but one case, 
the 2,3-anti product 26 in uniformly high yield (Scheme 10, Table 1). 
 
Scheme 10 
Table 1 
Entry R1 R2 R3 E/Z  Ratio of 2,3-
syn : 2,3-anti 26 
Yield (%) 
1 H H Me - 30 : 70 95 
2 H H Ph - 35 : 65 94 
3 Me H Me Z 5 : 95 95 
4 H Me Me E 75 : 25 95 
5 Me H Ph Z 10 : 90 97 
6 H Me Ph E 10 : 90 99 
 
The major product 2,3-anti-26 derived from a Cornforth transition state (TS A) for 
reactions of Z-crotytrifluoroborates (entries 3 and 5), while the same product derived 
from a Felkin–Anh type transition state (TS C) in the reactions of an E-
crotyltrifluoroborate (entry 6) in agreement with the predictions of Roush.11,13a The 
analogous behaviour when R3=Me was unexplained by the authors, but would suggest 
a greater gauche-pentane interaction between the allyl group and the aldehyde α-
methyl than between the allyl group and the α-siloxy substituent. Lower selectivity 
was observed in allylation reactions (entries 1 and 2), presumably resulting from less 
significant syn-pentane interactions in the transition state leading to 2,3-syn-26 (TS B) 
(Scheme 11). 
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Detailed studies of Cornforth transition states for the aldol reaction which combine 
experimental and computational data, have been performed. However, experimental 
discrimination between Cornforth and polar Felkin–Anh models is difficult, 
particularly as both often predict the same product. An experiment which would 
differentiate between the two models17 was proposed by Evans. As shown in the 
above examples of allylation and aldol reactions, such discrimination is possible when 
the nucleophile imposes a conformational constraint on the orientation of the 
stereocentre adjacent to the electrophilic carbonyl. For reactions of E- and Z-enolates, 
both Felkin–Anh and Cornforth transition states were proposed that lead to the 3,4-
anti product 27. The 2,3-relationship was set by the choice of E- or Z-boron enolate, 
the geometries of which are reliably reflected in the product stereochemistry. Lithium 
enolates were also included for generality, although they are inherently less 
diastereoselective (in defining the 2,3-relationship) (Scheme 12). 
 
Scheme 12 
In the prediction of the polar Felkin–Anh model, the Z-enolate substituent causes a 
destabilising syn-pentane interaction, while the E-enolate substituent experiences no 
such interaction. Therefore, E-enolates are predicted to give superior 3,4-anti 
selectivity relative to Z-enolates. Conversely, in the prediction of the Cornforth 
model, E-enolate substituent causes a destabilising syn-pentane interaction, while the 
Z-enolate substituent experiences no such interaction. Therefore, Z-enolates are 
predicted to give superior 3,4-anti selectivity relative to E-enolates. Thus, the E- and 
Z-boron and lithium enolates of 2-methyl-3-pentanone 28 were combined with a 
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representative set of α-oxy-substituted aldehydes 29 (Scheme 13, Table 2). In general, 
relative to Z-enolates, the E-isomers showed greatly diminished selectivity for the 3,4-
anti diastereomer, in support of the Cornforth model. 
 
Scheme 13 
Table 2 
Aldol reactions of Z-enolates  Aldol reactions of E-enolates 
Met P R 3,4-anti- : 
3,4-syn-30 
Yield 
(%) 
 Met P R 3,4-anti- : 
3,4-syn-30 
Yield 
(%) 
9-BBN Bn Me 89 : 11 95  (cHex)2B Bn Me 33 : 67 59 
9-BBN Bn iPr 98 : 2 73  (cHex)2B Bn iPr 67 : 33 77 
9-BBN TBS Me 98 : 2 77  (cHex)2B TBS Me 21 : 79 77 
9-BBN TBS iPr 98 : 2 72  (cHex)2B TBS iPr 43 : 57 85 
           
Li Bn Me 89 :11 67  Li Bn Me 93 : 7 92 
Li Bn iPr 98 : 2 77  Li Bn iPr 80 : 20 78 
Li TBS Me 95 : 5 65  Li TBS Me 85 : 15 78 
Li TBS iPr 99 : 1 71  Li TBS iPr 88 : 12 80 
 
More recently, Evans has performed a theoretical investigation of boron enolate 
addition to α-heteroatom-substituted aldehydes, comparing polar Felkin–Anh and 
Cornforth transition state models using DFT methods.18,19 Highly electronegative 
substituents (F, OMe, Cl) and less electronegative substituents (PMe2, SMe, NMe2) 
were assessed. For the halopropanals 31 (X=F, Cl) transition states leading to both 
anti- (TS A and C) and syn-32 (TS B and D) were calculated. For di- and tri-valent 
heteroatoms, where rotamers of the C—X bond are possible, only the transition states 
leading to the anti product were calculated (Scheme 14, Table 3). The relative 
energies of Cornforth and Felkin–Anh transition state structures are highly dependent 
on the nature of the heteroatom substituent, with chlorine, fluorine and oxygen 
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substituents favouring the Cornforth arrangement and nitrogen, sulfur and phosphorus 
substituents favouring the polar Felkin–Anh arrangement. 
 
Scheme 14 
Table 3 
  Cornforth Polar Felkin–Anh 
X  TS A TS B TS C TS D 
F ϕ  (deg) 166 196 264 76 
 Erela 0.0 0.8 2.4 3.7 
      
Cl ϕ  (deg) 175 186 267 76 
 Erela 0.0 0.6 0.4 2.4 
      
OMe ϕ  (deg) 171 - 267 - 
 Erela 0.0 - 1.7 - 
      
SMe ϕ  (deg) 174 - 271 - 
 Erela 3.3 - 0 - 
      
NMe2 ϕ  (deg) 172 - 272 - 
 Erela 0.8 - 0.0 - 
      
PMe2 ϕ  (deg) 175 - 276 - 
 Erela 3.5 - 0.0 - 
aCalculated using the B3LYP method with the 6-31G(d) basis set. Energies are 
given in kcal/mol. 
 
Further analysis suggested that the nucleophile→σ*C—X interaction central to the 
polar Felkin–Anh model was energetically insignificant in reactions of carbonyls with 
boron enolate nucleophiles. However, it was shown that when X=SMe and X=PMe2 
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perpendicular alignment of the C—X bond with the carbonyl group (as in the Felkin–
Anh model) was favoured due to σ*C—X→π*C=O delocalisation. Transition states were 
also calculated for the above aldol reactions17 in good agreement with experimental 
data. This work by Evans represents perhaps the most in-depth study in this area to 
date, and aspects of this methodology have been recently employed in the synthesis of 
the natural product (+)-peluroside A.20 
Similar relationships of Cornforth models with heteroatom electronegativity are 
evident in the investigations of Marco into doubly diastereoselective aldol reactions21 
of L-erythulose derivatives with aldehydes bearing an adjacent stereocentre.22 In the 
most striking case, aldehydes bearing α-fluoro- and α-benzyloxy groups reacted via 
Cornforth transition states, while α-amino aldehydes reacted via anti-Felkin–Anh 
transition states. In these cases, the non-stereogenic ketone 33 was used to form the 
corresponding Z-boron enolate 34. Additional conformational constraints are placed 
on the transition states by the dipolar repulsion between the enolate C—O and 
remaining α-C—OTBS bonds resulting in an antiperiplanar alignment (Scheme 15). 
Aldehydes bearing α-methyl groups were also studied, which reacted via Felkin–Anh 
transition states as predicted, although computational investigations by other groups 
have recently suggested that Felkin–Anh models might not be as generally applicable 
for attack on carbonyls adjacent to non-heteroatomic stereocentres.23 
 
1.2.4 Conclusions 
As the above discussion demonstrates, modelling of nucleophilic addition to 
carbonyls adjacent to a stereocentre is still a highly active area of development, with 
numerous studies over the last 10 years that challenge the dominance of the Felkin–
Anh model.24 Additional factors must be taken into account when the acyclic 
stereocontrol arises from the presence of stereocentres adjacent to well-defined 
transition states. In short, the rotational conformation around the α-stereocentre is 
dependent on the nature of the nucleophile. Additionally, although the Felkin–Anh 
model is still useful, its theoretical basis remains in question.25 There is no one model 
that reliably describes all cases. However, in the case of polar stereocentres, there has 
been a resurgence in use of the Cornforth model to describe diastereoselectivity.26 
Recent advances in acyclic stereocontrol 
 
 
 29 
  
Scheme 15 
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1.3 Addition to C=C double bonds with an adjacent stereocentre 
 
The case for addition of both nucleophiles and electrophiles to olefins is somewhat 
more complicated than for analogous reactions with carbonyls. Felkin–Anh-type 
models provide a theoretical basis for these reactions where the carbonyl group is 
replaced by a C=C double bond (Scheme 16).27 However, additional conformational 
constraints are imposed by the double bond substituents and the level of acyclic 
stereocontrol is often highly dependent on the double bond substitution pattern. As for 
the previous section, this area has been reviewed relatively recently by both Reiser4d 
and Fleming36 (vide infra). A brief historical treatment is given, followed by accounts 
of recent developments. 
 
Scheme 16 
 
1.3.1 Electrophilic Addition 
Calculations of torsional effects in additions of electrophiles to substituted butenes by 
Houk suggested that staggered transition states were preferred in additions of 
electrophiles to C=C double bonds adjacent to a stereocentre.28 Attack of the 
electrophile in these systems occurs perpendicular to the double bond; deviations 
from this trajectory suffered large energy penalties. Therefore, the lowest-energy 
structure is that in which the stereocentre exerts the least hindrance to the incoming 
electrophile, or in an alternative view, that which interacts least with the forming 
bond. For hydroboration,29 this corresponds to the staggered transition state 39 with 
the smaller (S) substituent pointing ‘inside’ the double bond, and attack anti to the L 
group. This conformation has the additional advantage of minimising 1,3-allylic 
strain. Notably, this corresponds to the anti-Felkin product 41, as in the example of 
Kishi (Scheme 17).30 
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Scheme 17 
Kishi reported similar results in the osmylation of protected and unprotected allylic 
alcohols 42 (Scheme 18, Table 4, showing selected examples).31 The selectivity is 
rationalised by invoking the Houk model. The increased selectivity upon switching 
from E- to Z-allylic double bond geometry is clear indication of the importance of 
1,3-allylic strain in this model. As we will see, 1,3-allylic strain is perhaps the most 
important control element in additions to C=C double bonds, and is a component of 
most models. This subject has been reviewed in detail by Hoffmann.32 
 
Scheme 18 
Table 4 
Entry R E/Z Ratio 3,4-anti- : 
3,4-syn-43 
1 H E 3.3 : 1 
2 C(O)CMe3 E 4.2 : 1 
3 TBDPS E 3.1 : 1 
4 H Z 6.1 : 1 
5 C(O)CMe3 Z 6.3 : 1 
6 TBDPS Z 8.0 : 1 
 
In a more recent example Donohoe has reported that syn selectivity is possible in 
osmylations of unsaturated alcohols 44 in the presence of TMEDA, which further 
illustrates the importance of 1,3-allylic strain for acyclic stereocontrol in additions to 
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C=C double bonds.33 The OsO4–TMEDA conditions, which exploit OH…O=Os 
hydrogen-bonding34 were compared with the substoichiometric OsO4–NMO ‘Upjohn’ 
conditions (Scheme 19, Table 5). 
 
Scheme 19 
Table 5 
    Upjohn Conditions Donohoe Conditions 
Entry R RE RZ Ratio syn- : 
anti-45 
Yield (%) Ratio syn- : 
anti-45 
Yield (%) 
1 nPr H H 25 : 75 80 60 : 40 74 
2 nPr nPr H 25 : 75 85 75 : 25 83 
3 nPr tBu H 17 : 83 83 80 : 20 75 
4 iPr nPr H 20 : 80 75 75 : 25 84 
5 nPr H nPr 62 : 38 76 96 : 4 74 
6 tBu H nPr 80 : 20 85 96 : 4 79 
7 nBu Me Me 66 : 34 96 96 : 4 78 
 
Transition states were proposed to account for these selectivity patterns (Scheme 20). 
The increase in magnitude of the observed syn selectivity on switching from E- to Z- 
isomers under Donohoe conditions is explained by TS A and TS B. In both, the 
hydrogen-bonding interaction is maintained that leads to attack of the oxidant from 
the same face as the alcohol. However, although TS B, which leads to the anti 
product satisfies the conditions for hydrogen-bonding, it is disfavoured by 1,3-allylic 
strain between the R and RZ groups. Therefore, when the RZ substituent is non-
hydrogen, reaction via TS A, which leads to the syn product is favoured.  Similar 
transition states TS C/D can be proposed to account for the reversal in selectivity 
under Upjohn conditions. Although selectivity is comparatively low under these 
conditions, the preferred anti products from reaction of E-allylic alcohols can be 
formed via TS C in which the R group eclipses the double bond. Conversely, TS D 
must be invoked for oxidation of Z-allylic alcohols to minimise 1,3-allylic strain.35 
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Scheme 20 
This is defined by in a recent review by Fleming as the ‘inside methyl’ effect:36 
where, in systems lacking a significant 1,3-allylic strain component, the major 
product can arise from a transition state in which the smallest group does not eclipse 
the double bond (cf. TS B/D, Scheme 20). Its occurrence is highly dependent upon 
both the substrate and reaction in question. The effect is also observed in nucleophilic 
additions. 
 
1.3.2 Nucleophilic additions 
The majority of studies in this area have concentrated on the conjugate addition of 
organocuprate nucleophiles to enoates 46 bearing a γ-stereocentre, in particular due to 
the use of this method in the synthesis of polypropionate building blocks for natural 
products.37 A summary of models for describing this reaction has recently been 
published by Kornienko.38 In the case of γ-alkoxy and γ-siloxy stereocentres, the anti 
product anti-47 generally predominates.39 The two most prevalent models for this 
selectivity are the ‘modified Felkin–Anh’ originally described by Roush,40 which 
parallels that for electrophilic addition to C=C double bonds, and the Yamamoto 
model,41 which has many features in common with the Cieplak42 and Houk ‘inside-
alkoxy’57 models vide infra (Scheme 21). Yamamoto argued that the reactive 
conformation is stabilised by overlap of the electron rich C—R bond with the 
developing C—Nu σ* orbital. The model correctly predicts a reversal from anti to syn 
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selectivity in reactions of Z-enoates, as increased 1,3-allylic strain favours the 
conformation with the hydrogen roughly eclipsing the double bond. 
 
Scheme 21 
Kornienko studied the addition of various diarylcuprates43 to a representative set of γ-
alkoxyenolates 48, with variations in the alkoxy group, R group and enolate geometry 
(Scheme 22, Table 6). The high selectivities in addition to E-enoates are consistent 
with the modified Felkin–Anh model, as the selectivity is independent of the size of 
the R’ group (Entry 1,2) which is orientated antiperiplanar to the incoming 
nucleophile. The reduction in selectivity with reducing size of the R group is also 
consistent with this model (Entry 2,3,4). The Yamamoto model leads to the opposite 
prediction: that selectivity should be highly dependent on the size of the R’ group 
(OR’ eclipses the enoate in the transition state leading to the anti product); and that 
selectivity should be largely independent of the R group. The moderate selectivities 
for addition to Z-enoates are poorly explained by both models. The modified Felkin–
Anh model suggests anti selectivity should be higher for Z-enoates, while the 
Yamamoto model suggests that syn products should predominate. 
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Scheme 22 
Table 6 
Entry R R’ R’’ E/Z Yield (%) Ratio anti- 
: syn-49 
1 CH2OTBDPS MOM Et E 80 >50 : 1 
2 CH2OTBDPS Bn Me E 88 >50 : 1 
3 CH2OBn Bn Me E 94 14.6 : 1 
4 Me Bn Me E 89 5.4 : 1 
5 CH2OTBDPS Bn Me Z 87 1.6 : 1 
6 CH2OBn Bn Me Z 72 2.8 : 1 
7 Me Bn Me Z 65 3.4 : 1 
 
A revised model was suggested that takes into account recent mechanistic studies in 
the conjugate additions of organocuprates,44 with the assumption that the reductive 
elimination step of the reaction is both rate- and stereochemistry-determining. This 
contrasts with the Yamamoto and modified Felkin–Anh models, which assume 
complexation with the enoate to be the step controlling facial selectivity (Scheme 23). 
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Scheme 23 
Both Felkin–Anh and Yamamoto transition states for the reductive elimination step 
contain eclipsing interactions with the complexed and almost planar organocuprate. 
The transition states proposed by Kornienko position the R and OR’ groups away 
from the large cuprate moiety.45 Also notable are the two roughly antiperiplanar 
relationships in this transition state: firstly between the Cγ—OR’ and forming Cβ—Ar 
bonds; and secondly between the Cγ—R and breaking Cβ—Cu bonds. In the former, 
favourable mixing of the σCβ—Ar and low-lying σ*Cγ—OR’ orbitals is maintained; while 
in the latter case overlap of the electron rich σCγ—R and σ*Cβ—Cu orbitals assists the 
departure of copper. These transition states are consistent with the experimental data. 
The sense of selectivity is reversed in the presence of γ-amino stereocentres, and the 
syn product predominates. This stereochemical divergence was discussed as early as 
1991 by Hanessian.46 Two substrates 50, derived from Garner’s aldehyde47 and 52 
underwent syn-selective addition with dimethylcuprate–TMSCl (Scheme 24).  
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According to Hanessian, the syn-products 51 and 53 could derive from either Felkin–
Anh or Yamamoto transition states, although neither of these give a convincing 
explanation of the reversal of selectivity in changing from oxygen to nitrogen.  
 
Scheme 24 
A more recent treatment of this dichotomy has been given by Kornienko.48 Substrates 
similar to those investigated by Hanessian were treated with a variety of 
diarylcuprates (Scheme 25, Table 7). Although diastereoselectivity was effectively 
absolute in all cases, much lower yields were observed for the bulkier substrate 54. 
 
Scheme 25 
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Table 7 
Reaction of 54  Reaction of 50 
Entry X Yield 
(%) 
Ratio syn- : 
anti-55 
 Entry X Yield 
(%) 
Ratio syn- : 
anti-56 
1 H 58 >20 : 1  8 H 95 >20 : 1 
2 4-OMe 50 >20 : 1  9 4-OMe 87 >20 : 1 
3 4-F 55 >20 : 1  10 4-F 92 >20 : 1 
4 4-Cl 58 >20 : 1  11 4-Cl 83 >20 : 1 
5 3,4-
OMe 
49 >20 : 1  12 3,4-
OMe 
70 >20 : 1 
6 H 52 >20 : 1  13 H 92 >20 : 1 
7 5-OMe 0 -  14 5-OMe 70 >20 : 1 
 
In common with the previous study, considering that the Felkin–Anh model predicts 
predominance of the anti product, a ‘reductive-elimination’ transition state was 
proposed to account for the observed syn selectivity (Scheme 26). Although the 
reduced yields in the case of bulkier R groups  (increased 1,3-allylic strain) agree with 
this model, it is unclear whether this transition state benefits from the favourable 
orbital interactions of the transition state leading to the anti product. 
 
Scheme 26 
In additions of organocuprates to C=C double bonds adjacent to a silicon-containing 
stereocentre, diastereoselectivity is somewhat lower. Fleming reported the 1,4-
addition of silylcuprates to enoates with silicon stereocentres at either the α- or β-
position.49 Attack occurred predominantly syn to the silicon substituent, with the 
hydrogen eclipsing the double bond. It is difficult to rationalise this result using the 
above reductive elimination transition states above, although it may be consistent with 
a Yamamoto-type model in which the anti product is disfavoured by the silicon group 
roughly eclipsing the double bond (Scheme 27). 
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Scheme 27 
Further recent examples of acyclic stereocontrol in organocuprate additions have been 
reported by Breit, who used phosphine substituents for directed delivery of the 
cuprate.50 While E-configured substrates E-61 afforded anti products, the syn 
products were obtained from the isomeric Z-configured substrates Z-61. The level of 
selectivity was independent of the size of the nucleophile (Scheme 28). 
 
Scheme 28 
Si
Ph
CO2MePhMe2 Si
Ph CO2Me
PhMe2
SiMe2Ph
Si
Ph CO2Me
PhMe2
SiMe2Ph
(i) (PhMe2Si)2CuLi·LiCN
(ii) NH4Cl, H2O
anti-58syn-58
dr = 58:42
57
R1
O
R2
O
Ph2P
R1 R2
RR1
O
O
R2 H
Ph2
P
[LnRCu]
o-DPPB-directed allylic substitution
O
Ph2P
o-DPPB
O(o-DPPB)
NBoc
O
NBoc
O
O(o-DPPB)
MeMgBr (2 equiv)
CuBrMe2S, Et2O, rt
(78%)
MeMgBr (2 equiv)
CuBrMe2S, Et2O, rt
(86%)
NBoc
O
Me
NBoc
O
Me
dr = 85:15
dr = 97:3
Stereospecific examples:
H
H
H
O
H
OC
Ph2P
[RCu]
R' = Boc
N
O
H R'
H
H
H
O
H
OC
Ph2P
[RCu]
NR'
O
H
H
H
O
H
H
O
Ph2P
[RCu]NR'
O Hor
Yamamoto Felkin–Anh
1,3-allylic strain
minimising
E-substrate Z-substrate
anti syn
59
60
E-61
Z-61
anti-62
syn-62
Recent advances in acyclic stereocontrol 
 
 
 40 
Carbon nucleophiles undergo stereoselective addition to enoates with a γ-stereocentre, 
and similar models have been used to explain these reactions. The sense of addition of 
lithium amides varies between syn and anti depending on substrate,51,52 while 
hydroxylamine nucleophiles generally give the syn product.53 Alkoxide nucleophiles 
have also been studied.54 The anti sense of rhodium-catalysed conjugate addition of 
boronic acids to γ,δ-alkoxy enoates has been recently explained using a reductive 
elimination model.55 
 
1.3.3 Conclusions 
Compared to analogous reactions of carbonyls, addition to double bonds adjacent to a 
stereocentre is less well defined. Although the Houk model correctly predicts the 
results of electrophilic addition in many cases, there are exceptions in which the 
major product arises from seemingly hindered transition states (cf. the inside-methyl 
effect). For nucleophilic additions, in particular 1,4-addition to enoates with γ-
stereocentres, the sense of diastereoselectivity follows clear trends. However, neither 
the modified Felkin–Anh, Yamamoto or reductive elimination models give conclusive 
explanations for the changing sense of selectivity with changing γ-heteroatom.  Above 
all, 1,3-allylic strain dominates as an essential control element. 
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1.4 Pericyclic reactions 
 
1.4.1 [3+2] Cycloadditions 
Models for [3+2] cycloadditions follow naturally from those for addition to C=C 
double bonds, although they differ significantly from Felkin–Anh type models. The 
case for 1,3-dipolar addition to a C=C double bond adjacent to a stereocentre has been 
extensively investigated, particularly for chiral allyl ethers 63. This area has been 
most recently reviewed in 2001, in which the authors highlight the accuracy with 
which the established theories predict the observed stereoselectivity.56 The two key 
factors at work are 1,3-allylic strain and the ‘inside-alkoxy’ effects first postulated by 
Houk (Scheme 29).57 
 
Scheme 29 
Houk calculated the relative energies of methyl and methoxy substituents at each of 
the staggered positions in the cycloaddition transition state. The methyl group 
preferentially adopted the anti configuration, avoiding the inside conformation on 
steric grounds, and allowing hyperconjugation of the σC—Me and electron-deficient 
π*C=C bonds. The methoxy group was situated inside in the lowest energy transition 
state. In the anti OMe position, overlap between the πC=C and σ*C—O orbitals removes 
electron density from the reacting olefin, disfavouring this transition state. Notably, 
the anti disposition of alkoxy groups relative to reacting olefins is shown to be a 
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stabilising interaction in other pericyclic reactions, particularly sigmatropic 
rearrangements, due to a π∗C=C/σ*C—O interaction (see Section 2.1). Overall, the most 
unfavourable orientation is OMe outside, which is electrostatically destabilised by 
interaction of the partial negative charges of the approaching oxygen atoms. 
In the case of Z-configured substrates where 1,3-allylic strain is greater, the alkoxy 
group adopts the anti position, with the smallest substituent lying inside. An example 
of this is shown in the intramolecular cycloaddition of Z-allylic ether 65 (Scheme 
30).58 Two possible allylic strain-minimising conformations are possible, yet the 
outside alkoxy/anti methyl transition state leading to syn-66 is electrostatically 
disfavoured. 
 
Scheme 30 
In contrast to the examples shown above of conjugate nucleophilic addition to 
enoates, alteration of the heteroatom causes little variation in the sense of the 
selectivity although some exceptions have been reported. Cycloadditions of nitrile 
oxides with allylic isoxazoles 67 occur in the inside alkoxy sense and the anti product 
68 predominates (Scheme 31).59 Selectivities are slightly lower than those for allylic 
ethers, which correlates with the lower electronegativity of nitrogen, causing less 
destabilisation in anti and outside transition states. Selectivities for the anti product 
are lower still for acyclic allylic amines.59a,60 
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More recently, the preferred conformations of allylic fluorides in transition states for 
their nitrile oxide cycloadditions have been studied and compared with experimental 
data.61 Allylic fluorides were found to react in the sense predicted by the inside 
alkoxy model, with fluorine taking the place of the alkoxy substituent.62 Three allylic 
fluorides 69, 71 and 74 were treated with propionitrile oxide to give the 
corresponding cycloadducts (Scheme 32). 69 reacted in favour of the anti adduct. 
Reaction of 71 and 74 both afforded mixtures of regio- and stereoisomers. For 71 in 
the series with the stereocentre at the isoxazole 4 position 72, there was a slight 
preference for the syn cycloadduct. For the series with the stereocentre at the 
isoxazole 5 position 73 (in common with the above examples), a distinct preference 
for the anti cycloadduct was observed. For 74 in the series with the stereocentre at the 
isoxazole 4 position 75, only the syn cycloadduct was observed; while with the 
stereocentre at the 5 position 76, there was a slight bias for the anti product. 
 
Scheme 32 
These observations were explained using transition state searches (Scheme 33, 
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energy transition state (A) has fluorine inside, with the methyl group in the anti 
position. The second lowest transition state (D), which leads to the syn product also 
has fluorine inside, but in this case, methyl is outside and overlaps poorly with the 
double bond. However, for transition states leading to the 4-substituted regioisomer, 
an inside fluorine is destabilising due to electrostatic interactions with the oxygen of 
the 1,3-dipole (transition states G and J), and the sense of selectivity is reversed. The 
lowest energy transition state, from which the syn product is formed (K) has fluorine 
outside, pointing away from the 1,3-dipole and methyl anti in good overlap with the 
dipolarophile double bond. These transition states are in good agreement with the 
above data. 
 
Scheme 33 
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derived from oximes 77 with homoallylic alcohol 78 in the presence of a metal 
counterion (Scheme 34).63 
  
Scheme 34 
Houk has proposed transition states to account for this selectivity, which are based on 
the inside alkoxy model (Scheme 35).64 Reactions with and without a chelating 
magnesium atom between the two oxygens were compared. For both, the lowest 
energy transition state had the alcohol in the outside position and the methyl group 
anti. This leads to the anti isoxazole product as observed. In the non-chelation case, a 
hydrogen-bonding interaction between the 1,3-dipole oxygen and the homoallylic 
alcohol was observed. The next lowest transition state, which leads to the syn product 
was destabilised by 1 kcal/mol. For the chelated transition state, the lowest syn 
transition state was destabilised relative to the lowest energy anti transition state by 3 
kcal/mol; consistent with the observed selectivities. Conformations placing the 
magnesium ether in an inside arrangement were further destabilised by around 7–8 
kcal/mol. For both cases, hydrogen-bonding or chelation withdraw electron density 
from the 1,3-dipole, contributing to electron deficiency in the transition state. Thus, it 
is important that the methyl group lies in the anti position, in hyperconjugation with 
the olefin, which is even more electron deficient in this reaction compared to 
cycloadditions of chiral allylic ethers. Similar chelation models have been reported 
for allylic alcohol substrates.65 
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Only a very small section of the literature on [3+2] cycloadditions has been discussed 
here, and acyclic stereocontrol is certainly not limited to nitrile oxide additions to 
olefins with adjacent stereocentres. There are many other examples of 
diastereoselective [3+2] cycloadditions that are beyond the scope of this review. As a 
representative example, Padwa has reported acyclic stereocontrol in the rhodium-
catalysed [3+2] cycloaddition of isomünchone dipoles with a variety of dipolarophiles 
(Scheme 36).66 The conformation of the acyclic amide substituent of 81 determined 
the sense of diastereoselectivity,67 with the hydrogen eclipsing the oxonium of the 
1,3-dipole to minimise 1,3-allylic strain. Attack of the electrophilic dipolarophile 
occurred on the most electron rich face of the 1,3-dipole. This effect, discussed by 
Kahn and Hehre,68 is also observed in [4+2] cycloadditions. 
 
Scheme 36 
 
1.4.2 [4+2] Cycloadditions 
Similarly well investigated and modelled are [4+2] cycloadditions; particularly the 
Diels–Alder and hetero-Diels–Alder reactions.69 Electrostatic interactions between the 
diene and dienophile have been shown to play an important role (cf. Scheme 36 
above). Diels–Alder reactions of electron-rich dienes and electron-poor dienophiles 
should occur preferentially onto the more nucleophilic diene face, and onto the face of 
the dienophile which exhibits greater electrophilicity (Scheme 37).68  
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Scheme 37 
Houk has suggested an inside alkoxy-type effect (which has an electrostatic 
component) to explain the stereoselective reactions of chiral allylic alcohols and 
ethers 83 with highly electron-deficient hexachlorocyclopentadiene 84, which is in 
good agreement with experimental data.70 In the analogous sense to [3+2] 
cycloadditions of nitrile oxides with chiral allylic ethers, the alkoxy group lies inside, 
avoiding electrostatic interactions with chlorine, while the alkyl group prefers anti 
alignment with the olefin (Scheme 38). 
 
Scheme 38 
Like [3+2] cycloaddition reactions of nitrile oxides with chiral allylic fluorides, 
Diels–Alder reactions of chiral allylic fluorides can be described by the inside alkoxy 
model.71 Grée et al. studied the Diels–Alder reactions of allylic fluorides 86 with 2,3-
dimethyl-1,3-butadiene 87 (Scheme 39, Table 8). Where observed (entries 2 and 3), 
selectivities were in the inside fluorine sense. The reaction was unselective when a 
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Scheme 39 
Table 8 
Entry R X Yield (%) Ratio 88 : 88’ 
1 Me CN 40 50 : 50 
2 Me COPh 85 76 : 24 
3 tBu COPh 90 81 : 19 
 
Acyclic stereocontrol in the intramolecular Diels–Alder (IMDA) reaction has also 
been of recent interest.72 The reaction can be controlled by stereocentres adjacent to 
the dienophile moiety. Sherburn studied the IMDA reactions of various ascorbate-
derived substrates 89. The level of selectivity varied greatly with the group P. Based 
on computational studies, a model was proposed to account for these selectivities, 
which is in agreement with both the inside alkoxy and Kahn/Hehre models (Scheme 
40, Table 9). 
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Table 9 
Entry P RE RZ t (h) Yield (%) Ratio  
90 a : b : c : d 
1 H H CO2Me 5 86 56 : 32 : 8 : 4 
2 TMS H CO2Me 12 67 80 : 14 : 4 : 2 
3 TBS H CO2Me 15 80 86 : 9 : 4 : 1 
4 TIPS H CO2Me 18 68 92 : 7 : 1 : 0 
5 PNB H CO2Me 12 95 49 : 39 : 6 : 6 
6 TBS CO2Me H 53 62 12 : 3 : 82 : 3 
 
1.4.3 [3,3]-Sigmatropic rearrangements 
Numerous examples have been reported of acyclic stereocontrol in the Claisen 
rearrangement.  A complete discussion of this area and the models for observed 
selectivity is given in Section 2.1, as it is directly relevant to our work in this area. 
However, in addition to the Claisen rearrangement, acyclic stereocontrol has also 
been reported in the related Overman rearrangement.73 Chida reports an example of 
such a reaction during the synthesis of (+)-lactacystin.74 Trichloracetimidate 91 
underwent rearrangement upon heating in toluene to give the product 92 with good 
diastereoselectivity. The product is derived from a transition state that shares many 
common features with those of Claisen rearrangement, in particular the antiperiplanar 
alignment of the incipient C—N and furanose C—O bonds (Scheme 41). 
 
Scheme 41 
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O/π*C=C overlap, which contributes to overall lowering of the LUMO. As shown by 
the complete syn selectivity in the rearrangement of Z-allylic substrate 96, 1,3-allylic 
strain is a component of this model (Scheme 42). 
 
Scheme 42 
Other examples have been reported of acyclic stereocontrol in similar [2,3]-Wittig 
rearrangements, and the above model explains these well.76 More recently, Davies has 
reported stereoselective [2,3]-sigmatropic rearrangements of lithium N-benzyl-O-
allylhydroxylamides.77  The substrates studied possessed both all-hydrocarbon 
stereocentres 97 and heteroatom-bearing stereocentres 99/101. In the latter case, both 
E- and Z-configured substrates were compared. All substrates underwent 
rearrangement to give the syn product. For all-hydrocarbon stereocentres, this can be 
explained using the same transition state model as Brückner, with attack of the anion 
antiperiplanar to the phenyl group. For heteroatom-bearing stereocentres, this model 
predicts the opposite anti product, and a chelation transition state was proposed to 
explain formation of the syn product (Scheme 43). 
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Scheme 43 
 
1.4.5 Conclusions 
The models presented for describing acyclic stereocontrol in pericyclic reactions have 
seen less recent development compared to those for acyclic stereocontrol in additions 
to carbonyls and double bonds. However, for both [3+2] and [4+2] cycloadditions the 
patterns of stereoselectivity are well defined. The inside alkoxy model developed by 
Houk is widely applied. The model holds well for other heteroatomic groups, 
particularly fluorides. Exceptions to the rule occur when chelation or hydrogen-
bonding interactions are possible between the heteroatom on the stereocentre and the 
approaching reactant. Although models have been proposed that explain [3,3]- and 
[2,3]-sigmatropic rearrangements, there are comparatively few examples in the 
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literature. In common with reactions of C=C double bonds adjacent to a stereocentre, 
1,3-allylic strain is an important factor in influencing acyclic stereocontrol. 
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1.5 Reactions adjacent to a metal stereocentre 
 
In addition to reactions of functional groups adjacent to carbon or sulfur stereocentres, 
acyclic stereocontrol is also possible for reactions of prochiral organic ligands on 
organometallic complexes. Widely explored in this sense are tricarbonyliron 
complexes. The subject has been comprehensively reviewed by Cox and Ley.78 A 
diene tricarbonyliron complex exhibits planar chirality. If the diene ligand contains an 
adjacent functional group, for example in 103 a carbonyl group, this may adopt a 
preferred reactive conformation with its two diastereotopic faces sterically 
differentiated by the tricarbonyliron moiety.79 S-cis and s-trans conformations of 104 
are possible, but the latter is disfavoured by 1,3-allylic strain. Attack of approaching 
nucleophiles occurs anti to the bulky tricarbonyliron moiety. Aldehydes react with 
lower diastereoselectivity due to the diminished interaction of the diene with the 
aldehydic hydrogen reducing the level of 1,3-allylic strain in the s-trans conformation 
(Scheme 44). Similar methodology has recently been used for the synthesis of 2-
dienyl piperidines80 and for controlling the sense of intramolecular pinacol 
couplings.81 Other stereogenic iron complexes have been used to attain acyclic 
stereocontrol: substituted diphosphaferrocenes have recently been reported to control 
the sense of addition of phosphorus82 and organometallic83 nucleophiles to an adjacent 
aldehyde. 
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This chemistry is not limited to iron complexes; tungsten-syn-π-pentadienyl 
complexes have been used to effect acyclic stereocontrol in the preparation of 
adjacent 1,3-diols. The Lewis-acid promoted Prins reaction of the tungsten complex 
106 with an aldehyde affords a η4-trans-diene cationic intermediate 107, which 
undergoes hydrolysis with water anti to the bulky complex (Scheme 45).84 This class 
of reaction is emerging as an interesting new area for investigations into acyclic 
stereocontrol. 
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1.6 Summary 
 
Recent developments in models for acyclic stereocontrol have been discussed in the 
context of three important classes of organic reaction and some recent organometallic 
reactions. For additions of nucleophiles to carbonyls with an adjacent stereocentre, 
both computational and experimental evidence have challenged the predominance of 
the Felkin–Anh and Cram models for predicting stereoselectivity. Various models for 
describing electrophilic and nucleophilic addition to double bonds have been 
proposed that account for variations in selectivity. However, these are often very 
specific to each particular reaction. In some cases, the major product arises from a 
seemingly high-energy transition state, for example in examples of the inside-methyl 
effect. Above all, 1,3-allylic strain appears to be the most important control element 
in reactions of C=C double bonds adjacent to a stereocentre. Many of the same 
models have been extended to explain acyclic stereocontrol in pericyclic reactions. In 
these cases, both stereoelectronic effects, again 1,3-allylic strain in particular, and 
electrostatic effects must be taken into account. Stereoselective reactions of 
unsaturated functional groups adjacent to organometallic complexes are also 
emerging as useful tools for establishing acyclic stereocontrol. 
Taking into account the above examples, some general conclusions can be drawn. 
There is no unified theory that explains all modes of acyclic stereocontrol. Rather, it 
appears that models are very specific to the individual reaction mechanism and the 
nature of the incoming electrophile or nucleophile must be considered. Additional 
complexity is encountered when stereoselectivity is a function of both acyclic and 
cyclic stereocontrol (double diastereoselection). These cannot be considered in 
isolation and models must take into account interactions between cyclic and acyclic 
transition states. Developments in computational methods have contributed to our 
ability to predict the sense of acyclic stereocontrol, although exceptions to these 
predictions are often encountered in experiment. Development of models and methods 
for establishing acyclic stereocontrol remains a highly active area of interest in 
synthetic chemistry. 
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2.1 Background 
 
2.1.1 Historical background 
The sigmatropic rearrangement of allyl phenyl ether 109 to give ortho-allyl phenol 
110 was first reported by Claisen in 1912.85 The paper contained an additional report 
of a rearrangement of O-allylated ethylacetoacetate 111 to 112; a reaction that is now 
generally referred to as the aliphatic Claisen rearrangement. The reaction, containing 
two π2s components and one σ2s component is thermally allowed under Woodward–
Hoffmann rules,86 whether it proceeds via a chair or boat transition state (Scheme 46). 
  
Scheme 46 
Nearly a century later, the Claisen rearrangement has become a well-established and 
general method for the synthesis of γ,δ-unsaturated carbonyl compounds.87 When the 
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Nevertheless, the stereochemical patterns governing the rearrangement are similarly 
well investigated. This statement is more appropriate for cases when substituents are 
bound directly to the pericyclic array. Explanations of stereoselectivity are generally 
rationalised by considering well-defined transition state models.88 
In addition to the case previously shown, in which the relative geometries of the 
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reported 1,3-transfer of the ether stereocentre in the reaction of 113 (Scheme 47).89 As 
we have previously defined, this represents cyclic stereocontrol. 
 
Scheme 47 
 
2.1.2 The effects of exopericyclic stereocentres: acyclic stereocontrol 
Less investigated has been the manner and extent to which stereocentres outside of 
the pericyclic array – which we shall refer to as ‘exopericyclic stereocentres’ – affect 
the stereochemistry of the new bonds formed during the sigmatropic process. This 
represents acyclic stereocontrol. In a generic ketene acetal Claisen precursor 115  
(Scheme 48), 1,2-induction of the newly formed C1—C6 bond via acyclic 
stereocontrol is possible when stereocentres are positioned adjacent to the C1 and C5–
6 positions. This area has been previously reviewed in the context of the Ireland–
Claisen rearrangement,87a and asymmetric [3,3]-sigmatropic rearrangements90 and 
although many of the same examples are cited, it is important that we highlight them 
here. During the rearrangement C4 becomes, and C5 remains, sp2-hybridised, and 
although stereocentres adjacent to these positions can affect stereochemistry in a 
similar sense,91 it is beyond the scope of this work. 
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2.1.2.1 Effects of stereocentres adjacent to C1 
Yamazaki92 and Martin93 have shown examples of C1 exopericyclic stereocontrol 
using trifluoromethyl and CO2Bn substituents respectively (Scheme 49). In both 
cases, the observed stereoselectivity is rationalised by invoking the Cieplak model in 
which attack occurs antiperiplanar to the more electron rich C—C σ bond. This 
allows for hyperconjugation between the C—R (or C—cyclopentyl) groups and the 
electron-deficient σ* orbital of the incipient C1—C6 bond. In the Yamazaki example, 
isosteric iPr and CF3 substituents on 117 were used to remove steric bias from the 
transition state model. Replacement of the CF3 group by methyl gave significantly 
reduced selectivity.94 Although deriving from different effects, this corresponds to 
reaction in the same sense as predicted by the Felkin–Anh model.95 Similar examples 
that occur in a Cieplak sense have been reported by Knight.96 Other examples have 
been described of Johnson–Claisen rearrangements with chiral ortholactones, 
although the selectivity in these processes is controlled by the relative energies of 
chair and boat transition states.97 
 
Scheme 49 
Attack in the opposite (non-Cieplak, anti-Felkin) sense has been reported by 
Fujisawa98 and Fleming (Scheme 50).112 In these examples,99 attack occurs 
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eclipsing the vinylic double bond to minimise 1,3-allylic strain: a reactive 
conformation that is commonplace in examples of C6 exopericyclic stereocontrol vide 
infra. 
 
Scheme 50 
In addition to rearrangements with carbon stereocentres, C1-sulfur substituents have 
been used for exopericyclic stereocontrol. The first reactions of this type were 
reported by Metzner, in which thioketene acetals 128 underwent thio-Claisen 
rearrangement to give thioesters 129 in very high diastereoselectivity (Scheme 51).100 
The transition states proposed to account for the sense of the selectivity were derived 
from the original Felkin model in which the best donor (in this case the sulfur lone 
pair) is placed antiperiplanar to the incipient bond. The oxygen is the smallest 
substituent and eclipses the ketene acetal (cf. hydrogen eclipsing in the above 
examples). Both E- and Z-transition states lead to the same product. Similar examples 
have been reported from our own laboratories in which C1-sulfoximine stereocentres 
are used for exopericyclic stereocontrol.101 Recently, we have used this methodology 
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for the stereoselective formation of cyclopropanes via decarboxylative Claisen 
rearrangement (dCr).102 
 
Scheme 51 
 
2.1.2.1 Effects of stereocentres adjacent to C6 
The earliest examples of exopericyclic stereocontrol adjacent to C6 used C6’ 
dioxolane substituents. Syn-selective Ireland–Claisen rearrangements of 130 were 
reported by Cha,103 with variations in allylic E/Z geometry and C1 substituent 
(Scheme 52, Table 10). The transition states proposed to account for the selectivity 
follow a similar pattern to those described for rearrangements with C1 
stereocentres.104 In this case the vinylic portion of the ketene acetal attacks 
antiperiplanar to the dioxolane C6’—O bond in the conformation where the C6’—H 
bond eclipses the allylic moiety. Similar, although significantly less selective 
Johnson–Claisen rearrangements featuring C6’ dioxolane substituents have also been 
reported by Suzuki105 and Takano.106 
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Scheme 52 
 
Table 10 
Entry E/Z R Yield (%) Ratio 131a : b : c : d 
1 E H 54    1 : 1.3 
2 E OCH3 59 4.4 : 1 : 0.2 : 0.3 
3 E OCH2OCH3 50 4.0 : 1 : 0.3 : 0.2 
4 E OBn 48 4.2 : 1 : 0.3 : 0.1 
5 Z H 50    1 : 1.4 
6 Z OCH3 48 0.5 : 0.3 : 9 : 1 
7 Z OCH2OCH3 51 0.1 : 0.2 : 1 : 0.2 
8 Z OBn 56 0.3 : 0.3 : 5 : 1 
 
Notable in this case is the slight increase in selectivity upon changing the allylic 
geometry from E to Z, which is consistent with an allylic strain model; and the 
significantly reduced selectivity in the absence of a C1 substituent. Similar 
rearrangements have been rationalised in terms of Houk’s inside-alkoxy rule although 
the sense of selectivity is the same107, 108 
Highly diastereoselective rearrangements, in the same sense as those described by 
Cha and others above have been reported with C6’ nitrogen substituents. Hauske109 
and Mulzer110 studied the Ireland–Claisen rearrangements of the BOC-protected 
valine- and proline-derived substrates 132 and 134 respectively (Scheme 53). 
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Scheme 53 
Two complementary explanations were for the high stereoselectivity were provided 
by Mulzer. The proposed transition state features, in common with other examples, 
antiperiplanar alignment of the C6’—N and the incipient C1—C6 bond, with the 
proline residue positioned in such a way that minimises 1,3-allylic strain. An 
additional explanation is given according to the model of Kahn and Hehre68 (modified 
for the Claisen rearrangement) in which the most electrophilic face of the allylic 
moiety approaches the most nucleophilic face of the vinylic moiety.111 The energy of 
the allylic LUMO is lowered via mixing of σ*C6’—N and π*C=C orbitals, while the 
vinylic π orbital (HOMO) is raised in energy by the two electron donating OTMS and 
OBn residues. Overall, this leads to a strong HOMO-LUMO interaction, lowering the 
activation barrier of the rearrangement. 
Fleming, in the same report that presented the effects of C1’ silicon stereocentres, also 
investigated the effects of C6’ silicon stereocentres (Scheme 54).112 Attack of the 
vinylic moiety antiperiplanar to the silicon substituent is maintained in all cases. 
Evidence for 1,3-allylic strain as a control element was shown by the high selectivity 
of Z substrates. The isomeric E substrates underwent rearrangement with moderate 
selectivity for the opposite diastereomer, which arises from a reactive conformation in 
which the methyl group is ‘inside’. Calculations showed this conformation to be more 
populated than the alternative in which the hydrogen is ‘inside’.  This conformation is 
accessible in the absence of significant 1,3-allylic strain effects.127 
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Scheme 54 
Thio-Claisen rearrangements have also been used to study the effects of C6’ 
stereocentres.113 In particular, numerous examples of exopericyclic stereocontrol from 
C6’ substituents in Belluš–Claisen114 (ketene Claisen) rearrangements of allylic 
sulfides have been reported, which follow the established patterns.115 The aza-
analogues of these reactions have also been investigated and reduced selectivity was 
reported for rearrangements lacking a C1 substituent on the pericyclic array (Scheme 
55).116  During the course of our studies, an additional example of a thio-Claisen 
rearrangement in the same sense was reported by Porter.117 
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Scheme 55 
Recent work in our own laboratories, in the context of the decarboxylative Claisen 
rearrangement reaction has stimulated our interest in this area.118 Esters 146–148, 
when treated with a silylating agent and sub-stoichiometric quantities of acetate 
underwent Claisen rearrangement followed by concomitant desilylation and 
decarboxylation to give the homoallylic sulfones 149–151 in varying 
diastereoselectivity (Scheme 56). Although the sense of selectivity was not assigned, 
we were interested in the variable selectivities and particularly in the effect of 
changing the heteroatom. 
R' XR
Cl2C XR
O
R' R'
XR
O
Cl
Cl
X = O, S, NR
O
XRR'
Cl Cl
Cl2C=C=O
[3,3]
R'
XR
Cl
Cl
O
O
SiPr
Cl Cl
OTBDMS
Me
O
Me
TBDMS
CCl3COCl, Et2O, Zn/Cu
40 °C (87%)
dr > 94:6
O
SiPr
Cl Cl
NTsBn
Me
N
Me
CCl3COCl, Et2O, Zn/Cu
40 °C (89%)
Ketene Claisen rearrangement:
SiPr
SiPr
dr = 90:10
Allylic thioethers:
Allylic amines:
SiPr
O
Cl
Cl
H
Me
X
‡
via
TsBn
OTBDMS
Me
N
O
N
O
Me
TBDMS Me
dr = 15:1
CH3CH2COCl, K2CO3
Me3Al, CH2Cl2 (73%)
138 139
140 141
143142
144 145
Results and Discussion 
 
 
 
 66 
 
Scheme 56 
 
2.1.3 Focus of the current work 
The work presented herein covers two areas.  Firstly, concentrating exclusively on 
Claisen rearrangements with C6’ stereocentres, we have performed investigations into 
the importance of the exopericyclic heteroatom in determining selectivity. We have 
also investigated in depth the relationship between allylic substitution pattern and 
stereoselectivity. 
Secondly, drawing on our own evidence and that already presented in the literature, 
we have attempted to exploit exopericyclic stereocontrolled Claisen rearrangements 
for the synthesis of synthesis of small, stereochemically complex molecules. During 
investigations into the effects of C6’ azide stereocentres, we have uncovered a novel 
reaction in which equilibrating mixtures of allylic azides undergo Claisen 
rearrangements with exopericyclic stereocontrol. 
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2.2 Effects of hydrocarbon substituents 
 
2.2.1 Background 
As an initial investigation, we decided to study the effects of C6’ hydrocarbon 
exopericyclic substituents on stereoselectivity (Scheme 57). This is relatively poorly 
explored in the literature, compared to rearrangements where the exopericyclic 
substituents are heteroatomic. 
 
Scheme 57 
Numerous different variants of the Claisen rearrangement have been used in 
preceding studies. Most attractive to us was the Johnson orthoester variant.119 
Treatment of an allylic alcohol 152 with an orthoester and sub-stoichiometric acid 
generates a ketene acetal 153 in situ with loss of ethanol, which can undergo Claisen 
rearrangement to give either of the esters syn- and/or anti-154. The lack of 
substitution at C1 removes the complication of setting a third stereocentre. Relative 
control of the C1 and C6 stereocentres is difficult to attain in the Johnson–Claisen 
rearrangement when a higher homologue of the orthoester is used, caused by rapid 
E/Z ketene acetal isomerisation.120 This should be taken into account if the process is 
extended to control more than one stereocentre. 
Various orthoesters and acid catalysts have been used in the Johnson–Claisen 
rearrangement.87a In our case, we chose triethyl orthoacetate as the orthoester, which 
was used as the solvent, and propionic acid as catalyst.  These conditions remained 
constant throughout our studies. 
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2.2.2 Synthesis and rearrangement of allylic alcohols 
Our strategy for the synthesis of allylic alcohols followed the previous example of 
Cha,103 in which aldehydes bearing an adjacent stereocentre were subjected to Wittig 
olefination to give the α,β-unsaturated ester, which in turn was reduced to the 
corresponding allylic alcohol using DIBAL-H. A variety of alkyl groups of increasing 
size were chosen as the group R. Both aliphatic and branched alkyl groups were 
studied. Phenyl substituents were also investigated. α,β-Unsaturated ester 
intermediates 158a and 158f were prepared by Horner–Wadsworth–Emmons reaction 
of commercially available aldehydes.121 The preparation of non-commercially 
available aldehydes was attempted using the Levine method,122 in which Wittig 
olefination of a ketone 155 affords a methyl enol ether 156, which is in turn 
hydrolysed with perchloric acid to give the aldehyde 157. The volatility of enol ether 
and aldehyde intermediates 156 and 157 was problematic, and therefore we sought a 
method for the synthesis of α,β-unsaturated esters in which isolation of the 
intermediates was not required.  
To this end, Wittig reaction123 of a representative set of ketones afforded the enol 
ethers 156b–e and 156g as solutions in diethyl ether. As a heterogeneous alternative 
to perchloric acid for the hydrolysis, sulfuric acid supported on wet silica gel was 
used,124 affording a dichloromethane solution of the aldehyde 157 after removal of the 
silica gel by filtration. To this solution was added the phosphorane to afford esters 
158b–e and 158f. Reduction of the esters 158a–g with DIBAL-H77 afforded the 
corresponding allylic alcohols 152a–g  (Scheme 58, Table 11). The moderate yields 
of this process are attributed to the high volatility of the products. 
 
Scheme 58 
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Table 11 
Entry R1 R2 Yield of 
158 (%) 
Yield of 
152 (%) 
a Me Et 72 30 
b Me cyclopropyl 7 96 
c Me cHex 37 83 
d Me nC5H11 22 35 
e Me tBu 15 66 
f Me Ph 80 20 
g Et Ph 24 44 
 
Exclusively E-configured esters were obtained by this method.  The isomeric Z-esters 
and allylic alcohols were not studied. Treatment of allylic alcohols 152a–g under 
Johnson–Claisen conditions afforded the γ,δ-unsaturated ester products 154a–g in 
high yield and widely ranging diastereoselectivity (Scheme 59, Table 12). 
 
Scheme 59 
Table 12 
Entry R1 R2 Yield (%) Ratio 
anti- : syn-154a 
a Me Et 98 50 : 50 
b Me cyclopropyl 89 50 : 50 
c Me cHex 91 83 : 17 
d Me nC5H11 98 50 : 50 
e Me tBu 67 67 : 33 
f Me Ph 99 68 : 32 
g Et Ph 99 68 : 32 
aDetermined by 1H-NMR analysis of crude reaction mixtures 
 
The structure of anti-154g was established by preparation of a derivative. Reduction 
(LiAlH4–Et2O) of the 68:32 mixture of diastereomeric products of Johnson–Claisen 
rearrangement of 152f gave a mixture of isomeric alcohols 159, which were separated 
and converted into the corresponding 3,5-dinitrobenzoyl esters 160 by treatment with 
3,5-dinitrobenzoyl chloride–TEA (Scheme 60).125 The anti stereochemistry of the 
major diastereoisomer anti-160 was assigned by X-ray crystallography (see 
Appendix).126 The same anti stereochemistry was inferred for the major products of 
Johnson–Claisen rearrangement 154c and 154e–f. 
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Scheme 60 
As shown previously, the stereoselectivity in the Johnson–Claisen rearrangement of 
152c and 152e–g, can be rationalised by invoking a modified Felkin–Anh model in 
which the C=O group is replaced with the allylic portion of the ketene acetal 153 
(Scheme 61). Such a model has been used to describe explain the diastereoselectivity 
of conjugate organocuprate addition to γ-alkyl-α,β-unsaturated esters.127 
Rearrangement is more likely to occur through the staggered conformation of the C6’ 
stereocentre in relation to the 6-membered chair transition state and the major product 
arises from transition state A, in an example of the ‘inside methyl’ effect.36 Such 
transition states are easily accessible in E-configured systems. This is also the product 
that would be predicted by the Felkin–Anh model. However, the generally moderate 
selectivity points to a low difference in energy between transition states A and B. 
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2.3 The relationship between the heteroatom and stereoselectivity 
 
2.3.1 Background 
In comparison with literature examples of Claisen rearrangements where the C6’ 
stereocentre bears a heteroatomic substituent, selectivities in the Johnson–Claisen 
rearrangements of 152a–g are non-existent or low. The next phase of our study 
concentrated on rearrangement of substrates where the exopericyclic stereocentre 
bears a heteroatomic substituent. The role of the heteroatom is clearly apparent from 
studies of Claisen rearrangements of dioxolanes and proline derived systems shown 
above. The syn product generally predominates, its formation explained in terms of 
favourable antiperiplanar alignment of the C—X and incipient C—C bond in the 
reactive conformation, with the allylic exopericyclic C—H bond eclipsing the 
adjacent C=C bond. 
From examination of the literature, exopericyclic oxygen, nitrogen and silicon 
substituents appear well studied. Relatively unexplored, however are the effects of 
exopericyclic halogen groups, We decided to investigate the effects of exopericyclic 
fluorine substituents, inspired both by the analogous Diels–Alder studies of Grée71 
and also Evans’ computational studies of aldol reactions of boron enolates18 (see 
Section 1). Additionally, since Evans showed a change from Cornforth to Felkin–Anh 
models upon reducing the electronegativity of the heteroatom, we decided to perform 
a similar study into the comparative effects of exopericyclic (C6’) thiophenyl 
substituents.  
 
2.3.2 Preparation and rearrangement of γ-fluorinated allylic alcohols 
We anticipated that the required fluorinated allylic alcohol 166 could be prepared by 
reduction of the corresponding γ-fluoro-α,β-unsaturated ester 165. A synthesis of 165 
from methyl lactate has been reported by Grée,71 in which fluorine is introduced by 
dehydroxyfluorination of the γ-hydroxy-α,β-unsaturated ester 164. 
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Scheme 62 
In our case, we chose the more acid-stable TBDPS group for protection of (S)-methyl 
lactate.128 Treatment of the product 161 with DIBAL-H afforded the O-protected 
aldehyde 162, which was subjected to Wittig reaction to afford the O-protected α,β-
unsaturated ester 163.129 Deprotection was attempted with both acetic acid and 
hydrochloric acid, but the reaction was very slow. Instead, TBAF130 was used to 
deprotect the alcohol, affording the desired γ-hydroxy-α,β-unsaturated ester 164. 
Racemisation of 164 occurred under these conditions, though this was inconsequential 
as the enantiopure compound was not required. Dehydroxyfluorination131 of 164 
mediated by DAST gave 165 in excellent yield, without the need for purification. 
However, reduction of 165 to the corresponding allylic alcohol 166 could not be 
achieved using either DIBAL-H or lithium aluminium hydride. Only low yields of 
unidentifiable decomposition products were observed (Scheme 62). 
Considering that 166 was likely to be relatively volatile at atmospheric pressure we 
prepared the higher homologue, exchanging the terminal methyl group for an n-pentyl 
chain. From earlier experiments, we predicted that this alteration would have no effect 
on the stereoselectivity of Johnson–Claisen rearrangement of the target allylic alcohol 
179. 
The homologous γ-hydroxy-α,β-unsaturated ester intermediate 172 was prepared 
using an additive Pummerer-type strategy developed in our own laboratory (Scheme 
63).132 Isopropyl benzenesulfinate 168 was prepared from sodium benzenesulfinate 
167 and subjected to a one-pot Horner–Wadsworth–Emmons procedure to afford the 
vinyl sulfoxide 169 in good yield. Addition of trifluoroacetic anhydride to 169 
effected the Pummerer rearrangement to give 170 in excellent yield, without the need 
for purification. Base-catalysed methanolysis of 170 gave the lactide 171, which was 
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shown by mass spectrometry to exist as a mixture of the monomer, dimer and trimer. 
Finally, Wittig reaction of 171 in refluxing benzene afforded ester 172. 
 
Scheme 63 
In contrast to 164, dehydroxyfluorination of 172 gave a mixture of products. In 
addition to the desired γ-fluoro compound 173, the isomeric product 174 and the 
eliminated product 175 were observed (Scheme 64).  
 
Scheme 64 
A mechanism was proposed to explain the formation of the rearranged side product 
174 (Scheme 65). It is presumed that the first step of this reaction is in common with 
the first step of the DAST dehydroxyfluorination mechanism133 involving formation 
of an O—S bond.  1,4-Attack of the liberated fluoride on the enoate system 176 gives 
the ester enolate 177 which, through ring closing expulsion of the 
diethylaminodifluorothiolate group generates the fluorinated cyclopropane 178. 
Collapse of 178, followed by double bond isomerisation gives the side product 174.  
The E-stereochemistry of the olefin was confirmed by NOESY-NMR. 
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Scheme 65 
This mechanism relies on the ability of fluorine to act as a π-donor (even though it is 
strongly σ-withdrawing); a property exhibited in the ortho/para-directing nature of 
fluorine in electrophilic aromatic substitution134 and shown by the reported upfield 
1H-NMR shifts of the allylic protons Hx in fluoroolfefins (Scheme 66).135 
 
Scheme 66 
The elimination product 175 was inseparable from 173 by both chromatography and 
distillation; although as it was only produced in small quantities, the mixture was 
carried through to the next step. We propose that the product forms via an 
intramolecular elimination of the intermediate 176 (Scheme 67). 
  
Scheme 67 
Reduction of 173 was attempted using DIBAL-H and lithium aluminium hydride, 
although, similarly to reactions of 165, only decomposition products were observed. 
Analysis of the decomposition product showed no signals in the 19F-NMR spectrum. 
Instead, 179 was prepared by saponification of 173 to give 180, followed by sodium 
borohydride reduction of the corresponding mixed anhydride 181 (Scheme 68).136 The 
allylic alcohol 179 was used in the next step directly following purification.  Samples 
of 179 decomposed to an intractable tar overnight, even when refrigerated. 
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Scheme 68 
Johnson–Claisen rearrangement of 179 afforded a 50:50 mixture of syn- and anti-182 
(Scheme 69). This lack of selectivity stands in contrast to that observed in the 
rearrangements of the proline- and dioxolane-containing substrates reported by 
Mulzer110 and Cha103 respectively. The lower yield for this substrate was attributed to 
its poor stability. 
 
Scheme 69 
 
2.3.3 Preparation and rearrangement of γ-thiophenyl allylic alcohols 
The Johnson–Claisen rearrangement of the analogous γ-thiophenyl allylic alcohol was 
then investigated. The previously prepared ester 164 was treated with 
methanesulfonyl chloride to give methanesulfonate 183, which was treated with 
sodium thiophenolate to give ester 184a. DIBAL-H reduction of 184a using the 
procedure of Bach147a afforded 185a (Scheme 70). Other routes towards substrates of 
this type have been reported, and a full discussion of these is given later. Johnson–
Claisen rearrangement of 185a was high-yielding, but like rearrangement of 179, 
unselective. Rigorously degassed triethyl orthoacetate was required in this reaction to 
prevent the formation of S-oxidation products. 
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Scheme 70 
Considering the many previous examples in both nucleophilic and electrophilic 
addition to C=C double bonds, we predicted that the olefin substitution pattern would 
play a role in stereoselectivity. This remains comparatively poorly investigated for 
Claisen rearrangements,112 but we expected a priori that the Z-isomers would show 
enhanced selectivity for the syn product via a transition state in which 1,3-allylic 
strain was minimised (Scheme 71). Therefore, the behaviour of (E)- and (Z)-allylic 
alcohols in the Johnson–Claisen rearrangement were compared using the isomers of 
the thiophenyl- and fluoro- compounds 185a and 179 as substrates. 
  
Scheme 71 
Although no syntheses of (Z)-γ-fluoroallylic alcohols have been reported, the 
dehydroxylfluorination of terminally protected propargyl diols has been 
demonstrated.137 Additionally, fluoroalkynes undergo cis-selective hydrogenation to 
the corresponding fluoroolefin in the presence of Lindlar’s catalyst.138 We predicted 
that the required Johnson–Claisen substrate Z-179 could be prepared by such a route 
(Scheme 72). The carbanion of THP-protected propargyl alcohol 187139 reacted with 
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hexanal to afford alcohol 188,140 which was treated with Deoxofluor 
[(CH3OCH2CH2)2NSF3] (a more thermally stable alternative to DAST)141,131b to 
afford propargyl fluoride 189. The yield was moderate for this step, although no side 
products were identified. Hydrogenation of 189 afforded the protected allylic alcohol 
190 in high purity and yield, without the need for further purification. The reaction 
time was carefully controlled.  Longer times resulted in over-reduction to the fully 
saturated compound, which was inseparable from 190. Deprotection of the alcohol 
was attempted with CSA and PPTS. In both cases the product decomposed upon 
isolation. This result, in conjunction with studies on E-179 points to the poor stability 
of these compounds, though analysis by 1H-NMR of the decomposed material did not 
show the formation of a discrete product. We concluded that the fluorinated system 
above was too unstable for its behaviour in the Johnson–Claisen rearrangement to be 
studied. 
 
Scheme 72 
In light of this setback our attention turned towards looking at the behaviour of (Z)-
thiophenyl allylic alcohols in the Johnson Claisen rearrangement. We attempted to 
prepare the Z- configured allylic alcohol 185b via a route similar to that above 
(Scheme 73). Again, the monoprotected diol 191 was prepared from THP-protected 
propargyl alcohol 187. Ultrasound-assisted Mitsunobu reaction142 installed the sulfide 
192, which could not be reduced under Lindlar conditions. We attribute this to 
poisoning of the catalyst by the sulfide.143 Instead, diimide,144 generated in situ from 
decomposition of NBSH145 was used. Tracking of this reaction proved difficult, 
owing to the very low polarity of 192. Prior deprotection increased the polarity of the 
system, and the propargyl alcohol 193 was reduced to give 185b. Although yields 
were generally low and this is clearly an inefficient route, a sufficient quantity of 
185b was prepared for further investigation. 
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Scheme 73 
In contrast to 185a, Johnson–Claisen rearrangement of 185b gave a 91:9 mixture of 
products 186a in excellent yield. As expected, the reaction time was longer for the Z-
isomer146 (Scheme 74). In the same manner as before, the structure of the major 
diastereomer was established by the synthesis of a derivative.  
 
Scheme 74 
The 3,5-dinitrobenzoyl esters of the alcohols derived from Johnson-Claisen products 
186a were prepared in the same fashion as 160. The corresponding esters were 
obtained as a viscous liquid, and therefore it was not possible to prepare pure samples 
suitable for crystallographic analysis. Instead, hydrolysis of the 91:9 mixture of 
isomers 186a gave a mixture of isomeric acids 196, which were converted to the 
corresponding highly crystalline 2,4-dinitroanilides 197 (Scheme 75). Separation of 
this mixture gave a pure sample of the major isomer syn-197, whose stereochemistry 
was assigned by X-ray crystallography (see Appendix). 
OTHP
OTHP
Me
OH
OTHP
Me
SPh
Me
SPh
OH
Me
SPh
OTHP
OH
Me
SPh
nBuLi, THF
–78 °C, 30 min
(85%)
(PhS)2, nBu3P, MeCN
ultrasound, rt, 1.5h  (90%)
PPTS (0.2 equiv)
EtOH, 55 °C, 14 h
(68%)
Me
SPh
OTHP
NBSH, TEA,
CH2Cl2, rt, 12 h
(55%)
NO2
HN
NH2
NBSH
NBSH, TEA,
CH2Cl2, rt
187 191
192 193
194 195
185b
Me
SPh
OH
Me
SPh
CO2Et Me
SPh
CO2Et
H3CC(OEt)3
C2H5CO2H
reflux, 24 h
(97%) syn-186a anti-186a
dr = 91:9
185b
Results and Discussion 
 
 
 
 79 
 
Scheme 75 
 
2.4 The effects of olefin substitution pattern on stereoselectivity 
 
2.4.1 Substrate synthesis 
Encouraged by the above result, we sought other examples of selectivity in this 
reaction. We decided to investigate the effects of larger (nC5H11) and branched (iPr) 
alkyl substituents on the stereoselectivity of the rearrangement. A route was required 
in which both the alkyl substituent and olefin geometry could be easily varied. The 
most commonly used route for synthesis of these compounds involves olefination of 
an α-sulfenyl aldehyde 200, followed by reduction of the resulting α,β-unsaturated 
ester 201 (Scheme 76).  The α-sulfenyl aldehyde itself is typically generated either 
from methyl lactate (Bach/Armstrong)147 or the sulfide 205 (Yadav).148 With the 
former, variation of the nature of the alkyl chain would be difficult.  
More recently, Armstrong has reported a route to both E- and Z-γ-sulfenyl-α,β-
unsaturated esters 201 by variation of the phosphonate anion.149 The α-sulfenyl 
aldehyde 200 was prepared in an organocatalytic, enantioselective fashion using the 
chemistry of Jørgensen.150 In the same pot (α-sulfenyl aldehydes racemised during 
purification over silica gel), use of triethyl phosphonoacetate in a Horner–
Wadsworth–Emmons reaction gave the E-γ-sulfenyl-α,β-unsaturated esters 201, 
while use of the Ando phosphonate151 gave the Z-isomers. DIBAL-H reduction of 
these esters would provide access to the required allylic alcohol substrates 185 and we 
chose to use a route of this type for our work. Other routes to compounds of this type 
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via radical isomerisation152 and Peterson153 olefination have also been reported, 
although these examples were deemed too specific for our work. 
 
Scheme 76 
As enantiopure substrates were not required we explored other methods of α-
sulfenylation of aldehydes. The reaction was optimised with the substrates 185a and 
185b, where R=Me was the ultimate targets. We did not attempt to reproduce the 
chemistry of Yadav148 for the synthesis of these intermediates. The preparation of α-
sulfenyl aldehydes by treatment of α-haloaldehydes with thiolates has been 
reported,154 and our attention turned to this method for the preparation of 204. 
Treatment of propanal with sulfuryl chloride afforded the α-chloroaldehyde 207a,155 
which existed in a stable oligomeric form at sub-ambient temperatures.156 Gentle 
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warming of the oligomeric material to room temperature revealed the monomeric 
aldehyde,157 which reacted with sodium thiophenolate, generated in situ from 
thiophenol and sodium hydride to afford the α-sulfenyl aldehyde 204a (Scheme 77). 
 
Scheme 77 
However, the isolated material decomposed, to some extent, to thiophenol, which 
quenched the phosphonate in the subsequent olefination reactions. Pre-washing of the 
aldehyde with sodium carbonate failed to alleviate this problem. We attempted a one-
pot sulfenylation/olefination approach similar to that of Armstrong. 
Reasoning that such a strong base as sodium hydride was not required for formation 
of the thiolate, we found that the α-chloroaldehyde 207a reacted rapidly at room 
temperature with triethylammonium thiophenolate in THF, generated in situ from 
TEA–thiophenol, to give a solution of 204a. The lower-temperature conditions for use 
of sodium hydride were not required. The solution of the α-sulfenyl aldehyde was 
filtered under nitrogen and added via cannula to a solution of the appropriate 
phosphonate anion. In common with Armstrong, use of triethyl phosphonoacetate in a 
Horner–Wadsworth–Emmons (HWE) reaction at 0 °C gave the E-γ-sulfenyl-α,β-
unsaturated ester 184a exclusively. Reaction with the anion of the Ando 
phosphonate151 at the lower temperature of –78 °C gave the esters 184b and 184a in a 
10:1 ratio respectively (Scheme 78). 
 
Scheme 78 
We extended this route to other substrates. The analogous chloroaldehydes were 
prepared using the organocatalytic method of Jørgensen;150b,158 207b using proline 
and 207c using prolinamide as the catalyst. Yields for the olefination were moderate, 
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although the reaction was easily scalable and sufficient material was prepared for 
further investigation (Scheme 79, Table 13). 
 
Scheme 79 
Table 13 
Entry Substrate R Phosphonate E/Z Yield (%) 
a 207a Me HWE E 47 
b 207a Me Ando Z 29 
c 207b nC5H11 HWE E 57 
d 207b nC5H11 Ando Z 73 
e 207c iPr HWE E 60 
f 207c iPr Ando Z 27 
 
During the synthesis of these substrates, particularly when the reaction time was 
extended, formation of the isomeric product 208 was observed as a 30:70 
(unassigned) mixture of E and Z stereoisomers, which was inseparable from 184. An 
NMR experiment suggested a base-catalysed mechanism for the formation of 208 
(Scheme 80, Table 14). The ratio of stereoisomers remained constant over time. 
  
Scheme 80 
Table 14 
Time Conversion to 208 (%) 
10 min 38 
1 h 67 
16 h 100 
 
Reducing the amount of base used for the olefination reaction, reduced the yield. The 
milder Masamune–Roush (DBU–LiCl) conditions for the synthesis of E-isomers121 
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and modified Ando (DBU–NaI) conditions151b for the synthesis of Z-isomers, might 
be used in future work.  
The esters 184a–f were reduced to the corresponding allylic alcohols 185a–f with 
DIBAL-H (Scheme 81, Table 15). Much lower (ca. 20%) yields were observed upon 
switching the chromatography eluent from TBME/heptane to ether/heptane, which 
may be related to the lower level of ether peroxides present in TBME. 
 
Scheme 81 
Table 15 
Entry R E/Z Yield (%) 
a Me E 71 
b Me Z 70 
c nC5H11 E 83 
d nC5H11 Z 60 
e iPr E 83 
f iPr Z 54 
 
2.4.2 Rearrangements of E- and Z-allylic alcohols 
Allylic alcohols 185a–f were subjected to Johnson–Claisen rearrangement conditions 
(Scheme 82, Table 16) to give 186a–c. The contrasting behaviour observed for 
185a,b was also observed with the geometric isomers 185c,d and 185e,f; yields were 
uniformly excellent. Reaction times followed the expected pattern, with the more 
hindered substrates undergoing rearrangement more slowly. In light of the results of 
the X-ray crystallography studies on 186b above, syn stereochemistry was inferred 
also for the major products of the Johnson–Claisen rearrangements of 185d and 
185e,f. 
 
Scheme 82 
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Table 16 
Entry Substrate R E/Z time 
(h) 
Product Yield 
(%) 
Ratio syn- : 
anti-186a 
1 185a Me E 7 186a 98 50 : 50 
2 185b Me Z 24 186a 97 91 :  9 
3 185c nC5H11 E 12 186b 98 50 : 50 
4 185d nC5H11 Z 48 186b 94 90 : 10 
5 185e iPr E 24 186c 93 60 : 40 
6 185f iPr Z 48 186c 87 90 : 10 
aDetermined by 1H-NMR analysis of the crude reaction mixture 
 
We rationalise the marked difference in behaviour of E- and Z-185 by comparison of 
the diastereomeric transition states A–D for the rearrangement (Scheme 83). In all 
cases there is antiperiplanar alignment of the C6’–SPh and incipient C1–C6 bond. For 
Z-185, the major product syn-186 arises from an orientation in which the C6’–H bond 
(transition state A) rather than the C6’–R bond (transition state B) eclipses the allylic 
C4–C5 double bond. For E-185, the corresponding allylic 1,3-interactions are 
between C5–H and the C6’–H (transition state C leading to syn-186) or C6’–R 
(transition state D leading to anti-186) bonds; the lesser steric bulk associated with 
C5–H compared to C4–C5 leads to lower selectivity for the E-substrates. This lack of 
discrimination is in contrast to that observed in the rearrangement reactions of 
analogous dioxolane- and proline-containing systems reported by Cha103 and 
Mulzer110 respectively, and taking into account the results presented in the next 
chapter, may be a consequence of the lack of substitution at C1 in our acetate-derived 
substrates. 
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Scheme 83 
 
2.4.3 Preparation and rearrangement of a trisubstituted allylic alcohol 
In light of the transition state analysis presented above an additional substrate was 
prepared and its Johnson–Claisen rearrangement investigated. We reasoned that 
rearrangement of an E-configured substrate possessing a substituent at C5 would be 
more selective than those of E-185, since, upon introducing an unfavourable 1,3-
diaxial interaction, there would be a disproportionately greater energy penalty 
associated with the transition state corresponding to D in Scheme 83, which leads to the 
anti product.  
The allylic alcohol 210 bearing an additional olefinic methyl group was prepared in 
the same manner as 185: addition of the α-sulfenyl aldehyde 204a to the anion of the 
appropriate phosphonate afforded ester 209, which was subsequently reduced with 
DIBAL-H to afford 210. Subjection of 210 to the previously established Johnson–
Claisen conditions gave in quantitative yield a 71:29 mixture of rearrangement 
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products 211 (Scheme 84). From prior evidence, we tentatively assigned the major 
product as the syn isomer. Additional evidence in support of this assignment is given 
by the similar rearrangements of azide-bearing systems shown later. This result is in 
contrast with those of Takano, who observed no selectivity increase in rearrangements 
of trisubstituted allylic systems.106 In summary, we have shown that in the case of C6’ 
thiophenyl substituents, the level of selectivity is highly dependent on the allylic 
substitution pattern. 
 
Scheme 84 
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2.5 Synthetic applications of exopericyclic control in Claisen rearrangements 
 
2.5.1 Background 
With reliable patterns of stereoselectivity emerging, we wished to exploit these effects 
in the synthesis of small molecules. We had shown the importance of a heteroatom-
bearing stereocentre in attaining stereoselectivity and now wished to explore reactions 
of the heteroatomic group. This section details our efforts in this area, concentrating 
on further transformations of rearrangement products. Also described is initial work 
on elaboration of the new olefin furnished by the Claisen rearrangement. 
We envisaged that oxidative cleavage of the olefin of 213 to give the corresponding 
aldehyde or ketone 214 would provide scope for further transformations of this 
system (Scheme 85). 
 
Scheme 85 
In particular, we became interested in Claisen rearrangements of allylic systems 
bearing nitrogenous exo-pericyclic stereocentres, envisaging that the Claisen 
rearrangement product 216 of a ketene acetal bearing an exopericyclic amine 215 
could be converted into the corresponding γ-lactam 217 (Scheme 86).  
 
Scheme 86 
Free amines are poorly tolerated by the Claisen rearrangement and prior examples of 
this reaction typically use protecting groups to overcome this problem. In our case, 
introducing the stereoelectronic complication of a bulky protecting group was 
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unattractive.  Instead, we decided to use the azide group as a surrogate amine, 
encouraged by its small steric profile and its potential for use in a wide variety of 
subsequent reactions.159 We quickly realised that this process would be complicated 
by a second rearrangement – that of the allylic azide itself; a reaction that has 
previously been viewed as a synthetic limitation of this functional group. 
 
2.5.2 Sigmatropic rearrangements of allylic azides 
The rearrangement of allylic azides was discovered in 1960, when Winstein and co-
workers found that treatment of γ,γ-dimethallyl chloride with sodium azide in acetone 
gave an equilibrating mixture of α,α-dimethallyl and γ,γ-dimethallyl azides.160 The 
rearrangement was rapid at room temperature, although the isomers could be 
separated by fractional crystallisation at –80 °C. Similar rearrangements of allylic 
diazides were observed by Heasley, who noted that tertiary and secondary allylic 
azides rearrange faster than primary allylic azides.161 A very small solvent effect on 
the rate of rearrangement was reported by Winstein; which, in addition to NMR 
studies by Closs indicates charge separation in the transition state.162 Nevertheless, the 
stereospecific nature of the rearrangement, as explored by Padwa,163 suggests a cyclic, 
concerted transition state and the reaction may be viewed as a [3,3]-sigmatropic 
rearrangement (Scheme 87). 
 
Scheme 87 
Allylic azides are generally obtained as thermodynamic mixtures. For acyclic allylic 
azides the rearrangement is rapid at room temperature, while cyclic allylic azides 
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often rearrange more slowly.164 The vast majority of allylic azides described in the 
literature exist as a single regioisomer in which the olefin is in conjugation with an 
aryne,172,165 carbonyl or nitrile.166 Recently, steric factors have been found to influence 
the equilibrium. 
Of key importance for our studies is the small class of reactions in which equilibrating 
mixtures of allylic azides are transformed into a single product. The earliest report of 
this reactivity mode is described by Danishefsky in the synthesis of N-
acetylactinobolamine.167 Osmylation of the mixture 218 and 219 occurred exclusively 
via the more nucleophilic glycal 219 to give 220 exclusively (Scheme 88). 
  
Scheme 88 
More recently, Sharpless and Fokin studied the behaviour of mixtures of allylic azides 
in the Cu(I)-catalysed cycloaddition with phenylacetylene and in MCPBA-mediated 
epoxidation reactions.168 The differences between primary, secondary and tertiary 
allylic azides were explored. Mixtures of primary and tertiary (221,222), and 
secondary and tertiary azides reacted selectively via the most reactive isomer (the less 
hindered azide, or the more electron-rich olefin), while dramatically reduced 
selectivity was observed with mixtures of primary and secondary azides 225,226 
(Scheme 89). Notably, in all but one example, the most abundant isomer of the 
mixture was also the most reactive. 
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Scheme 89 
 
2.5.3 Development of a tandem rearrangement process 
In light of these examples, we proposed a reaction in which a ketene acetal bearing an 
allylic azide 231 undergoes a pair of [3,3]-sigmatropic rearrangements via 232 to give 
the product 233 (Scheme 90). Conceptually related are the isomerisation-Claisen 
rearrangements most recently explored by Nelson et al.169 and other examples in the 
literature of tandem conjugate addition/enolate Claisen rearrangements.170 However, 
in these prior examples an isomerisation establishes the vinylic portion of the ketene 
acetal Claisen precursor. To the best of our knowledge, the studies presented herein 
represent the only example of isomerisation establishing exclusively the allylic 
portion of a ketene acetal.171 
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Scheme 90 
The work presented in this section describes our work into the development, scope 
and limitations of this reaction. We have continued to explore the stereochemical 
patterns previously discussed. 
 
2.5.4 Synthesis and initial rearrangements of allylic azidoalcohol substrates 
We decided to study this reaction using a Johnson–Claisen rearrangement of the 
mixture of allylic azidoalcohols 235a and 236a, which would be converted into the 
required mixture of equilibrating ketene acetals in situ. In particular, for this initial 
study we chose compounds bearing an n-pentyl chain, in order to reduce volatility and 
improve thermal stability.  A similar compound 235e, reported by Whitesides et al.172 
was prepared by reaction of oxirane 234e with sodium azide.  The oxirane was 
prepared by sulfur-ylide epoxidation of trans-cinnamaldehyde 237 (Scheme 91). 
 
Scheme 91 
Our initial attempts to form oxirane 234a from trans-2-octenal 238a under these 
conditions failed.  The oxirane was unstable to chromatography over silica gel and 
was difficult to separate from the DMSO reaction solvent by distillation.  Instead, 
234a was prepared via the chlorohydrin 239a (Scheme 92).173 Addition of 
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lithiochloromethane to 238a gave the chlorohydrin 239a, which was then converted 
into 234a by treatment with sodium hydride and sub-stoichiometric sodium iodide. 
When the precursor chlorohydrin was of high purity no purification of the oxirane 
was required, allowing its use directly in the next step.  Reaction of 234a with sodium 
azide in refluxing acetone/water gave a 73:27 (by 1H-NMR) mixture of 235a and 
236a respectively in good yield. The regioisomers were partially separable by column 
chromatography, although they equilibrated prior to analysis to give a mixture having 
the same ratio as the crude mixture.  Assignment of each isomer was performed using 
COSY and 15N-HMBC NMR techniques. Notably, the more abundant isomer 235a is 
that which requires a further isomerisation to participate in the Claisen rearrangement. 
 
Scheme 92 
To eliminate the possibility that the regioisomeric distribution was controlled by 
relative rates of 1,2- and 1,4-opening of the oxirane rather than an equilibration 
process, we studied the ring-opening of 234a with potassium cyanide, which could 
potentially give a mixture of the non-equilibrating allylic nitriles 240 and 241 
(Scheme 93).174  Although opening of the oxirane by water competed with opening by 
cyanide,175 only the 1,2-opening products 241 and 242 were observed. This indicated 
that in the reaction of 234a with sodium azide, the 1,2-product 235a is initially 
formed, followed by isomerisation via reversible sigmatropic rearrangement to give 
the observed mixture of regioisomers. The low yield may be attributed to the poor 
stability of the oxirane at elevated temperature over long periods of time. 
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Scheme 93 
The mixture of 235a and 236a was then treated under the Johnson–Claisen conditions 
used previously (Scheme 94). Complete conversion of the mixture was observed in 6 
h and the product was isolated in very high yield. This represents the first example of 
a reaction that discriminates between two acyclic secondary allylic azides. It is also 
the first example of any such transformation of allylic azides where the product arises 
from the significantly less abundant component of the equilibrium mixture.  
 
Scheme 94 
 
2.5.5 Attempts to develop a stereoselective rearrangement 
In the initial reactions described above, no stereoselectivity was observed, although 
this was not unexpected considering our previous investigations into the effects of 
olefin substitution pattern. Although we have shown that Z-allylic alcohols undergo 
selective Claisen rearrangements, we predicted that Z-allylic azidoalcohols might 
undergo olefin isomerisation during Winstein rearrangement. Given that the rate of 
Claisen rearrangement of an E-allylic system is faster than the Z-isomer,146 we 
predicted that equilibrating mixtures of Z-allylic azidoalcohols would undergo Claisen 
rearrangement with significantly reduced stereoselectivity. Thus, in the course of our 
studies into the scope and limitations of this process, our interest turned to other 
methods of attaining selectivity in the Claisen rearrangement of E-allylic alcohols. 
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Specifically, we wished to study trisubstituted allylic systems 244, which we 
predicted would favour the anti-Felkin product 3,3-syn-245 (Scheme 95). 
 
Scheme 95 
The generality of this tandem process was tested using variations of the R and R’ 
groups. Substrates were prepared by a general route, in the same manner as that 
reported by Whitesides172 (Scheme 96). Variations of the R group enabled the study of 
the relative effects of straight chain and branched alkyl groups, and this was examined 
both for R’=H and R’=Me where possible. In addition, we chose to explore the case 
where R=aryl, with regard to its effects on product distribution in both the Winstein 
and Claisen rearrangements. 
 
Scheme 96 
As shown above, where R=Ph the allylic azidoalcohol 235e exists as a single isomer 
which would require isomerisation to participate in the Claisen rearrangement. 
Aromaticity decreases across the series benzene>pyridine>furan176 so we proposed 
the series R=Ph, 2-pyridyl and 2-furyl to investigate the effects of lowering 
aromaticity, and therefore conjugative stabilisation of 235 on the system.  In doing so, 
we predicted that the barrier to isomerisation might be lowered, increasing the rate 
with which mixtures of these compounds undergo Claisen rearrangement. Conversely, 
we reasoned that if R’=Ph, then the allylic azidoalcohol would be stabilized as the 
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reactive form 236. Indeed, we were interested to explore whether under appropriate 
conditions, allylic azidoalcohols that exist exclusively in the unreactive form might 
still undergo Claisen rearrangement. 
Chlorohydrins 239a–f and 239h were prepared using the conditions shown above 
(Scheme 97, Table 17). In each case, the reaction was complete within 1 h. Where the 
precursor ketone or aldehyde 238 was not commercially available, it was prepared via 
Wittig olefination of the corresponding aldehyde. Ketone 238f was prepared by 
addition of phenylmagnesium chloride to crotonaldehyde and PDC oxidation of the 
alcohol intermediate. 
 
Scheme 97 
Table 17 
Entry R R’ Yield (%) Entry R R’ Yield (%) 
a nC5H11 H 81 f Me Ph 52 
b nC5H11 Me 92 g 2-pyridyl H 0 
c Me Me 35 h 2-pyridyl Me 88 
d cHex Me 84 i 2-furyl H 0 
e Ph H 99 j 2-furyl Me 0 
 
Yields were generally high, with some exceptions. The low yield of 239c was 
attributed to its volatility. The furans 239i and 239j decomposed violently upon 
isolation to give an intractable tar. A similar, albeit slower decomposition of the 
pyridine 239g was observed. A mechanism is proposed involving formation of the 
oxirane 234 with loss of HCl. This could be followed by ring-opening of 234 and 
subsequent acid-assisted decomposition, with the furyl group stabilising the 
developing partial positive charge on the more substituted oxirane carbon (Scheme 
98). 
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Treatment of the chlorohydrins 239a–f and 239h with sodium hydride and 
substoichiometric sodium iodide afforded the oxiranes 234a–g (Scheme 99, Table 
18). No further purification was required and these compounds were used directly in 
the next step. 234c (R=Me) was highly volatile, and could only be isolated as a 
solution in THF. The concentration of the solution was determined by 1H-NMR 
analysis. 
 
Scheme 99 
Table 18 
Entry R R’ Yield (%) Entry R R’ Yield (%) 
a nC5H11 H 97 e Ph H >99 
b nC5H11 Me 40 f Me Ph 98 
c Me Me 46 g 2-pyridyl Me 66 
d cHex Me 98     
 
Treatment of the oxiranes 234a–g with sodium azide in acetone/water gave the allylic 
azidoalcohols 235/236a–f (Scheme 100, Table 19).  The reaction was performed 
under reflux with the exception of 236f, which was isolated in low (<14%) yield 
under these conditions. Stabilisation of the developing partial positive charge by both 
phenyl and vinyl groups bound directly to the quaternary carbon enhance the rate of 
opening of the oxirane 234f. Elevated temperatures are therefore not required and 
only cause decomposition of the starting material. The reaction was repeated at room 
temperature, affording the allylic azidoalcohol 236f in good yield. 
 
Scheme 100 
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Table 19 
Entry R R’ Yield (%) Ratio 235 : 236a 
a nC5H11 H 70 73 : 27 
b nC5H11 Me 25 61 : 39 
c Me Me 71 64 : 36 
d cHex Me 59 63 : 37 
e Ph H 60 100 : 0 
fb Me Ph 74 0 : 100c 
g 2-pyridyl Me 79 100 : 0 
aRatio determined by 1H-NMR analysis; bat room temperature, 4 h; cas 
a 3:1 E:Z mixture 
 
Mixtures of trisubstituted allylic azidoalcohols 235/236b–d were obtained in similar 
ratios, favouring the tertiary (vicinal) azidoalcohol.  This isomer was less favoured 
compared to 235a. Azidoalcohols 235e and 235g were obtained as single isomers 
with the olefin in conjugation with the aryne as predicted. 236f was obtained as an 
inseparable 3:1 E:Z mixture of isomers (determined by NOESY-NMR), both 
secondary azides as predicted. A full discussion of the individual factors affecting 
ratios of allylic azides is given later. 
Allylic azidoalcohols 235/236a–g were exposed to Johnson–Claisen conditions. 
(Scheme 101, Table 20).  In addition to the rearrangement product 243a, 243b–d and 
f were obtained in good yield, although extended reaction times were required for 
these more sterically demanding substrates.  
 
Scheme 101 
Table 20 
Entry R R’ t (h) Yield (%) Ratio syn- : anti-243a 
a nC5H11 H 6 99 50 : 50 
b nC5H11 Me 24 72 59 : 41 
c Me Me 12 86 60 : 40 
d cHex Me 26 94 63 : 37 
e Ph H 48 0 - 
f Me Ph 24 75 50 : 50 
g 2-pyridyl Me 48 <4 (77 : 23) 
aBy 1H-NMR analysis 
 
Trisubstituted allylic systems 235/236b–d rearranged with moderate stereoselectivity; 
of lower magnitude than analogous sulfide systems. 236f was the only example of a 
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Z-configured allylic system undergoing rearrangement.  Interestingly, in contrast to 
previous examples, no stereoselectivity was observed. 235e did not rearrange under 
these conditions. 243g was obtained as an impure compound in very low yield, thus 
the magnitude of this selectivity is likely to be invalid. To exclude the effects of 
neutralisation of the propionic acid catalyst by the 2-pyridyl substituent (examination 
of pKa values suggests the pyridine would be fully protonated), the reaction was 
repeated using 1.2 equivalents of propionic acid. The yield was unaffected. Clearly, 
substrates where R=Ar do not participate in this tandem sigmatropic process. 
 
2.5.6 Synthesis of γ-lactams 
In the next phase of the work, the conversion of Claisen products into the 
corresponding lactams was investigated. The intention was both to demonstrate the 
synthetic utility of the preceding reaction and to impose a conformational constraint, 
such that the sense of stereoinduction could be assigned by spectroscopic methods. 
The transformation of azidoesters into lactams via Staudinger reduction177 of the azide 
and in situ cyclisation of the intermediate aminoester is well precedented.178 
Triphenyl-, tributyl- and trimethylphosphine are commonly used to generate the 
iminophosphorane intermediate, which is intercepted by water. This technique has 
been used previously for the cyclisation of Claisen rearrangement products bearing 
azide groups.178c We chose the mixture of stereoisomers 243c to investigate this 
process.  
Treatment of 243c with triphenylphosphine in water under microwave irradiation 
afforded the lactam 244a, although due to its high polarity it was difficult to separate 
from the triphenylphosphine oxide by-product. Switching to polystyrene resin-
supported diphenylphosphine179 alleviated this problem as the reagent and by-
products could be removed by filtration. Under these conditions the mixture of 
lactams syn- and anti-244a was obtained in good yield and with no change in 
diastereomeric ratio (Scheme 102). The starting material was not consumed when the 
reaction was performed at room temperature, indicating that heat was required to 
generate the iminophosphorane intermediate. NOESY-NMR of the product mixtures 
showed an nOe enhancement between H4-H5 in the major product, confirming its 
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identity as the predicted syn-diastereomer. Separation of the diastereomers was not 
attempted. 
 
Scheme 102 
The products of other moderately selective rearrangements 243b and 243d were 
unreactive under these conditions; neither the lactam product nor the intermediate 
amine was observed. Reasoning that the lack of reactivity was caused by steric 
crowding around the internal azide nitrogen, smaller and more nucleophilic 
trimethylphosphine was used to generate the intermediate iminophosphorane.180 Neat 
samples of 243b and 243d were treated with water and a solution of 
trimethylphosphine in THF at room temperature to give the lactams syn- and anti-
244b and 244c respectively (Scheme 103, Table 21). Inspection of 1H-NMR spectra 
and NOE enhancements showed a change in the product distribution; the anti-
diastereomer becoming more abundant. When the reaction of 243c (R=Me) was 
repeated using trimethylphosphine a similar change in ratio was observed. 243f was 
also converted into the corresponding lactam 244d. 
 
Scheme 103 
Table 21 
R R’ Phosphine Conditions Product Yield 
(%) 
Ratio syn- : 
anti-244a 
Me Me py-PPh2 30 min, 120 °C (m/w) 244a 87 60 : 40 
Me Me PMe3 40 min, rt 244a 59 45 : 55 
nC5H11 Me PMe3 40 min, rt 244b 75 56 : 44 
cHex Me PMe3 18 h, rt 244c 59 33 : 66 
Me Ph PMe3 8 h, rt 244d 80 50 : 50 
aBy 1H-NMR analysis 
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The change in product distribution may be rationalised by considering the relative 
rates of cyclisation of aminoester intermediates syn-245 and anti-245 (Scheme 104). 
The reactive conformation of syn-245 exhibits an unfavourable interaction between 
the R and methallyl groups not present in the reactive conformation of anti-245. The 
yields and product ratios are consistent with this difference in reactivity: in each 
case,181 the yields of the syn and anti products are consistent with the ratio of syn and 
anti isomers in the starting material (Table 22). As this model suggests, the syn 
cyclohexyl substrate 243d appears to be the least reactive, and overall, syn azidoesters 
are significantly less reactive than their anti isomers. 
Table 22 
R=Me, Yield 59% 60 syn : 40 anti → 45 syn : 55 anti  
 Yield (syn)  = (45 x 59%) = 27% (27<60) 
 Yield (anti)  = (55 x 59%) = 32% (33<40) 
R=nC5H11, Yield 75% 59 syn : 41 anti → 56 syn : 44 anti  
 Yield (syn)  = (56 x 75%) = 42% (42<59) 
 Yield (anti)  = (44 x 75%) = 33% (33<41) 
R=cHex, Yield 59% 63 syn : 37 anti → 33 syn : 66 anti  
 Yield (syn)  = (33 x 59%) = 19% (19<63) 
 Yield (anti)  = (66 x 59%) = 39% (39>37) 
 
 
Scheme 104 
 
2.5.7 Decarboxylative Claisen rearrangements of allylic azides 
Our interest returned to the low stereoselectivity of these rearrangements.  
Considering that further exploration of the effects of olefin substitution pattern would 
be difficult using this particular system, we decided to investigate the previously 
unexplored effects of substitution on the vinylic portion (C1) of the ketene acetal. 
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Examples from our own laboratory and others103,110,118 are reported of trans-allylic 
esters bearing substituents adjacent to the carbonyl undergoing stereoselective 
Ireland–Claisen rearrangements. We proposed that increased steric bulk at C1 would 
increase the diastereofacial selectivity of attack on the allylic portion of the ketene 
acetal.  
The dCr reaction developed in our own laboratory182 appeared particularly attractive 
for further study of the tandem Winstein–Claisen rearrangement process. α-Tosyl 
esters of the type 246, when treated with a silylating agent (typically BSA, although 
TBDMSOTf–DBU has been used for tosylmalonate substrates) and sub-
stoichiometric KOAc undergo Claisen rearrangement followed by concomitant 
desilylation and decarboxylation to afford homoallylic sulfones 247. Heating of the 
ester substrate with BSA in the absence of KOAc affords the non-decarboxylated 
product, and a catalytic cycle has been proposed which accounts for this (Scheme 
105). Reaction of BSA with KOAc gives TMSOAc 249 and the acetamide salt 248, 
which together effect silylation and enolisation of the substrate, giving 250. Following 
[3,3]-sigmatropic rearrangement, the nucleophilic acetate anion abstracts the TMS 
group from the product silyl ester 251 with concomitant loss of carbon dioxide. 
Abstraction of a proton of the resulting α-sulfonyl anion regenerates the active system 
248/249 and gives the homoallylic sulfone product 247.  
The dCr reaction is a very active area of interest in the Craig group. The reaction has 
been applied to the synthesis of both small molecules (among which are phenols,183 
pyridines,184 vinylcyclopropanes,185,102 dearomatised furans125 and other 
heteroaromatic substrates186) and complex natural products.187 We have also 
performed NMR kinetic studies of the reaction.188 We are currently developing total 
syntheses of several natural products based on this methodology and are developing 
base-free variants of the reaction. 
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Scheme 105 
As with other Claisen rearrangements, the rate of reaction is highly substrate-
dependent.  Tosylmalonate substrates undergo dCr reaction under mild conditions,189 
while microwave heating has been extensively used to trigger rearrangement of less 
reactive substrates. Nevertheless, the scope of the transformation is very wide. Indeed, 
we were very interested to explore the behaviour of equilibrating mixtures of allylic 
azides in this reaction.  The attractiveness of the dCr reaction for this study lies in two 
factors: the steric bulk of the C1 tosyl group should enhance selectivity; and the 
subsequent decarboxylation process removes the complication of a third stereocentre. 
Thus, any observed stereoselectivity in the reaction of the substrates presented herein 
results exclusively from exopericyclic stereocontrol. 
In common with previous studies, the system 235a/236a was used for initial 
investigation and optimisation of this reaction. Esterification of the mixture of allylic 
azidoalcohols 235a/236a with DCC and substoichiometric DMAP gave the mixture 
of esters 252a/253a (Scheme 106). The ratio of allylic azide isomers changed slightly, 
with the vicinal oxy-azido isomer 252a less abundant than in the corresponding 
mixture of allylic azidoalcohols. 
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Scheme 106 
Treatment of the azidoesters 235a/236a with BSA and sub-stoichiometric potassium 
acetate in toluene under reflux resulted in no reaction taking place.  However under 
microwave conditions, the homoallylic sulfone 254a was obtained in low yield but 
good diastereoselectivity; particularly when compared to the non-selective 
rearrangement of the analogous allylic azidoalcohol to give 243a. The diastereomers 
were separable, and X-ray crystallography (see Appendix) showed the major product 
to be the predicted syn diastereomer (Scheme 107).  
 
Scheme 107 
We performed studies to optimise this reaction and increase its yield. More forcing 
conditions and removal of the solvent from the reaction mixture gave only a slight 
increase in yield (Table 23, entry 2). Complete decomposition of the starting material 
was observed upon increasing the reaction temperature to 200 °C (entry 3). Noting 
that potassium acetate is required for decarboxylation, the reaction was run in non-
decarboxylative mode118 using TEA as an alternative base (entry 4). Under these 
conditions complete conversion to the silyl ester was observed, which was hydrolysed 
to the acid 255 upon workup, confirming that the Claisen rearrangement was 
occurring under these conditions. In the presence of sub-stoichiometric quantities of 
TEA, the reaction was sluggish and required high temperatures (only achievable in 
DMF) to achieve modest conversion. 
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Table 23 
Entry BSA 
(equiv) 
Additive Solventa Microwave           
Heating Conditions 
Yield (%) 
1 1.2 KOAc (0.1 equiv) PhMe 1.5 h, 175 °C 28% 
2 5.0 KOAc (0.1 equiv) none 2 x 175 °C 5 min 32% 
3 5.0 KOAc (0.1 equiv) none 2 x 200 °C, 5 min 0%b 
4 3.0 TEA (1.1 equiv) PhMe 160 °C, 15 min 0% (100%)c 
5 3.0 TEA (0.1 equiv) DMF 2 x 180 °C, 15 min 0% (62%)c 
6 3.0 TEA (0.1 equiv), 
KOAc, (0.1 equiv) 
DMF 180 °C, 15 min 20 % 
aAll reactions, unless solvent-free were performed at 1.0 M. bComplete decomposition was observed. 
cConversion to acid intermediate 255 by 1H-NMR. 
 
Inspection of the dCr reaction mechanism (Scheme 105) shows the reaction should be 
catalytic in BSA, so we investigated why such an excess was required in this case. 
The thermal decomposition of BSA to acetonitrile (and also its stabilisation by 2-
mercaptobenzothiazole) has been reported (Scheme 108).190 
 
Scheme 108 
Samples of BSA in d8-toluene were heated in a microwave for various periods of time 
at different temperatures and then analysed by 1H-NMR. No decomposition was 
observed, even when heating BSA under solvent-free conditions for extended times.  
Additionally, no decomposition of BSA was observed in the presence of potassium 
acetate, indicating that BSA is stable under the dCr reaction conditions (Figure 1). 
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Taking into account the above observations, we concluded that the low yield for the 
dCr reaction was caused by the forcing conditions required for the decarboxylation 
step. Alternative conditions have been reported for the decarboxylation of α-tosyl 
acids,102 and we reasoned that the dCr reaction could be performed over two separate 
steps (Scheme 109). Treatment of the mixture of esters 252a/253a with BSA and 
TEA followed by microwave heating afforded the acid 255 upon hydrolytic workup 
as a mixture of four stereoisomers. The purity of the intermediate acid on isolation 
and the efficiency of microwave heating were improved by changing the reaction 
solvent to acetonitrile. Residual BSA and TEA were removed by passing a solution of 
the crude acid through an SCX ion-exchange column. Decarboxylation with sodium 
carbonate in DMF gave the dCr products syn- and anti-254a in 86% yield over two 
steps, with the same diastereoselectivity as was observed previously. 
 
Scheme 109 
Having optimised the conditions for rearrangement of 252a/253a, the behaviour of 
the other previously prepared allylic azides under dCr conditions was investigated.  
We were particularly interested to explore whether the effects of the olefin 
substitution pattern would reinforce those of increased steric bulk on the vinylic 
moiety of the ketene acetal. Treatment of mixtures of allylic azidoalcohols under the 
same conditions as 235a/236a gave the corresponding allylic azidoesters 252/253b–g 
(Scheme 110, Table 24). In addition to the change in allyic azide ratio for 252a/253a, 
an inversion in the position of the equilibrium for substrates 252/253b–d was 
observed. 
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Scheme 110 
Table 24 
Entry R R’ Ratio of azidoalcohol 
substrates 235 : 236a 
Yield of  
252/253 (%) 
Ratio of azidoester 
products 252 : 253a 
a nC5H11 H 73 : 27 99 58 : 42 
b nC5H11 Me 61 : 39 69 32 : 68 
c Me Me 64 : 36 97 30 : 70 
d cHex Me 63 : 37 92 36 : 65 
e Ph H 100 : 0 97 100 : 0 
f Me Ph 0 : 100 75 0 : 100 
g 2-pyridyl Me 100 : 0 52 100 : 0 
aBy 1H-NMR analysis 
 
2.5.8 The equilibrium position of allylic azides 
We propose that the equilibrium position for the interconversion of allylic azides via 
[3,3]-sigmatropic rearrangement depends on the subtle interplay of numerous factors, 
including olefin substitution pattern, azide–alcohol hydrogen-bonding, conjugation 
with aromatic groups and to a lesser extent, 1,3-allylic strain.  These factors are 
discussed below: 
For equilibrating mixtures of a secondary and tertiary allylic azide the regioisomer 
containing the more substituted olefin would be expected to predominate.  Recent 
computational studies on the theoretical basis of Saytzeff’s rule show that each 
additional alkyl substituent contributes 1–2 kcal/mol to the stability of the olefin.191  
However, with the exception of isomers stabilised by conjugation with an aromatic 
group (vide infra), this is not the case, and the vicinal azidoalcohol 253 (bearing the 
less substituted olefin) predominates.   
Other effects must therefore contribute to the stability of this isomer.  Sharpless et al. 
speculated168 that an azide–alcohol hydrogen-bonding interaction might exist in 
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vicinal azidoalcohols. A similar explanation was given by Trost et al. for the position 
of equilibrium between the cyclic allylic azides 256 and 257 (Scheme 111).164a 
 
Scheme 111 
We decided to investigate this in depth, assuming that the interaction would take the 
form of a 5-membered ring incorporating a hydrogen bond between the internal 
nitrogen of the azide and the alcohol hydrogen 260. Hydrogen bonds of this type are 
reported (supported by extensive spectroscopic evidence) in 2-
hydroxyalkylpiperidines 258 and 2-hydroxyalkylpyridines 259 (Scheme 112).192 
 
Scheme 112 
Although the azide ion is reportedly a very strong hydrogen bond acceptor,193 studies 
on the hydrogen-bonding nature of organic azides are scarce. However, a search of 
the Cambridge X-ray structure database for distances between the internal azide 
nitrogen and an alcohol hydrogen less than 2.50 Å revealed some examples of 
hydrogen-bonding interactions 261–264 (Scheme 113).194 
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Scheme 113 
Enthalpies of hydrogen-bonding are typically within the range 2–10 kcal/mol;195 and 
although the reported interactions in 261–264 are relatively long-range and the N…H–
O angle deviates from linearity, a hydrogen-bonding interaction could make a 
significant contribution to the stability of vicinal azidoalcohols 235. An NMR 
experiment was carried out to explore the effect of hydrogen-bonding on the 
equilibrium position. We predicted that d4-methanol would compete with the 
dissolved azidoalcohol for hydrogen-bonding interactions, perturbing the equilibrium 
away from the vicinal regioisomer 235 (Scheme 114, Table 25). No change in ratio 
was observed for the mixture of secondary allylic azidoalcohols 235a/236a when 
spectra were measured on CD3OD rather than CDCl3 solutions. For the mixture of 
secondary and tertiary allylic azidoalcohols 235c/236c however, a small shift in the 
equilibrium position towards 236c was observed, suggesting a weak hydrogen-
bonding interaction. 
 
Scheme 114 
Table 25 
 Ratio  Ratio 
Solvent 235a : 236aa  235c : 236ca 
CDCl3 73 : 27  64 : 36 
CD3OD 73 : 27  58 : 42 
aBy 1H-NMR analysis 
 
Esterification of azidoalcohols 235/236 removes the possibility of hydrogen-bonding, 
leaving olefin stability as the dominant effect.  Thus, in the absence of hydrogen-
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bonding interactions, the isomer containing the more substituted double bond 
predominates. Furthermore, in the absence of hydrogen-bonding interactions, it 
appears that 1,3-allylic strain has less effect on the equilibrium position than olefin 
substitution.  A greater, energetically unfavourable 1,3-allylic strain component 
would be predicted for the more abundant regioisomer in mixtures of allylic 
azidoesters 252/253b–d and 252/253f–g.196 These combined effects in total are small 
compared to those of conjugative stabilisation. Indeed, for both allylic azidoalcohols 
and their ester equivalents, whenever the olefin can lie in conjugation with an 
aromatic group, this is the only regioisomer observed. 
 
2.5.9 Further examples of allylic azides in the dCr reaction 
Esters 252/253a–g were exposed to the optimised dCr conditions. With the exception 
of 252g, all underwent Claisen rearrangement (Scheme 115, Table 26). More 
hindered substrates required increased amounts of BSA and TEA to react efficiently. 
Aside from conjugatively stabilised substrates there appeared to be no correlation 
between azide ratios and yields. Syn stereochemistry for the major products 254b–f 
was inferred from the X-ray crystallography studies carried out previously on syn-
254a. 
 
Scheme 115 
Table 26 
Entry R R’ BSA 
(equiv) 
TEA 
(equiv) 
t (min) Yield 
(%) 
Ratio syn- : 
anti-254a 
a nC5H11 H 3.0 1.2 15 86 84 : 16 
b nC5H11 Me 5.0 2.0 30 68 68 : 32 
c Me Me 3.0 1.2 30 82 91 : 9 
d cHex Me 5.0 2.0 30 44 82 : 18 
e Ph H 5.0 2.0 90 22 75 : 25 
f Me Ph 3.0 1.2 40 32 73 : 27b 
g 2-pyridyl Me 3.0 1.2 30 0 - 
aBy 1H-NMR analysis; bThis substrate partially decarboxylated during first step. 
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In each case, stereoselectivity was more pronounced than that observed for Johnson–
Claisen rearrangement of the corresponding allylic azidoalcohol. We conclude that 
the effects of C1 substitution and olefin substitution pattern are reinforcing. In 
contrast to the unreactive phenyl-bearing azidoalcohol 235e, the single-regioisomer 
azidoester 252e underwent rearrangement and decarboxylation to give 254e in low 
yield. The pyridyl-bearing substrate 252g decomposed under these conditions, 
possibly caused by N-silylation of the pyridine moiety with BSA. We therefore 
conclude that this reaction works generally when R=alkyl. Selectivities are higher, but 
yields lower (except in the case of 254e) than the related Johnson–Claisen 
rearrangements of allylic azidoalcohols bearing the same R and R’ groups. 
 
2.5.10 Ireland–Claisen Rearrangements: Control of 3 contiguous stereocentres  
Our interest returned to the chelate-controlled Ireland–Claisen rearrangements of 
Mulzer,110 in which three contiguous stereocentres are established.  We decided to 
study the behaviour of allylic azidoesters in this process, allowing us to probe the 
effects of temperature on both the rate of rearrangement and stereoselectivity. The 
mixture of esters 265/266 was prepared from 235c/236c by reaction with 
benzyloxyacetic acid. The ratio of allylic azide isomers was consistent with the 
analogous α-tosyl ester 252c/253c; and a similar reversal in the position of 
equilibrium was observed. Ireland–Claisen rearrangement of 265/266 under the 
reported conditions gave the product 267 as a mixture of 4 diastereomers, 
accompanied by unreacted starting material (Scheme 116). The structures of the 
individual diastereomers were not assigned, although the ratio of products shows 
incomplete stereocontrol at C1. Clearly, further optimisation of this reaction is 
required. 
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Scheme 116 
Nevertheless, although we remain unable to control three contiguous stereocentres 
using this methodology, our results clearly show that a wide variety of equilibrating 
allylic azidoesters may be converted to azide-bearing γ,δ-unsaturated esters or 
homoallylic sulfones via a pair of sigmatropic rearrangements. In the latter case, the 
reaction occurs with good stereoselectivity in the predicted syn sense.  
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2.6 Reactions of β-azidoketones derived from dCr reactions 
 
2.6.1 Background 
The work presented in this section demonstrates our investigations into further 
transformations of dCr products 254. From the outset, we wished to subject these 
rearranged products to ozonolytic cleavage to form β-azidoketones 268. We 
envisaged a sequence in which these β-azidoketones are subjected to either Beckmann 
or Baeyer–Villiger rearrangement. In the former reaction, stereospecific migration of 
the bulkier moiety would give the 1,2-azidoamide 270, while the same migratory 
pattern for the latter reaction would give the 1,2-azidoacetate 272. These represent 
differentially protected 1,2-diamines 271197,198 and 1,2-amino alcohols 273199 
respectively, which are useful synthetic intermediates (Scheme 117). 
 
Scheme 117 
 
2.6.2 Ozonolysis of dCr products 
We were concerned that commonly used reagents for reductive quench of the 
intermediate ozonide such as phosphines might also reduce the azide group.  
However, examples of reductive quench of ozonides in the presence of azides using 
dimethylsulfide are reported.200  These reactions are typically performed in a mixture 
of dichloromethane and methanol. A diastereomerically pure sample of syn-254b was 
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treated with ozone at –78 °C for 10 min under the reported conditions (Scheme 118) 
to give not only the ketone syn-274 but also the hemiacetal 275 as the major product, 
both as single diastereomers. 
 
Scheme 118 
The hemiacetal 275 was unusually stable and we propose a cyclic, internally 
hydrogen-bonded structure (Scheme 119) to support this. In addition to the previously 
discussed examples of N3…H—O hydrogen-bonding, there is strong spectroscopic 
evidence for this assignment. Firstly the coupling constant JH3-H4 is large (10.0 Hz) 
compared to ketone syn-274 (JH3-H4, 6.5 Hz). Addition of D2O to the NMR sample 
caused disappearance of the OH signal and a reduction of JH3-H4 suggesting inhibition 
of hydrogen-bonding and conversion into an acyclic structure. Additionally, sharp OH 
signals in both the 1H-NMR and infrared spectra support this evidence for hydrogen-
bonding. 
  
Scheme 119 
Presuming that 275 could only be formed by addition of methanol to either the 
intermediate ozonide or the ketone product, the reaction was repeated in its absence, 
affording solely the diastereomerically pure ketone syn-274 in 88% yield (Scheme 
120). We have therefore shown that this methodology may be used for the synthesis 
of β-azidoketones in good yield and without epimerization of the rearranged product. 
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Scheme 120 
 
2.6.3 Synthesis of a model system 
Before studying further chemistry of the ketone syn-274 directly, we chose to study 
and optimise this work using the model system 276.  Although the chemistry 
described here was not eventually applied to the dCr products, it provides an 
interesting area for further investigation. We envisaged that 276 could be easily 
prepared via conjugate addition of hydrazoic acid to the enone 238b (Scheme 121). 
 
Scheme 121 
Highly toxic and explosive hydrazoic acid is typically generated in situ from the 
disproportionation of an azide source (typically sodium azide or azidotrimethylsilane) 
and an acid (acetic acid or strong mineral acid).201  The reaction may be performed in 
the presence of a sub-stoichiometric amount of a Lewis-basic amine or phosphine, 
which accelerates the disproportionation step.202 Under these conditions, the azide 
anion does not undergo conjugate addition to the enone and an acid is still required. 
The transformation can also be carried out in enantioselectively in the presence of a 
salen/aluminium catalyst.203 Using the conditions of Miller et al,202a 238b was 
converted in very high yield into the β-azidoketone 276 (Scheme 122). 
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2.6.4 Beckmann rearrangements of β-azioketones 
With β-azidoketone 276 in hand, we investigated the Beckmann rearrangement of the 
corresponding oxime 277.204 Treatment of 276 with hydroxylamine hydrochloride and 
sodium acetate205 afforded the oxime 277 (Scheme 123). Increasing the concentration 
of the reaction mixture from the reported procedure significantly improved the yield. 
It should be noted that these conditions may require alteration if used to form the 
oxime of 274; base-mediated epimerization of the stereocentre adjacent to the ketone 
is possible. 
 
Scheme 123 
The product was isolated as a 2:1 mixture of E and Z isomers. This assignment was 
based on the relative chemical shifts of the methylene group adjacent to the ketoxime, 
which appeared at lower field for the Z (syn) isomer than the E (anti) isomer.206 
Examination of literature data for analogous ketoximes suggests interconversion of 
these isomers is likely to be facile at room temperature, favouring the desired 
migration of the E isomer (Scheme 124, Table 27) in the Beckmann rearrangement. A 
preference for E-geometry in the oxime of 274 would be strongly expected. 
 
Scheme 124 
Table 27 206 
R (E)-oxime (Z)-oxime ΔGisomerisation 
Et 74 26 0.64 
iPr 91 9 1.41 
tBu 100 0 >2.7 
Bn 74 26 0.64 
Ph 94 6 1.68 
 
We chose to investigate the Beckmann rearrangement using an intermediate O-
tosyloxime, envisaging that E-oxime would be more sterically favoured in this 
Me
O
C5H11
N3
276
Me
N
C5H11
N3
OH
277
H2NOH!HCl, NaOAc
MeCN/H2O (4:1 v/v), rt,
[276] = 0.13 M, 3 h, (54%)
[276] = 0.24 M, 2 h, (94%)
R
N
Me
OH
R
N
Me
HO
(E)-oxime (Z)-oxime
Results and Discussion 
 
 
 
 116 
system.204,205 Formation of the O-tosyloxime 278 under the reported conditions was 
slow.  Addition of sub-stoichiometric DMAP accelerated the reaction. No rearranged 
product was observed at this stage.  Heating of 278 in IPA/water afforded a mixture 
of both the desired acetamide 279 and the amide 280: the product of methyl migration 
(Scheme 125). 
 
Scheme 125 
The product distribution is related to a subtle combination of effects and it is unclear 
whether the presence of the methyl migration product 280 is a result of slow E/Z 
oxime interconversion, or a surprisingly high migratory aptitude of the methyl group 
in this system. We predict that the branched Claisen products would migrate with 
higher selectivity under this process.207 However, the reaction clearly requires further 
development. This transformation of β-azidoketones could also be carried out under 
Schmidt rearrangement conditions, although we have not investigated this.208 
 
2.6.5 Baeyer–Villiger rearrangements of β-azidoketones 
The Baeyer–Villiger rearrangement209 of the model ketone 276 was also briefly 
investigated. The ketone was treated with MCPBA in the presence of sodium 
bicarbonate in chloroform,210 but no oxidised product was formed and only starting 
material was recovered (Scheme 126). The reaction may be possible with a more 
powerful peracid (e.g trifluoroperacetic acid). It is unlikely that reactions of the 
ketone 276 will be complicated by acid-mediated intramolecular Schmidt-type 
processes due to the short distance between the ketone and azide.211 
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Scheme 126 
In summary, although the above studies on the model ketone 276 were not applied to 
a ketone derived from a dCr reaction, we have shown from preliminary results that a 
Beckmann rearrangement of this substrate will be possible. Further investigation of 
Beckmann, Baeyer–Villiger and Schmidt processes will allow us to further develop a 
synthesis of differentially-protected 1,2-aminoalcohols and 1,2-diamines based on a 
Claisen rearrangement strategy. 
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2.7 Conclusions 
Numerous contributions have been made to the area of acyclic stereocontrol in 
Claisen rearrangements. Our conclusions are divided into two sections: the former 
covering contributions to the nature of stereoselectivity in the reaction; and the latter 
summarising our attempts to exploit these selectivity patterns in synthesis. 
 
2.7.1 Investigations into acyclic stereocontrol 
The Johnson–Claisen rearrangements of substrates bearing all-hydrocarbon C6’ 
stereocentres were investigated. Moderate anti selectivities were observed in the 
opposite sense to cases where the C6’ stereocentre possessed a heteroatom.  The 
major product arose from a transition state in which the medium-sized group was 
roughly eclipsing the double allylic double bond of the ketene acetal. Only examples 
of E-configured substrates were investigated; study and comparison of the Z-isomers 
would be recommended for future work. 
An investigation was proposed to compare the effects of C6’ fluorine and thiophenyl 
substituents. No stereoselectivity was observed in either case for E-configured 
substrates, while high syn selectivity, in line with prediction, was observed in the 
Johnson–Claisen rearrangement of the isomeric Z-allylic alcohols in the thiophenyl-
substituted series. Work on the fluorine system was hampered by the instability of 
rearrangement substrates. 
Stereoselectivity in rearrangements of E-configured allylic systems may be achieved 
in two ways. Moderate selectivity was observed in the Johnson–Claisen 
rearrangements of trisubstituted allylic systems and disubstituted allylic systems 
bearing a C1 substituent on the ketene acetal. Studies in the context of the dCr 
reaction showed these effects to be reinforcing. 
Although attempts were made to combine cyclic and acyclic stereocontrol modes, 
they form only a small part of this work and were largely unsuccessful. Further work 
in this area is also recommended. 
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2.7.2 Synthetic applications of acyclic stereocontrol in Claisen rearrangements 
In the course of work to prepare disubstituted γ-lactams via a Claisen rearrangement 
route, we discovered a novel process where equilibrating mixtures of allylic azides 
can undergo a pair of sigmatropic rearrangements in a tandem process.  This was 
investigated in the context of the Johnson–Claisen and dCr reactions. Our work in this 
area studied the factors contributing to the equilibrium position of various mixtures of 
allylic azides. NMR studies, synthetic studies and examination of crystallographic 
data showed evidence for an intramolecular hydrogen bond between the azide and 
alcohol functionalities. 
Studies were performed to show that the products of allylic azide Claisen 
rearrangements could be converted into useful compounds. Products of Johnson–
Claisen rearrangement of allylic azidoalcohols were converted into γ-lactams via 
Staudinger reduction and cyclisation, although the differing rates of cyclisation of syn 
and anti substrates lead to varying product distributions. We have also shown that 
products of dCr reaction of allylic tosylazidoesters may be converted into β-
azidoketones via ozonolytic cleavage. Finally, the Baeyer–Villiger and Beckmann 
chemistry of a model β-azidoketone was investigated in an effort to convert oxidised 
dCr products into differentially-protected 1,2-aminoalcohol and 1,2-diamine 
equivalents respectively. This represents an additional interesting area for future 
studies.
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3.1 General laboratory procedures 
 
All reactions were performed under nitrogen unless otherwise stated. Melting points 
were determined using Stuart Scientific SMP1 melting point apparatus and are 
uncorrected. Infrared spectra were recorded on Mattson 5000 FT-IR or Perkin-Elmer 
Spectrum RX FT-IR System spectrometers. Proton nuclear magnetic resonance (1H 
NMR), carbon nuclear magnetic resonance (13C NMR) and fluorine nuclear magnetic 
resonance (19F NMR) spectra were recorded in CDCl3 unless otherwise stated on a 
Brüker AV-400 or Brüker AV-500 spectrometer. Chemical shifts are in parts per 
million (ppm) and are referenced relative to the residual proton-containing solvent (1H 
NMR: 7.26 ppm for CDCl3; 13C NMR: 77.0 ppm for CDCl3). Coupling constants are 
given in Hertz (Hz). Mass spectra (CI, EI and ESI) were recorded using Micromass 
AutoSpec-Q, Micromass Platform II or Micromass AutoSpec Premier instruments. 
Elemental analyses were performed at the microanalytical laboratories of the London 
Metropolitan University. Optical rotations were measured on an Optical Activity Ltd. 
instrument.  Analytical thin layer chromatography (TLC) was performed on pre-
coated glass-backed Merck Kieselgel 60 F254 plates. Visualisation was effected with 
ultraviolet light, potassium permanganate or vanillin as appropriate. Flash column 
chromatography was performed using a Biotage Flash+ reservoir system with Biotage 
SNAP HP-Sil (30 µm) silica gel cartridges or using a Teledyne Isco Companion 
system fitted with RediSep (35–70 µm) silica gel cartridges. Kugelrohr distillations 
were performed using a Büchi D56 Kugelrohr oven and controller system. The quoted 
boiling point corresponds to the internal oven temperature. Standard solvents were 
distilled under nitrogen prior to use; ether and THF from sodium-benzophenone ketyl, 
CH2Cl2 and acetonitrile from CaH2 and toluene from sodium. All other solvents were 
distilled prior to use. Petrol refers to petroleum ether of the fraction bp 40–60 °C. 
Ether refers to diethyl ether. All liquid reagents were distilled prior to use with the 
exception of TMS-azide, DAST and Deoxofluor which are thermally unstable. 
Potassium acetate was oven-dried at 120 °C for several days prior to use. Microwave 
reactions were performed in a Biotage Initiator upgraded to version 2.5 and cooled 
using compressed air (4 bar).  Ozone gas was generated from oxygen gas using a 
Triogen LAB2B ozone generator. 
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3.2 Safety note 
 
The preparation of numerous potentially explosive low molecular weight organic 
azides is reported herein. Although we did not experience any explosive behaviour 
during the course of our studies, all reactions involving azides were carried out behind 
a blast shield. Particular care was taken during the concentration and purification of 
organic azides. Sodium azide was handled using non-metallic utensils. 
 
3.3 General synthetic procedures 
 
General procedure A, for the preparation of α ,β-unsaturated esters 158b–e,g 
 
Part 1 
To a stirred suspension of (methoxymethylene)triphenylphosphonium chloride (18.8 
g, 55.0 mmol 1.12 equiv) in dichloromethane (75 mL) was added potassium tert-
butoxide (6.18 g, 55.0 mmol, 1.12 equiv) in three portions at rt.  A deep red colour 
resulted almost immediately upon complete addition.  The resulting suspension was 
stirred at rt for 90 min to complete the formation of the ylide.  Ketone 155 (49.0 
mmol, 1.0 equiv) was added dropwise at rt over 15 min.  The reaction mixture was 
stirred for 6 h, after which the deep red colour had dissipated and FT-IR showed 
disappearance of the ketone, and water (60 mL) was added. The phases were 
separated and the organic layer was washed with water (70 mL) and brine (50 mL).  
The organic layer was dried (MgSO4), filtered and partially concentrated under 
reduced pressure (until ca. 10 mL of solvent remained) to afford a solution of the enol 
ether 156 in dichloromethane. 
 
Part 2 
To a suspension of silica gel (18.8 g) in dichloromethane (15 mL) was added water 
(1.88 mL, 10% by mass of silica gel). After stirring for 5 min, sulfuric acid (98%, 2 
mL) was added dropwise.  The enol ether 156 solution from Part 1 was added and the 
resulting suspension was stirred overnight at rt.  1H-NMR analysis of a filtered sample 
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of the reaction mixture showed formation of the aldehyde.  Excess solid sodium 
hydrogencarbonate was added to neutralise the reaction.  The resulting suspension 
was filtered to give a solution of the aldehyde 157 in dichloromethane, to which 
carbethoxymethylenetriphenylphosphorane (17.07 g, 49.0 mmol, 1.0 equiv) was 
added in one portion.  The resulting suspension was stirred for 48 h and poured onto 
water (60 mL).  The phases were separated and the aqueous phase was extracted with 
dichloromethane (2 x 60 mL).  The combined organic phases were dried (MgSO4) and 
concentrated under reduced pressure. The crude product was passed through a silica 
gel plug (15% EtOAc/petrol) to remove triphenylphosphine oxide.  Further 
purification (if required) over silica gel or by distillation under reduced pressure 
afforded the ester 158. 
 
General procedure B, for the preparation of allylic alcohols 152a–g 
To a solution of ester 158 (2.60 mmol, 1.0 equiv) in dichloromethane (15 mL) at –78 
°C was added diisobutylaluminium hydride (6.50 mL of a 1.0 M solution in toluene, 
6.50 mmol, 2.5 equiv) dropwise via syringe. The resulting mixture was stirred at –78 
°C for 1 h, warmed to rt and stirred overnight. MeOH (1.5 mL) was added, followed 
by sodium sulfate decahydrate (10.0 g).  The resulting slurry was stirred for 1 h and 
filtered over Celite, washing with dichloromethane.  The filtrate was washed with 
aqueous HCl (1 M, 2 x 50 mL) followed by saturated aqueous sodium bicarbonate (2 
x 50 mL) and brine (50 mL).  The organic layer was dried (MgSO4) and concentrated 
under reduced pressure to give the allylic alcohol 152 as a colourless oil after 
purification over silica gel or by Kugelrohr distillation as appropriate. 
 
General procedure C, for the preparation of esters 154a–g, 182 and 243a–g 
To a solution of the allylic alcohol (1.57 mmol, 1.0 equiv) in triethyl orthoacetate 
(20.4 mmol, 13.0 equiv) was added propionic acid (0.314 mmol, 0.2 equiv) dropwise 
via syringe. After heating under reflux until the starting material had been consumed, 
the reaction mixture was cooled to rt and concentrated under reduced pressure to give 
the ester 154, 182, or 243. 
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General procedure D, for the preparation of (E)-γ-sulfenyl-α ,β-unsaturated 
esters 184a,c,e 
To a solution of TEA (3.90 mL, 28.0 mmol, 1.4 equiv) in THF (40 mL) was added 
thiophenol (2.05 mL, 20.0 mmol, 1.0 equiv) dropwise via syringe. The colourless 
solution was stirred at rt for 10 min and a solution of chloroaldehyde 207 (20.0 mmol, 
1.0 equiv) in THF (20 mL) was added dropwise via syringe. The rapid formation of a 
white precipitate was observed upon addition and the resulting suspension was stirred 
at rt for 1 h.  In a separate flask, a solution of triethyl phosphonoacetate (4.80 mL, 
24.0 mmol, 1.2 equiv) in THF (80 mL) was added to a suspension of sodium hydride 
(60% w/w in mineral oil, 1.20 g, 30.0 mmol, 1.5 equiv) in THF (40 mL) at 0 ºC via 
cannula.  The mixture was allowed to warm to rt with stirring until all sodium hydride 
had dissolved. The previously prepared sulfenyl-aldehyde solution was filtered under 
nitrogen and added via cannula to the phosphonate anion solution at 0 ºC.  After 
stirring for 1 h at 0 °C saturated aqueous NH4Cl (100 mL) was added and the mixture 
extracted with EtOAc (3 x 100 mL).  The combined organic extracts were washed 
with brine (150 mL), dried (MgSO4) and concentrated under reduced pressure. 
Purification over silica gel afforded the ester E-184. 
 
General procedure E, for the preparation of (Z)-γ-sulfenyl-α ,β-unsaturated 
esters 184b,d,f 
To a solution of TEA (3.90 mL, 28.0 mmol, 1.4 equiv) in THF (40 mL) was added 
thiophenol (2.05 mL, 20.0 mmol, 1.0 equiv) dropwise via syringe. The colourless 
solution was stirred at rt for 10 min and a solution of chloroaldehyde 207 (20.0 mmol, 
1.0 equiv) in THF (20 mL) was added dropwise via syringe. The rapid formation of a 
white precipitate was observed upon addition and the resulting suspension was stirred 
at rt for 1 h.  In a separate flask, a solution of 2-(diphenylphosphoryl)acetate (6.41 g, 
20.0 mmol, 1.0 equiv) in THF (80 mL) was added to a suspension of sodium hydride 
(60% w/w in mineral oil, 1.20 g, 30.0 mmol, 1.5 equiv) in THF (40 mL) at 0 ºC via 
cannula. The mixture was allowed to warm to rt with stirring until all sodium hydride 
had dissolved. The previously prepared sulfenyl-aldehyde solution was filtered under 
nitrogen and added via cannula to the phosphonate anion solution at –78 ºC.  After 
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stirring for 1 h at –78 ºC saturated aqueous NH4Cl (150 mL) was added and the 
mixture extracted with EtOAc (3 x 100 mL).  The combined organic extracts were 
washed with brine (150 mL), dried (MgSO4) and concentrated under reduced 
pressure. Purification over silica gel afforded the ester Z-184. 
 
General procedure F, for the preparation of allylic alcohols 185a–f 
To a solution of ester 184 (4.91 mmol, 1.0 equiv) in THF (50 mL) at 0 ºC was added 
diisobutylaluminium hydride (14.7 mL of a 1.0 M solution in toluene, 14.7 mmol, 3.0 
equiv) dropwise via syringe.  The resulting colourless solution was warmed to rt and 
stirred for 1.5 h.  The reaction mixture was diluted with dichloromethane (60 mL) and 
quenched with MeOH (5 mL). Water (10 mL) was added, followed by saturated 
aqueous sodium hydrogencarbonate (20 mL) and the mixture was filtered. The filtrate 
was extracted with dichloromethane (3 x 65 mL), dried (MgSO4) and concentrated 
under reduced pressure. Purification over silica gel (5–75 % TBME/heptane) afforded 
the allylic alcohol 185. 
 
General procedure G, for the preparation of esters 186a–c 
The general procedure C was followed; with the exception that triethyl orthoacetate 
was degassed by three freeze-vacuum pump-thaw cycles prior to use. 
 
General procedure H, for the preparation of α ,β-unsaturated ketones 238b,d,h,j 
To a solution of 1-(triphenylphosphanylidene)propan-2-one (22.5 mmol, 1.5 equiv) in 
dichloromethane (15 mL) was added the aldehyde (15.0 mmol, 1.0 equiv) dropwise 
via syringe at rt.  The resulting mixture was stirred until TLC (20% EtOAc/petrol) 
confirmed the consumption of starting material.  Aqueous HCl (2 M, 15 mL) was 
added, the phases were separated and the aqueous layer was extracted with 
dichloromethane (3 x 10 mL).  The combined organic extracts were dried (MgSO4) 
and concentrated under reduced pressure.  The residue was taken up in ether, filtered 
and purified by Kugelrohr distillation to afford the α,β-unsaturated ketone 238. 
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General procedure I, for the preparation of chlorohydrins 239a–g 
To a solution of α,β-unsaturated carbonyl 238 (10.0 mmol, 1.0 equiv) in THF (20 
mL) at –78 ºC was added chloroiodomethane (15.0 mmol, 1.5 equiv), followed by 
slow addition of n-butyllithium (6.0 mL of a 2.50 M solution in hexanes, 15.0 mmol, 
1.5 equiv) over 30 min.  The resulting yellow solution was stirred at –78 ºC for 1 h 
and quenched with saturated aqueous NH4Cl (25 mL).  The mixture was warmed to rt 
and ether (50 mL) was added.  The phases were separated and the aqueous layer was 
extracted with ether (2 x 50 mL), dried (MgSO4) and concentrated.  Purification over 
silica gel afforded the chlorohydrin 239. 
 
General procedure J, for the preparation of oxiranes 234a–g 
To a suspension of pentane-washed sodium hydride (60% w/w in mineral oil, 10.2 
mmol, 1.3 equiv) and sodium iodide (0.78 mmol, 0.1 equiv) in THF (11 mL) was 
added a solution of the chlorohydrin 239 (7.8 mmol, 1.0 equiv) in THF (11 mL) at 0 
°C.  The resulting white suspension was stirred at 0 °C for 1 h and quenched with 
saturated aqueous NH4Cl (30 mL).  The phases were separated and the aqueous layer 
was extracted with ether (30 mL).  The combined organic extracts were dried 
(Na2SO4) and concentrated under reduced pressure to give the oxirane 234, which 
were used without further purification. 
 
General procedure K, for the preparation of allylic azidoalcohols 235/236a–g 
To a solution of oxirane 234 (31.5 mmol, 1.0 equiv) in acetone (45 mL) and water (19 
mL) was added sodium azide (94.5 mmol, 3.0 equiv) in one portion.  After heating the 
resulting solution under reflux for 8 h, the reaction mixture was cooled to rt and 
NH4Cl (5.0 g) was added.  Water (50 mL) was added and the reaction mixture was 
concentrated under reduced pressure to remove acetone.  The remaining aqueous 
layer was extracted with dichloromethane (3 x 100 mL).  The combined organic 
extracts were dried (Na2SO4), concentrated under reduced pressure and purified over 
silica gel to give a mixture of the allylic azidoalcohols 235/236. 
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General procedure L, for the preparation of pyrrolidin-2-ones 244a–d 
To a mixture of ester 243 (0.44 mmol, 1.0 equiv) and water (0.66 mmol, 1.5 equiv) 
was added trimethylphosphine (0.66 mL of a 1 M solution in THF, 0.66 mmol, 1.5 
equiv) dropwise via syringe at rt. The resulting solution was stirred until TLC (20% 
ether/petrol) confirmed consumption of the starting material.  Water (5 mL) was 
added and the mixture was extracted with ether (3 x 5 mL).  The combined organic 
extracts were dried (MgSO4) and concentrated under reduced pressure to afford the 
pyrrolidin-2-one 244 after purification over silica gel. 
 
General procedure M, for the preparation of allylic azidoesters 252/253a–g 
To a solution of azidoalcohols 235/236 (5.46 mmol, 1.0 equiv) in dichloromethane 
(10 mL) was added DMAP (0.546 mmol, 0.1 equiv), followed by a solution of DCC 
(6.01 mmol, 1.1 equiv) in dichloromethane (10 mL) at rt.  The mixture was stirred for 
5 min before addition of 2-p-toluenesulfonylacetic acid (1.29 g, 6.01 mmol, 1.1 
equiv).  After stirring the colourless suspension for 16 h, the reaction mixture was 
filtered through Celite and the filtrate was concentrated under reduced pressure. 
Purification of the residue over silica gel afforded mixtures of the esters 252/253. 
 
General procedure N, for the preparation of homoallylic sulfones 254a,c,f 
To a solution of the azidoesters 252/253 (0.132 mmol 1.0 equiv) in acetonitrile (1.0 
M) was added N,O-bistrimethylsilylacetamide (0.396 mmol, 3.0 equiv) and TEA 
(0.158 mmol, 1.2 equiv) in a capped microwave vial.  The mixture was heated by 
microwave at 160 °C until TLC showed consumption of the starting material.  The 
reaction mixture was cooled to rt, quenched with aqueous HCl (2 M, 10 mL) and 
extracted with dichloromethane (3 x 10 mL).  The combined organic extracts were 
passed though an SCX ion exchange column (conditioned with 10% 
MeOH/dichloromethane) and concentrated under reduced pressure to afford the acid 
255 without further purification. To solution of the crude acid 255 (1.0 equiv) in DMF 
(1.0 M) was added sodium hydrogencarbonate (1.2 equiv) in a microwave vial.  The 
mixture was heated by microwave at 160 °C for 35 min and cooled to rt. Water (10 
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mL) was added and the mixture was extracted with dichloromethane (3 x 10 mL).  
The combined organic extracts were dried (MgSO4) and concentrated under reduced 
pressure.  Purification of the residue over silica gel afforded sulfone 254.  
 
General procedure O, for the preparation of homoallylic sulfones 254b,d,e 
To solution of the azidoesters 252/253 (0.132 mmol 1.0 equiv) in acetonitrile (1.0 M) 
was added N,O-bistrimethylsilylacetamide (0.660 mmol, 5.0 equiv) and TEA (0.264 
mmol, 2.0 equiv) in a capped microwave vial.  The mixture was heated by microwave 
at 160 °C until TLC showed consumption of the starting material.  The reaction 
mixture was cooled to rt, quenched with aqueous HCl (2 M, 10 mL) and extracted 
with dichloromethane (3 x 10 mL).  The combined organic extracts were passed 
though an SCX ion exchange column (conditioned with 10% 
MeOH/dichloromethane) and concentrated under reduced pressure to afford the acid 
255 without further purification. To solution of the crude acid 255 (1.0 equiv) in DMF 
(1.0 M) was added sodium hydrogencarbonate (1.2 equiv) in a microwave vial.  The 
mixture was heated by microwave at 160 °C for 35 min and cooled to rt. Water (10 
mL) was added and the mixture was extracted with dichloromethane (3 x 10 mL).  
The combined organic extracts were dried (MgSO4) and concentrated under reduced 
pressure.  Purification of the residue over silica gel afforded sulfone 254.  
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3.4 Individual procedures 
 
3.4.1 Compounds relevant to section 2.2 
 
(E)-Ethyl 4-methylhex-2,3-enoate (158a) 
 
 
 
 
 
Lithium chloride (0.509 g, 12.0 mmol, 1.2 equiv) was placed in a 20 mL microwave 
vial, which was capped and purged with argon. Acetonitrile (10 mL) was added via 
syringe, followed by DBU (1.79 mL, 12.0 mmol, 1.2 equiv).  Triethyl 
phosphonoacetate (2.38 mL, 12.0 mmol, 1.2 equiv) was added dropwise at rt and the 
resulting solution was stirred for 5 min.  2-Methylbutyraldehyde (1.05 mL, 10.0 
mmol, 1.0 equiv) was added dropwise, resulting in a slightly exothermic reaction, to 
give a cloudy mixture. After heating by microwave to 100 °C for 5 min, the reaction 
was cooled to rt, quenched with aqueous HCl (2 M, 10 mL) and poured onto ether (20 
mL).  The phases were separated and the aqueous phase was extracted with ether (2 x 
50 mL). The combined organic extracts were washed with brine (2 x 50 mL), dried 
(MgSO4) and concentrated under reduced pressure. Distillation of the residue under 
reduced pressure afforded (E)-ethyl 4-methylhex-2,3-enoate 158a (1.18 g, 76%) as a 
colourless oil: bp30 120–125 °C; νmax (film) 1720, 1652, 1461, 1269, 1186, 1041, 986 
cm-1; δH (400 MHz, CDCl3) 6.88 (1H, dd, J 15.5, 7.0, H-3), 5.80 (1H, d, J 15.5, H-2), 
4.21 (2H, q, J 7.0, OCH2), 2.23 (1H, sept, J 7.0, H-4), 1.42 (2H, dq, J 7.5, 7.0, H-5), 
1.31 (3H, t, J 7.0, OCH2CH3), 1.06 (3H, d, J 7.0, 4-CH3), 0.90 (3H, t, J 7.5, H-6); δC 
(101 MHz, CDCl3) 167.0 (C-1), 154.5 (C-3), 119.7 (C-2), 60.2 (OCH2), 38.1 (C-4), 
28.8 (C-5), 18.9 (4-Me), 14.3 (OCH2CH3), 11.6 (C-6); in agreement with published 
data. 212 
 
O
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(E)-Ethyl 4-cyclopropylpent-2-enoate (158b) 
 
 
 
 
 
1-Cyclopropylethanone (2.31 g, 23.8 mmol, 1.0 equiv) was reacted according to 
general procedure A to afford (E)-ethyl 4-cyclopropylpent-2-enoate 158b (0.247 g, 
7%) as a colourless oil without further purification: νmax (film) 1721, 1652 cm-1; δH 
(400 MHz, CDCl3) 6.54 (1H, dd, J 16.0, 6.5, H-3), 5.86 (1H, d, J 16.0, H-2), 4.22 
(2H, q, J 7.0, OCH2), 1.58–1.55 (1H, m, H-4), 1.32 (3H, t, J 7.0, OCH2CH3), 1.16 
(3H, d, J 7.0, H-5), 0.72–0.63 (1H, m, CH(CH2)2) 0.49–0.54 (2H, m, CH(CHH)2) 
0.14–0.18 (2H, m, CH(CHH)2); δC (101 MHz, CDCl3) 167.1 (C-1), 153.6 (C-3), 
119.3 (C-2) 60.2 (OCH2), 41.3 (C-4), 18.9 (C-5), 16.4 (CH(CH2)2), 14.3 (OCH2CH3), 
[4.0 and 3.8 (CH(CH2)2]; m/z (CI) 186 [MNH4]+, 169 [MH]+, 100 (Found: [MNH4]+, 
186.1494. C10H16O2 requires [MNH4]+, 186.1494). 
 
(E)-Ethyl 4-cyclohexylpent-2-enoate (158c) 
 
 
 
 
 
1-Cyclohexylethanone (3.00 g, 23.8 mmol, 1.0 equiv) was reacted according to 
general procedure A to afford (E)-ethyl 4-cyclohexylpent-2-enoate 158c (1.36 g, 37%) 
as a colourless oil after purification over silica gel (5% EtOAc/petrol): νmax (film) 
1722, 1650, 1452, 1140, 1086 cm-1; δH (400 MHz, CDCl3) 6.91 (1H, dd, J 15.5, 8.5, 
H-3), 5.77 (1H, d, J 15.5, H-2), 4.21 (2H, q, J 7.0, OCH2), 2.20–2.11 (1H, m, H-4), 
1.76–1.62 (6H, m, cyclohexyl), 1.32 (3H, t, J 7.0, OCH2CH3), 1.03 (3H, d, J 7.0, H-5) 
Me
O Me CO2Et
158b
Me
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1.25–0.89 (5H, m, cyclohexyl); δC (101 MHz, CDCl3) 166.9 (C-1), 153.9 (C-3), 120.3 
(C-2) 60.2 (OCH2CH3), 42.6 (C-3), 30.5, 26.5, 16.4, (cyclohexyl), 14.3 (C-5 and 
OCH2CH3); m/z (ESI) 214, 211 [MH]+, 165 [M–CO2Et]+ (Found: [MH]+, 211.1708. 
C13H22O2 requires [MH]+, 211.1698). 
 
(E)-Ethyl 4-methylnon-2-enoate (158d) 
 
 
 
 
 
2-Heptanone (2.72 g, 23.8 mmol 1.0 equiv) was reacted according to general 
procedure A to afford (E)-ethyl 4-methylnon-2-enoate 158d (1.13 g, 22%) as a 
colourless oil after purification over silica gel (5% EtOAc/petrol): νmax (film) 1720, 
1650 cm-1; δH (400 MHz, CDCl3) 6.68 (1H, dd, J 15.5, 8.0, H-3), 5.76 (1H, d, J 15.5, 
H-2), 4.20 (2H, q, J 7.0, OCH2), 2.31 (1H, m, H-4), 1.37–1.26 (8H, m, H-5,6,7,8), 
1.05 (3H, d, J 6.5, 4-Me), 0.90 (3H, t, J 7.0, OCH2CH3); δC (101 MHz, CDCl3) 167.0 
(C-1), 154.8 (C-3), 119.5 (C-2), 60.2 (OCH2), 36.5, 36.0, 31.9, 26.9, 22.6, 19.4, 14.3, 
14.1; in agreement with published data.213 
 
(E)-Ethyl 4,5,5-trimethylhex-2-enoate (158e) 
 
 
 
 
 
3,3-Dimethyl-2-butanone (4.91 g, 49.0 mmol, 1.0 equiv) was reacted according to 
general procedure A to afford (E)-ethyl 4,5,5-trimethylhex-2-enoate 158e (1.35 g, 
15%) as a yellow oil after Kugelrohr distillation: bp0.5 100–105 °C; νmax (film) 1722, 
1650, 1463, 1367, 1039, 985, 865 cm-1; δH (400 MHz, CDCl3) 6.95 (1H, dd, J 14.0, 
Me C5H11
O Me
C5H11
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15.5, H-3), 5.80 (1H, d, J 15.5, H-2), 4.15 (2H, q, J 7.0, OCH2), 2.10 (1H, dq, J 14.0, 
7.0, H-4), 1.30 (3H, t, J 7.0, OCH2CH3), 1.05 (3H, d, J 7.0, 4-Me), 0.85 (9H, s, 
C(CH3)3); δC (101 MHz, CDCl3), 152.7 (C-1), 128.5 (C-3), 120.9 (C-2), 60.1 (OCH2), 
47.0 (C-4) 33.2 (C(CH3)3), 27.5 (C(CH3)3), 14.6 (OCH2CH3), 14.3 (4-CH3); m/z (CI) 
202 [MNH4]+, 185 [MH]+ (Found: [MNH4]+, 202.1805. C11H20O2 requires [MNH4]+, 
202.1807). 
 
(E)-Ethyl 4-phenylpent-2,3-enoate (158f) 
 
 
 
 
 
To a solution of 2-phenylpropanal (1.49 mL, 11.0 mmol, 1.0 equiv) in dry 
dimethylsulfoxide (10 mL) in a microwave vial was added 
carbethoxymethylenetriphenylphosphorane (3.83 g, 11.0 mmol, 1.0 equiv) and 
lithium chloride (0.510 g, 12.0 mmol, 1.09 equiv). The reaction mixture was heated 
by microwave for 30 min at 120 °C to give a colourless solution upon cooling.  The 
reaction mixture was poured onto water (70 mL) and ether (150 mL) was added.  The 
phases were separated and the aqueous phase was extracted with ether (2 x 100 mL). 
The combined organic extracts were dried (MgSO4) and concentrated under reduced 
pressure to afford (E)-ethyl 4-phenylpent-2,3-enoate 158f (1.79 g, 80%) as a 
colourless oil after purification over silica gel (8% EtOAc/petrol): νmax (film) 1732, 
1651, 1446, 1266, 1177, 1028, 699 cm-1; δH (400 MHz, CDCl3) 7.40–7.20 (5H, m, 
Ph), 7.16 (1H, dd, J 15.5, 7.0, H-3), 5.85 (1H, d, J 15.5, H-2), 4.22 (2H, q, J 7.0, 
OCH2), 3.65 (1H, dq, J 7.0, 7.0, H-4), 1.47 (3H, d, J 7.0 H-5), 1.21 (3H, t, J 7.0, 
OCH2CH3); δC (101 MHz, CDCl3) 166.7 (C-1), 152.6 (C-3), 143.4 (i-Ph), 128.7 (m-
Ph), 127.3 (o-Ph), 126.7 (p-Ph), 120.2 (C-2), 60.3 (OCH2), 42.1 (C-4), 20.2 (C-5), 
14.3 (OCH2CH3); in agreement with published data.77 
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(E)-Ethyl 4-methylhex-2-enoate (158g) 
 
 
 
 
 
1-Phenylpropanone (3.35 g, 25.0 mmol, 1.0 equiv) was reacted according to general 
procedure A to afford (E)-ethyl 4-methylhex-2-enoate 158g (1.28 g, 24%) as a 
colourless oil after purification by Kugelrohr distillation: bp5 170–175 °C; νmax (film) 
1716, 1650, 1454 cm-1; δH (400 MHz, CDCl3) 7.15–7.35 (5H, m, Ph) 7.09 (1H, dd, J 
15.5, 8.0, H-3), 5.81 (1H, d, J 15.5, H-2), 4.19 (2H, q, J 7.0, OCH2), 3.31 (1H, dt, J 
8.0, 7.0, H-4), 1.29 (3H, t, J 7.0, OCH2CH3), 1.83 (2H, m, H-5), 0.90 (3H, t, J 7.5, H-
6); δC (101 MHz, CDCl3) 166.7 (C-1), 151.7 (C-3), 142.1, 128.6, 127.9, 126.7 (Ph), 
120.8 (C-2), 60.2 (OCH2), 50.2 (C-4), 27.9, 14.2, 12.1; in agreement with published 
data.214 
 
(E)-4-Methylhex-2-en-1-ol (152a) 
 
 
 
 
 
Ester 158a (809 mg, 5.20 mmol, 1.0 equiv) was reacted according to general 
procedure B to afford (E)-4-methylhex-2-en-1-ol 152a (176 mg, 30%) as a colourless 
oil after purification over silica gel (20% EtOAc/petrol): νmax (film) 3392, 1641, 1461 
cm-1; δH (400 MHz, CDCl3) 5.66–5.57 (2H, m, H-2,3), 4.91 (2H, d, J 5.0, H-1), 2.11–
2.04 (1H, m, H-4), 1.34 (2H, dq, J 7.5, 7.0, H-5), 1.01 (3H, d, J 7.0, 4-Me), 0.87 (3H, 
t, J 7.5, H-6); δC (101 MHz, CDCl3) 139.1 (C-3), 127.2 (C-2), 63.9 (C-1), 38.0 (C-4), 
29.5 (C-5), 19.9 (4-Me), 11.8 (C-6); m/z (CI) 114 [M]+, 103; in agreement with 
published data.215 
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(E)-4-Cyclopropylpent-2-en-1-ol (152b) 
 
 
 
 
 
Ester 158b (224 mg, 1.33 mmol, 1.0 equiv) was reacted according to general 
procedure B to afford (E)-4-cyclopropylpent-2-en-1-ol 152b (162 mg, 96%) as a 
colourless oil, which was used without further purification: νmax (film) 3336, 1668 
cm-1; δH (400 MHz, CDCl3) 5.76 (1H, dd, J 15.5, 6.0, H-3), 5.67 (1H, dt, J 15.5, 6.0, 
H-2), 4.14 (2H, d, J 6.0, H-1), 1.45–1.43 (2H, m, H-4, OH), 1.10 (3H, d, J 6.0, H-5), 
0.63–0.61 (1H, m, CH(CH2)2), 0.46–0.44 (2H, m, CH(CHH)2), 0.13–0.12 (2H, m, 
CH(CHH)2); δC (101 MHz, CDCl3) 138.0 (C-3), 126.8 (C-2), 64.0 (C-1) 41.0 (C-5), 
19.7, 17.1, [3.7 and 3.6 (cyclopropyl)]; m/z (CI) 126 [M]+, 109 (Found:  [MNH4]+, 
144.1388. C8H14O requires [MNH4]+, 144.1387). 
 
(E)-4-Cyclohexylpent-2-en-1-ol (152c) 
 
 
 
 
 
Ester 158c (1.14 g, 5.41 mmol, 1.0 equiv) was reacted according to general procedure 
B to afford the (E)-4-cyclohexylpent-2-en-1-ol 152c (0.757 g, 83%) as a colourless oil 
after purification by Kugelrohr distillation: bp10 175 °C; νmax (film) 3388, 1641 cm-1; 
δH (400 MHz, CDCl3) 5.62–5.51 (2H, m, H-2,3), 4.08 (2H, d, J 4.5, H-1), 1.99–1.94 
(1H, m, H-4), 1.85 (1H, s (br), OH), 1.73–1.61 (6H, m, cyclohexyl), 1.23–1.12 (5H, 
m, cyclohexyl), 0.96 (3H, d, J, 7.0, H-5); δC (101 MHz, CDCl3) 137.8 (C-3), 127.8 
(C-2), 63.8 (C-1) 43.0 (C-4), 42.0, 32.0, 30.3, 26.6 (cyclohexyl), 17.3 (C-5); m/z (CI) 
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186 [MNH4]+, 169 [MH]+ (Found: [MNH4]+, 186.1863. C11H20O requires [MNH4]+, 
186.1858). 
 
(E)-4-Methylnon-2-en-1-ol (152d) 
 
 
 
 
 
Ester 158d (1.14 g, 5.73 mmol, 1.0 equiv) was reacted according to general procedure 
B to afford (E)-4-methylnon-2-en-1-ol 152d (0.313 g, 35%) as a colourless oil after 
purification by Kugelrohr distillation: bp4 95 °C; νmax (film) 3318, 1668, 1457, 1378, 
971 cm-1; δH (400 MHz, CDCl3) 5.61–5.58 (2H, m, H-2,3), 4.10 (2H, d, J 4.5, H-1), 
2.14 (1H, m, H-4), 1.40 (1H, s (br), OH), 1.29–1.27 (8H, m, H-5,6,7,8), 0.99 (3H, d, J 
7.0, 4-Me), 0.89 (3H, t, J 7.0, H-9); δC (400 MHz, CDCl3) 139.4 (C-3), 127.0 (C-2), 
63.9 (C-1), 36.8, 36.3, 32.0, 26.9, 22.7, 20.4, 14.1; m/z (ESI) 155 [M–H]+, 151, 137. 
 
(E)-4,5,5-Trimethylhex-2-en-1-ol (152e) 
 
 
 
 
 
Ester 158e (568 mg, 3.10 mmol, 1.0 equiv) was reacted according to general 
procedure B to afford (E)-4,5,5-trimethylhex-2-en-1-ol 152e  (290 mg, 66%) as a 
colourless oil after purification by Kugelrohr distillation: bp5 150 °C; νmax (film) 
3450, 1639 cm-1; δH (400 MHz, CDCl3) 5.70–5.57 (2H, m, H-2,3), 4.12 (2H, d, J 5.0, 
H-1), 1.95 (1H, dq, J 8.0, 6.5, H-4), 1.42 (1H, s (br), OH), 0.96 (3H, d, J 6.5, 4-Me), 
0.87 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 136.6 (C-3), 128.6 (C-2), 64.0 (C-1), 
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46.8 (C-5) 32.8 (C-4), 27.5 (C(CH3)3), 15.4 (4-CH3); m/z (CI) 142 [M]+, 125 [M–
OH]+ (Found: [M]+, 142.1595. C9H18O requires [M]+, 142.1358). 
 
(E)-4-Phenylpent-2-en-1-ol (152f) 
 
 
 
 
 
Ester 158f (527 mg, 2.58 mmol, 1.0 equiv) was reacted according to general 
procedure B to afford (E)-4-phenylpent-2-en-1-ol 152f (303 mg, 77%) as a colourless 
oil after purification over silica gel (25% EtOAc/petrol): νmax (film) 3420, 1638 cm-1; 
δH (400 MHz, CDCl3) 7.35–7.23 (5H, m, Ph), 5.91 (1H, dd, J 15.5, 7.0, H-3) 5.70 
(1H, dt, J 15.5, 6.0, H-2), 4.15 (2H, d, J 6.0, H-1), 3.53 (1H, m, H-4), 1.44 (1H, s (br), 
OH) 1.41 (3H, d, J 7.0, 4-Me); δC (101 MHz, CDCl3) 145.5 (i-Ph), 137.5 (C-3), 128.5, 
127,7, 127.2 (Ph), 126.3 (C-2), 63.7 (C-1), 42.0 (C-4), 21.1 (C-5); in agreement with 
published data.77 
 
(E)-4-Phenylhex-2-en-1-ol (152g) 
 
 
 
 
 
Ester 158g (1.03 g, 5.04 mmol, 1.0 equiv) was reacted according to general procedure 
B to afford (E)-4-phenylhex-2-en-1-ol 152g (0.361 g, 45%) as a colourless oil after 
purification by Kugelrohr distillation: bp5 175 °C; νmax (film) 3401, 1641, 1492, 1080, 
972 cm-1; δH (400 MHz, CDCl3) 5.85 (1H, dd, J 15.5, 7.0, H-3), 5.66 (1H, dt, J 15.5, 
6.0, H-2), 4.13 (2H, d, J 6.0, H-1), 3.18 (1H, dt, J 7.5, 7.0, H-4), 1.77 (2H, dq, J 7.5, 
7.5, H-5), 0.88 (3H, t, J 7.5, H-6), 1.44 (1H, s (br), OH); δC (101 MHz, CDCl3) 144.4 
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(C-3), 136.5 (C-2), 128.5 (i-Ph), 126.0 (p-Ph), 126.2 (m-Ph), 127.6 (o-Ph), 63.7 (C-1), 
50.39 (C-4), 12.2 (C-5), 28.6 (C-6); m/z (CI) 194 [MNH4]+, 176 [M]+, 159 [M-OH]+ 
(Found: [MNH4]+, 194.1539. C12H16O requires [MNH4]+, 194.1545). 
 
Ethyl 3-ethenyl-4-methylhexanoate (154a) 
 
 
 
  
 
Allylic alcohol 152a (147 mg, 1.57 mmol, 1.0 equiv) was reacted according to general 
procedure C to afford ethyl 3-ethenyl-4-methylhexanoate 154a (285 mg, 98%, 50:50 
syn:anti mixture of diastereomers) as a colourless oil: νmax (film) 1736, 1639, 1463, 
1374, 1249, 1035 cm-1; δH (400 MHz, CDCl3) 5.73–5.65 (2H, m, syn+anti CHCH2), 
5.06–5.00 (4H, m, syn+anti CHCH2), 4.19–4.09 (4H, m, syn+anti OCH2), 2.80–2.04 
(4H, m, syn+anti H-3,4), [1.40–1.30 (5H, m) and 0.90–0.80 (6H, m) syn+anti H-
5,6,4-Me and OCH2CH3]; δC (101 MHz, CDCl3) 182.3 (C-1), 127.9 (CHCH2), 116.1 
(CHCH2), 60.1 (OCH2), 57.4, 26.0, 15.2, 14.3; m/z (CI) 202 [MNH4]+, 185 [MH]+ 
(Found: [MH]+, 185.1490. C11H20O2 requires [MH]+, 185.1497). 
 
Ethyl 3-ethenyl-4-cyclopropylpentanoate (154b) 
 
 
 
  
 
Allylic alcohol 152b (156 mg, 1.23 mmol, 1.0 equiv) was reacted according to 
general procedure C to afford ethyl 3-ethenyl-4-cyclopropylpentanoate 154b (217 mg, 
89%, 50:50 syn:anti mixture of diastereomers) as a yellow oil: νmax (film) 1737, 1639, 
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1461 cm-1; δH (400 MHz, CDCl3) [5.81 (1H, ddd, J 17.0, 11.0, 8.5) and 5.73 (1H, ddd, 
J 17.0, 10.5, 8.5), syn+anti CHCH2], [5.09–5.07 (2H, m) and 5.05–5.04 (2H, m), 
syn+anti CHCH2], [4.13 (2H, q, J 7.0) and 4.12 (2H, q, J 7.0), syn+anti OCH2), 2.69–
2.20 (2H, m, syn+anti H-3), [2.59–2.45 (2H, m, H-2) and 2.35 (2H, dd, J 14.0, 7.0), 
syn+anti H-2), [1.26 (3H, d, J 7.0) and 1.25 (3H, d, J 7.0), syn+anti OCH2CH3], 0.96 
(6H, d, J 7.0, syn+anti H-5), 0.85–0.64 (4H, m, syn+anti H-4), 0.58–0.40 (10H, m, 
syn+anti cyclopropyl); δC (101 MHz, CDCl3) [173.1 and 173.0, (C-1)], [139.1 and 
139.0, (CHCH2)], [115.9 and 115.7, (CHCH2)], 60.1 (OCH2), [57.6 and 57.4, (C-4)], 
46.3, 42.47, 38.0 (C-2), 20.1, 16.3, 3.5, 3.6; m/z (CI) 214 [MNH4]+, 197 [MH]+ 
(Found: [MH]+, 197.1541. C12H20O2 requires [MH]+, 197.1541). 
 
Ethyl 3-ethenyl-4-cyclohexylpentanoate (154c) 
 
 
 
  
 
Allylic alcohol 152c (300 mg, 1.78 mmol, 1.0 equiv) was reacted according to general 
procedure C to afford ethyl 3-ethenyl-4-cyclohexylpentanoate 154c (385 mg, 91%, 
17:83 syn:anti mixture of diastereomers) as a colourless oil. 
Data for the mixture: νmax (film) 1738, 1639, 1448, 1368, 1256 cm-1; m/z (CI) 239 
[MNH4]+, 256 [MH]+ (Found: [MH]+, 239.2021. C15H26O2 requires [MH]+, 
239.2011). 
NMR data for syn-154c: δH (400 MHz, CDCl3) 5.71–5.62 (1H, m, CHCH2), 5.01–4.99 
(2H, m, CHCH2), 4.11 (2H, q, J 7.0, OCH2), 2.65–2.58 (1H, m, H-3), 2.48–2.07 (1H, 
m, H-4), 1.75–1.66 (11H, m, cyclohexyl), 1.28–1.21 (5H, m, H-2, OCH2CH3), 0.99 
(3H, d, J 7.0, H-5); δC (101 MHz, CDCl3) 174.3 (C-1), 138.2 (CHCH2), 115.1 
(CHCH2), 60.2 (OCH2), 57.4 (C-4); 43.0, 41.4, 36.5, 26.7, 20.0, 17.2, 14.0. 
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NMR data for anti-154c: δH (400 MHz, CDCl3) 5.71–5.62 (1H, m, CHCH2), 5.06–
5.03 (2H, m, CHCH2), 4.13 (2H, q, J 7.0, OCH2), 2.79–2.72 (1H, m, H-3), 2.48–2.07 
(1H, m, H-4), 1.75–1.66 (11H, m, cyclohexyl), 1.28–1.21 (5H, m, H-2, OCH2CH3), 
0.97 (3H, d, J 7.0, H-5); δC (101 MHz, CDCl3) 174.6 (C-1), 138.6 (CHCH2), 116.0 
(CHCH2), 60.2 (OCH2), 57.6 (C-4), 43.2, 41.8, 38.7, 26.9, 19.4, 17.4, 14.5. 
 
Ethyl 3-ethenyl-4-methylnonate (154d) 
 
 
 
  
 
Allylic alcohol 152d (200 mg, 1.28 mmol, 1.0 equiv) reacted according to general 
procedure C to afford ethyl 3-ethenyl-4-methylnonate 154d (285 mg, 98%, 50:50 
syn:anti mixture of diastereomers) as a yellow oil: νmax (film) 1739, 1640, 1463, 1337 
cm-1; δH (400 MHz, CDCl3) 5.73–5.63 (2H, m, syn+anti CHCH2), 5.07–4.99 (4H, m, 
syn+anti CHCH2) [4.12 (2H, q, J 7.0) and 4.13 (2H, q, J 7.0), syn+anti OCH2], [2.58 
(1H, dt, J 9.0, 5.0) and 2.50 (1H, dt, J 9.0, 4.0), syn+anti H-3], 2.41–2.25 (4H, m, 
syn+anti H-2), 1.37–1.14 (20H, m, syn+anti H-4,5,6,7,8), 0.92–0.83 (12H, m, 
syn+anti OCH2CH3 and H-9); δC (101 MHz, CDCl3) 173.1 (syn+anti C-1), [139.6 and 
138.2 (CHCH2)], [116.1 and 113.4 (CHCH2)], 60.2 (OCH2), [45.7 and 44.7 (syn+anti 
C-2)], 37.8, 36.6, 34.6, 33.3, 32.1, 27.0, 22.7, 16.7, 15.5, 14.3, 14.1; m/z (CI) 245 
[MH+NH4]+, 187, 169 (Found: [MH+NH4]+, 245.2359. C14H26O2 requires 
[MH+NH4]+, 245.2355). 
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Ethyl 3-ethenyl-4,5,5-trimethyl-hexanoate (154e) 
 
 
 
  
 
Allylic alcohol 152e (279 mg, 1.96 mmol, 1.0 equiv) was reacted according to general 
procedure C to afford ethyl 3-ethenyl-4,5,5-trimethyl-hexanoate 154e (280 mg, 67%, 
33:67 syn:anti mixture of diastereomers) as a yellow oil.  
Data for the mixture: νmax (film) 1738, 1637, 1466, 1366, 1267, 1176 cm-1; δC (101 
MHz, CDCl3); 142.8 (anti C-1), 142.7 (syn C-1), 134.0 (syn+anti CHCH2), 129.6 
(anti CHCH2), 129.2 (syn CHCH2), 60.2 (OCH2), 41.7, 41.6, 21.5, 23.3, 14.4, 12.7; 
m/z (CI) 230 [MNH4]+, 213 [MH]+ (Found: [MH]+, 213.1859. C13H24O2 requires 
[MH]+, 213.1855). 
1H-NMR data for syn-154e: δH (400 MHz, CDCl3) 5.87–5.77 (1H, m, CHCH2) 4.98–
4.95 (2H, m, CHCH2), 4.12 (2H, q, J 7.0, OCH2), 2.50–2.20 (3H, m, H-2,3), 1.31–
1.52 (1H, m, H-4), 1.20 (3H, d, J 7.0, 4-Me), 0.95 (2H, d, J 7.0, OCH2CH3), 0.85 (9H, 
s, tBu). 
1H-NMR data for anti-154e: δH (400 MHz, CDCl3) 5.87–5.77 (1H, m, CHCH2) 5.07–
5.01 (2H, m, CHCH2), 4.13 (2H, q, J 7.0, OCH2), 2.50–2.20 (3H, m, H-2,3), 1.31–
1.52 (1H, m, H-4), 1.30 (3H, d, J 7.0, 4-Me), 0.96 (2H, d, J 7.0, OCH2CH3), 0.92 (9H, 
s, tBu). 
 
Ethyl 3-ethenyl-4-phenylpentanoate (154f) 
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Allylic alcohol 152f (200 mg, 1.25 mmol, 1.0 equiv) was reacted according to general 
procedure C to afford ethyl 3-ethenyl-4-phenylpentanoate 154f (280 mg, 97%, 32:68 
syn:anti mixture of diastereomers) as a yellow oil. 
Data for the mixture: νmax (film) 1734, 1640, 1494, 1374, 1176, 1032 cm-1; m/z (CI) 
250 [MNH4]+, 233 [MH]+ (Found [MH]+, 233.1463. C15H20O2 requires [MH]+, 
233.1463). 
NMR data for syn-154f: δH (400 MHz, CDCl3) 7.33–7.15 (5H, m, Ph), 5.56 (1H, ddd, 
J 17.0, 11.0, 9.0, CHCH2), 5.03–4.96 (2H, m, CHCH2), 4.11 (2H, q, J 7.0, OCH2), 
2.90–2.83 (1H, m, H-4), 2.83–2.77 (1H, m, H-3), [2.42 (1H, dd, J 15.0, 5.0) and 2.34 
(1H, dd, J 15.0, 7.0), H-2], 1.31 (3H, d, J 7.0, H-5), 1.21 (1H, d, J 7.0, OCH2CH3); δC 
(101 MHz, CDCl3) 172.6 (C-1), 138.4 (CHCH2), 128.3, 128.1, 126.2, 116.4 
(CHCH2), 60.1 (OCH2), 46.6, 43.1, 37.5, 18.5, 14.3. 
NMR data for anti-154f: δH (400 MHz, CDCl3) 7.33–7.15 (5H, m, Ph), 5.68 (1H, ddd, 
J 17.5, 10.0, 8.0, CHCH2), 5.12–5.08 (2H, m, CHCH2), 4.05 (2H, q, J 7.0, OCH2), 
2.73–2.68 (1H, m, H-4), 2.67–2.61 (1H, m, H-3), [2.24 (1H, dd, J 14.5, 9.0) and 2.10 
(1H, dd, J 14.5, 6.0), H-2], 1.25 (3H, d, J 7.0, H-5), 1.21 (1H, d, J 7.0, OCH2CH3); δC 
(101 MHz, CDCl3) 172.6 (C-1), 139.4 (CHCH2), 128.5, 127.6, 126.3, 116.7 
(CHCH2), 60.1 (OCH2), 47.5, 43.7, 38.6, 19.8, 14.3. 
 
Ethyl 3-ethenyl-4-phenylhexanoate (154g) 
 
 
 
  
 
Allylic alcohol 152g (307 mg, 1.87 mmol, 1.0 equiv) was reacted according to general 
procedure C to afford ethyl 3-ethenyl-4-phenylhexanoate 154g (460 mg, 99%, 32:68 
syn:anti mixture of diastereomers) as a yellow oil. 
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Data for the mixture: νmax (film) 1734, 1640, 1494, 1453 cm-1; m/z (CI) 264 [MNH4]+, 
247 [MH]+ (Found: [MH]+, 247.1698. C16H22O2 requires [MH]+, 247.1698). 
NMR data for syn-154g: δH (400 MHz, CDCl3) 7.34–7.16 (5H, m, Ph), 5.56 (1H, ddd, 
J 17.0, 9.0, 8.0, CHCH2), 5.04–5.01 (2H, m, CHCH2), 4.13 (2H, q, J 7.0, OCH2), 2.87 
(1H, ddt, J 8.0, 5.5, 3.5, H-3), 2.44–2.30 (1H, m, H-4), 2.22–2.13 (2H, m, H-2), .93–
1.83 (2H, m, H-5), 1.20 (3H, d, J 7.0, OCH2CH3), 0.81 (3H, t, J 7.5, H-6); δC (101 
MHz, CDCl3) 172.7 (C-1), 141.6 (i-Ph), 138.0 (CHCH2), 129.1, 127.9, 126.5, 116.4 
(CHCH2), 60.2 (OCH2), 51.1 (C-4), 38.1 (C-2), 25.9 (C-5), 14.9 (OCH2CH3), 12.3 (C-
6). 
NMR data for anti-154g: δH (400 MHz, CDCl3) 7.34–7.16 (5H, m, Ph), 5.69 (1H, 
ddd, J 17.0, 9.0, 8.0, CHCH2), 5.16–5.10 (2H, m, CHCH2), 4.04 (2H, q, J 7.0, OCH2), 
2.75 (1H, ddt, J 8.0, 6.0, 4.0, H-3), 2.44–2.30 (1H, m, H-4), 2.08–2.01 (2H, m, H-2), 
1.79–1.69 (2H, m, H-5), 1.26 (3H, d, J 7.0, OCH2CH3), 0.70 (3H, t, J 7.5, H-6); δC 
(101 MHz, CDCl3) 172.6 (C-1), 142.9 (i-Ph), 139.1 (CHCH2), 128.5, 126.8, 126.5, 
116.6 (CHCH2), 60.1 (OCH2), 51.7 (C-4), 38.7 (C-2), 26.8 (C-5), 15.2 (OCH2CH3), 
12.1 (C-6). 
 
4-Phenyl-3-ethenylhexan-1-ol (159) 
 
  
 
  
 
To a stirred solution of lithium aluminium hydride (74 mg, 1.95 mmol, 1.2 equiv) in 
THF (10 mL) was added a solution of ester 154g (400 mg, 1.62 mmol, 1.0 equiv) in 
THF (5 mL) at 0 °C.  Slight effervescence was observed.  The reaction mixture was 
warmed to rt and stirred for 35 min before quenching with ethanol (1.5 mL), water (3 
mL) and aqueous HCl (2 M, 3 mL).  The mixture was taken up in EtOAc (25 mL) and 
the phases were separated.  The aqueous phase was extracted with EtOAc (2 x 25 mL) 
and the combined organic extracts were washed with brine (25 mL) before drying 
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(MgSO4) and concentration under reduced pressure.  Repeated chromatography over 
silica gel (50% ether/petrol) afforded analytical samples of the separated 
diastereoisomers of 4-phenyl-3-ethenylhexan-1-ol 159: 
Less polar syn-159 (99 mg, 30%): νmax (film) 3335, 1630 cm-1; δH (400 MHz CDCl3) 
7.32 (2H, m, m-Ph), 7.22–7.20 (1H, m, p-Ph), 7.15–7.13 (2H, m, o-Ph), 5.63 (1H, 
ddd, J 17.0, 9.5, 7.5, CHCH2), 5.13 (2H, m, CHCH2), [3.59 (1H, ddd, J 11.0, 7.0, 5.0) 
and 3.50 (1H, ddd, J 11.0, 8.0, 6.5), H-1], 2.40–2.27 (2H, m, H-2), 1.92–1.82 (1H, m, 
H-4), 1.53–1.41 (2H, m, H-5), 1.34–1.24 (1H, m, H-3), 0.69 (3H, t, J 7.5, H-6); δC 
(101 MHz CDCl3) 143.7, 141.9 (CHCH2), 128.5, 128.3, 126.1, 116.3, 61.5 (C-1), 
52.4, 47.5, 35.6 (C-3), 26.9 (C-4), 12.2 (C-6) m/z (CI), 222 [MNH4]+ (Found: 
[MNH4]+, 222.1856. C14H20O requires [MNH4]+, 222.1858). 
More polar anti-159 (54 mg, 16%): νmax (film) 3336, 1630 cm-1; δH (400 MHz 
CDCl3) 7.38 (2H, m, m-Ph), 7.22–7.20 (1H, m, p-Ph), 7.12–7.11 (2H, m, o-Ph), 5.49 
(1H, ddd, J 17.0, 10.0, 7.0, CHCH2), 5.06–4.98 (2H, m, CHCH2), [3.65 (1H, ddd, J 
11.0, 7.0, 5.0) and 3.57 (1H, ddd, J 11.0, 7.0 and 5.0), H-1], 2.58–2.43 (2H, m, H-2), 
1.82–1.69 (1H, m, H-4), 1.53–1.48 (2H, m, H-5), 1.39–1.32 (1H, m, H-3), 0.81 (3H, t, 
J 7.5, H-6); δC (101 MHz CDCl3) 143.7, 139.8 (CHCH2), 128.7, 128.4, 126.2, 116.3, 
61.4 (C-1), 52.1, 45.9, 35.6 (C-3), 25.9 (C-4), 12.1 (C-6); m/z (CI), 222 [MNH4]+ 
(Found: [MNH4]+, 222.1856. C14H20O requires [MNH4]+, 222.1858). 
 
Anti-4-phenyl-3-ethenylhexyl 3,5-dinitrobenzoate (anti-160) 
 
 
 
 
 
To a solution of alcohol anti-159 (90 mg, 0.44 mmol, 1.0 equiv) in dichloromethane 
(1 mL) was added TEA (0.19 mL, 1.32 mmol, 3.0 equiv) followed by a solution of 
3,5-dinitrobenzoyl chloride (112 mg, 0.49 mmol, 1.1 equiv) in dichloromethane (1.2 
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mL) at 0 °C.  The resulting orange solution was warmed to rt and stirred for 48 h 
before quenching with aqueous HCl (2 M, 2 mL).  The mixture was partitioned 
between dichloromethane (7 mL) and water (15 mL) and the phases were separated.  
The aqueous phase was extracted with dichloromethane (2 x 7 mL).  The combined 
organic extracts were dried (MgSO4) and concentrated under reduced pressure. 
Purification over silica gel (20% ether/petrol) and recrystallisation (EtOAc/60–80 
petrol) afforded anti-(±)-4-phenyl-3-ethenylhexyl 3,5-dinitrobenzoate anti-160 (145 
mg, 89%) as yellow crystalline plates: mp 58–60 °C; νmax (film) 3085, 3026, 1723, 
1629, 1546, 1462, 1344, 1280, 1172, 1078 cm-1; δH (500 MHz CDCl3) 9.24 (1H, s, 
Ar), 9.10 (2H, s, Ar), 7.35 (2H, t, J 7.5, m-Ph), 7.22 (1H, t, J 7.5, p-Ph), 7.17–7.16 
(2H, m, o-Ph), 5.62 (1H, ddd, J 17.0, 10.0, 9.0, CHCH2), 5.20 (1H, d, J 10.0, trans-
CHCH2), 5.12 (1H, d, J 17.0, cis-CHCH2), 4.31 (1H, dddd, J 6.0, 8.0, 11.0, 15.0, H-
1), 2.36 (2H, m, H-2), 1.86 (1H, m, H-4), 1.75 (1H, m, H-3), 1.48 (2H, m, H-5), 0.68 
(3H, t, J 7.5, H-6); δC (126 MHz CDCl3) 162.3 (C-1), 148.6, 143.3, 140.6, 134.1, 
128.4, 126.4, 122.3, 117.1, 65.5, 52.3, 47.6, 31.3 (C-3), 27.1 (C-4), 12.1 (C-6); m/z 
(ESI) 399 [MH]+, 391, 217 (Found: C, 63.39; H, 5.52; N, 6.95. C21H22N2O6 requires 
C, 63.31; H, 5.57; N, 7.03). 
 
Syn-4-phenyl-3-ethenylhexyl 3,5-dinitrobenzoate (syn-160) 
 
 
 
 
 
To a solution of alcohol syn-159 (23 mg, 0.11 mmol, 1.0 equiv) in dichloromethane (1 
mL) was added TEA (0.046 mL, 0.33 mmol, 3.0 equiv) followed by a solution of 3,5-
dinitrobenzoyl chloride (32 mg, 0.14 mmol, 1.1 equiv) in dichloromethane (0.5 mL) 
at 0 °C.  The resulting orange solution was warmed to rt and stirred overnight before 
quenching with aqueous HCl (2 M, 2 mL).  The mixture was partitioned between 
dichloromethane (7 mL) and water (15 mL) and the phases were separated.  The 
aqueous phase was extracted with dichloromethane (2 x 7 mL).  The combined 
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organic extracts were dried (MgSO4) and concentrated under reduced pressure. 
Purification over silica gel (20% ether/petrol) afforded syn-(±)-4-phenyl-3-
ethenylhexyl 3,5-dinitrobenzoate syn-160 (24 mg, 53%) as a yellow gum: νmax (film) 
3084, 3026, 2958, 1722, 1629, 1546, 1462, 1344, 1280, 1172, 1078 cm-1; δH (500 
MHz CDCl3) 9.22 (1H, s, Ar), 9.12 (2H, s, Ar), 7.29 (2H, t, J 7.5, m-Ph), 7.20 (1H, t, 
J 7.5, p-Ph), 7.14 (2H, m, o-Ph), 5.52 (1H, ddd, J 17.0, 10.0, 7.0, CHCH2), 5.10 (1H, 
d, J 10.0, trans-CHCH2), 5.02 (1H, d, J 17.0, cis-CHCH2), 4.43–4.34 (1H, m, H-1), 
2.48–2.43 (2H, m, H-2), 2.01–2.00 (1H, m, H-4), 1.77 (1H, m, H-3), 1.41 (2H, m, H-
5), 0.81 (3H, t, J 7.5, H-6); δC (126 MHz CDCl3) 162.4 (C-1), 148.6 143.3, 140.6, 
134.1, 128.4, 126.4, 122.3, 117.1, 65.7 (C-1), 52.0, 45.9, 31.5 (C-3), 25.7 (C-4), 12.2 
(C-6); m/z (ESI) 399 [MH]+, 391, 217. 
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3.4.2 Compounds relevant to sections 2.3 and 2.4 
 
Methyl (2S)-2-(tert-butyldiphenylsilyloxy)propanoate (161) 
 
 
 
 
 
(S)-Methyl lactate (5.67 g, 54.5 mmol, 1.0 equiv) was added dropwise via syringe to a 
solution of tert-butyldiphenylchlorosilane (16.5 g, 60.0 mmol, 1.1 equiv), TEA (19.0 
mL, 136.4 mmol, 2.5 equiv) and DMAP (0.67 g, 5.45 mmol, 0.1 equiv) in THF (50 
mL) at 0 °C, to give a white suspension.  The reaction mixture was warmed to rt 
overnight and concentrated under reduced pressure.  The remaining white residue was 
triturated with ether (100 mL) and the solids were removed by filtration.  The filtrate 
was sequentially washed with acetic acid (15% w/w in water, 150 mL), water (150 
mL), saturated sodium hydrogencarbonate solution (100 mL) and water (100 mL), 
dried (MgSO4) and concentrated under reduced pressure.  Purification over silica gel 
(50% dichloromethane/petrol) afforded methyl (2S)-2-(tert-
butyldiphenylsilyloxy)propanoate 161 (12.61 g, 68%) as a colourless oil: [α]D20 –34.1 
(c 0.82, CHCl3), lit –51.8 (c 0.78, EtOH); νmax (film) 1762, 1281, 1137, 1113 cm-1; δH 
(400 MHz CDCl3) 7.69–7.68 (4H, m, o-Ph), 7.47–7.38 (6H, m, m,p-Ph), 4.30 (1H, q, 
J 7.0, H-2), 3.58 (3H, s, OMe), 1.39 (3H, d, J 7.0, H-3), 1.12 (9H, s, C(CH3)3); δC 
(101 MHz CDCl3) 174.2 (C-1), 135.8, 129.8, 127.6 (Ph), 68.9 (OMe), 51.6 (C-2), 
26.8 (C(CH3)3), 21.3, 19.3; in agreement with published data.216 
 
(2S)-2-(Tert-butyldiphenylsiloxy)propanal (162) 
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Diisobutylaluminium hydride (15.45 mL of a 1.5 M solution in toluene, 18.54 mmol, 
1.0 equiv) was added dropwise via syringe to a solution of ester 161 (6.35 g, 18.54 
mmol, 1.0 equiv) in dichloromethane (25 mL) at –78 °C over 15 min.  The reaction 
mixture was stirred for 2 h at –78 °C before the addition of water (16 mL) with 
vigorous stirring.  The reaction mixture was allowed to warm to rt and solid sodium 
hydrogen carbonate was added to bind the resultant precipitate.  The precipitate was 
filtered and washed with ether (100 mL) before separation of excess water from the 
filtrate, drying (MgSO4) and concentration under reduced pressure.  Purification over 
silica gel (40% dichloromethane/petrol) afforded (2S)-2-(tert-
butyldiphenylsiloxy)propanal 162 (4.43 g, 77%) as a colourless oil: [α]D20 –15.2 (c 
0.56, CHCl3); νmax (film) 1739, 1445, 1112, 1007, 740 cm-1; δH (400 MHz CDCl3) 
9.68 (1H, s, H-1), 7.67–7.65 (4H, m, o-Ph), 7.43–7.41 (6H, m, m,p-Ph), 4.12 (1H, q, J 
7.0, H-2), 1.25 (3H, d, J 7.0, H-3), 1.14 (9H, s, C(CH3)3); δC (101 MHz CDCl3) 203.9 
(C-1), 135.9, 130.1, 127.8, 76.7 (C-2), 26.9 (C(CH3)3), 19.2, 18.4; m/z (CI) 330 
[MNH4]+, 312 [M]+, 235; in agreement with published data.216 
 
Ethyl [4S]-(2E)-4-(tert-butyldiphenylsilyloxy)-2-pentenoate (E-163) and ethyl 
[4S]-(2Z)-4-(tert-butyldiphenylsilyloxy)-2-pentenoate (Z-163) 
 
 
 
  
 
To a solution of aldehyde 162 (4.43 g, 14.16 mmol, 1.0 equiv) in dichloromethane (14 
mL) was added carbethoxymethylenetriphenylphosphorane (4.47 g, 14.16 mmol, 1.0 
equiv) over 3 min at rt.   After stirring for 48 h the reaction mixture was concentrated 
under reduced pressure.  The resultant solid triphenyl phosphine oxide was removed 
by filtration and the residue was washed extensively with ether. The filtrate was 
concentrated under reduced pressure and purified over silica gel (5% ether/petrol) to 
afford the separated esters: desired ethyl [4S]-(2E)-4-(tert-butyldiphenylsilyloxy)-2-
pentenoate E-163 (3.81 g, 74%) as a colourless oil: [α]D20 –38.8 (c 0.43, CHCl3); νmax 
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(film) 1720, 1660, 1590, 1427, 1118 cm-1; δH (400 MHz CDCl3) 7.71–7.64 (4H, m, o-
Ph), 7.46–7.36 (6H, m, m,p-Ph), 6.91 (1H, dd, J 15.5, 4.5, H-3), 6.02 (1H, d, J 15.5, 
H-2), 4.45–4.47 (1H, m, H-4), 4.21 (2H, q, J 7.0, OCH2), 1.32 (3H, t, J 7.0,  
OCH2CH3), 1.15 (3H, d, J 6.5, H-5), 1.10 (9H, s, C(CH3)3); δC (101 MHz CDCl3)  
190.8 (C-1), 151.5, 135.8, 134.0 129.8, 127.6, 119.13, 68.7, 60.3, 26.9, 23.3, 19.2, 
14.3; m/z (CI), 400 [MNH4]+; and undesired ethyl [4S]-(2Z)-4-(tert-
butyldiphenylsilyloxy)-2-pentenoate Z-163 (0.347 g, 7%) as a colourless oil: νmax 
(film) 1728, 1660, 1591, 1427, 1118 cm-1; δH (400 MHz CDCl3) 7.68–7.63 (2H, m, o-
Ph), 7.40–7.33 (3H, m, m,p-Ph), 6.27 (1H, dd, J 8.0, 11.5, H-3), 5.50 (1H, d, J 11.5, 
H-2), 5.43–5.41 (1H, m, H-4), 4.00 (2H, q, J 7.0, OCH2), 1.27 (3H, d, J 6.5, H-5), 
1.16 (3H, t, J 7.0, OCH2CH3), 1.08 (9H, s, C(CH3)3); δC (101 MHz CDCl3) 190.9, 
153.7, 135.8, 134.0 129.8, 127.4, 117.0, 66.8, 60.0, 27.0, 23.3, 19.2, 14.1; m/z (CI), 
400 [MNH4]+; as colourless oils, in agreement with literature data.129  
 
Ethyl (E)-4-hydroxypent-2-enoate (164) 
 
 
 
 
 
To a solution of TBAF trihydrate (2.58 g, 8.17 mmol, 3.0 equiv) in THF (15 mL) at 0 
°C was added a solution of ester E-163 (1.00 g, 2.61 mmol, 1.0 equiv) in THF (1 mL). 
The reaction mixture was warmed to rt and stirred for 30 min before addition of acetic 
acid (2.5 mL) and filtration of the mixture over a pad of silica gel (1 cm x 10 cm, 50 
% EtOAc/petrol).  The filtrate was washed with saturated aqueous sodium 
hydrogencarbonate (2 x 75 mL) and brine (50 mL) before drying (MgSO4) and 
concentration under reduced pressure.  Purification over silica gel (25% EtOAc in 
40/60 petrol) afforded the ester (±)-164 (264 mg, 70%) as a colourless oil: νmax (film) 
3345, 1716, 1653 cm-1; δH (400 MHz CDCl3) 6.99 (1H, dd, J 15.4, 4.5, H-3), 6.04 
(1H, d, J 15.5, H-2), 4.51–4.49 (1H, m, H-4), 4.22 (2H, q, J 7.0, OCH2), 1.79 (1H, s 
(br), OH), 1.36 (3H, d, J 6.5, H-5), 1.32 (3H, t, J 7.0, OCH2CH3); δC (101 MHz 
CDCl3) 166.5 (C-1) 150.9 (C-3), 119.6 (C-2), 67.2 (C-4), 60.5 (OCH2), 22.8 
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(OCH2CH3), 14.1 (C-5); m/z (CI) 162 [MNH4]+, 145 [MH]+, 127 [M-OH]+ (Found: 
[MH]+, 145.0873. C7H13O3 requires [MH]+, 145.0865); in agreement with published 
data.71  
 
Ethyl (E)-4-fluoropent-2-enoate (165) 
 
 
 
 
 
To a solution of DAST (1.80 mL, 14.6 mmol, 1.4 equiv) in dichloromethane (10 mL) 
at rt was added a solution of ester 164 (1.50 g, 10.4 mmol, 1.0 equiv) in 
dichloromethane (10 mL) via syringe.  The resultant solution was stirred at rt for 5 
min before sodium carbonate (2.6 g) was carefully added via a wide-bore needle. The 
mixture was stirred for 25 min and filtered.  The filtrate was washed with saturated 
aqueous sodium carbonate (50 mL), dried (MgSO4) and concentrated using a rotary 
evaporator at atmospheric pressure (water bath temperature 40 °C) to give ethyl (E)-
4-fluoropent-2-enoate 165 (1.19 g, 98%) as a yellow oil without further 
purification: νmax (film) 1722, 1641, 1305 cm-1; δH (400 MHz, CDCl3) 6.94 (1H, ddd, 
J 20.0, 15.5, 8.0, H-3), 6.07 (1H, dt, J 15.5, 2.0, H-2), 5.26 (1H, ddt, J 48.0, 8.0, 6.5, 
H-4), 4.24 (2H, q, J 7.0, OCH2), 1.50 (3H, dd, J 23.5, 6.5, H-5), 1.33 (3H, t, J 7.0, 
OCH2CH3); δF (376 MHz, CDCl3) –176.7 (ddt, J 48.0, 22.0, 20.0); δC (101 MHz, 
CDCl3) 166.1 (C-1), 146.0, 145.8 (C-3), 120.7 (C-2), 88.7, 87.0 (C-4), 60.7 (OCH2), 
20.8, 20.6 (C-5), 14.2 (OCH2CH3); m/z (EI) 124 [M–HF]+; in agreement with 
published data.71 
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Isopropyl benzenesulfinate  (168) 
 
 
 
 
 
To a suspension of sodium benzenesulfinate 167 (73.87 g, 450 mmol, 1.0 equiv) in 
1,2-dichloroethane (120 mL) was added thionyl chloride (80.31 g, 49.0 mL, 675 
mmol, 1.5 equiv) dropwise via syringe at 0 °C.  The resulting mixture was warmed to 
rt and stirred for 2 h before removal of excess thionyl chloride by distillation under 
reduced pressure.  The residue was taken up in ether (200 mL) and added via a 
syringe fitted with a wide-bore needle to a solution of IPA (42.4 mL, 540 mmol, 1.2 
equiv) in pyridine (72.5 mL, 900 mmol, 2.0 equiv) at 0 °C.  The solution was warmed 
to rt, stirred for 2.5 h and water (200 mL) was added.  The mixture was poured onto 
ether (200 mL) and the phases were separated.  The organic phase was washed with 
aqueous HCl (2 M, 4 x 100 mL) followed by brine (100 mL), dried (MgSO4) and 
concentrated under reduced pressure.  Distillation of the residue under reduced 
pressure afforded isopropyl benzenesulfinate 168 (55.2 g, 67%) as a colourless oil: 
bp1 88–90 °C; νmax (film) 1444, 1384, 1139, 912, 840, 734 cm-1; δH (400 MHz 
CDCl3) 7.76–7.73 (2H, m, Ph), 7.57–7.55 (3H, m, Ph), 4.64 (1H, hept, J 6.5, 
CH(CH3)2), [1.42 (3H, d, J 6.5) and 1.28 (3H, d, J 6.5), CH(CH3)2]; δC (101 MHz, 
CDCl3) 145.7 (i-Ph), 131.9 (p-Ph), 129.0 (m-Ph), 125.1 (o-Ph), 73.0 (CH(CH3)3), 
24.0, 23.8 (CH(CH3)3); m/z (CI) 185 [MH]+, 202 [MNH4]+; in agreement with 
published data.132 
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(E)-(Hept-1-enylsulfinyl)benzene and (Z)-(hept-1-enylsulfinyl)benzene (169) 
 
 
 
  
 
To a solution of dimethyl methylphosphonate (6.46 mL, 59.5 mmol, 2.2 equiv) in 
THF (60 mL) at –78 ºC was added n-butyllithium (25.7 mL of a 2.21 M solution in 
hexanes, 56.8 mmol 2.1 equiv) dropwise via syringe.  The resultant colourless anion 
solution was stirred at –78 ºC for 10 min before dropwise addition of isopropyl 
benzenesulfinate 168 (5.00 g, 27.0 mmol, 1.0 equiv).  The cloudy white reaction 
mixture was stirred at –78 °C for 30 min, and hexanal (3.90 mL, 32.4 mmol, 1.2 
equiv) was added dropwise via syringe to give a clear, colourless solution.  The 
reaction mixture was warmed immediately to room temperature and quenched with 
saturated aqueous NH4Cl (100 mL).  The mixture was partitioned between 
dichloromethane (150 mL) and water (75 mL), and the phases were separated.  The 
aqueous phase was extracted with dichloromethane (2 x 100 mL). The combined 
organic extracts were dried (MgSO4), concentrated under reduced pressure and 
purified over silica gel (20–50% ether/petrol) to afford a mixture of (E)-(hept-1-
enylsulfinyl)benzene and (Z)-(hept-1-enylsulfinyl)benzene 169 (3.56 g, 60%, 1:1 E:Z 
mixture of isomers) as a colourless oil.  
Data for the mixture: νmax (film) 1651, 1622, 1583, 1468, 1304, 1050, 922, 775, 701 
cm-1;  m/z (EI) 222 [M]+, 205  [M–OH]+ (Found: [M]+, 222.1074. C13H18OS requires 
[M]+, 222.1078).  
NMR data for E-169: δH (400 MHz, CDCl3) 7.65–7.63 (2H, m, SPh), 7.53–7.51 (3H, 
m, SPh), 6.65 (1H, dt, J 15.0, 7.0, H-2), 6.25 (1H, dt, J 15.0, 1.5, H-1), 2.24 (2H, AB 
quartet, J 7.0, 1.5, H-3), 1.55–1.47 (2H, m, H-4), 1.33–1.29 (4H, m, H-5,6), 0.92– 
0.88 (3H, m, H-7); δC (101 MHz, CDCl3) 144.7 142.5, 136.7, 130.8, 128.9, 124.5, 
123.7, 31.23, 22.4, 21.6, 13.6, 13.2. 
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NMR data for Z-169: δH (400 MHz, CDCl3) 7.64 (2H, d, J 6.5, o-SPh), 7.56–7.50 
(3H, m, m,p-SPh), 6.26–6.23 (2H, m, H-1,2), 2.72–2.52 (2H, m, H-3), 1.57–1.52 (2H, 
m, H-4), 1.42–1.39 (4H, m, H-5,6), 0.95 (3H, t, J 7.0, H-7); δC (400 MHz, CDCl3) 
144.6, 142.5, 136.8, 130.7, 129.3, 124.1, 31.3, 29.4, 28.8, 22.4, 14.0. 
 
1,2-Bis(trifluoroacetoxy)-1-(phenylsulfenyl)heptane (170) 
 
  
 
 
 
To a solution of vinyl sulfinate 169 (3.58 g, 16.1 mmol, 1.0 equiv, 1:1 E:Z mixture of 
isomers) in dichloromethane (30 mL) at 0 °C under was added TFAA (2.27 mL, 
16.10 mmol, 1.0 equiv) dropwise via syringe.  The resulting colourless solution was 
stirred at 0 °C for 10 min before further addition of TFAA (3.39 g, 2.27 mL, 16.10 
mmol, 1.0 equiv) dropwise via syringe.  The reaction mixture was stirred for 30 min 
at 0 °C before quenching with saturated aqueous sodium hydrogencarbonate (75 mL).  
The phases were separated and the aqueous phase was extracted with 
dichloromethane (2 x 30 mL).  The combined organic extracts were dried (MgSO4) 
and concentrated under reduced pressure to afford 1,2-bis(trifluoroacetoxy)-1-
(phenylsulfenyl)heptane 170 (6.68 g, 96%, 1:1 syn:anti mixture of diastereomers) as a 
colourless oil without further purification: νmax (film) 1787, 1641, 1226 cm-1; δH (400 
MHz, CDCl3) 7.53–7.39 (10H, m, syn+anti SPh), 6.35 (1H, d, J 4.0, anti H-1), 6.19 
(1H, d, J 8.5, syn H-1), 5.42 (1H, AB quartet, J 4.0, 2.0, anti H-2), 5.26 (1H, AB 
quartet, J 8.5, 3.5, syn H-2), 2.01–1.83 (4H, m, syn+anti H-3), 1.45–1.27 (12H, m, 
syn+anti H-4,5,6), 0.94–0.90 (6H, m, syn+anti H-7); δC (101 MHz, CDCl3) 134.8, 
134.3, 130.1, 129.8, 129.7, 129.6, 129.5, 127.8, 86.1, 83.8, 31.1, 30.2, 29.2, 24.5, 
23.9, 22.3, 22.2, 13.8; m/z (ESI) 432 [M]+, 276, 203 (Found: [M]+, 432.0885. 
C17H18F6O4S requires [M]+, 432.0830). 
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2-Hydroxyheptanal (171) 
 
 
 
 
 
To a solution of 170 (6.67 g, 15.44 mmol, 1.0 equiv) in dichloromethane (10 mL) at 0 
°C were added, consecutively, dropwise via syringe; MeOH (1.56 mL, 38.6 mmol, 
2.50 equiv) and TEA (0.22 mL, 1.54 mmol, 0.1 equiv).  The resulting solution was 
stirred at 0 °C for 15 min and concentrated under reduced pressure.  The residue was 
purified over silica gel (40–50% ether/petrol) to afford 2-hydroxyheptanal 171 (1.34 
g, 67%) as a white solid: mp 86–88 °C; NMR data were complicated as the aldehyde 
existed as a mixture of oligomeric forms; m/z (ESI) 413 [M3Na]+, 283 [M2Na]+, 131 
[M]+ (Found: [M]+, 131.1076. C7H15O2 requires [M]+ 131.1027). 
 
Ethyl (E)-4-hydroxynon-2-enoate (172) 
 
 
 
 
 
To a refluxing solution of aldehyde 171 (1.30 g, 10.0 mmol, 1.0 equiv) in benzene (15 
mL) was added a suspension of carbethoxymethylenetriphenylphosphorane (3.83 g, 
11.0 mmol, 1.1 equiv) in benzene (20 mL) dropwise via a pressure-equalised 
dropping funnel. After refluxing for 5.5 h, the reaction mixture was cooled and 
concentrated under reduced pressure.  The residue was purified over silica gel (30% 
ether/petrol) to afford the ethyl (E)-4-hydroxynon-2-enoate 172 (1.61 g, 81%) as a 
colourless oil: νmax (film) 3345, 1717, 1652; δH (400 MHz, CDCl3) 6.97 (1H, dd, J 
15.5, 5.0, H-3), 6.07 (1H, d, J 15.5, H-2), 4.35–4.32 (1H, m, H-4), 4.23 (2H, q, J 7.0, 
OCH2), 1.65–1.58 (4H, m, H-5,6), 1.37–1.31 (7H, m, H-7,8,9), 0.92 (3H, t, J 7.0, 
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OCH2CH3); δC (101 MHz, CDCl3) 166.5 (C-1), 150.1 (C-3), 120.2 (C-2), 71.2 (C-4), 
60.5 (OCH2), 36.6 (C-5), 31.7 (C-6), 24.9 (C-7), 22.5 (C-8), 14.2, 14.0; m/z (CI) 218 
[MNH4]+, 201 [MH]+ (Found: [MH]+, 201.1485. C11H20O3 requires [MH]+, 
201.1491); in agreement with published data.129a 
 
Ethyl (E)-4-fluoronon-2-enoate (173) and ethyl (E)-3-(fluoromethyl)oct-2-enoate 
(174) 
 
 
 
  
 
To a solution of DAST (367 µL, 3.00 mmol, 1.2 equiv) in dichloromethane (2.5 mL) 
at –78 °C under a dry nitrogen atmosphere was added ester 172 (500 mg, 2.50 mmol, 
1.0 equiv) via syringe. The reaction mixture was allowed to warm to 0 °C over 15 min 
and was cooled to –78 °C.   MeOH (4 mL) was added and the mixture was allowed to 
warm to rt.  Water (6 mL) was poured on and the phases were separated.  The 
aqueous phase was extracted with dichloromethane (2 x 10 mL).  The combined 
organic extracts were dried (MgSO4) and concentrated under reduced pressure.  The 
residue was purified over silica gel (5% EtOAc/20% dichloromethane/petrol) to 
afford the separated esters: Less polar ethyl (E)-3-(fluoromethyl)oct-2-enoate 174 (25 
mg, 5%) as a colourless oil: νmax (film) 1718, 1662, 1462 cm-1; δH (400 MHz, CDCl3) 
5.93 (1H, s, H-2), 4.87 (2H, dd, JHF 47.0, JH2H4 1.5, CH2F), 4.20 (2H, q, J 7.0, OCH2), 
2.56 (2H, dt, J 8.0, 1.5, H-4), 1.59–1.49 (2H, m, H-5), 1.38–1.32 (7H, m, H-6,7,8), 
0.93 (3H, t, J 7.0, OCH2CH3); δF (376 MHz, CDCl3) –219.5 (t, JHF 47.0, CH2F); δC 
(101 MHz, CDCl3) 166.0 (C-1), 156.5 (C-3), 114.6 (C-2), 84.0 (d, JCF 177, CH2F), 
59.9 (OCH2), 32.0 (C-4), 29.7 (C-5), 28.4 (C-6), 22.4 (C-7), [14.3 and 14.0 (C-8 and 
OCH2CH3)]; m/z (ESI) 203 [MH]+, 183 [M-F]+ (Found: [MH]+, 203.1442. C11H19FO2 
requires [MH]+, 203.1447); and more polar ethyl (E)-4-fluoronon-2-enoate 173 (154 
mg, 31%) as a colourless oil: νmax (film) 1722, 1647 cm-1; δH (400 MHz, CDCl3) 6.92 
(1H, ddd, JHF 25.0, JHH 16.0, 7.0, H-3), 6.07 (1H, d, J 16.0, H-2), 5.11 (1H, dm, JHF 
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48.0, H-4), 4.20 (2H, q, J 7.0, OCH2) 1.78–1.60 (2H, m, H-5), 1.46–1.38 (9H, m, H-
6,7,8,9), 0.91 (3H, t, J 7.0 OCH2CH3); δF (376 MHz, CDCl3) –184.1 (ddt, J 48.0, 
25.0, 21.0); δC (101 MHz, CDCl3) 166.1 (C-1), 145.3, 145.1 (C-3), 120.1 (C-2), 91.0 
(C-4) 60.6 (OCH2), 34.8, 31.5, 24.3, 21.7, 14.2; m/z (CI) 220 [MNH4]+, 200, 183 [M-
F]+, (Found: [MNH4]+, 220.1719. C11H19FO2 requires [MNH4]+ 220.1713); the 
fraction contained <3% of the elimination product 175 in agreement with published 
data.217 
 
(E)-4-Fluoronon-2-enoic acid (180) 
 
 
 
 
 
To a solution of ester 173 (1.00 g, 4.95 mmol, 1.0 equiv) in THF (8 mL) and water (2 
mL) in a microwave vial was added lithium hydroxide monohydrate (0.415 g, 9.90 
mmol, 2.0 equiv). After heating by microwave at 110 °C for 45 min, the reaction was 
cooled to rt and aqueous HCl (2 M, 20 mL) was added.  The mixture was poured onto 
dichloromethane (20 mL) and the phases were separated. The aqueous layer was 
extracted with dichloromethane (2 x 20 mL), the combined organic extracts were 
dried (MgSO4) and concentrated under reduced pressure to afford (E)-4-fluoronon-2-
enoic acid 180 (467 mg, 55%) as a white solid which was used without further 
purification: mp 30–32 °C; δH (400 MHz, CDCl3) 7.04 (1H, ddd, JH3F4 21.0, J 16.0, 
9.5, H-3), 6.10 (1H, d, J 16.0, H-2), 5.10 (1H, dm, JH4F4 47.0, H-4), 1.81–1.69 (2H, m, 
H-5), 1.52–1.34 (6H, m, H-6,7,8), 0.93 (3H, t, J 7.0, H-9); δF (376 MHz, CDCl3)  
185.1 (ddt, JH4F4  47.0, JH3F4 21.0, JH5F4 22.5); δC (101 MHz, CDCl3) 170.9 (C-1), 
147.1 (d, J 19.0, C-3), 133.9 (d, J 11.0, C-2), 91.2 (C-4), 34.6 (d, J 21.0, C-5), 31.5 
(C-6), 24.2 (C-7), 22.5 (C-8), 14.0 (C-9). 
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(E)-4-Fluoronon-2-en-1-ol (179) 
 
 
 
 
 
To a solution of acid 180 (567 mg, 3.26 mmol, 1.0 equiv) in dichloromethane (10 mL) 
at 0 °C was added TEA (0.489 mL, 3.52 mmol, 1.08 equiv), followed by 
isobutylchloroformate (0.456 mL, 3.58 mmol, 1.10 equiv).  A fine white precipitate of 
triethylamine hydrochloride developed.  The reaction mixture was warmed to rt, 
stirred for 1.5 h and filtered directly into a suspension of sodium borohydride (492 
mg, 13.03 mmol, 4.0 equiv) in dimethoxyethane (10 mL) under nitrogen.  The white 
suspension was stirred for 2.5 h and water (50 mL) was poured on, resulting in 
vigorous effervescence. The mixture was extracted with dichloromethane (3 x 45 
mL).  The combined organic extracts were washed with brine (30 mL), dried 
(MgSO4), concentrated and purified over silica gel (10% EtOAc/petrol) to afford (E)-
4-fluoronon-2-en-1-ol 179 (252 mg, 49%) as a colourless oil which decomposed on 
standing: νmax (film) 3343, 1653, 1461, 1379, 1086, 972 cm-1; δH (400 MHz, CDCl3) 
5.99–5.92 (1H, m, H-3), 5.86–5.77 (1H, m, H-2), 4.93 (1H, ddt, JH4F4 48.0, JHH 12.5, 
6.0, H-4), 4.24–4.21 (2H, m, H-1), 1.79–1.34 (9H, m, OH, H-5,6,7,8), 0.92 (3H, t, J 
7.0, H-9); δF (376 MHz, CDCl3) –174.0 (m); δC (101 MHz, CDCl3) 132.1 (d, J 11.0, 
C-3), 129.6 (d, J 19.5, C-2), 93.1 (d, J 165.5, C-4), 62.7 (C-1), 35.4 (d, J 22.0, C-5), 
31.6 (C-6), 24.4 (C-7), 22.6 (C-8), 14.0 (C-9); m/z (CI) 178 [MNH4]+, 158 [M-2H]+, 
140 [M-HF]+, 123. 
 
Ethyl 4-fluoro-3-ethenylnonanoate (182) 
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Allylic alcohol 179 (86 mg, 0.538 mmol, 1.0 equiv) was reacted according to general 
procedure C to afford ethyl 4-fluoro-3-ethenylnonanoate 182 (82 mg, 66%, 1:1 
syn:anti mixture of diastereomers) as a yellow oil: νmax (film) 1726, 1678, 1456, 1355, 
1158, 1120, 1026, 903, 871 cm-1; δH (500 MHz, CDCl3) [5.69 (1H, ddd, J 17.0, 11.0, 
9.0) and 5.68 (1H, ddd, J 17.0, 11.0, 9.0), syn+anti CHCH2], 5.17–5.10 (4H, m, 
syn+anti CHCH2), [4.48 (1H, ddt, JHF 48.5, JHH 9.0, 6.0) and 4.36 (1H, ddt, JHF 48.5, 
JHH 7.5, 5.0), syn+anti H-4], 3.55 (4H, q, J 7.0, syn+anti OCH2), 2.87–2.68 (2H, m, 
syn+anti H-3), [2.64 (1H, dd, J 15.0, 5.0), 2.57 (1H, dd, J 15.0, 5.5), 2.45 (1H, dd, J 
15.0, 8.0) and 2.35 (1H, dd, J 15.0, 9.5), syn+anti H-2], 1.35–1.27 (12H, m, H-6,7,8), 
1.22 (4H, ddt, JHF 22.0, JHH 7.0, 3.0, syn+anti H-5), [0.89 (6H, t, J 7.0) and 0.88 (6H, 
t, J 7.0), syn+anti H-9 and OCH2CH3]; δF (376 MHz, CDCl3) –186.4, –191.4; δC (126 
MHz, CDCl3) [172.3 and 172.2 (C-1)], [136.3 and 135.0 (CHCH2)], [118.3 and 117.8 
(CHCH2)], [96.2 (d, J 24.0) and 94.5 (d, J 24.0), C-4], [60.5 and 60.4 (OCH2)], [45.4 
and 44.7 (C-3)], [36.2 and 35.6 (C-2)], 32.9, 32.5, 24.5, 22.3, 14.8, 14.0; m/z (CI) 248 
[MNH4]+, 231 [MH]+, 211 [M-F]+ (Found: [MNH4]+, 248.2014. C13H23FO2 requires 
[MNH4]+, 248.2026). 
 
2-(Prop-2-ynyloxy)tetrahydro-2H-pyran (187) 
 
   
 
Propargyl alcohol (5.19 mL, 89.2 mmol, 1.0 equiv) was reacted according to the 
procedure of Larock et al to afford 2-(prop-2-ynyloxy)tetrahydro-2H-pyran 187 (9.83 
g, 79%) as a colourless oil after distillation under reduced pressure (bp4 60–61 °C) in 
agreement with literature data.139 
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1-(Tetrahydro-2H-pyran-2-yloxy)non-2-yn-4-ol (188) 
 
  
 
 
To a solution of propargyl ether 187 (4.00 g, 28.4 mmol, 1.0 equiv) in THF (50 mL) 
at –78 °C was added n-butyllithium (11.36 mL of a 2.42 M solution in hexanes, 28.4 
mmol, 1.0 equiv) dropwise via syringe.  The resulting yellow anion solution was 
stirred at –78 °C for 30 min before addition of hexanal (3.41 g, 34.08 mmol, 1.2 
equiv) dropwise via syringe.  The colourless reaction mixture was warmed to 0 °C 
and saturated aqueous NH4Cl (100 mL) was added.  Dichloromethane (100 mL) and 
water (20 mL) were added and the phases were separated.  The aqueous layer was 
extracted with dichloromethane (2 x 75 mL).  The combined organic extracts were 
dried (MgSO4), concentrated under reduced pressure and purified over silica gel (25– 
35% ether/petrol) to afford 1-(tetrahydro-2H-pyran-2-yloxy)non-2-yn-4-ol 188 (5.24 
g, 77%) as a colourless oil: νmax (film) 3423, 2360, 2341, 1455, 1388, 1023 cm-1; δH 
(400 MHz, CDCl3) 4.83 (1H, t, J 3.5, OCHO), 4.43 (1H, dt, J 6.5, 2.0, H-4), 4.32 (2H, 
AB quartet, J 15.5, 2.0, H-1), 3.85 (1H, ddd, J 12.0, 9.0, 6.0, OCHaxial), 3.58–3.55 
(1H, m, OCHequatorial), 1.61 (1H, s (br), OH), 1.83–1.32 (14H, m), 0.91 (3H, t, J 7.0, 
H-9); δC (101 MHz, CDCl3) 96.8 (OCHO), 87.1 (C-3), 80.8 (C-2), 62.6 (THP-OCH2), 
62.0 (C-4), 54.3 (C-1), 37.7, 31.5, 30.3, 25.4, 24.8, 22.6, 19.1, 14.0; m/z (CI) 258 
[MNH4]+, 223, 174, 102; in agreement with published data.218 
 
2-(4-Fluoronon-2-ynyloxy)tetrahydro-2H-pyran (189) 
 
 
 
 
 
To a solution of Deoxofluor (2.12 mL of 50% w/w solution in THF, 4.98 mmol, 1.2 
equiv) in dichloromethane (20 mL) at –78 °C was added a solution of propargyl 
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alcohol 188 (1.00 g, 4.15 mmol, 1.0 equiv).  The reaction mixture was stirred at –78 
°C for 1.5 h, and quenched at –78 °C with saturated aqueous potassium carbonate (25 
mL) before warming to rt.  The phases were separated and the aqueous layer was 
extracted with dichloromethane (2 x 50 mL).  The combined organic extracts were 
washed with brine (40 mL), dried (MgSO4), decolourised with charcoal, concentrated 
under reduced pressure and purified over silica gel (5% ether/petrol) to afford 2-(4-
fluoronon-2-ynyloxy)tetrahydro-2H-pyran 189 (502 mg, 50%) as a colourless oil: νmax 
(film) 2359, 2342 1462, 1379, 1355, 1202, 1121, 1029, 903 cm-1; δH (400 MHz, 
CDCl3) 5.16 (1H, dt, JHF 48.5, JH4H5 6.5, H-4), 4.85–4.83 (1H, m, OCHO), 4.35–4.30 
(2H, m, H-1), 3.86 (1H, dt, J 11.0, 3.0, OCHaxial), 3.57 (1H, m, OCHequatorial), 1.84 
(4H, m), 1.76 (7H, m), 1.15 (4H, m) 0.92 (3H, t, J 7.0, H-9); δF (376 MHz, CDCl3) –
172.9 (m, F-4); δC (101 MHz, CDCl3) 96.9 (OCHO), 84.3 (d, J 10.0), 82.8 (d, J 25.5), 
82.7 (d, J 166.5), 62.0 (d, J 5.0, C-4), 54.1 (C-1), 35.9, 35.7, 31.3, 30.2, 25.3, 24.2, 
22.5, 19.0, 18.9, 14.0; m/z (CI) 260 [MNH4]+, 235, 219, 102, 85 (Found: 260.2030. 
C14H23FO2 requires [MNH4]+, 260.2026) (Found: C, 69.29; H, 9.51. C14H23FO2 
requires C, 69.39; H, 9.57). 
 
(Z)-2-(4-Fluoronon-2-enyloxy)tetrahydro-2H-pyran (190) 
 
 
 
 
 
A mixture of propargyl fluoride 189 (480 mg, 1.98 mmol, 1.0 equiv) in THF (3 mL) 
and Lindlar’s catalyst (40 mg) was stirred vigorously under an atmosphere of 
hydrogen gas for 75 min. The reaction mixture was filtered over a pad of Celite, 
washing with dichloromethane (20 mL).  The filtrate was dried (MgSO4) and 
concentrated to afford (Z)-2-(4-fluoronon-2-enyloxy)tetrahydro-2H-pyran 190 (435 
mg, 91%) as a colourless oil, without further purification: νmax (film) 1670, 1461, 
1380, 1119, 1032, 904 cm-1; δH (400 MHz, CDCl3) 5.78–5.75 (1H, m, H-3), 5.68–
5.65 (1H, m, H-2), 5.25 (1H, ddt, JHF 48.0, JHH 7.5, 5.5, H-4), 4.66 (1H, t, J 3.5, 
OCHO), 4.39–4.27 (1H, m, H-1), 4.18–4.08 (1H, m, H-1), 3.88–3.84 (1H, m, 
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OCHaxial), 3.55 (1H, m, OCHequatorial), 1.80–1.72 (3H, m), 1.63–1.56 (7H, m), 1.39–
1.33 (5H, m), 0.92 (3H, t, J 6.5, H-9); δF (376 MHz, CDCl3) –172.2 (ddt, J 48.0, 27.5, 
14.0), δC (101 MHz, CDCl3) 131.1 (d, J 22.5, C-3), 131.0 (d, J 21.5, C-3), 130.2 (d, J 
10.0, C-2); 129.8 (d, J 10.0, C-2), 98.1 (OCHO), 89.2 (d, J 161.5, C-4), 62.9 (d, J 
23.0, C-1), 62.2 (d, J 20.0, C-1), 35.6 (d, J 22.5, C-5), 31.6, 30.6, 25.4, 24.4, 22.6, 
19.5, 19.3, 14.0; m/z (CI) 262 [MNH4]+, 225, 102 [THPNH4]+, 85 [THP]+ (Found: 
[MNH4]+, 262.2178. C14H25FO2 requires [MNH4]+, 262.2182) (Found: C, 68.76; H, 
10.29. C14H25FO2 requires C, 68.82; H, 10.31). 
 
2-(4-(Hydroxyl)pentynyloxy)tetrahydro-2H-pyran (191) 
 
  
 
 
To a solution of propargyl ether 187 (1.00 g, 7.14 mmol, 1.0 equiv) in THF (15 mL) 
was added n-butyllithium (3.15 mL of a 2.27 M solution in hexanes, 7.14 mmol, 1.0 
equiv) dropwise via syringe at –78 °C. The resulting anion solution was stirred at –78 
°C for 10 min before addition of acetaldehyde (0.49 mL, 8.57 mmol, 1.2 equiv) 
dropwise via syringe.  The resulting solution was stirred at –78 °C for 30 min and 
quenched with saturated aqueous NH4Cl (10 mL) followed by water (10 mL).  Ether 
(30 mL) was poured on and the phases were separated.   The aqueous phase was 
extracted with ether (2 x 30 mL).  The combined organic extracts were dried 
(MgSO4), concentrated under reduced pressure and purified over silica gel (5–40% 
EtOAc/petrol) to afford 2-(4-(hydroxyl)pentynyloxy)tetrahydro-2H-pyran 191 (1.12 
g, 85%) as a colourless oil νmax (film) 3391, 1647, 1442, 1202 cm-1; δH (400 MHz, 
CDCl3) 4.82 (1H, t, J 3.0, OCHO), 4.59–4.56 (1H, m, H-2), [4.25 (1H, dd, J 15.0, 2.0) 
and 4.35 (1H, dd, J 15.0, 2.0), H-5), 3.86 (1H, ddd, J 12.0, 9.0, 3.0, OCHaxial), 3.51–
3.59 (1H, m, OCHequatorial), 1.86 (1H, s, OH), 1.78–1.55 (6H, m, THP), 1.48 (3H, d, J 
6.5, H-1); δC (400 MHz, CDCl3) 96.9 (OCHO), 87.9 (C-3), 80.0 (C-4), 61.9 (THP 
OCH2), 58.4 (C-2), 54.2, 30.23, 25.3, 24.2, 19.0; m/z (CI) 202 [MNH4]+, 186 [MH]+, 
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85 [THP]+ (Found: [MNH4]+, 202.1440. C10H16O3 requires [MNH4]+, 202.1443); in 
agreement with literature data.219 
 
2-(4-(Thiophenyl)pentynyloxy)tetrahydro-2H-pyran (192) 
 
 
 
 
 
To a solution of propargyl alcohol 191 (500 mg, 2.71 mmol, 1.0 equiv) and diphenyl 
disulfide (774 mg, 3.55 mmol, 1.3 equiv, recrystallised from ether) in acetonitrile (25 
mL) was added tri-n-butylphosphine (1.56 mL, 6.24 mmol, 2.3 equiv) dropwise via 
syringe at rt to give a biphasic mixture.  The reaction mixture was immersed in an 
ultrasound bath at rt for 1.5 h before dilution with dichloromethane (50 mL) and 
washing with aqueous NaOH (2 M, 2 x 45 mL).  The organic phase was dried 
(MgSO4) and concentrated under reduced pressure.  The residue was purified over 
silica gel (10 % ether/petrol) to afford 2-(4-(thiophenyl)pentynyloxy)tetrahydro-2H-
pyran 192 (571 mg, 90%) as a yellow oil: νmax (film) 1583, 1480, 1440, 1388, 1346 
cm-1; δH (400 MHz, CDCl3) 7.54 (2H, d, J 6.5, o-SPh), 7.35–7.29 (3H, m, m,p-SPh), 
4.73 (1H, t, J 3.5, OCHO), [4.28 (1H, dd, J 15.5, 5.5) and 4.27 (1H, dd, J 15.5, 7.5),  
H-5], 3.99 (1H, q, J 7.0, OCHaxial), 3.85–3.80 (1H, m OCHequatorial), 3.54–3.50 (1H, m, 
H-2), 1.84–1.63 (2H, m, THP), 1.52 (3H, d, J 7.0, H-1); δC (101 MHz, CDCl3) 133.9 
(i-SPh), 132.2, 128.8, 127.7 (SPh), 96.5 (OCHO), 86.6 (C-3), 79.3 (C-2), 62.0 
(OCH2), 54.3 (C-1), 33.4, 30.2, 25.4, 21.7, 19.1; m/z (CI) 294 [MNH4]+, 277 [MH]+, 
210 [M-THPNH4]+, (Found: [MH]+, 277.1273. C16H20O2S requires [MH]+, 277.1262). 
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4-(Phenylthio)pent-2-yn-1-ol (193) 
 
 
 
 
 
To a solution of propargyl ether 192 (1.76 g, 6.37 mmol, 1.0 equiv), in ethanol (15 
mL) was added pyridinium paratoluenesulfonate (160 mg, 0.637 mmol, 0.1 equiv) 
with stirring. The mixture was heated to 55 ºC for 6 h, after which TLC showed some 
remaining 192.  Pyridinium paratoluenesulfonate (160 mg, 0.637 mmol, 0.1 equiv) 
was added and heating at 55 ºC was continued for a further 9 h.  The reaction mixture 
was cooled and concentrated under reduced pressure.  The residue was purified over 
silica gel (20% ether/petrol) to afford 4-(phenylthio)pent-2-yn-1-ol 193 (836 mg, 
68%) as a yellow oil: νmax (film) 3357, 2351, 1583, 1479, 1483, 1038, 1009, 744, 691 
cm-1; δH (400 MHz, CDCl3) 7.54 (2H, dd, J 8.0, 7.5, m-SPh), 7.38–7.32 (3H, m, o,p-
SPh), 4.27 (2H, d, J, 2.5, H-1), 3.97 (1H, ddt, J 14.0, 7.0, 2.5, H-4), 1.61 (1H, s (br), 
OH), 1.55 (3H, d, J 7.0, H-5);  δC (101 MHz, CDCl3) 133.8, 133.0, 128.9, 127.9, 86.6 
(C-3), 81.7 (C-2), 51.3 (C-1), 33.4 (C-4), 21.7 (C-5); m/z (CI) 210 [MNH4]+, 192 [M]+ 
(Found: [MNH4]+, 210.0957. C11H12OS requires [MNH4]+, 210.0953). 
 
2-Chloropropanal (207a) 
 
 
 
 
 
To a solution of propanal (54.6 mL, 750 mmol, 1.0 equiv) in dichloromethane (30 
mL) at –10 ºC was added sulfuryl chloride (60.3 mL, 750 mmol, 1.0 equiv) dropwise 
via an addition funnel over 30 minutes and the reaction mixture was allowed to warm 
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to rt overnight.  The reaction mixture was heated to reflux for 2 h, cooled and distilled 
through a 15 cm Vigreux column, collecting the fraction containing 2-chloropropanal 
207a (33.1 g, 66%) as a colourless oil: bp760 82–84 ºC; δH (400 MHz, CDCl3) 9.54 
(1H, s (br), H-1), 4.30 (1H, dq, J 7.0, 2.0 H-2), 1.63 (3H, d, J 7.0, H-3); δC (101 MHz, 
CDCl3) 195.1 (C-1), 58.8 (C-2), 18.3 (C-1), m/z (CI) 388, 294 [(3M)NH4]+, 260, 92 
[M]+; in agreement with published data.155 
 
2-Chloroheptanal (207b) 
 
 
 
 
To a solution of heptanal (3.94 mL, 26.8 mmol, 1.0 equiv) at 0 ºC was added D,L–
proline (313 mg, 2.68 mmol, 0.1 equiv), followed by N-chlorosuccinimide (4.85 g, 
34.8 mmol, 1.3 equiv).  The suspension was warmed to rt, stirred for 16 h and pentane 
(100 mL) was added. The mixture was filtered and concentrated under reduced 
pressure.  The residue was added to pentane (50 mL), filtered, concentrated under 
reduced pressure and distilled under reduced pressure to afford 2-chloroheptanal 207b 
(3.37 g, 85%) as a colourless oil: bp90 80–82 ºC; νmax (film) 1735, 1466, 1379, 1102 
cm-1; δH (400 MHz, CDCl3) 9.47 (1H, d, J 2.5, H-1), 4.14 (1H, dt, J 5.5, 2.5, H-2), 
2.00–1.78 (2H, m, H-3), 1.36–1.29 (6H, m, H-4,5,6), 0.89 (3H, t, J 7.0, H-7); δC (101 
MHz, CDCl3) 185.2 (C-1), 64.1 (C-2), 32.3, 31.1, 25.4, 22.5, 14.1; m/z (CI), 148 
[M]+, 166 [MNH4]+, 462, 428 [(3M)NH4]+; in agreement with published data.220 
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2-Chloro-3-methylbutanal (207c) 
 
 
 
 
 
To a solution of 3-methylbutanal (5.36 mL, 50.0 mmol, 1.0 equiv) at 0 ºC was added 
D,L–prolinamide (571 mg, 5.00 mmol, 0.1 equiv), followed by N-chlorosuccinimide 
(5.46 g, 65.0 mmol, 1.3 equiv). The reaction mixture was warmed to rt during 16 h 
and pentane (100 mL) was added. The mixture was filtered and concentrated under 
reduced pressure.  The residue was added to pentane (50 mL), filtered, concentrated 
under reduced pressure and distilled to afford 2-chloro-3-methylbutanal 207c (3.88 g, 
64%) as a colourless oil: bp760 130–132 ºC; νmax (film) 1737, 1465, 1369, 1058, 830 
cm-1; δH (400 MHz, CDCl3) 9.42 (1H, d, J 3.0, H-1), 3.95 (1H, dd, J 5.5, 3.0, H-2), 
2.28 (1H, dsept, J 7.0, 5.5, H-3), [1.00 (3H, d, J 7.0) and 0.98 (3H, d, J 7.0), H-4]; δC 
(101 MHz, CDCl3) 196.1 (C-1), 70.6 (C-2), 31.1 (C-3), 17.8 (C-4); m/z (CI) 120 [M]+, 
138 [MNH4]+, 344, 378 [(3M)NH4]+; in agreement with published data.158 
 
Ethyl (E)-4-thiophenypent-2-enoate (184a) 
 
From 164: 
 
 
 
 
 
 
To a solution of ester 164 (1.00 g. 6.94 mmol, 1.0 equiv) in dichloromethane (15 mL) 
was added TEA (1.95 mL, 13.9 mmol, 1.0 equiv) followed by methanesulfonyl 
chloride (0.81 mL, 10.4 mmol, 1.5 equiv) at 0 °C. After warming to rt and stirring for 
8 h, aqueous HCl (2 M, 30 mL) was added, the phases were separated and the 
aqueous layer was extracted with dichloromethane (2 x 50 mL). The combined 
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organic extracts were dried (MgSO4) and concentrated under reduced pressure to give 
methanesulfonate 183 (1.49 g, 97%) as a colourless oil. To a solution of sodium 
hydride (60% w/w on mineral oil, 295 mg, 7.38 mmol, 1.1 equiv) in THF (40 mL) at 
0 °C was added thiophenol (813 mg, 0.756 mL, 7.38 mmol, 1.1 equiv) dropwise via 
syringe.  The reaction mixture was allowed to warm to rt for 5 min before cooling to –
20 °C and addition of a solution of methanesulfonate 183 (1.49 g, 6.71 mmol) in THF 
(5 mL) dropwise via syringe.  The resulting light orange suspension was stirred at –20 
°C for 1 h before warming to 0 °C and quenching with aqueous HCl (2 M, 30 mL).  
The mixture was partitioned between water (20 mL) and ether (30 mL) and the phases 
were separated. The aqueous phase was extracted with ether (2 x 30 mL).  The 
combined organic extracts were washed with saturated aqueous sodium hydrogen 
carbonate (35 mL) and brine (35 mL), dried (MgSO4) and concentrated under reduced 
pressure.  The residue was purified over silica gel (40% ether in 40/60 petrol) 
affording ethyl (E)-4-thiophenypent-2-enoate 184a (1.19 g, 75%) as a colourless oil.  
 
From 207a: 
 
 
 
 
 
 
2-Chloropropanal 207a (2.29 mL, 20.0 mmol, 1.0 equiv) was reacted according to 
general procedure D to afford ethyl (E)-4-thiophenypent-2-enoate 184a (2.38 g, 47%) 
as a colourless oil after purification over silica gel (5–20% ether/heptane): νmax (film) 
1716, 1650, 747, 692 cm-1; δH (400 MHz, CDCl3) [7.42–7.40 (2H, m) and 7.34–7.28 
(3H, m), SPh], 6.89 (1H, dd, J 15.5, 8.0, H-3), 5.60 (1H, d, J 15.5, H-2), 4.18 (2H, q, 
J 7.0, OCH2), 3.81 (1H, dq, J 8.0, 7.0, H-4), 1.45 (3H, d, J 7.0, H-5), 1.28 (3H, t, J 7.0 
OCH2CH3); δC (101 MHz, CDCl3) 166.3 (C-1), 148.4 (C-3), 133.5 (o-SPh), 133.3, (i-
SPh), 128.9 (m-SPh), 127.9 (p-SPh), 120.5 (C-2), 60.4 (OCH2), 44.9 (C-4), 19.5 (C-
5), 14.2 (OCH2CH3); m/z (CI) 254 [MNH4]+, 237 [MH]+, 146 [M-(SPh)NH4]+ 
(Found: [MNH4]+, 254.1219. C13H16O2S requires 254.1215); in agreement with 
published data.147a 
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Ethyl (Z)-4-(phenylthio)pent-2-enoate (184b) 
 
 
 
 
 
 
 
2-Chloropropanal 207a (2.29 mL, 20.0 mmol, 1.0 equiv) was reacted according to 
general procedure E to afford ethyl (E)-5-methyl-4-thiophenylhex-2-enoate 184b 
(1.37 g, 29%) as a colourless oil after purification over silica gel (5–20% 
ether/heptane): νmax (film) 2979, 1715, 1639, 1186, 1029, 826, 744, 692 cm-1; δH (400 
MHz, CDCl3) [7.40–7.30 (2H, m) and 7.27–7.21 (3H, m), SPh], 6.02 (1H, dd, J 11.5 
10.5, H-3), 5.61 (1H, d, J 11.5, H-2), 5.25 (1H, dq, J 10.5, 7.0, H-4), 4.05 (2H, q, J 
7.0, OCH2), 1.39 (3H, d, J 7.0, H-5), 1.21 (3H, t, J 7.0, OCH2CH3); δC (101 MHz, 
CDCl3) 166.3 (C-1), 150.3 (C-3), 134.1, 133.2, 128.9, 127.5, 118.9 (C-2), 60.2 
(OCH2), 40.4 (C-4), 32.1, 20.0, 14.4; m/z (CI) 254 [MNH4]+, 237 [MH]+ (Found: C, 
65.84; H, 6.80. C13H16O2S requires C, 66.07; H, 6.82). 
 
Ethyl (E)-4-thiophenylnon-2-enoate (184c) 
 
 
 
 
 
 
 
2-Chloroheptanal 207b (743 mg, 5.0 mmol, 1.0 equiv) was reacted according to 
general procedure D to afford ethyl (E)-4-thiophenylnon-2-enoate 184c (785 mg, 
57%) as a colourless oil after purification over silica gel (5–40% ether/heptane): νmax 
(film) 2931, 1720, 1648, 1438, 1160, 746, 692 cm-1; δH (400 MHz, CDCl3) [7.38–
7.35 (2H, m) and 7.31–7.23 (3H, m), SPh], 6.77 (1H, dd, J 15.5, 9.0, H-3), 5.50 (1H, 
dd, J 15.5, 1.0, H-2), 4.15 (2H, q, J 7.0, OCH2), 3.60 (1H, dt, J 9.0, 6.5, H-4), 1.79–
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1.61 (2H, m, H-5), 1.47–1.29 (6H, m, H-6,7,8), 1.26 (3H, t, J 7.0, OCH2CH3), 0.89 
(3H, t, J 7.0, H-9); δC (101 MHz, CDCl3) 166.4 (C-1), 147.9 (C-3), 133.7, 129.1, 
128.0, 124.0, 121.3 (C-2), 60.5 (OCH2), 51.1 (C-4), 33.8, 31.7, 27.2, 22.7, 14.4, 14.2; 
m/z (CI) 310 [MNH4]+, 293 [MH]+, 282, 268 (Found: [MH]+, 293.1581. C17H24O2S 
requires [MH]+ 293.1575) (Found C, 69.63; H, 8.29. C17H24O2S requires C, 69.82; H, 
8.27). 
 
Ethyl (Z)-4-(thiophenyl)non-2-enoate (184d) 
 
 
 
 
 
 
 
2-Chloroheptanal 207b (2.91 ml, 20.0 mmol, 1.0 equiv) was reacted according to 
general procedure E to afford the ester to afford ethyl (Z)-4-(thiophenyl)non-2-enoate 
184d (4.35 g, 73%) as a colourless oil after purification over silica gel (5–40% 
ether/heptane): νmax (film) 2931, 2859, 1717, 1640, 1583, 1178, 1026, 744, 692 cm-1; 
δH (400 MHz, CDCl3) [7.43–7.41 (2H, m) and 7.29–7.45 (3H, m), SPh], 5.99 (1H, dd, 
J 11.0, 11.5, H-3), 5.65 (1H, d, J 11.5, H-2), 5.20–5.14 (1H, m, H-4), 4.05 (2H, q, J 
7.5, OCH2), 1.64–1.28 (8H, m, H-5,6,7,8), 1.23 (3H, t, J, 7.5, OCH2CH3), 0.93–0.89 
(3H, m, H-9); δC (101 MHz, CDCl3) 166.1 (C-1), 149.1 (C-3), 133.9, 133.0, 128.6, 
127.2, 119.4 (C-2), 60.0 (OCH2), 45.2, 34.0, 31.5, 26.8, 22.5, 14.2, 14.0; m/z (CI) 310 
[MNH4]+, 293 [MH]+, 268 (Found: [MH]+, 293.1579. C17H24O2S requires [MH]+, 
293.1575). 
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Ethyl (E)-5-methyl-4-thiophenylhex-2-enoate (184e) 
 
 
 
 
 
 
 
2-Chloro-3-methylbutanal 207c (551 mg, 5.0 mmol, 1.0 equiv) was reacted according 
to general procedure D to afford ethyl (E)-5-methyl-4-thiophenylhex-2-enoate 184e 
(795 mg, 60%) as a colourless oil after purification over silica gel (5–40% 
ether/heptane): νmax (film) 1717, 1682, 1583, 1182, 1026, 744, 690 cm-1; δH (400 
MHz, CDCl3) [7.30–7.27 (2H, m) and 7.22–7.16 (3H, m), SPh], 6.75 (1H, dd, J 15.5, 
10.0, H-3), 5.40 (1H, d, J 15.5, H-2), 4.07 (2H, q, J 7.0, OCH2), 3.36 (1H, dd, J 10.0, 
6.5, H-5), 1.18 (3H, t, J 7.0, OCH2CH3), [1.03 (3H, d, J 6.5) and 0.98 (3H, d, J 6.5), 
H-6]; δC (101 MHz, CDCl3) 166.3 (C-1), 146.2 (C-3), 136.5, 133.5, 129.1, 127.8, 
121.8 (C-2), 60.5 (OCH2), 59.0 (C-4), 32.4 (C-5), [20.8 and 20.1, (C-6)], 14.4 
(OCH2CH3); m/z (CI) 282 [MNH4]+, 265 [MH]+, 233 (Found: [MNH4]+, 282.1357. 
C15H20O2S requires [MNH4]+, 282.1528) (Found: C, 67.49; H, 7.68. C15H20O2S 
requires C, 68.14; H, 7.62). 
 
Ethyl (Z)-5-methyl-4-(thiophenyl)hex-2-enoate (184f) 
 
 
 
 
 
 
 
2-Chloro-3-methylbutanal 207c (2.41 g, 20.0 mmol, 1.0 equiv) was reacted according 
to general procedure E to afford ethyl (Z)-5-methyl-4-(thiophenyl)hex-2-enoate 184f 
(1.41 g, 27%) as a colourless oil after purification over silica gel (5–20% 
ether/heptane): νmax (film) 1716, 1683, 1583, 1182, 1026, 744, 691 cm-1; δH (400 
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MHz, CDCl3) [7.40 (2H, d, J 7.0) and 7.28–7.19 (3H, m), SPh], 6.10 (1H, dd, J 11.5, 
11.0, H-3), 5.68 (1H, d, J 11.5, H-2), 5.02 (1H, dd, J 11.0, 7.0, H-4), 4.03 (2H, q, J 
7.0, OCH2), 1.96 (1H, sext, J 7.0, H-5), 1.22 (3H, t, J 7.0, OCH2CH3), [1.15 (3H, d, J 
7.0) and 1.06 (3H, d, J 7.0), H-6]; δC (101 MHz, CDCl3) 166.2 (C-1), 147.5 (C-3), 
134.3 (i-SPh) 132.9 (o-SPh), 128.6 (m-SPh), 127.1 (p-SPh), 119.6 (C-2), 59.9 
(OCH2), 32.2 (C-5), [20.5 and 19.8, (C-6)], 14.2 (OCH2CH3); m/z (CI) 282 [MNH4]+, 
265 [MH]+ (Found: [MH]+, 265.1265. C15H20O2S requires [MH]+, 265.1262) (Found: 
C, 68.19; H, 7.62. C15H20O2S requires C, 68.14; H, 7.62). 
 
Ethyl (E)-4-(phenylthio)-pent-3-enoate and ethyl (Z)-4-(phenylthio)-pent-3-
enoate (208) 
 
 
 
 
 
 
To a solution of ester 184b (20 mg, 0.09 mmol, 1.0 equiv) in d6-DMSO (0.7 mL) in 
an NMR tube was added potassium tert-butoxide (5 mg, 0.045 mmol, 0.5 equiv) in 
one portion. The tube was shaken and a red colour developed.  The 1H-NMR 
spectrum of the mixture was measured at intervals of 10 min, 1 h and 16 h showing 
conversion to a 70:30 mixture of ethyl (E)-4-(phenylthio)-pent-3-enoate E-208 and 
ethyl (Z)-4-(phenylthio)-pent-3-enoate and Z-208: δH (400 MHz, CDCl3) inter alia 
7.35–7.02 (10H, m, E+Z SPh), [6.64 (1H, t, J 7.5) and 6.39 (1H, t, J 7.0) E+Z H-3], 
4.07–3.95 (4H, m, E+Z OCH2), 2.50 (4H, m, E+Z H-2). 
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(E)-4-(Thiophenyl)pent-2-en-1-ol (185a) 
 
 
 
 
 
Ester 184a (1.16 g, 4.91 mmol, 1.0 equiv) was reacted according to general procedure 
F to afford (E)-4-(thiophenyl)pent-2-en-1-ol 185a (676 mg, 71%) as a colourless oil 
after purification over silica gel (5–75 % TBME/heptane):  νmax (film) 3378, 1639, 
1372, 1196, 750, 693 cm-1; δH (400 MHz, CDCl3) [7.35–7.69 (3H, m,) and 7.43–7.41 
(2H, m), SPh], 5.69 (1H, ddt, J 15.5, 9.0, 1.5, H-3), 5.52 (1H, dt, 15.5, 6.0, H-2), 4.05 
(2H, m, H-1), 3.80 (1H, dq, J 9.0, 7.5, H-4), 1.42 (3H, d, J 7.5, H-5), 1.15 (1H, s (br), 
OH); δC (101 MHz, CDCl3) 134.6 (C-3), 133.7, 133.15, 129.5, 128.7, 127.4 (C-2), 
63.1 (C-1), 45.3 (C-4), 20.3 (C-5); m/z (EI) 194 [M]+, 163 [M-CH2OH]+, 110 [SPh]+, 
84 [M-SPh]+ (Found: [M]+, 194.0765. C11H14OS requires [M]+, 194.0762); in 
agreement with published data.147a 
 
(Z)-4-(Phenylthio)pent-2-en-1-ol (185b) 
 
From 193: 
 
 
 
 
To a solution of propargyl alcohol 193 (377 mg, 1.96 mmol, 1.0 equiv) in 
dichloromethane (20 mL) was added TEA (1.08 mL, 7.84 mmol, 4.0 equiv) followed 
by NBSH221 (1.06 g, 4.91 mmol, 2.5 equiv) in one portion.  The suspension was 
stirred for 12 h to give a dark red solution.  Saturated aqueous sodium 
hydrogencarbonate (50 mL) was poured on and the mixture was stirred for 10 min.  
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The phases were separated and the aqueous layer was extracted with dichloromethane 
(2 x 50 mL).  The combined organic extracts were washed with brine (75 mL), dried 
(MgSO4), concentrated under reduced pressure and purified over silica gel (25% 
TBME/petrol) to afford (Z)-4-(thiophenyl)pent-2-en-1-ol 185b (210 mg, 55%) as a 
colourless oil. 
 
From 184b: 
 
 
 
 
Ester 184b (1.16 g, 4.91 mmol, 1.0 equiv) was reacted according to general procedure 
F to afford (Z)-4-(thiophenyl)pent-2-en-1-ol 185b (670 mg, 70%) as a colourless oil 
after purification over silica gel (5–75% TBME/heptane): νmax (film) 3366, 1651, 
1583, 1474, 1438, 1195, 1041, 1013, 750, 692 cm-1; δH (400 MHz, CDCl3), [7.52–
7.50 (2H, m) and 7.36–7.29 (3H, m), SPh], 5.56–5.50 (1H, m, H-2), 5.44 (1H, dd, J 
11.0, 10.5, H-3), 4.10 (1H, dq, J 10.5, 7.0, H-4), [3.83 (1H, dd, J 13.0, 6.0) and 3.73 
(1H, dd, J 13.0, 7.0), H-1], 1.60 (1H, s, OH), 1.40 (3H, d, J 7.0, H-5); δC (101 MHz, 
CDCl3) 134.8 (SPh), 134.4 (C-3), 132.1 (i-SPh), 128.9 (SPh), 128.2, 126.8 (C-2), 58.3 
(C-1), 42.0 (C-4), 20.7 (C-5); m/z (CI) 212 [MNH4]+, 194, [M]+, 177 [M-OH]+, 163 
(Found: [MNH4]+, 212.1113. C11H14OS requires [MNH4]+, 212.1109). 
 
(E)-4-(Thiophenyl)non-2-en-1-ol (185c) 
 
 
 
 
 
Ester 184c (746 mg, 2.55 mmol, 1.0 equiv) was reacted according to general 
procedure F to afford (E)-4-(thiophenyl)non-2-en-1-ol 185c (531 mg, 83%) as a 
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colourless oil after purification over silica gel (5–60% TBME/heptane): νmax (film) 
3350, 1663, 1583, 1438, 747, 691 cm-1; δH (400 MHz, CDCl3) [7.38–7.36 (2H, m) 
and 7.29–7.23 (3H, m), SPh], 5.55 (1H, dd, J 15.5, 9.0, H-3), 5.42 (1H, dt, J 15.5, 5.5, 
H-2), 3.99 (2H, t, J 6.0, H-1), 3.59 (1H, m, H-4), 1.80–1.20 (8H, m, H-5,6,7,8), 0.85 
(3H, t, J, 7.0, H-9); δC (400 MHz, CDCl3) 135.0 (i-SPh), 133.5 (C-3), 133.1 (o-SPh), 
130.6 (m-SPh), 128.8 (C-2), 127.4 (p-SPh), 62.3 (C-1), 51.5 (C-4), 34.5 (C-5), 31.8 
(C-6), 27.2 (C-7), 22.7 (C-8), 14.2 (C-9); m/z (CI) 268 [MNH4]+, 251 [MH]+, 233 [M-
OH]+ (Found: [MNH4]+, 268.1738. C15H22OS requires [MNH4]+, 268.1735) (Found: 
C, 71.42; H, 8.81. C15H22OS requires C, 71.95; H, 8.86). 
 
(Z)-4-(Thiophenyl)non-2-en-1-ol (185d) 
 
 
 
 
 
Ester 184d (3.00 g, 10.3 mmol, 1.0 equiv) was reacted according to general procedure 
F to afford (Z)-4-(thiophenyl)non-2-en-1-ol 185d (1.54 g, 60%) as a colourless oil 
after purification over silica gel (5–75% TBME/heptane): νmax (film) 3388, 1651, 
1583, 1467, 1438, 1378, 1176, 1025, 747, 692 cm-1; δH (400 MHz, CDCl3) [7.52–7.50 
(2H, m) and 7.36–7.33 (3H, m), SPh], 5.57 (1H, dt, J 11.0, 7.0, H-2), 5.39 (1H, dd, J 
11.0, 9.0, H-3), 3.91 (1H, dt, J 9.0, 5.5, H-4), 3.80–3.71 (2H, m, H-1), 1.60 (1H, s 
(br), OH), 1.44–1.40 (2H, m, H-5), 1.37–1.31 (6H, m, H-6,7,8), 0.91 (3H, t, J 7.0, H-
9); δC (101 MHz, CDCl3) 134.9, 134.3, 133.5, 129.4, 128.9, 128.2, 58.4 (C-1), 47.4 
(C-4), 34.5, 31.5, 31.3, 27.2, 22.5, 14.0; m/z (CI) 268 [MNH4]+, 251 [MH]+, 233, 158 
(Found: C, 72.03; H, 8.72. C15H22OS requires C, 71.95; H, 8.86). 
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(E)-5-Methyl-4-(thiophenyl)hex-2-en-1-ol (185e) 
 
 
 
 
 
Ester 184e (279 mg, 1.06 mmol) was reacted according to general procedure F to 
afford (E)-5-methyl-4-(thiophenyl)hex-2-en-1-ol 185e (195 mg, 83%) as a colourless 
oil after purification over silica gel (5–75% TBME/heptane): νmax (film) 3367, 1663, 
1583, 1438, 969, 748, 692 cm-1; δH (400 MHz, CDCl3) [7.38–7.36 (2H, m) and 7.27–
7.20 (3H, m), SPh], 5.58 (1H, dd, J 15.0, 9.5, H-3), 5.38 (1H, dt, J 15.0, 6.0, H-2), 
3.98 (1H, t, J 6.0, H-1), 3.45 (1H, dd, J 9.50, 6.5, H-4), 1.96 (1H, sext, J 6.5, H-5), 
[1.06 (3H, d, J 6.5) and 1.03 (3H, d, J 6.64), H-6], 0.93 (1H, t, J 6.0, OH); δC (400 
MHz, CDCl3) 135.4, 133.4, 131.3, 131.0, 128.8, 127.3, 63.3 (C-1), 59.3 (C-4), 32.3 
(C-5), 20.9, 19.8 (C-6); m/z (CI) 240 [MNH4]+, 223 [MH]+, 205 [M-OH]+ (Found: 
[MH]+, 223.1166. C13H18OS requires [MH]+, 223.1157) (Found: C, 70.28; H, 8.13. 
C13H18OS requires C, 70.22; H, 8.16). 
 
(Z)-5-Methyl-4-(thiophenyl)hex-2-en-1-ol (185f) 
 
 
 
 
 
Ester 184f (81 mg, 0.31 mmol, 1.0 equiv) was reacted according to general procedure 
F to afford (Z)-5-methyl-4-(thiophenyl)hex-2-en-1-ol 185f (36 mg, 54%) as a 
colourless oil after purification over silica gel (5–20% TBME/heptane): νmax (film) 
3350, 1650, 1583, 750, 690 cm-1; δH (400 MHz, CDCl3) [7.51–7.49 (2H, dd, J 8.0, 
2.0) and 7.37–7.29 (3H, m), SPh], 5.62–5.48 (2H, m, H-2,3), 3.77–3.70 (3H, m, H-
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1,4), 1.92 (1H, sext, J 6.5, H-5), [1.10 (3H, d, J 6.5) and 1.03 (3H, d, J 6.5), H-6]; δC 
(101 MHz, CDCl3) 134.9 (C-3), 134.7, 131.3, 129.5, 128.9, 128.0, 58.2 (C-1), 54.8 
(C-4), 32.0 (C-5), 20.8 (C-6), 19.6 (C-6); m/z (CI) 240 [MNH4]+, 223 [MH]+ (Found: 
C, 70.34; H, 8.17. C13H18OS requires C, 70.22; H, 8.16). 
 
Ethyl 3-ethenyl-4-(phenylthio)-pentanoate (186a) 
 
From 185a: 
 
 
  
 
Allylic alcohol 185a (100 mg, 0.515 mmol, 1.0 equiv) was reacted according to 
general procedure G to afford ethyl 3-ethenyl-4-(phenylthio)-pentanoate 186a (133 
mg, 98%, 1:1 syn:anti mixture of diastereomers) as a colourless oil. 
 
From 185b: 
 
 
  
 
Allylic alcohol 185b (100 mg, 0.515 mmol, 1.0 equiv) was reacted according to 
general procedure G to afford ethyl 3-ethenyl-4-(phenylthio)-pentanoate 186a (131 
mg, 97%, 91:9 syn:anti mixture of diastereoisomers) as a colourless oil. 
Data for the mixture: νmax (film) 1734, 1639, 1584, 1479, 1176, 1090 cm-1; m/z (ESI) 
454, 391, 265 [MH]+, 219, 177 [M-SPhNa]+ (Found: [MH]+, 265.1269, C15H20O2S 
requires [MH]+, 265.1262). 
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NMR data for syn-186a: δH (400 MHz, d6-acetone) [7.46 (2H, d, J 7.0), 7.35 (2H, dd, 
J 7.5, 7.0) and 7.27 (1H, dd, J 7.5, 7.0), SPh], 5.81 (1H, ddd, J 16.5, 11.0, 8.0, 
CHCH2), 5.11 (1H, d, J 11.0, trans-CHCH2), 5.10 (1H, d, J 16.5, cis-CHCH2), 4.06 
(2H, q, J 7.0, OCH2), 3.51 (1H, dq, J 7.0, 3.5, H-4), 2.85–2.80 (1H, m, H-3), [2.75 
(1H, dd, J 15.0, 5.5) and 2.43 (1H, dd, J 15.0, 9.0), H-2], 1.27 (3H, d, J 7.0, H-5), 
1.18 (3H, t, J 7.0, OCH2CH3); δC (101 MHz, d6-acetone) 172.1 (C-1), 138.3 
(CHCH2), 136.1 (i-SPh), 132.2, 129.6, 127.4, 117.1 (CHCH2), 60.3 (OCH2), 47.9 (C-
4), 45.3 (C-3), 36.1 (C-2), 18.5 (C-5), 14.2 (OCH2CH3) 
NMR data for anti-186a: δH (400 MHz, d6-acetone) [7.46 (2H, d, J 7.0), 7.35 (2H, dd, 
J 7.5, 7.0) and 7.27 (1H, dd, J 7.5, 7.0), SPh], 5.83 (1H, ddd, J 17.0, 11.0, 8.0, 
CHCH2), 5.10 (1H, d, J 11.0, trans-CHCH2), 5.07 (1H, d, J 17.0, cis-CHCH2), 4.06 
(2H, q, J 7.0, OCH2), 3.41 (1H, dq, J 13.5, 6.5, H-4), 2.82–2.77 (1H, m, H-3), [2.73 
(1H, dd, J 15.0, 5.5) and 2.45 (1H, dd, J 15.0, 8.5), H-2], 1.25 (3H, d, J 7.0, H-5), 
1.18 (3H, t, J 7.0, OCH2CH3); δC (101 MHz, d6-acetone) 172.8 (C-1), 137.9 
(CHCH2), 135.7 (i-SPh), 132.2, 129.5, 127.4, 117.1 (CHCH2), 60.3 (OCH2), 46.6 (C-
4), 45.3 (C-3), 37.7 (C-2), 17.8 (C-5), 14.2 (OCH2CH3). 
 
Ethyl 3-ethenyl-4-(phenylthio)-nonate (186b) 
 
From 185c: 
 
 
  
 
Allylic alcohol 185c (65 mg, 0.26 mmol, 1.0 equiv) was reacted according to  general 
procedure G to afford ethyl 3-ethenyl-4-(phenylthio)-nonate 186b (82 mg, 98%, 50:50 
syn:anti mixture of diastereomers) as a colourless oil. 
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From 185d: 
 
 
  
 
Allylic alcohol 185d (65 mg, 0.26 mmol, 1.0 equiv) was reacted according to general 
procedure G to afford ethyl 3-ethenyl-4-(phenylthio)-nonate 186b (78 mg, 94%, 90:10 
syn:anti mixture of diastereomers) as a colourless oil. 
Data for the mixture: νmax (film) 1733, 1639, 1584, 1479, 1351, 1173, 745, 692 cm-1; 
m/z (CI) 328 [MNH4]+, 321 [MH]+, 264, 233 (Found: [MH]+, 321.1909. C19H28O2S 
requires [MH]+, 321.1888). 
NMR data for syn-186b: δH (400 MHz, d6-acetone) [7.47 (2H, d, J 8.0), 7.35 (2H, dd, 
J 8.0, 6.5) and 7.26 (1H, dd, J 8.0, 6.5), SPh], 5.83 (1H, ddd, J 17.0, 10.0, 8.0, 
CHCH2), 5.13 (1H, d, J 10.0, trans-CHCH2), 5.11 (1H, d, J 17.0, cis-CHCH2), 4.07 
(2H, q, J 7.0, OCH2), 3.83–3.33 (1H, m, H-4), 2.92 (1H, m, H-3), [2.79 (1H, dd, J 
15.0, 6.0) and 2.46 (1H, dd, J 15.0, 8.0), H-2], 1.75–1.27 (8H, m, H-5,6,7,8), 1.18 
(3H, t, J 7.0, OCH2CH3); δC (101 MHz, d6-acetone) 171.6 (C-1), 137.6 (CHCH2), 
131.3 (o-SPh), 136.5, 129.0 (m-SPh), 126.6 (p-SPh), 116.6 (CHCH2), 59.8 (OCH2), 
53.5 (C-4), 43.7 (C-3), 33.0, 31.3, 26.9, 22.3, 13.7, 13.4. 
NMR data for anti-186b: δH (400 MHz, d6-acetone) [7.47 (2H, d, J 8.0), 7.35 (2H, dd, 
J 8.0, 6.5) and 7.26 (1H, dd, J 8.0, 6.5), SPh], 5.86 (1H, ddd, J 17.0, 10.0, 8.0, 
CHCH2), 5.13 (1H, d, J 10.0, trans-CHCH2), 5.11 (1H, d, J 17.0, cis-CHCH2), 4.08 
(2H, q, J 7.0, OCH2), 3.29–3.24 (1H, m, H-4), 2.90–2.83 (1H, m, H-3), [2.78 (1H, dd, 
J 15.0, 5.5) and 2.45 (1H, dd, J 15.0, 9.0), H-2], 1.75–1.27 (8H, m, H-5,6,7,8), 1.18 
(3H, t, J 7.0, OCH2CH3); δC (101 MHz, d6-acetone) 171.4 (C-1), 138.2 (CHCH2), 
136.5, 131.4 (o-SPh), 128.9 (m-SPh), 127.4 (p-SPh), 116.4 (CHCH2), 59.8 (OCH2), 
52.7 (C-4), 44.5 (C-3), 36.9 (C-2), 36.2 (C-2), 33.0, 31.4, 26.5, 22.3, 13.7, 13.4. 
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Ethyl 5-methyl-3-ethenyl-4-(phenylthio)-hexanoate (186c) 
 
From 185e: 
 
 
  
 
Allylic alcohol 185e (58 mg, 0.26 mmol, 1.0 equiv) was reacted according to general 
procedure G to afford ethyl 5-methyl-3-ethenyl-4-(phenylthio)-hexanoate 186c (71 
mg, 93%, 60:40 syn:anti mixture of diastereoisomers) as a colourless oil. 
 
From 185f: 
 
 
  
 
Allylic alcohol 185f (36 mg, 0.16 mmol, 1.0 equiv) was reacted according to general 
procedure G to afford ethyl 5-methyl-3-ethenyl-4-(phenylthio)-hexanoate 186c (41 
mg, 87%, 90:10 syn:anti mixture of diastereoisomers) as a colourless oil. 
Data for the mixture: νmax (film) 1734, 1640, 1582, 1440, 1351, 745, 692 cm-1; m/z 
(CI) 310 [MNH4]+, 293 [MH]+, 205, 117 (Found: [MH]+, 293.1587. C17H24O2S 
requires [MH]+, 293.1575). 
NMR data for syn-186c: δH (400 MHz, CDCl3) [7.83–7.80 (2H, m) and 7.67–7.56 
(3H, m), SPh], 6.21 (1H, ddd, J 17.0, 10.0, 8.0, CHCH2), 5.54 (1H, d, J 17.0, cis-
CHCH2), 5.48 (1H, d, J 10.0, trans-CHCH2), 3.95–3.87 (2H, m, OCH2), 3.95–3.87 
(1H, m, OCH2), 3.21–3.13 (1H, m, H-3), [2.74 (1H, dd, J 15.5, 6.0) and 2.51 (1H, dd, 
J 15.5, 7.0), H-2], 2.00–1.91 (1H, m, H-4), 1.19–1.15 (3H, m, OCH2CH3), [1.16 (3H, 
d, J 7.0) and 1.10 (3H, d, J 7.0), H-6], 1.08–1.02 (2H, m, H-5); δC (101 MHz, CDCl3) 
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171.9 (C-1), 138.3 (CHCH2), 134.4, 130.9, 129.5, 126.6, 117.1 (CHCH2), 60.3 
(OCH2), 43.4 (C-3), 38.7 (C-2), 33.1 (C-4), [21.1 and 21.0 (C-6)], 16.1, 14.7. 
NMR data for anti-186c: δH (400 MHz, CDCl3) [7.83–7.80 (2H, m) and 7.67–7.56 
(3H, m), SPh], 6.36 (1H, ddd, J 16.5, 10.0, 7.0, CHCH2), 5.50 (1H, d, J 16.5, cis-
CHCH2), 5.42 (1H, d, J 10.0, trans-CHCH2), 3.95–3.87 (2H, m, OCH2), 3.95–3.87 
(1H, m, OCH2), 3.21–3.13 (1H, m, H-3), [2.97 (1H, dd, J 14.5, 4.0) and 2.36 (1H, dd, 
J 14.5, 9.5), H-2], 2.00–1.91 (1H, m, H-4), 1.19–1.15 (3H, m, OCH2CH3), 1.08–1.02 
(2H, m, H-5), [0.95 (3H, d, J 7.0) and 0.89 (3H, d, J 7.9), H-6]; δC (101 MHz, CDCl3) 
172.0 (C-1), 138.7 (CHCH2), 133.3, 130.6, 129.4, 126.5, 116.5 (CHCH2), 60.2 
(OCH2), 43.4 (C-3), 38.6 (C-2), 33.1 (C-4), [22.2 and 21.9 (C-6)], 16.1, 14.2. 
 
4-(Thiophenyl)-3-ethenyl-pentanoic acid (196) 
 
  
 
  
 
To a solution of ester 186a (1.20 g, 4.24 mmol, 1.0 equiv, 91:9 mixture of 
diastereomers) in THF (15 mL) and water (15 mL) was added lithium hydroxide (1.01 
g, 42.4 mmol, 10.0 equiv) in one portion at rt.  The stirred mixture was heated under 
reflux for 4 h cooled to rt, quenched with aqueous HCl (2 M, 30 mL) and extracted 
with ether (3 x 25 mL). The combined organic extracts were dried (Na2SO4) and 
concentrated under reduced pressure to afford an inseparable mixture of 4-
(thiophenyl)-3-ethenyl-pentanoic acid 196 (0.93 g, 93%, 91:9 mixture of 
diastereomers) as a colourless oil which was used without further purification. 
Data for syn-196: νmax (film) 3075, 1709, 1639, 1584, 1480, 1438, 1284, 923, 741, 
692; δH (400 MHz, CDCl3) 7.44 (2H, d, J 7.0, o-SPh), 7.33–7.24 (3H, m, m,p-SPh), 
5.79 (1H, ddd, J 17.0, 10.0, 8.0, CHCH2), 5.18 (1H, d, J 10.0, trans-CHCH2), 5.14 
(1H, d, J 17.0, cis-CHCH2), 3.40 (1H, dq, J 7.0, 4.0, H-4), 2.91–2.78 (2H, m, H-2,3), 
2.51 (1H, dd, J 14.0, 8.0, H-2’), 1.29 (3H, d, J 7.0, H-5); δC (101 MHz, CDCl3), 178.0 
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(C-1), 137.0 (CHCH2), 135.0 (i-SPh), 132.2 (o-SPh), 129.0 (m-SPh), 127.1 (p-SPh), 
117.6 (CHCH2), 47.9 (C-4), 44.3 (C-3), 35.4 (C-2), 18.2 (C-5). 
Characteristic NMR signals for anti-196: δH (400 MHz, CDCl3) inter alia 4.12–4.04 
(1H, m, H-4), 1.39 (3H, d, J 6.5, H-5); δC (101 MHz, CDCl3) 46.7 (C-4), 44.7 (C-3), 
37.2 (C-2), 18.1 (C-5). 
 
N-(2,4-dinitrophenyl)-4-(thiophenyl)-3-ethenyl-pentamide (197) 
 
 
  
 
 
 
To a solution of acid 196 (919 mg, 3.89 mmol, 1.0 equiv, 91:9 mixture of 
diastereoisomers) in dichloromethane (20 mL) was added DCC (803 mg, 3.89 mmol, 
1.0 equiv) and DMAP (47.5 mg, 0.389 mmol, 0.1 equiv) at rt.  The mixture was 
stirred for 5 min and a solution of 2,4-dinitroaniline (783 mg, 4.28 mmol, 1.1 equiv) 
in dichloromethane (20 mL) was added dropwise via syringe.  The resulting yellow 
mixture was stirred overnight at rt and filtered over Celite.  The filtrate was washed 
with sodium hydrogencarbonate (30 mL) and aqueous HCl (2 M, 30 mL), dried 
(MgSO4) and concentrated under reduced pressure.  Purification of the residue over 
silica gel (15% ether/hexane) afforded N-(2,4-dinitrophenyl)-4-(thiophenyl)-3-
ethenyl-pentamide 197 (967 mg, 62%, 91:9 mixture of diastereoisomers) as a yellow 
solid.  Further purification of the mixture over silica gel (5–15% ether/hexane) and 
recrystallisation (EtOAc) afforded an analytical sample of syn-197 (435 mg, 28%) as 
a yellow crystalline solid. 
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Data for syn-197: mp 82–83 °C; νmax (film) 1712, 1615, 1599, 1499, 1335, 1307, 
1141, 748, 696; δH (400 MHz, CDCl3) 10.54 (1H, s (br), NH), 9.13 (1H, d, J 2.5, 3-
Ar), 9.06 (1H, d, J 9.5, 4-Ar), 8.46 (1H, dd, J 9.5, 2.5, 5-Ar), [7.42 (2H, d, J 8.5), 
7.28–7.24 (2H, m) and 7.21–7.16 (1H, m), SPh], 5.87 (1H, ddd, J 17.0, 10.0, 8.5, 
CHCH2), 5.22 (1H, d, J 10.0, trans-CHCH2), 5.18 (1H, d, J 17.0 cis-CHCH2), 3.50 
(1H, dq, J 9.5, 7.0, H-4), 3.05–2.96 (2H, m, H-2,3), 2.66 (1H, dd, J 14.0, 7.5, H-2), 
1.36 (3H, d, J 7.0, H-5); δC (101 MHz, CDCl3) 171.1 (C-1), 141.7, 139.6, 136.5 
(CHCH2), 135.1, 134.8, 131.7 (SPh), 130.1 (5-Ar), 129.1 (SPh), 127.0 (SPh), 122.3 
(4-Ar), 122.0 (3-Ar), 118.5 (CHCH2), 47.7 (C-4), 45.2 (C-3), 40.6 (C-2), 18.8 (C-5);  
m/z (CI) 419 [MNH4]+, 402 [MH]+, 369, 326, 201 (Found: [MNH4]+  419.1388; 
C19H19N3O5S requires [MNH4]+ 419.1389) (Found: C, 56.88; H, 4.74; N, 10.41. 
C19H19N3O5S requires C, 56.85; H, 4.77; N, 10.47). 
NMR data for anti-197: δH (400 MHz, CDCl3) 10.68 (1H, s (br), NH), 9.13 (1H, d, J 
2.5, 3-Ar), 9.11 (1H, d, J 9.5, 4-Ar), 8.47 (1H, dd, J 9.5, 2.5, 5-Ar), 7.42–7.19 (5H, m, 
SPh), 5.80 (1H, ddd, J 17.0, 10.5, 8.5, CHCH2), 5.16 (1H, d, J 10.5, trans-CHCH2), 
5.12 (1H, d, J 17.0, cis-CHCH2), 3.49 (1H, dq, J 10.0, 7.0, H-4), 3.01–2.95 (1H, m, 
H-3), [2.83 (1H, dd, J 15.0, 6.5) and 2.85 (1H, dd, J 15.0, 7.5), H-2], 1.30 (3H, d, J 
7.0, H-5); δC (101 MHz, CDCl3) 171.7 (C-1), 153.8, 137.6, 137.2 (CHCH2), 135.5, 
131.9, 131.1, 129.0, 126.9, 126.7, 122.3, 122.0, 117.6 (CHCH2), 47.4 (C-4), 45.4 (C-
3), 37.3 (C-2), 18.4 (C-5). 
 
Ethyl (E)-4-(phenylthio)-2-methylpent-2-enoate (209) 
 
 
 
 
 
 
 
To a solution of TEA (3.97 mL, 28.8 mmol, 1.4 equiv) in THF (40 mL) was added 
thiophenol (2.1 mL, 20.6 mmol, 1.0 equiv) dropwise via syringe. The colourless 
solution was stirred at rt for 10 min and a solution of 2-chloropropanal 207a (1.89 g, 
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20.6 mmol, 1.0 equiv) in THF (20 mL) was added dropwise via syringe. The rapid 
formation of a white precipitate was observed upon addition and the resulting 
suspension was stirred at rt for 1 h.  In a separate flask, a solution of triethyl 2-
phosphonopropionate (6.86 g, 28.8 mmol, 1.0 equiv) in THF (80 mL) was added to a 
suspension of sodium hydride (60% w/w in mineral oil, 1.23 g, 30.9 mmol, 1.5 equiv) 
in THF (40 mL) at 0 ºC via cannula.  The mixture was allowed to warm to rt with 
stirring until all sodium hydride had dissolved. The previously prepared sulfenyl-
aldehyde solution was filtered under nitrogen and added via cannula to the 
phosphonate anion solution at –78 ºC.  After stirring for 2 h at –78 ºC saturated 
aqueous NH4Cl (150 mL) was added and the mixture extracted with EtOAc (3 x 100 
mL). The combined organic extracts were washed with brine (150 mL), dried 
(MgSO4), concentrated under reduced pressure and purified over silica gel (10% 
TBME/petrol) to afford ethyl (E)-4-(phenylthio)-2-methylpent-2-enoate 209 (1.57 g, 
31%) as a colourless oil: νmax (film) 1711, 1646, 1439, 1252, 1110, 753, 693 cm-1; δH 
(400 MHz, CDCl3) [7.46–7.44 (2H, m) and 7.32–7.29 (3H, m), SPh], 6.62 (1H, dd, J 
10.5, 1.5, H-3), 4.20 (2H, q, J 7.0, OCH2), 4.03 (1H, dq, J 10.5, 6.5, H-4), 1.52 (3H, 
d, J 1.5, 2-Me), 1.43 (3H, d, J 6.5, H-5), 1.31 (3H, t, J 7.0, OCH2CH3); δC (101 MHz, 
CDCl3), 167.9 (C-1), 142.3, 134.3, 133.5, 129.2, 128.8, 128.0, 60.7 (OCH2), 42.4 (C-
4), 20.2, 14.2, 12.2; m/z (CI) 268 [MNH4]+, 251 [MH]+, 205, 141 (Found: [MNH4]+, 
251.1096; C14H18O2S requires [MNH4]+, 251.1106) (Found: C, 67.19; H, 7.25. 
C14H18O2S requires C, 67.16; H, 7.25). 
 
(E)-4-(Thiophenyl)-2-methylpent-2-en-1-ol (210) 
 
 
 
 
 
Ester 209 (1.18 g, 4.72 mmol, 1.0 equiv) was reacted according to general procedure 
F to afford (E)-4-(thiophenyl)-2-methylpent-2-en-1-ol 210 (924 mg, 94%) as a 
colourless oil after purification over silica gel (5–20% TBME/heptane): νmax (film) 
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3349, 1582, 1438, 1024, 752, 692 cm-1; δH (400 MHz, CDCl3) [7.46–7.44 (2H, m) 
and 7.33 (3H, m), SPh], 5.36 (1H, dd, J 10.0, 1.5, H-3), 4.05 (1H, dq, J 10.0, 7.0, H-
4), 3.96 (2H, s, H-1), 1.45 (3H, d, J 1.5, Me), 1.37 (3H, d, J 7.0, H-5); δC (101 MHz, 
CDCl3) 136.3, 133.8, 129.0, 128.6, 127.9, 127.5, 68.3, 41.7, 21.1, 13.6; m/z (CI) 226 
[MNH4]+, 209 [MH]+, 191, 116 (Found: [MH]+, 209.1008. C12H16O2S requires 
[MH]+, 209.1000). 
 
Ethyl 4-(phenylthio)-3-(prop-1-enyl)pentanoate (211) 
 
 
 
  
 
Allylic alcohol 210 (150 mg, 0.72 mmol, 1.0 equiv) was reacted according to general 
procedure G to afford ethyl 4-(phenylthio)-3-(prop-1-enyl)pentanoate 211 (200 mg, 
>99%, 71:29 syn:anti mixture of diastereoisomers) as a colourless oil. 
Data for the mixture: νmax (film) 1738, 1646, 1584, 1439, 1376, 1160, 1051, 749, 693 
cm-1; m/z (CI), 296 [MNH4]+, 279 [MH]+, 191, 169, 117 (Found: [MH]+, 279.1414. 
C16H22O2S requires [MH]+, 279.1419). 
NMR data for syn-211: δH (400 MHz, CDCl3) [7.47–7.43 (2H, m) and 7.34–7.26 (3H, 
m), SPh], 4.93 (1H, s, trans-CMeCH2), 4.82 (1H, s, cis-CMeCH2), 4.11 (2H, q, J 7.0, 
OCH2), 3.60–3.52 (1H, m, H-4), 3.43–3.35 (1H, m, H-3), [2.85–2.77 (1H, m) and 
2.53–2.44 (1H, m), H-2], 1.76 (3H, s, CMeCH2), 1.26–1.22 (6H, m, OCH2CH3, H-
5); δC (101 MHz, CDCl3) 171.7 (C-1), 144.8 (CMeCH2), 135.2, 132.0, 129.0, 127.2, 
112.2 (CMeCH2), 60.3 (OCH2), 46.6 (syn + anti C-4), 45.0 (C-3), 34.2 (C-2), 21.6, 
17.0, 14.2. 
NMR data for anti-211: δH (400 MHz, CDCl3) [7.47–7.43 (2H, m) and 7.34–7.26 
(3H, m), SPh], 4.87 (1H, s, trans-CMeCH2), 4.82 (1H, s, cis-CMeCH2), 4.14 (2H, q, J 
7.0, OCH2), 3.60–3.52 (1H, m, H-4), 3.43–3.35 (1H, m, H-3), [2.85–2.77 (1H, m) and 
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2.53–2.44 (1H, m), H-2], 1.73 (3H, s, CMeCH2), 1.26–1.22 (6H, m, OCH2CH3, H-5); 
δC (101 MHz, CDCl3) 171.5 (C-1), 144.7 (CMeCH2), 135.1, 131.0, 128.6, 127.1, 
114.3 (CMeCH2), 60.3 (OCH2), 46.6 (C-4), 45.0 (C-3), 34.2 (C-2), 21.6, 17.0, 14.2. 
Experimental 
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3.4.3 Compounds relevant to section 2.5 
 
(E)-Non-3-en-2-one (238b) 
 
 
 
 
 
Hexanal (1.85 mL, 15.0 mmol, 1.0 equiv) was reacted according to general procedure 
H to afford (E)-non-3-en-2-one 238b (1.07 g, 51%) as a colourless oil: bp4 100–102 
°C; νmax (film) 1677, 1628, 1466, 1360, 1253, 1176, 982 cm-1; δH (400 MHz, CDCl3) 
6.92 (1H, dt, J 16.0, 7.0, H-4), 6.08 (1H, d, J 16.0, H-3), 2.25 (3H, s, H-1), 2.25–2.21 
(2H, m, H-5), 1.52–1.44 (2H, m, H-6), 1.36–1.27 (4H, m, H-7,8), 0.90 (3H, t, J 6.5, 
H-9); δC (101 MHz, CDCl3) 198.8 (C-2), 148.7 (C-4), 131.3 (C-3), 32.4, 31.3, 27.8, 
26.8, 22.4, 14.0; m/z (CI) 158 [MNH4]+, 141 [MH]+, 125; in agreement with published 
data.222 
 
(E)-4-(Cyclohexyl)-but-3-en-2-one (238d) 
 
 
 
 
 
Cyclohexanecarboxaldehyde (1.82 mL, 15.0 mmol, 1.0 equiv) was reacted according 
to general procedure H to afford (E)-4-(cyclohexyl)-but-3-en-2-one 238d (917 mg, 
40%) as a colourless oil: bp4 95–100 °C, νmax (film) 1698, 1676, 1624, 1449, 1357, 
1253, 980 cm-1; δH (400 MHz, CDCl3) 6.73 (1H, dd, J 16.0, 7.0, H-4), 6.05 (1H, d, J 
16.0, H-3), 2.45 (3H, s, H-1), 2.20–2.12 (1H, m, H-5), 1.78 (4H, d, J 11.0, 
cyclohexyl), 1.69 (1H, d, J 13.5, cyclohexyl), 1.36–1.15 (5H, m, cyclohexyl); δC (101 
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MHz, CDCl3) 199.2 (C-2), 153.4 (C-4), 128.8 (C-3), 40.6 (C-5), 31.8 (cyclohexyl) 
26.8 (C-1), 25.9 (cyclohexyl), 25.7 (cyclohexyl); m/z (CI) 170 [MNH4]+, 153 [MH]+ 
(Found: [MH]+, 153.1281. C10H16O requires [MH]+, 153.1279). 
 
(E)-1-Phenylbut-2-en-1-one (238f) 
 
 
 
 
 
 
 
A solution of phenylmagnesium chloride (26.3 mL of a 1.90 M solution in THF, 50.0 
mmol, 1.0 equiv) was added to a flask containing THF (150 mL) at 0 °C and 
crotonaldehyde (4.1 mL, 50.0 mmol, 1.0 equiv) was added. After stirring at 0 °C for 
30 min, the reaction was quenched with saturated aqueous NH4Cl (25 mL). The 
reaction mixture was warmed to rt, partially concentrated under reduced pressue to 
remove THF and extracted with ether (2 x 120 mL). The combined organic extracts 
were washed with aqueous HCl (2 M, 40 mL), water (2 x 40 mL) and brine (40 mL), 
dried (MgSO4) and concentrated under reduced pressure. The residue was taken up in 
DMF (10 mL) and added to a stirred solution of pyridinium dichromate (20.4 g, 1.08 
equiv) in DMF (40 mL). After 1 h, the reaction mixture was diluted with ether (100 
mL) and poured onto water (100 mL). The phases were separated and the organic 
layer was washed with water (2 x 100 mL) and brine (40 mL). Concentration under 
reduced pressure and Kugelrohr distillation afforded (E)-1-phenylbut-2-en-1-one 238f 
(2.02 g, 28%) as a colourless oil: bp4 120–125 °C; νmax (film) 1668, 1624, 1577, 
1449, 1296, 1220, 966 cm-1; δH (400 MHz, CDCl3) 7.58–7.42 (5H, m, Ph), 7.10 (1H, 
dq, J 15.0, 7.0, H-3), 6.93 (1H, d, J 15.0, H-2), 2.03 (3H, d, J 7.0, H-4); δC (101 MHz, 
CDCl3) 190.1 (C-1), 145.1, 143.5, 137.9, 132.6, 128.5, 128.2, 18.6 (Me); m/z (CI) 164 
[MNH4]+, 147 [MH]+, 131; in agreement with published data.223 
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(E)-4-(Pyridin-2-yl)-but-3-en-2-one (238h) 
 
 
 
 
 
2-Pyridinecarboxaldehyde (1.43 mL, 15.0 mmol, 1.0 equiv) was reacted according to 
general procedure H to afford (E)-4-(pyridin-2-yl)-but-3-en-2-one 238h (1.41 g, 64%) 
as a colourless oil: bp4 120–125 °C; νmax (film) 1667, 1621, 1583, 1469, 1432, 1359, 
1312, 1200, 1152, 980, 766 cm-1; δH (400 MHz, CDCl3) 8.57 (1H, s (br), 6-pyridyl), 
7.75–7.71 (1H, m, pyridyl), 7.52 (1H, d, J 16.5, H-4), 7.50–7.48 (1H, m, pyridyl), 
7.30–7.27 (1H, m, pyridyl), 7.14 (1H, d, J 16.5, H-3), 2.41 (3H, s, H-1); δC (101 
MHz, CDCl3) 198.6 (C-2), 153.1 (2-pyridyl), 150.1 (6-pyridyl), 141.9 (C-4), 136.9 
(pyridyl), 130.2 (C-3), 124.4, 124.3 (pyridyl), 28.1 (C-1); m/z (ESI) 148 [MH]+, 130, 
120 (Found: [MH]+, 148.0754. C9H9NO requires [MH]+, 148.0762). 
 
(E)-4-(Furan-2-yl)-but-3-en-2-one (238j) 
 
 
 
 
 
Furfural (1.24 mL, 15.0 mmol, 1.0 equiv) was reacted according to general procedure 
H to afford (E)-4-(furan-2-yl)-but-3-en-2-one 238j (1.16 g, 57%) as white crystals: 
bp4 105–110 °C; mp 37–39 °C; νmax (film) 1657, 1622, 1477, 1272, 1252, 932 cm-1; 
δH (400 MHz, CDCl3) 7.52 (1H, d, J 2.0, 5-furanyl), 7.29 (1H, d, J 16.5, H-4), 6.69 
(1H, d, J 3.0, 3-furanyl), 6.64 (1H, d, J 16.5, H-3), 6.51 (1H, dd, J 3.0, 2.0, 4-furanyl), 
2.38 (3H, s, H-1); δC (101 MHz, CDCl3) 197.9 (C-2), 150.9 (C-5), 145.0 (5-furanyl), 
129.5 (C-4), 124.3 (C-3), 115.7 (3-furanyl), 112.6 (4-furanyl), 27.9 (C-1); m/z (CI) 
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154 [MNH4]+, 137 [MH]+, 121 (Found: [MH]+, 137.0604. C8H8O2 requires [MH]+, 
137.0603). 
 
 (E)-1-Chloronon-3-en-2-ol (239a) 
 
 
 
 
 
Octen-2-al 238a (1.49 mL, 10.0 mmol, 1.0 equiv) was reacted according to general 
procedure I to afford (E)-1-chloronon-3-en-2-ol 239a (1.42 g, 81%) as a colourless 
oil after purification over silica gel (20% ether/petrol): νmax (film) 3354, 1671, 972, 
760, 730 cm-1; δH (400 MHz, CDCl3) 5.84 (1H, dt, J 15.5, 7.5, H-4), 5.48 (1H, ddt, J 
15.5, 7.5, 1.5, H-3), 4.32 (1H, m, H-2), [3.65 (1H, dd, J 11.0, 3.5) and 3.52 (1H, dd, J 
11.0, 7.5), H-1], 2.08 (1H, m, H-5), 1.45–1.29 (6H, m, H-6,7,8), 0.91 (3H, t, J 6.5, H-
9); δC (101 MHz, CDCl3) 135.2 (C-4), 127.9 (C-3), 72.4 (C-2), 50.0 (C-1), 32.2 (C-5), 
31.3 (C-6), 28.6 (C-7), 22.5 (C-8), 14.0 (C-9); m/z (CI) 194 [MNH4]+, 176 [M]+ 
(Found: [MNH4]+, 194.1313. C9H17ClO requires [MNH4]+, 194.1312) (Found: C, 
61.08; H, 9.72. C9H17ClO requires C, 61.18; H, 9.70). 
 
(E)-1-Chloro-2-methylnon-3-en-2-ol (239b) 
 
 
 
 
 
3-Nonen-2-one 238b (936 mg, 6.68 mmol, 1.0 equiv) was reacted according to 
general procedure I to afford (E)-1-chloro-2-methylnon-3-en-2-ol 239b (1.17 g, 92%) 
as a colourless oil after purification over silica gel (20% TBME/petrol): νmax (film) 
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3411, 1669, 1457, 1376, 973, 745 cm-1;  δH (400 MHz, CDCl3) 5.80 (1H, dt, J 15.5, 
6.5, H-4), 5.53 (1H, dt, J 15.5, 1.0, H-3), 3.55 (2H, AB quartet, J 10.0, H-1), 2.10 
(2H, dt, J 13.0, 6.5, H-5), 1.39 (3H, s, 2-Me), 1.40–1.30 (6H, m, H-6,7,8), 0.92 (3H, t, 
J 7.0, H-9);  δC (101 MHz, CDCl3) 132.8 (C-3), 131.3 (C-4), 72.0 (C-2), 54.7 (C-1), 
32.2 (C-5), 31.3 (C-6), 28.8 (C-7), 25.6 (2-Me), 14.1 (C-9); m/z (CI) 190 [MNH4–
H2O]+, 177, 172 [M–OH]+, 137 (Found: [MNH4–H2O]+, 190.1363. C10H19ClO 
requires [MNH4–H2O]+, 190.1357).  
 
(E)-1-Chloro-2-methylpent-3-en-2-ol (239c) 
 
 
 
 
 
3-Penten-2-one 238c (2.44 mL, 25.0 mmol, 1.0 equiv) was reacted according to 
general procedure I to afford (E)-1-chloro-2-methylpent-3-en-2-ol 239c (1.18 g, 35%) 
as a colourless oil after purification over silica gel (20% ether/petrol): νmax (film) 
3419, 1671, 1450, 968, 801, 743 cm-1; δH (400 MHz, CDCl3) 5.82 (1H, dq, J 15.5, 
6.5, H-4), 5.55 (1H, d, J 15.5, H-3), 3.53 (2H, AB quartet, J 15.0, H-1), 2.16 (1H, s 
(br), OH), 1.74 (3H, dd, J 6.5, 1.5, H-5), 1.38 (3H, s, 2-Me); δC (101 MHz, CDCl3) 
134.1 (C-3), 125.9 (C-4), 72.0 (C-2), 54.6 (C-1), 25.5 (C-5), 17.8 (2-Me); m/z (CI) 
136 [M–H]+, 134 [MNH4–H2O]+, 100 (Found: [MNH4–H2O]+, 134.0739. C6H11ClO 
requires [MNH4–H2O]+, 134.0737). 
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(E)-1-Chloro-4-cyclohexyl-2-methylbut-3-en-2-ol (239d) 
 
 
 
 
 
(E)-4-(Cyclohexyl)-but-3-en-2-one 239d (508 mg, 3.94 mmol, 1.0 equiv) was reacted 
according to general procedure I to afford (E)-1-chloro-4-cyclohexyl-2-methylbut-3-
en-2-ol 239d (562 mg, 84%) as a colourless oil after purification over silica gel (10% 
ether/hexane): νmax (film) 3430, 1668, 1449, 1373, 1263, 970, 745 cm-1;  δH (400 
MHz, CDCl3) 5.75 (1H, dd, J 15.5, 7.5, H-4), 5.46 (1H, dd, J 15.5, 1.5, H-3), 3.53 
(2H, AB quartet, J 11.0, H-1), 2.18 (1H, s (br), OH), 2.04–1.95 (1H, m, H-5), 1.78–
1.65 (5H, m, cyclohexyl), 1.39 (3H, s, 2-Me), 1.38–1.05 (5H, m, cyclohexyl); δC (101 
MHz, CDCl3) 136.9 (C-4), 130.3 (C-3), 72.0 (C-2), 54.7 (C-1), 40.3 (C-5), 32.8, 26.1, 
26.0 (cyclohexyl), 25.7 (2-Me); m/z (CI) 222, 220 [MNH4]+, 204, 202 [M]+, 187, 185 
(Found: [MNH4]+,  220.1473. C11H19ClO requires [MNH4]+, 220.1468) (Found: C, 
65.13; H, 9.36. C11H19ClO requires C, 65.17; H, 9.45). 
 
(E)-1-Chloro-4-phenylbut-3-en-2-ol (239e) 
 
 
 
 
 
Cinnamaldehyde 238e (1.50 g, 11.35 mmol, 1.0 equiv) was reacted according to 
general procedure I to afford (E)-1-chloro-4-phenylbut-3-en-2-ol 239e (2.06 g, 99%) 
as a colourless oil after purification over silica gel (10% ether/petrol): νmax (film) 
3390, 3026, 1659, 1598, 1578, 1494, 1449, 1296, 1071, 967, 754, 693 cm-1; δH (400 
MHz, CDCl3) 7.43 (2H, d, J 7.5, o-Ph), 7.37 (2H, dd, J 13.5, 7.5, m-Ph), 7.31 (1H, dd, 
J 13.5, 6.5, p-Ph), 6.76 (1H, d, J 15.5, H-4), 6.24 (1H, dd, J 15.5, 6.0, H-3), 4.57 (1H, 
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dt, J 7.0, 6.0, H-2), [3.57 (1H, dd, J 11.0, 3.5) and 3.64 (1H, dd, J 11.0, 6.5), H-1]; δC 
(101 MHz, CDCl3) 136.1 (i-Ph), 132.8 (C-4), 128.7 (m-Ph), 128.2 (p-Ph), 127.2 (C-
3), 126.7 (o-Ph), 72.3 (C-2), 49.7 (C-1); m/z (CI) 200 [MNH4]+, 182 [M]+, 165 
(Found: [MNH4]+, 200.0842. C10H11ClO requires [MNH4]+, 200.0842); in agreement 
with published data.172 
 
(E)-1-Chloro-2-phenyl-pent-3-en-2-ol (239f) 
 
 
 
 
 
(E)-1-Phenylbut-2-en-1-one 238f (1.89 g, 12.91 mmol, 1.0 equiv) was reacted 
according to general procedure I to afford (E)-1-chloro-2-phenyl-pent-3-en-2-ol 239f 
(1.31 g, 52%) as a colourless oil after purification over silica gel (10% 
ether/hexane): νmax (film) 3466, 1667, 1623, 1494, 1448, 1336, 1161, 1050, 967, 724, 
699 cm-1;  δH (400 MHz, CDCl3) 7.49 (2H, d, J 8.5, o-Ph), 7.40 (2H, dd, J 8.5, 7.0, m-
Ph), 7.32 (1H, dd, J 7.5, 7.0, p-Ph), 5.83–5.80 (2H, m, H-3 and H-4), 3.89 (2H, AB 
quartet, J 11.5, H-1), 2.74 (1H, s, OH), 1.78 (3H, dd, J 5.0, 1.5, H-5);  δC (101 MHz, 
CDCl3) 142.8 (i-Ph), 133.5, 128.5 (m-Ph), 128.4, 127.6, 125.6 (o-Ph), 75.9 (C-2), 54.0 
(C-1), 17.8 (C-5); m/z (CI) 216, 214 [MNH4]+, 198, 196 [MH]+, 181, 179 (Found: 
[MNH4]+, 214.1003. C11H13ClO requires [MNH4]+, 214.0999) (Found: C, 67.24; H, 
6.59. C11H13ClO requires C, 67.18; H, 6.66). 
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(E)-1-Chloro-2-methyl-4-(pyridin-2-yl)but-3-en-2-ol (239h) 
 
 
 
 
 
(E)-4-(Pyridin-2-yl)-but-3-en-2-one 238h (1.00 g, 6.80 mmol, 1.0 equiv) was reacted 
according to general procedure I to afford (E)-1-chloro-2-methyl-4-(pyridin-2-yl)but-
3-en-2-ol 239h (1.18 g, 88%) as a yellow oil after purification over silica gel (25% 
EtOAc, 5% TEA/hexane): νmax (film) 3348, 1657, 1589, 1566, 1472, 1432, 1371, 977, 
801, 768, 747 cm-1;  δH (400 MHz, CDCl3) 8.58 (1H, d, J 5.5, 6-pyridyl), 7.66 (1H, 
ddd, J 9.5, 8.0, 2.0, 4-pyridyl), 7.29 (1H, d, J 8.0, 3-pyridyl), 7.16 (1H, ddd, J 7.5, 5.0, 
2.0, 5-pyridyl), 6.84 (2H, d, J 17.0, H-3, H-4), 3.67 (2H, AB quartet, J 11.0, H-1), 
2.70 (1H, s (br), OH), 1.29 (3H, s, 2-Me);  δC (101 MHz, CDCl3) 154.7 (2-pyridyl), 
149.6 (6-pyridyl), 137.0 (C-4), 136.7 (4-pyridyl), 129.4 (C-3), 122.5 (5-pyridyl), 
122.4 (3-pyridyl), 72.6 (C-2), 54.2 (C-1), 25.7 (2-Me); m/z (ESI) 201, 200, 198 [MH]+ 
(Found: [MH]+, 198.0680. C10H12ClNO requires [MH]+, 198.0686) (Found: C, 60.69; 
H, 6.03; N, 6.99. C10H12ClNO requires C, 60.76; H, 6.12; N, 7.09). 
 
(E)-2-(Hept-1-enyl)oxirane (234a) 
 
 
 
 
 
Chlorohydrin 239a (1.38 g, 7.82 mmol, 1.0 equiv) was reacted according to general 
procedure J to afford (E)-2-(hept-1-enyl)oxirane 234a (1.06 g, 97%) as a yellow oil: 
νmax (film) 1669, 1466, 1369, 1245, 964, 835, 771, 727 cm-1; δH (400 MHz, CDCl3) 
5.98 (1H, dt, J 15.5, 6.5, H-4), 5.15 (1H, ddt, J 15.5, 8.0, 1.5, H-3), 3.34 (1H, ddd, J 
8.0, 4.0, 3.0), [2.95 (1H, dd, J 5.0, 4.0) and 2.67 (1H, dd, J 5.0, 3.0), H-1], 2.09 (2H, 
Me
O
N
238h
OH
Cl
Me
N
239h
C5H11
OH
Cl
239a
C5H11
234a
O
Experimental 
 
 
 
 192 
dt, J 7.5, 6.5, H-5), 1.46–1.38 (2H, m, H-6), 1.37–1.28 (4H, m H-7,8), 0.91 (3H, t, J 
7.0, H-9); δC (101 MHz, CDCl3) 137.4 (C-4), 127.4 (C-3), 52.7 (C-2), 48.8 (C-1), 
32.3 (C-5), 31.3 (C-7), 28.6 (C-6), 22.5 (C-8), 14.0 (C-9); m/z (CI) 158 [MNH4]+, 141 
[MH]+, 123 [M–OH]+ (Found: [MNH4]+, 158.1545. C9H16O requires [MNH4]+, 
158.1545).  
 
(E)-2-Methyl-2-(hept-1-enyl)oxirane  (234b) 
 
 
 
 
 
Chlorohydrin 239b (1.12 g, 5.88 mmol, 1.0 equiv) was reacted according to general 
procedure J to afford (E)-2-methyl-2-(hept-1-enyl)oxirane 234b (1.06 g, 40%) as a 
colourless oil: νmax (film) 1668, 1585, 1457, 1379, 968, 905 cm-1; δH (400 MHz, 
CDCl3) 5.81 (1H, dt, J 16.0, 7.0, H-4), 5.27 (1H, dt, J 16.0, 1.5, H-3), [2.82 (1H, d, J 
5.0) and 2.75 (1H, d, J 5.0), H-1], 2.06 (2H, dt, J 8.0, 7.0, H-5), 1.46–1.23 (6H, m, H-
6,7,8), 0.90 (3H, t, J 7.5, H-9); δC (101 MHz, CDCl3) 134.0 (C-4), 130.9, (C-3), 55.8 
(C-1), 55.6 (C-2), 32.4 (C-5), 31.4 (C-6), 28.8 (C-7), 22.5 (C-8), 19.7 (2-Me), 14.0 
(C-9); m/z (CI) 155 [MH]+ (Found: [MH]+, 155.1434. C10H18O requires [MH]+, 
155.1436). 
 
(E)-2-Methyl-2-(prop-1-enyl)oxirane  (234c) 
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Chlorohydrin 239c (1.13 g, 8.40 mmol, 1.0 equiv) was reacted according to general 
procedure J. Incomplete concentration under reduced pressure of the combined 
organic extracts afforded (E)-2-methyl-2-(prop-1-enyl)oxirane 234c (1.06 g of a 
colourless solution, 35% w/w in THF by 1H-NMR analysis, 46%): δH (400 MHz, 
CDCl3) 5.83 (1H, dq, J 15.5, 6.5, H-4), 5.30 (1H, d, J 15.5, H-3), [2.81 (1H, d, J 5.0) 
and 2.75 (1H, d, J 5.0), H-1], 1.75 (3H, dd, J 6.5, 1.5, H-5), 1.46 (3H, s, 2-Me); δC 
(101 MHz, CDCl3) 132.2 (C-3), 128.5 (C-4), 60.4 (C-2), 55.7 (C-1), 19.7 (2-Me), 
17.8 (C-5). 
 
2-[(E)-2-Cyclohexylethenyl]-2-methyloxirane (234d) 
 
 
 
 
 
Chlorohydrin 239d (0.533 g, 2.64 mmol, 1.0 equiv) was reacted according to general 
procedure J to afford 2-[(E)-2-Cyclohexylethenyl]-2-methyloxirane 234d (431 mg, 
98%) as a colourless oil: νmax (film) 1677, 1449, 1387, 1064, 968 cm-1; δH (400 MHz, 
CDCl3) 5.75 (1H, dd, J 16.0, 6.5, H-4), 5.23 (1H, dd, J 16.0, 1.5, H-3), [2.82 (1H, d, J 
5.0) and 2.75 (1H, d, J 4.0), H-1], 2.03–1.96 (1H, m, H-5), [1.78–1.61 and 1.35–1.03 
(10H, m, cyclohexyl)], 1.46 (3H, s, 2-Me); δC (101 MHz, CDCl3) 139.5 (C-4), 128.5 
(C-3), 55.9 (C-1), 55.7 (C-2), 40.5 (C-5), 32.7, 26.1, 26.0, 19.7 (2-Me); m/z (CI) 184 
[MNH4]+, 165 [M–H]+, 149 (Found: [MNH4]+, 184.1700. C11H18O requires [MNH4]+, 
184.1701). 
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(E)-2-Styryloxirane (234e) 
 
 
 
 
 
Chlorohydrin 239e (1.20 g, 6.59 mmol, 1.0 equiv) was reacted according to general 
procedure J to afford (E)-2-styryloxirane 234e (963 mg, >99%) as a yellow oil: νmax 
(film) 3027, 1601, 1578, 1492, 1393, 1244, 1134, 1072, 965 747, 693 cm-1; δH (400 
MHz, CDCl3) 7.43–7.27 (5H, m, Ph), 6.85 (1H, d, J 16.5, H-4), 5.91 (1H, dd, J 16.5, 
7.5, H-3), 3.56 (1H, ddd, J 7.5, 5.0, 3.0, H-2), [3.10 (1H, dd, J 5.5, 4.0) and 2.81 (1H, 
dd, J 5.0, 3.0), H-1];  δC (101 MHz, CDCl3) 136.3 (i-Ph), 134.6 (C-4), 128.7, 128.1 
(Ph), 127.0 (C-3), 126.5 (Ph), 52.7 (C-2), 49.3 (C-1); m/z (CI) 164 [MNH4]+, 147 
[MH]+, 129 [M–H2O]+ (Found: [MH]+, 147.0812. C10H10O requires [MH]+, 
147.0810); in agreement with published data.172 
 
(E)-2-Methyl-2-styryloxirane (234f)  
 
 
 
 
 
Chlorohydrin 239f (1.26 g, 6.43 mmol, 1.0 equiv) was reacted according to general 
procedure J to afford (E)-2-Methyl-2-styryloxirane 234f (1.01 g, 98%): νmax (film) 
1681, 1598, 1495, 1448, 965, 760, 700 cm-1; δH (400 MHz, CDCl3) 7.44–7.32 (5H, m, 
Ph), 5.73–5.70 (2H, m, CHCHMe), [3.14 (1H, d, J 5.5) and 3.00 (1H, d, J 5.5), 
OCH2], 1.77 (3H, dd, J 5.0, 2.0, Me); δC (101 MHz, CDCl3) 153.0 (i-Ph), 131.2, 
130.4, 128.2 (o-Ph), 127.7 (p-Ph), 127.0 (m-Ph), 60.1 (C-2), 56.7 (OCH2), 17.8 (Me); 
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m/z (CI) 178 [MNH4]+, 161 [MH]+, 143, 105 (Found: [MNH4]+, 178.1231. C11H12O 
requires [MNH4]+, 178.1232). 
 
2-[(E)-2-(2-Methyloxiran-2-yl)ethenyl]pyridine (234g) 
 
 
 
 
 
Chlorohydrin 239h (1.16 g, 5.87 mmol, 1.0 equiv) was reacted according to general 
procedure J to afford 2-[(E)-2-(2-Methyloxiran-2-yl)ethenyl]pyridine 234g (623 mg, 
66%) as yellow oil: νmax (film) 1654, 1555, 1387, 1305, 1150, 1065, 973, 907, 793, 
766, 742, 611 cm-1; δH (400 MHz, CDCl3) 8.57 (1H, d, J 5.0, 6-pyridyl), 7.65 (1H, 
ddd, J 9.5, 8.0, 2.0, 4-pyridyl), 7.29 (1H, d, J 8.0, 3-pyridyl), 7.16 (1H, ddd, J 8.0, 5.0, 
2.0, 5-pyridyl), [6.77 (1H, d, J 16.0) and 6.57 (1H, d, J 16.0), H-3,4], [2.94 (1H, d, J 
5.0) and 2.89 (1H, d, J 5.0), H-1], 1.61 (3H, s, 2-Me); δC (101 MHz, CDCl3) 154.8 (2-
pyridyl), 149.6 (6-pyridyl), 136.6 (4-pyridyl), [135.2 and 131.3 (C-3 and C-4)], 122.4 
(5-pyridyl), 121.7 (3-pyridyl), 55.3 (C-1), 55.7 (C-2), 19.7 (2-Me); m/z (ESI) 181, 
180, 162 [MH]+, 130 (Found: [MH]+, 162.0912. C10H11NO requires [MH]+, 
162.0919). 
 
(E)-2-Azidonon-3-en-1-ol (235a) and (E)-4-azidonon-2-en-1-ol (236a) 
 
 
 
 
 
 
 
Oxirane 234a (4.41 g, 31.5 mmol, 1.0 equiv) was reacted according to general 
procedure K to afford a 73:27 mixture of (E)-2-azidonon-3-en-1-ol 235a and (E)-4-
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azidonon-2-en-1-ol 236a respectively (4.04 g, 70%) as a colourless oil after 
purification over silica gel (30% TBME/petrol). 
Data for the mixture: νmax (film) 3352, 2101, 1667, 1462, 1240, 1072 cm-1; m/z (CI) 
201 [MNH4]+, 191, 158, 126 (Found: [MNH4]+, 201.1715. C9H17N3O requires 
[MNH4]+, 201.1715. 
NMR data for 235a: δH (500 MHz, CDCl3) 5.85 (1H, dt, J 15.5, 6.5, H-4), 5.40 (1H, 
ddt, J 15.5, 8.0, 1.5, H-3), 4.03 (1H, dt, J 11.5, 5.0, H-2), [3.60 (1H, dd, J 11.5, 5.0) 
and 3.52 (1H, dd, J 11.5, 7.5), H-1], 2.09–2.11 (2H, m, H-5), 1.66 (2H, s (br), OH), 
1.43–1.25 (12H, m, H-6,7,8), 0.89 (6H, t, J 7.0, H-9); δC (101 MHz, CDCl3) 138.2, 
123.4, 66.3, 65.0, 32.3, 31.2, 28.7, 22.4, 14.0. 
NMR data for 236a: δH (500 MHz, CDCl3) 5.88 (1H, dt, J 15.0, 5.5, H-2), 5.66 (1H, 
ddt, J 15.5, 7.5, 1.5, H-3), 4.21 (2H, dd, J 5.5, 1.5, H-1), 3.85 (1H, dt, J 14.0, 7.5, H-
4), 1.66 (2H, s (br), OH), 1.56–1.49 (2H, m, H-5), 1.43–1.25 (12H, m, H-6,7,8), 0.89 
(6H, t, J 7.0, H-9); δC (101 MHz, CDCl3) 132.9, 128.9, 64.0, 62.6, 34.5, 31.4, 35.5, 
22.5, 14.0. 
 
(E)-2-Azido-2-methylnon-3-en-1-ol (235b) and (E)-4-azido-2-methylnon-2-en-1-ol 
(236b) 
 
 
 
 
 
 
 
Oxirane 234b (497 mg, 3.22 mmol, 1.0 equiv) was reacted according to general 
procedure K to afford a 61:39 mixture of (E)-2-azido-2-methylnon-3-en-1-ol 235b 
and (E)-4-azido-2-methylnon-2-en-1-ol 236b respectively (150 mg, 25%) as a 
colourless oil after purification over silica gel (20% TBME/hexane). 
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Data for the mixture: νmax (film) 3370, 2102, 1666, 1456, 1379, 1247, 1056 cm-1; m/z 
(CI) 215 [MNH4]+, 172, 155 [M-N3]+, 137 (Found: [MNH4]+, 215.1872. C10H19N3O 
requires [MNH4]+, 215.1871). 
NMR data for 235b: δH (400 MHz, CDCl3) 5.82 (1H, dt, J 16.0, 7.0, H-4), 5.50 (1H, 
dt, J 16.0, 2.0, H-3), 3.46 (2H, AB quartet, J 11.5, H-1), 2.11 (2H, dt, J 9.0, 7.0, H-5), 
1.71–1.55 (1H, s (br), OH), 1.40 (3H, s, 2-Me), 1.38–1.27 (6H, m, H-6,7,8), 0.99 (3H, 
t, J 6.5, H-9); δC (101 MHz, CDCl3) 134.1 (C-4), 128.5 (C-3), 69.3 (C-1), 66.1 (C-2), 
32.5, 31.3, 28.9, 22.4 (2-Me), 20.2, 14.0 (C-9). 
NMR data for 236b: δH (400 MHz, CDCl3) 5.44 (1H, d, J 10.0, H-3), 4.22–4.15 (1H, 
m, H-4), 4.11 (2H, s, H-1), 1.77 (3H, s, 2-Me), 1.71–1.55 (1H, s (br), OH), 1.38–1.27 
(8H, m, H-5,6,7,8), 0.99 (3H, t, J 6.5, H-9); δC (101 MHz, CDCl3) 140.3 (C-2), 122.7 
(C-3), 67.7 (C-1), 59.4 (C-4), 35.0, 31.5, 25.5, 22.5 (2-Me), 14.3, 14.0 (C-9). 
 
(E)-2-Azido-2-methylpent-3-en-1-ol (235c) and (E)-4-azido-2-methylpent-2-en-1-
ol (236c) 
 
 
 
  
 
 
 
A solution of oxirane 234c in THF (6.36 mmol, 1.0 equiv) was reacted according to 
general procedure K to afford a 64:36 mixture of (E)-2-azido-2-methylpent-3-en-1-ol 
235c and (E)-4-azido-2-methylpent-2-en-1-ol 236c respectively (634 mg, 71%) as a 
colourless oil after purification over silica gel (20% ether/petrol). 
Data for the mixture: νmax (film) 3374, 2105, 1652, 1449, 1379, 1250, 1052, 970 cm-1; 
m/z (CI) 159 [MNH4]+, 116, 114, 96 (Found: [MNH4]+, 159.1248. C6H11N3O requires 
[MNH4]+, 159.1246). 
NMR data for 235c: δH (400 MHz, CDCl3) 5.85 (1H, dq, J 15.5, 6.5, H-4), 5.53 (1H, 
dd, J 15.5, 1.5, H-3), 3.47 (2H, AB quartet, J 12.0, H-1), 1.80 (3H, dd, J 6.5, 1.5, H-
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5), 1.41 (3H, s, 2-Me); δC (101 MHz, CDCl3) 129.9 (C-3), 128.6 (C-4), 69.2 (C-1), 
67.5 (C-2), 20.1 (2-Me), 18.0 (C-5). 
NMR data for 236c: δH (400 MHz, CDCl3) 5.46 (1H, dd, J 9.5, 1.5, H-3), 4.37 (1H, 
dq, J 9.5, 6.5, H-4), 4.10 (2H, s, H-1), 1.77 (3H, s, 2-Me), 1.28 (3H, d, J 6.5, H-5); δC 
(101 MHz, CDCl3) 139.5 (C-2), 123.7 (C-3), 66.0 (C-1), 54.7 (C-4), 20.8 (C-Me), 
14.1 (C-5). 
 
(E)-2-Azido-4-cyclohexyl-2-methylbut-3-en-1-ol (235d) and (E)-4-azido-4-
cyclohexyl-2-methylbut-2-en-1-ol (236d) 
 
 
 
 
 
 
 
Oxirane 234d (265 mg, 1.60 mmol, 1.0 equiv) was reacted according to general 
procedure K to afford a 72:28 mixture of (E)-2-azido-4-cyclohexyl-2-methylbut-3-en-
1-ol 235d and (E)-4-azido-4-cyclohexyl-2-methylbut-2-en-1-ol 236d respectively (196 
mg, 59%) as a colourless oil after purification over silica gel (15% ether/hexane). 
Data for the mixture: νmax (film) 3359, 2103, 1665, 1448, 1250, 1052, 970 cm-1; m/z 
(CI) 227 [MNH4]+, 210 [MH]+, 184, 149 (Found: [MNH4]+, 227.1870. C11H19N3O 
requires [MNH4]+, 227.1872). 
NMR data for 235d: δH (400 MHz, CDCl3) 5.76 (1H, dd, J 15.5, 6.5, H-4), 5.45 (1H, 
dd, J 15.5, 1.5, H-3), 3.50 (2H, m, H-1), 2.08–0.85 (11H, m, cyclohexyl), 1.40 (3H, s, 
2-Me); δC (101 MHz, CDCl3) 139.9 (C-4), 125.9 (C-3), 69.3 (C-1), 42.4 (C-2), 40.7, 
33.0, 32.9, 25.9, 20.2. 
NMR data for 236d: δH (400 MHz, CDCl3) 5.47 (1H, d, J 10.0, H-3), 4.12 (2H, d, J 
4.0, H-1), 3.96 (1H, dd, J 10.0, 7.5, H-4), 2.08–0.85 (11H, m, cyclohexyl), 1.75 (3H, 
s, 2-Me); δC (101 MHz, CDCl3) 121.2 (C-3), 67.7 (C-1), 65.9 (C-2), 64.6 (C-4), 29.5, 
29.3, 26.3, 26.0, 14.3. 
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(E)-2-Azido-4-phenylbut-3-en-1-ol (235e) 
 
 
 
 
 
Oxirane 234e (950 mg, 6.50 mmol, 1.0 equiv) was reacted according to general 
procedure K to afford (E)-2-azido-4-phenylbut-3-en-1-ol 235e (739 mg, 60%) as a 
yellow oil after purification over silica gel (20% EtOAc/hexane): νmax (film) 2109, 
1650, 1449, 1246, 1040, 969, 750, 693 cm-1; δH (400 MHz, CDCl3) 7.45 (1H, d, J 8.0, 
p-Ph), 7.38 (2H, dd, J 8.0, 7.5, m-Ph), 7.35 (2H, d, J 7.5, o-Ph), 6.76 (1H, d, J 17.0, 
H-4), 6.18 (1H, dd, J 17.0, 8.0, H-3), 4.28 (1H, dt, J 8.0, 4.5, H-2), [3.76 (1H, dd, J 
11.0, 4.5) and 3.67 (1H, dd, J 11.0, 7.0), H-1], 1.99 (1H, s (br), OH); δC (101 MHz, 
CDCl3) 135.7 (i-Ph), 135.4 (C-4), 128.7 (o-Ph), 128.5 (p-Ph), 126.7 (m-Ph), 122.9 (C-
3), 66.3 (C-2), 65.0 (C-1); m/z (CI) 207 [MNH4]+, 189 [M]+, 164, 147 (Found: 
[MNH4]+, 207.1247. C10H11N3O requires [MNH4]+, 207.1246); in agreement with 
published data.172 
 
(E)-4-Azido-2-methyl-4-phenylbut-2-en-1-ol (E-236f) and (Z)-4-azido-2-methyl-4-
phenylbut-2-en-1-ol (Z-236f) 
 
 
 
 
 
 
 
To a solution of oxirane 234f (490 mg, 3.06 mmol, 1.0 equiv) in acetone (10 mL) and 
water (3 mL) was added sodium azide (597 mg, 9.18 mmol, 3.0 equiv) in one portion.  
The reaction mixture was stirred at rt for 4 h, and ammonium chloride (500 mg) was 
added.  The resulting mixture was stirred at rt for 10 min. Water (10 mL) was added 
and the mixture was concentrated under reduced pressure to remove acetone. The 
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aqueous layer was extracted with dichloromethane (3 x 15 mL) and the combined 
organic extracts were dried (Na2SO4) and concentrated under reduced pressure.  
Purification of the residue over silica gel (10% EtOAc/petrol) afforded a 75:25 
mixture of (E)-4-azido-2-methyl-4-phenylbut-2-en-1-ol E-236f and (Z)-4-azido-2-
methyl-4-phenylbut-2-en-1-ol Z-236f respectively (461 mg, 74%) as a colourless oil. 
Data for the mixture: νmax (film) 3366, 2101, 1492, 1446, 1238, 1074, 702 cm-1; m/z 
(CI) 221 [MNH4]+, 210, 178 [MNH4–N3]+, 161 [MH–N3]+ (Found: [MNH4]+, 
221.1411. C11H13N3O requires [MNH4]+, 221.1402). 
NMR data for E-236f: δH (500 MHz, CDCl3) [7.47–7.38 (3H, m) and 7.19–7.17 (2H, 
m), Ph], 5.71 (1H, dt, J 10.0, 1.5, H-3), 4.36 (2H, s (br), H-1), 4.06 (1H, dq, J 10.0, 
6.5, H-4), 1.62 (1H, s (br), OH), 1.24 (3H, d, J 6.5, H-5); δC (126 MHz, CDCl3), 
144.5, 136.9, 128.6, 128.5, 126.9, 125.6 (C-3), 66.9 (C-1), 55.4 (C-4), 20.6 (C-5). 
NMR data for Z-236f: δH (500 MHz, CDCl3) [7.47–7.38 (3H, m) and 7.19–7.17 (2H, 
m), Ph], 5.47 (1H, d, J 9.0, H-3), 4.62 (2H, s (br), H-1), 4.59 (1H, dq, J 9.0, 7.0, H-4), 
1.57 (1H, s (br), OH), 1.39 (3H, d, J 7.0, H-5); δC (126 MHz, CDCl3), 142.7, 139.6, 
130.0 (C-3), 128.1, 127.9, 126.7, 60.1 (C-1), 54.7 (C-4), 20.8 (C-5). 
 
(E)-2-Azido-2-methyl-4-(pyridin-2-yl)but-3-en-1-ol (235g) 
 
 
 
 
 
Oxirane 234g (600 mg, 3.73 mmol, 1.0 equiv) was reacted according to general 
procedure K to afford (E)-2-azido-2-methyl-4-(pyridin-2-yl)but-3-en-1-ol 235g (600 
mg, 79%) as a colourless oil after purification over silica gel (20% EtOAc/5% 
TEA/hexane): νmax (film) 3339, 2105, 1656, 1590, 1473, 1260, 1153, 1061, 975, 766 
cm-1; δH (400 MHz, CDCl3) 8.55 (1H, d, J 5.0, 6-pyridyl), 7.68 (1H, dt, J 7.5, 1.5, 4-
pyridyl), 7.32 (1H, d, J 7.5, 3-pyridyl), 7.19 (1H, dd, J 8.0, 7.5, 5-pyridyl), 6.81 (1H, 
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d, J 16.0, H-4), 6.77 (1H, d, J 16.0, H-3), 3.64 (2H, dd, J 3.0, 2.5, H-1), 1.55 (3H, s, 
2-Me); δC (101 MHz, CDCl3) 154.4 (2-pyridyl), 149.6 (6-pyridyl), 136.8 (4-pyridyl), 
[133.3 and 131.2, (C-3) and (C-4)], 122.8 (5-pyridyl), 122.5 (3-pyridyl), 69.1 (C-1), 
66.0 (C-2), 20.4 (2-Me); m/z (CI), 205 [MH]+, 164, 145, 102 (Found: [MH]+, 
205.1081. C10H12N4O requires [MH]+, 205.1076) (Found: C, 58.88; H, 5.87; N, 27.59. 
C10H12N4O requires C, 58.81; H, 5.92; N, 27.43). 
 
(E)-2-(Hydroxymethyl)non-3-enenitrile (241) and (E)-non-3-ene-1,2-diol (242) 
 
 
 
  
 
To a solution of oxirane 234a (1.19 g, 8.52 mmol, 1.0 equiv) in acetone (10 mL) and 
water (5 mL) was added potassium cyanide (0.61 g, 9.37 mmol, 1.1 equiv) in one 
portion at rt.  The resulting solution was stirred at rt for 30 min and heated to reflux 
for 16 h.  The reaction mixture was cooled to rt and NH4Cl (500 mg) was added.  
After stirring for 10 min, the reaction mixture was concentrated under reduced 
pressure to remove acetone and the residue was extracted with dichloromethane (3 x 
10 mL).  The combined organic extracts were dried (MgSO4) and concentrated under 
reduced pressure.  Purification of the residue over silica gel (25% ether/petrol) 
afforded less polar (E)-2-(hydroxymethyl)non-3-enenitrile 241 (271 mg, 19%) as a 
colourless oil: νmax (film) 3435, 2252, 1671, 1467, 1042, 973 cm-1; δH (400 MHz, 
CDCl3) 5.84 (1H, dt, J 15.5, 6.5, H-4), 5.55 (1H, ddt, J 15.5, 6.5, 2.0, H-3), 4.42 (1H, 
dt, J 6.5, 6.0, H-2), 2.60 (2H, doublet of AB quartets, J 16.5, 6.0, CH2), 2.33 (1H, s 
(br), OH), 2.08 (2H, dt, J 7.5, 6.5, H-5), 1.44–1.27 (6H, m, H-6,7,8), 0.91 (3H, t, J 
7.0, H-9); δC (101 MHz, CDCl3) 135.3 (C-4), 129.2 (C-3), 117.4 (CN), 68.7 (C-2), 
32.0 (C-5), 31.3 (C-6), 28.5 (C-7), 26.3 (C-1), 22.5 (C-8), 14.0 (C-9); m/z (CI) 185 
[MNH4]+, 52 (Found: [MNH4]+, 185.1660. C10H17NO requires [MNH4]+, 185.1654) 
(Found: C, 71.89; H, 10.26; N, 8.43. C10H17NO requires C, 71.81; H, 10.25; N, 8.37); 
and more polar (E)-non-3-ene-1,2-diol 242 (82 mg, 6%) as a colourless oil: νmax 
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(film) 3433, 1671, 1456, 1074, 1027, 971 cm-1; δH (400 MHz, CDCl3) 5.77 (1H, dt, J 
15.5, 6.5, H-4), 5.44 (1H, dd, J 15.5, 6.5, H-3), 4.19 (1H, dt, J 7.0, 3.5, H-2), [3.62 
(1H, dd, J 11.0, 3.5) and 3.47 (1H, dd, J 11.0, 8.0), H-1], 3.02 (1H, s (br), OH), 2.04 
(2H, dt, J 7.5, 7.0, H-5), 1.42–1.24 (6H, m, H-6,7,8), 0.90 (3H, t, J 7.0, H-9); δC (101 
MHz, CDCl3) 134.2 (C-4), 128.2 (C-3), 73.2 (C-2), 66.6 (C-1), 32.3 (C-5), 31.4 (C-6), 
28.7 (C-7), 22.5 (C-8), 14.0 (C-9); m/z (CI) 176 [MNH4]+, 158 [MH]+, 96 (Found: 
[MNH4]+, 176.1653. C9H18O2 requires [MNH4]+, 176.1651). 
 
Ethyl 4-azido-3-ethenylnonanoate (243a) 
 
 
 
  
 
A 73:27 mixture of allylic azides 235a and 236a respectively (100 mg, 0.546 mmol, 
1.0 equiv) was reacted according to general procedure C to afford ethyl 4-azido-3-
ethenylnonanoate 243a (137 mg, 99%, 50:50 syn:anti mixture of diastereomers) as a 
colourless oil without further purification: νmax (film) 2102, 1736, 1641, 1465, 1257, 
923 cm-1; δH (400 MHz, CDCl3) [5.74 (1H, ddd, J 17.0, 10.0, 4.0), and 5.65 (1H, ddd, 
J 17.0, 10.0, 4.0), syn+anti CHCH2), 5.19–5.13 (4H, m, syn+anti CHCH2), [4.14 (2H, 
q, J 7.5) and 4.15 (2H, q, J 7.5), syn+anti OCH2], [3.84–3.43 (1H, m) and 3.26–3.06 
(1H, m), syn+anti H-4], 2.77–2.69 (2H, m, syn+anti H-3), [2.56 (2H, dd, J 15.0, 5.0) 
and 2.41 (2H, dd, J 15.0, 8.0), syn+anti H-2], 1.62–1.32 (16H, m, syn+anti H-5,6,7,8), 
[1.27 (3H, t, J 7.5), and 1.26 (3H, t, J 7.5), syn+anti OCH2CH3], 0.91 (6H, t, J 6.0 
syn+anti H-9); δC (101 MHz, CDCl3) 172.0 (C-1), [137.2 and 135.6, (CHCH2)], 
[118.3 and 117.8, (CHCH2)], [65.8 and 65.3, (C-4)], 60.5 (OCH2), [44.9 and 44.5, (C-
3)], [37.0 and 36.3, (C-2)], 32.2, 32.0, 31.5, 26.0, 25.8, 22.5, 14.2, 14.0; m/z (CI) 271 
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[MNH4]+, 254 [MH]+, 226 (Found: [MH]+, 254.1858. C13H23N3O2 requires [MH]+, 
254.1869).  
 
Ethyl 4-azido-3-(prop-1-enyl)nonanoate (243b) 
 
 
 
  
 
A 61:39 mixture of allylic azides 235b and 236b respectively (88 mg, 0.446 mmol, 
1.0 equiv) was reacted according to general procedure C to afford ethyl 4-azido-3-
(prop-1-enyl)nonanoate 243b (86 mg, 72%, 59:41 syn:anti mixture of diastereomers) 
as a colourless oil after purification over silica gel (10% ether/hexane). 
Data for the mixture: νmax (film) 2012, 1733, 1648, 1464, 1379, 1273, 1123, 1073, 
899 cm-1; m/z (CI) 285 [MNH4]+, 268 [MH]+, 240 (Found: [MH]+, 268.2025 
C14H25N3O2 requires [MH]+, 268.2025). 
NMR data for syn-243b: δH (400 MHz, CDCl3) 4.94 (1H, t, J 1.5, trans-CMeCH2), 
4.86 (1H, s (br), cis-CMeCH2), 4.15 (2H, q, J 7.0, OCH2), 3.44–3.39 (1H, m, H-4), 
2.81 (1H, dt, J 8.0, 6.0, H-3), 2.49 (2H, dd, J 15.0, 9.0, H-2), 1.80 (3H, s, Me), 1.60–
1.25 (8H, m, H-5,6,7,8), 1.27 (3H, t, J 7.0, OCH2CH3), 0.93 (6H, t, J 6.5, H-9); δC 
(101 MHz, CDCl3) 172.1 (C-1), 143.4 (CMeCH2), 114.5 (CMeCH2), 65.1 (C-4), 60.5 
(OCH2), 47.0 (C-3), 35.7, 31.7, 31.6, 26.2, 22.5, 21.0, 14.0. 
NMR data for anti-243b: δH (400 MHz, CDCl3) 4.93 (1H, t, J 1.5, trans-CMeCH2), 
4.86 (1H, s (br), cis-CMeCH2), 4.13 (2H, q, J 7.0, OCH2), 3.24 (1H, dt, J 8.0, 3.0, H-
4), 2.67 (1H, dt, J 8.0, 5.0, H-3), 2.57 (2H, dd, J 15.0, 6.0, H-2), 1.74 (3H, s, Me), 
1.60–1.25 (8H, m, H-5,6,7,8), 1.26 (3H, t, J 7.0, OCH2CH3), 0.93 (6H, t, J 6.5, H-
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9); δC (101 MHz, CDCl3) 172.2 (C-1), 143.8 (CMeCH2), 114.3 (CMeCH2), 64.6 (C-
4), 60.4 (OCH2), 47.9 (C-3), 36.3, 32.5, 31.5, 25.9, 22.5, 20.1, 14.2. 
 
Ethyl 4-azido-3-(prop-1-enyl)pentanoate (243c) 
 
 
 
  
 
A 64:36 mixture of allylic azides 235c and 236c respectively (88 mg, 0.446 mmol, 1.0 
equiv) was reacted according to general procedure C to afford ethyl 4-azido-3-(prop-
1-enyl)pentanoate 243c (86 mg, 86%, 60:40 syn:anti mixture of diastereomers) as a 
colourless oil after purification over silica gel (10% ether/hexane). 
Data for the mixture: νmax (film) 2101, 1736, 1650, 1446, 1378, 1258, 1034 cm-1; m/z 
(CI) 229 [MNH4]+, 212 [MH]+, 184, 117 (Found: [MNH4]+, 229.1666. C10H17N3O2 
requires [MNH4]+, 229.1665). 
NMR data for syn-243c: δH (400 MHz, CDCl3) 4.93 (1H, t, J 1.5, trans-CMeCH2), 
4.83 (1H, s (br), cis-CMeCH2), 4.13 (2H, q, J 7.0, OCH2), 3.64 (1H, dq, J 13.0, 6.0, 
H-4), 2.74–2.69 (1H, m, H-3), 2.56–2.36  (2H, m, H-2), 1.78 (3H, s, CMeCH2), 1.27 
(3H, t, J 7.0, OCH2CH3), 1.25 (3H, d, J 6.0, H-5); δC (101 MHz, CDCl3) 176.2 (C-1), 
139.3 (CMeCH2), 116.7 (CMeCH2), 60.1 (OCH2), 46.6 (C-4), 43.9 (C-3), 34.8 (C-2), 
20.3 (CMeCH2), 14.3 (C-5), 14.0 (OCH2CH3). 
NMR data for anti-243c: δH (400 MHz, CDCl3) 4.89 (1H, t, J 1.5, trans-CMeCH2), 
4.83 (1H, s (br), cis-CMeCH2), 4.12 (2H, q, J 7.0, OCH2), 3.40 (1H, dq, J 9.0, 6.5, H-
4), 2.74–2.69 (1H, m, H-3), 2.56–2.36  (2H, m, H-2), 1.72 (3H, s, CMeCH2), 1.26 
(3H, t, J 7.0, OCH2CH3), 1.24 (3H, d, J 6.5, H-5); δC (101 MHz, CDCl3) 176.7 (C-1), 
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139.9 (CMeCH2), 116.0 (CMeCH2), 60.0 (OCH2), 47.0 (C-4), 44.0 (C-3), 33.4 (C-2), 
20.3 (CMeCH2), 14.3 (C-5), 13.9 (OCH2CH3). 
 
Ethyl 4-azido-4-cyclohexyl-3-(prop-1-enyl)pentanoate (243d) 
 
 
 
  
 
A 63:37 mixture of allylic azides 235d and 236d respectively (50 mg, 0.239 mmol, 
1.0 equiv) was reacted according to general procedure C to afford ethyl 4-azido-4-
cyclohexyl-3-(prop-1-enyl)pentanoate 243d (86 mg, 94%, 63:37 syn:anti mixture of 
diastereomers) as a colourless oil without further purification.  
Data for the mixture: νmax (film) 2099, 1738, 1647, 1449, 1256, 1156, 1038, 899 cm-1; 
m/z (CI) 297 [MNH4]+, 280 [MH]+, 252 (Found: [MH]+, 280.2018 C15H25N3O2 
requires [MH]+, 280.2025). 
NMR data for syn-243d: δH (400 MHz, CDCl3) [4.92 (1H, s) and 4.88 (1H, s), 
CMeCH2], 4.13 (2H, q, J 7.0, OCH2), 3.17–3.13 (1H, m, H-4), 2.82 (1H, dt, J 10.0, 
4.5, H-3), 2.63–2.42 (2H, m, H-2), 1.75 (3H, s, CMeCH2), 1.70–1.10 (11H, m, 
cyclohexyl), 1.28–1.23 (3H, m, OCH2CH3); δC (101 MHz, CDCl3) 172.2 (=C-1), 
143.7 (CMeCH2), 114.3 (CMeCH2), 71.4 (C-4), 60.4 (OCH2), 45.0 (C-3), 40.6 (C-5), 
36.0 (C-2), 31.3, 27.1, 26.0, 20.0, 14.2. 
NMR data for anti-243d: δH (400 MHz, CDCl3) [4.93 (1H, s) and 4.90 (1H, s), 
CMeCH2], 4.14 (2H, q, J 7.0, OCH2), 3.17–3.13 (1H, m, H-4), 2.93 (1H, dt, J 9.0, 6.5, 
H-3), 2.63–2.42 (2H, m, H-2), 1.79 (3H, s, CMeCH2), 1.70–1.10 (11H, m, 
cyclohexyl), 1.28–1.23 (3H, m, OCH2CH3); δC (101 MHz, CDCl3) 171.9 (C-1), 143.6 
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(CMeCH2), 115.1 (CMeCH2), 70.8 (C-4), 60.5 (OCH2), 44.5 (C-3), 40.3 (C-5), 36.8 
(C-2), 31.1, 27.8, 26.3, 26.1, 20.5, 14.2. 
 
Ethyl 3-(1-azidoethyl)-4-phenylpent-4-enoate (243f) 
 
 
 
  
 
A 75:25 mixture of allylic azide E-236 and Z-236 respectively (100 mg, 0.492 mmol, 
1.0 equiv) was reacted according to general procedure C to afford ethyl 3-(1-
azidoethyl)-4-phenylpent-4-enoate 243f (100 mg, 75%, 50:50 syn:anti mixture of 
diastereomers) as a colourless oil after purification over silica gel (5% ether/hexane): 
νmax (film) 2105, 1734, 1631, 1256, 1176, 1037 cm-1; δH (400 MHz, CDCl3) 7.46–
7.33 (10H, m, syn+anti Ph), [5.41 (2H, d, J 3.0) and 5.19 (2H, s (br)), syn+anti 
CPhCH2], [4.17 (2H, q, J 7.0) and 4.03 (2H, q, J 7.0), syn+anti OCH2], [3.65 (1H, dq, 
J 6.5, 4.5) and 3.54 (1H, dq, J 7.0, 6.5), syn+anti CHN3)], [3.46 (1H, dt, J 6.5, 5.5) 
and 3.21 (1H, dt, J 6.5, 5.5), syn+anti CHCPhCH2)], 2.84–2.63 (4H, m, syn+anti 
CH2CO2Et), [1.27 (3H, t, J 7.0) and 1.24 (3H, t, J 7.0), syn+anti OCH2CH3)], [1.27 
(3H, d, J 6.5) and 1.16 (3H, d, J 6.5), syn+anti Me)]; δC (101 MHz, CDCl3) [172.3 
and 172.1 (syn+anti C=O)], [149.2 and 148.1 (syn+anti CPhCH2)], [142.3 and 142.2 
(syn+anti i-Ph)], [128.5, 128.4, 127.8, 127.7, 126.9 and 126.7 (syn+anti Ph)], [115.1 
and 114.8 (syn+anti CPhCH2)], [60.7 and 60.6 (syn+anti OCH2)], [60.6 and 58.9 
(syn+anti CHN3)], [46.0 and 44.7 (syn+anti CHCPhCH2)], [36.1 and 34.4 (syn+anti 
CH2CO2Et)], [18.0 and 15.1 (syn+anti Me)], 14.2 (syn+anti OCH2CH3); m/z (CI) 291 
[MNH4]+, 274 [MH]+, 246, 205 (Found: [MH]+, 274.1563. C15H19N3O2 requires 
[MH]+, 274.1556). 
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Ethyl 4-azido-4-(pyridin-2-yl)-3-(prop-1-enyl)pentanoate (243g) 
 
 
 
  
 
Allylic azide 235g (80 mg, 0.392 mmol, 1.0 equiv) was reacted according to general 
procedure C to afford an impure sample of ethyl 4-azido-4-(pyridin-2-yl)-3-(prop-1-
enyl)pentanoate 243g (4 mg, <4%, 77:23 syn:anti mixture of diastereomers) as a 
brown oil after purification over silica gel (10% ether/5% TEA/petrol). 
NMR data for syn-243g inter alia: δH (400 MHz, CDCl3) 8.60 (1H, d, J 5.0, 6-
pyridyl), 7.78–7.67 (1H, m, 4-pyridyl), 7.34–7.19 (2H, m, 3,5-pyridyl), 4.80 (1H, s, 
trans-CMeCH2), 4.77 (1H, s, cis-CMeCH2), 4.58 (1H, d, J 8.0, H-4), 4.20–4.05 (2H, 
m, OCH2), 3.26, 1H, dd, J 8.0, 5.0, H-3), [2.73 (1H, dd, J 14.5, 4.0) and 2.59 (1H, dd, 
J 14.5, 9.5), H-2], 1.69 (3H, s, CMeCH2), 1.31–1.23 (3H, m, OCH2CH3); δC (101 
MHz, CDCl3) 149.7 (6-pyridyl), 136.8 (4-pyridyl), 114.5 (CMeCH2), 68.9 (C-4), 60.4 
(OCH2), 47.4 (C-3), 35.5 (C-2), 20.3 (CMeCH2), 14.0 (OCH2CH3). 
NMR data for anti-243g inter alia: δH (400 MHz, CDCl3) 8.63 (1H, d, J 5.0, 6-
pyridyl), 7.78–7.67 (1H, m, 4-pyridyl), 7.34–7.19 (2H, m, 3,5-pyridyl), 5.00 (1H, s, 
trans-CMeCH2), 4.96 (1H, s, cis-CMeCH2), 4.51 (1H, d, J 9.5, H-4), 4.20–4.05 (2H, 
m, OCH2), 3.35–3.28 (1H, m, H-3), [2.34 (1H, dd, J 15.0, 10.0) and 2.21 (1H, dd, J 
15.0, 5.0), H-2], 1.83 (3H, CMeCH2), 1.31–1.23 (3H, m, OCH2CH3); δC (101 MHz, 
CDCl3) 149.5 (6-pyridyl), 136.7 (4-pyridyl), 69.1 (C-4), 60.4 (OCH2), 47.4 (C-3), 
20.9 (CMeCH2), 14.0 (OCH2CH3). 
 
 
 
 
N3
OHN
Me
235g N3
CO2Et
Me
N
syn-243g N3
CO2Et
Me
N
anti-243g
Experimental 
 
 
 
 208 
5-Methyl-4-(prop-1-enyl)pyrrolidin-2-one (244a) 
 
  
 
  
 
General procedure (using PMe3): 
Ester 243c (85 mg, 0.403 mmol, 1.0 equiv, 60:40 syn:anti mixture of diastereomers) 
was reacted according to general procedure L to afford 5-methyl-4-(prop-1-
enyl)pyrrolidin-2-one 244a (33 mg, 59% 45:55 syn:anti mixture of diastereomers) as 
a colourless oil after purification over silica gel (20–30 % EtOAc/dichloromethane). 
 
Alternative procedure (using polystyrene-PPh2): 
To a solution of ester 243c (51 mg, 0.242 mmol, 1.0 equiv) in THF (242 µL) in a 0.2–
0.5 mL microwave vial was added polystyrene supported diphenylphosphine (286 mg 
of a 1.10 mmol/g resin, 0.314 mmol, 1.3 equiv) and water (5.6 µL, 0.314 mmol, 1.3 
equiv). The vial was flushed with nitrogen gas and capped. After heating by 
microwave at 120 °C for 30 min, the mixture was cooled and filtered, washing the 
resin with dichloromethane (15 mL). The filtrate was concentrated under reduced 
pressure and the residue purified over silica gel (20–30 % EtOAc/dichloromethane) to 
afford 5-methyl-4-(prop-1-enyl)pyrrolidin-2-one 244a (33 mg, 87% 60:40 syn:anti 
mixture of diastereomers) as a colourless oil after purification over silica gel. 
Data for the mixture: νmax (film) 3321, 1693, 1652 cm-1; m/z (CI) 157 [MNH4]+, 140 
[MH]+ (Found: [MH]+, 140.1081. C8H13NO requires [MH]+, 140.1075). 
NMR data for syn-244a: δH (500 MHz, CDCl3) 6.83 (1H, s, NH), 4.81 (1H, s, trans-
CMeCH2) 4.76 (1H, s, cis-CMeCH2), 3.85 (1H, dq, J 7.0, 6.0, H-5), 3.06 (1H, dt, J 
10.0, 7.0, H-4), [2.43 (1H, dd, J 17.0, 4.0) and 2.23 (1H, dd, J 17.0, 8.0), H-3], 1.73 
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(3H, s, CMeCH2), 0.97 (3H, d, J 6.0, 5-Me); δC (126 MHz, CDCl3) 177.5 (C-2), 143.2 
(CMeCH2), 112.5 (CMeCH2), 51.7 (C-5), 45.6 (C-4), 32.6 (C-3), 21.9 (CMeCH2), 
16.5 (5-Me). 
NMR data for anti-244a: δH (500 MHz, CDCl3) 6.83 (1H, s, NH), 4.93 (1H, s, trans-
CMeCH2), 4.81 (1H, s, cis-CMeCH2), 3.59 (1H, dq, J 7.0, 6.0, H-5), 2.57 (1H, dt, J 
9.5, 7.0, H-4), [2.45 (1H, dd, J 16.5, 4.5) and 2.32 (1H, dd, J 16.5, 10.0), H-3], 1.72 
(3H, s, CMeCH2), 1.21 (3H, d, J 6.0, 5-Me); δC (126 MHz, CDCl3) 176.9 (C-2), 141.9 
(CMeCH2), 112.4 (CMeCH2), 53.6 (C-5), 50.7 (C-4), 36.0 (C-3), 20.7 (CMeCH2), 
19.7 (5-Me). 
 
5-Pentyl-4-(prop-1-enyl)pyrrolidin-2-one (244b) 
 
  
 
  
 
Ester 243b (22 mg, 0.082 mmol, 1.0 equiv, 59:41 syn:anti mixture of diastereomers) 
was reacted according to general procedure L to afford 5-pentyl-4-(prop-1-
enyl)pyrrolidin-2-one 244b (12 mg, 75%, 56:44 syn:anti mixture of diastereomers) as 
a colourless oil after purification over silica gel (20% EtOAc/dichloromethane). 
Data for the mixture: νmax (film) 3207, 1697, 1450, 1377, 1073, 892, 728 cm-1; m/z 
(CI) 213 [MNH4]+, 196 [MH]+ (Found: [MH]+, 196.1694. C12H21NO requires [MH]+, 
196.1701). 
NMR data for syn-244b: δH (500 MHz, CDCl3) 6.04 (1H, s (br), NH), 4.97 (1H, s, 
trans-CMeCH2), 4.81 (1H, s, cis-CMeCH2) 3.69–3.65 (1H, m, H-5), 3.14 (1H, dt, J 
9.5, 8.0, H-4), 2.44 (1H, dd, J 17.0, 10.5, Ha), 2.28 (1H, dd, J 9.5, 8.0, Hb), 1.76–1.74 
(3H, s, CMeCH2), 1.35–1.21 (8H, m, pentyl), 0.90–0.86 (3H, m, CH3 of pentyl); δC 
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(126 MHz, CDCl3) 177.3 (C-2), 141.9 (CMeCH2), 112.8 (CMeCH2), 56.4 (C-5), 45.9 
(C-4), 35.5, 31.7, 30.5, 26.2, 22.5, 21.9, 14.0. 
NMR data for anti-243b: δH (500 MHz, CDCl3) 5.93 (1H, s (br), NH), 4.84 (2H, s 
(br), CMeCH2), 3.49 (1H, dt, J 7.0, 6.0, H-5), 2.71 (1H, dt, J 8.0, 7.0, H-4), 2.48 (1H, 
dd, J 17.0, 9.0 Ha), 2.29 (1H, dd, J 10.0, 8.0, Hb), 1.76–1.74 (3H, s, CMeCH2), [1.61–
1.55 (1H, m) and 1.45–1.39 (1H, m), CH2 of pentyl], 1.35–1.21 (6H, m, pentyl) 0.90–
0.86 (3H, m, CH3 of pentyl); δC (126 MHz, CDCl3) 176.6 (C-2), 144.2 (CMeCH2), 
112.3 (CMeCH2), 58.0 (C-5), 48.5 (C-4), 35.8, 33.1, 31.7, 25.9, 22.4, 19.6, 14.0. 
 
5-Cyclohexyl-4-(prop-1-enyl)pyrrolidin-2-one (244c) 
 
  
 
  
 
Ester 243d (122 mg, 0.437 mmol, 1.0 equiv 63:37 syn:anti mixture of distereomers) 
was reacted according to general procedure L to afford 5-cyclohexyl-4-(prop-1-
enyl)pyrrolidin-2-one 244c (53 mg, 59%, 33:66 syn:anti mixture of diastereomers) as 
a while solid after purification over silica gel (20–60% EtOAc/dichloromethane). 
Data for the mixture: mp 78–82 °C; νmax (film) 3209, 1690, 1652, 1448, 1256, 890, 
764 cm-1; m/z (CI) 225 [MNH4]+, 208 [MH]+ (Found: [MH]+, 208.1704. C13H21NO 
requires [MH]+, 208.1701). 
NMR data for syn-244c δH (500 MHz, CDCl3) 6.15 (1H, s (br), NH), 4.97 (1H, s, 
trans-CMeCH2), 4.81 (1H, s, cis-CMeCH2), 3.46 (1H, dd, J 7.0, 6.5, H-5), 3.12 (1H, 
dt, J 7.5, 7.0, H-4), [2.39 (1H, dd, J 16.5, 8.0) and 2.35 (1H, dd, J 16.5, 7.0), H-3], 
1.79 (3H, s, CMeCH2), 1.67–0.84 (11H, m, cyclohexyl); δC (126 MHz, CDCl3) 177.9 
(C-2), 142.6 (CMeCH2), 113.5 (CMeCH2), 61.8 (C-5), 45.3 (C-4), 38.7 (cyclohexyl 
CH), 33.9 (C-3), 30.5, 28.8, 25.8, 25.6, 24.9, 21.4 (CMeCH2). 
N3
CO2Et
Me
syn-243d N3
CO2Et
Me
anti-243d
HN
O
Me
Ha
Hb
syn-244c
HN
O
Me
Ha
Hb
anti-244c
Experimental 
 
 
 
 211 
NMR data for anti-244c δH (500 MHz, CDCl3) 6.15 (1H, s (br), NH), 4.80 (1H, s, cis-
CMeCH2), 4.77 (1H, s, trans-CMeCH2), 3.25 (1H, dd, J 5.5, 5.0, H-5), 2.83 (1H, dt, J 
9.5, 5.0, H-4), 2.51 (1H, dd, J 17.5, 9.5, Ha), 2.21 (1H, dd, J 17.5, 5.5, Hb), 1.74 (3H, 
s, CMeCH2), 1.67–0.84 (11H, m, cyclohexyl); δC (126 MHz, CDCl3) 177.0 (C-2), 
145.9 (CMeCH2), 111.5 (CMeCH2), 63.2 (C-5), 44.6 (C-4), 42.8 (cyclohexyl CH), 
35.6 (C-3), 29.6, 28.3, 26.2, 26.0, 25.9, 19.4 (CMeCH2). 
 
5-Methyl-4-(1-phenylethenyl)pyrrolidin-2-one (244d) 
 
  
 
  
 
Ester 243f (78 mg, 0.286 mmol, 1.0 equiv, 50:50 syn:anti mixture of diastereomers) 
was reacted according to general procedure L to afford 5-methyl-4-(1-
phenylethenyl)pyrrolidin-2-one 244d (46 mg, 80%, 50:50 syn:anti mixture of 
diastereomers) as a while solid after purification over silica gel (20% 
EtOAc/dichloromethane). Data for the mixture: mp 64–68 °C; νmax (film) 3202, 1694, 
1631, 1262, 905, 764, 697 cm-1; δH (500 MHz, CDCl3) 7.40–7.30 (10H, m, syn+anti 
Ph), 6.36 (2H, s (br), syn+anti NH), 5.47 (1H, d, J 1.0, syn trans-CPhCH2), 5.32 (1H, 
s, anti trans-CPhCH2), 5.19 (1H, s, anti cis-CPhCH2), 5.13 (1H, d, J 1.0, syn cis-
CPhCH2), 3.85 (1H, dt, J 12.0, 7.5, syn H-4), 3.75 (2H, dq, J 12.0, 6.5, syn+anti H-5), 
3.09 (1H, dt, J 8.0, 7.0, anti H-4), 2.65 (1H, dd, J 16.0, 11.5, anti Ha), 2.62 (1H, dd, J 
17.0, 8.5, syn Hb), 2.41 (1H, dd, J 16.0, 13.5, anti Hb), 2.39 (1H, dd, J 16.0, 14.0, syn 
Ha), 1.24 (3H, d, J 6.5, anti 5-Me), 0.84 (3H, d, J 6.5, syn 5-Me); δC (126 MHz, 
CDCl3) [176.7 and 176.3 (syn+anti C-2)], [148.6 and 145.6 (syn+anti CPhCH2)], 
[141.3 and 140.7 (syn+anti i-Ph)], 128.6, 128.4, 127.9, 127.7, 126.7, 126.2, 114.5 (syn 
CPhCH2), 113.2 (anti CPhCH2), [55.1 and 51.4 (syn+anti C-5)], 47.5 (anti C-4), 42.8 
(syn C-4), 37.3 (anti C-3), 32.5 (syn C-3), 20.1 (anti 5-Me), 16.7 (syn 5-Me); m/z (CI) 
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219 [MNH4]+, 202 [MH]+ (Found: [MH]+, 202.1223. C13H15NO requires [MH]+, 
202.1232). 
 
(E)-2-Azidonon-3-enyl 2-tosylacetate (252a) and (E)-4-azidonon-2-enyl 2-
tosylacetate (253a) 
 
 
 
 
A 73:27 mixture of allylic azides 235a and 236a respectively (1.00 g, 5.46 mmol, 1.0 
equiv) was reacted according to general procedure M to afford a 58:42 mixture of the 
esters (E)-2-azidonon-3-enyl 2-tosylacetate 252a and (E)-4-azidonon-2-enyl 2-
tosylacetate 253a (2.05 g, 99%) respectively as a colourless oil after purification over 
silica gel (25% ether/petrol).  
Data for the mixture: νmax (film) 2932, 2099, 1747, 1598, 1455, 1330, 1152, 1085, 
975, 814, 728, 646, cm-1; δC (126 MHz, CDCl3) 162.2, 162.1, 138.7, 133.2, 129.9, 
128.5, 125.9, 128.5, 125.9, 122.3, 67.1, 65.5, 63.5, 62.0, 60.8, 34.2, 32.2, 31.4, 31.2, 
28.5, 25.4, 22.5, 22.4, 21.7, 14.0; m/z (CI) 397 [MNH4]+, 352, 243 (Found: [MNH4]+, 
397.1926. C18H25N3O4S requires [MNH4]+, 397.1910). 
1H-NMR data for 252a: δH (500 MHz, CDCl3) 7.85–7.81 (2H, m, o-Ts), 7.39–7.37 
(2H, m, m-Ts), 5.82 (1H, dt, J 15.0, 7.0, H-4), 5.31 (1H, ddt, J 15.0, 7.0, 1.5, H-3), 
4.62 (2H, d, J 5.0, H-1), 4.13 (2H, d, J 5.0, CH2Ts), 4.10–3.90 (1H, m, H-2), 2.47 
(3H, s, TsMe), 2.10–2.15 (2H, m, H-5), 1.57–1.28 (6H, m, H-6,7,8), 0.89 (3H, t, J 7.5, 
H-9). 
1H-NMR data for 253b: δH (500 MHz, CDCl3) 7.85–7.81 (2H, m, o-Ts), 7.39–7.37 
(2H, m, m-Ts), 5.74–5.65 (2H, m, H-2,3), 4.62 (2H, d, J 5.0, H-1), 4.13 (2H, d, J 5.0, 
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CH2Ts), 3.82 (1H, dt, J 14.0, 7.0, H-4), 2.47 (3H, s, TsMe), 1.57–1.28 (8H, m, H-
5,6,7,8), 0.89 (3H, t, J 7.5, H-9). 
 
(E)-2-Azido-2-methylnon-3-enyl 2-tosylacetate (252b) and (E)-4-azido-2-
methylnon-2-enyl 2-tosylacetate (253b) 
 
 
 
 
 
A 61:39 mixture of allylic azides 235b and 236b respectively (795 mg, 4.03 mmol, 
1.0 equiv) was reacted according to general procedure M to afford a 65:35 mixture 
the esters (E)-4-azido-2-methylnon-3-enyl 2-tosylacetate 253b and (E)-2-azido-2-
methylnon-2-enyl 2-tosylacetate 252b respectively (1.09 g, 69%) as a colourless oil 
after purification over silica gel (20% ether/petrol).  
Data for the mixture: νmax (film) 2099, 1745, 1673, 1597, 1454, 1331, 1157, 1085, 
831, 727 cm-1; δC (101 MHz, CDCl3) 162.2, 162.1, 145.6, 145.5, 135.8, 134.5, 134.1, 
130.2, 129.9, 129.34, 129.1, 128.5, 127.7, 127.3, 70.7, 70.4, 62.9, 61.0, 60.8, 59.1, 
34.7, 33.6, 32.4, 31.5, 31.2, 28.8, 27.7, 26.1, 25.4, 22.5, 21.7, 20.9, 14.4; m/z (CI) 411 
[MNH4]+, 366, 207, 137 (Found: [MNH4]+, 411.2074. C19H27N3O4S requires 
[MNH4]+, 411.2066). 
1H-NMR data for 253b: δH (400 MHz, CDCl3), 7.84 (2H, d, J 7.5, o-Ts), 7.39 (2H, d, 
J 7.5, m-Ts), 5.42, (1H, d, J 9.5, H-3), 4.16 (2H, s, CH2Ts), 4.02 (2H, AB quartet, J 
11.0, H-1), 2.48 (3H, s, TsMe), 1.72 (3H, d, J 1.5, 2-Me), 1.63–1.26 (8H, m, H-
5,6,7,8), 0.91 (6H, t, J 7.0, H-9). 
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1H-NMR data for 252b: δH (400 MHz, CDCl3), 7.83 (2H, d, J 7.5, o-Ts), 7.40 (2H, d, 
J 7.5, m-Ts), 5.79 (1H, dt, J 15.5, 7.0, H-4), 5.40 (1H, d, J 15.5, H-3), 4.57 (2H, s, 
CH2Ts), 4.14–4.11 (2H, m, H-1), 2.48 (3H, s, TsMe), 2.09 (2H, dt, J 7.5, 7.0, H-5), 
1.63–1.26 (6H, m, H-6,7,8), 1.35 (3H, s, 2-Me), 0.91 (6H, t, J 7.0, H-9). 
 
(E)-2-Azido-2-methylpent-3-enyl 2-tosylacetate (252c) and (E)-4-azido-2-
methylpent-2-enyl 2-tosylacetate (253c) 
 
 
 
 
 
A 64:36 mixture of allylic azides 235c and 236c respectively (300 mg, 2.13 mmol, 1.0 
equiv) was reacted according to general procedure M to afford a 70:30 mixture of 
(E)-4-azido-2-methylpent-3-enyl 2-tosylacetate 253c and (E)-2-azido-2-methylpent-2-
enyl 2-tosylacetate 252c respectively (667 mg, 97%) as a colourless oil after 
purification over silica gel (30% ether/petrol).  
Data for the mixture: νmax (film) 2102, 1744, 1664, 1597, 1450, 1328, 1152, 1085, 
813, 727 cm-1; δC (101 MHz, CDCl3) 162.2, 162.1, 145.6, 145.55, 135.9, 133.9, 
130.4, 130.0, 129.1, 128.6, 128.3, 70.7, 70.3, 63.0, 61.1, 60.9, 54.5, 32.4, 30.5, 25.9, 
24.8, 21.8, 20.8, 20.3, 18.0, 14.3; m/z (CI) 355 [MNH4]+, 310, 295, 201 (Found: 
[MNH4]+, 355.1446. C15H19N3O4S requires [MNH4]+, 355.1440). 
1H-NMR data for 253c: δH (400 MHz, CDCl3) 7.85 (2H, d, J 7.5, o-Ts), 7.00 (2H, d, J 
7.5 m-Ts), 5.44 (1H, d, J 9.5, H-3), 4.33 (1H, dq, J 9.5, 7.0, H-4), 4.17 (2H, s, 
CH2Ts), 3.98 (2H, s, H-1), 2.46 (3H, s, TsMe), 1.68 (3H, d, J 1.5, 2-Me), 1.24 (3H, d, 
J 7.0, H-5). 
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1H-NMR data for 252c: δH (400 MHz, CDCl3) 7.85 (2H, d, J 7.5, o-Ts), 7.00 (2H, d, J 
7.5 m-Ts), 5.83 (1H, dq, J 15.5, 6.5, H-4), 5.45 (1H, d, J 15.5, H-3), 4.56 (2H, s, 
CH2Ts), 4.16 (2H, s, H-1), 2.46 (3H, s, TsMe), 1.32 (3H, s, 2-Me), 1.21 (3H, d, J 6.5, 
H-5). 
 
(E)-2-Azido-4-cyclohexyl-2-methylbut-3-enyl 2-tosylacetate (252d) and (E)-4-
azido-4-cyclohexyl-2-methylbut-2-enyl 2-tosylacetate (253d). 
 
 
 
 
 
A 72:28 mixture of allylic azides 235d and 236d respectively (618 mg, 2.96 mmol, 
1.0 equiv) was reacted according to general procedure M to afford a 68:32 mixture of  
(E)-4-azido-4-cyclohexyl-2-methylbut-3-enyl 2-tosylacetate 253d and (E)-2-azido-4-
cyclohexyl-2-methylbut-2-enyl 2-tosylacetate 252d respectively (1.10 g, 92%) as a 
colourless oil after purification over silica gel (20% ether/petrol). 
Data for the mixture: νmax (film) 2096, 1742, 1650, 1598, 1450, 1329, 1152, 1085, 
813, 727, 697, 603 cm-1; δC (101 MHz, CDCl3) 162.2, 145.6, 145.5, 140.1, 135.8, 
135.7, 134.6, 129.9, 128.5, 128.4, 128.3, 127.9, 125.9, 125.2, 70.7, 70.5, 64.4, 64.3, 
62.9, 61.0, 42.3, 40.6, 32.9. 32.8, 29.5, 26.3, 25.9, 25.8, 21.7, 20.9, 14.5; m/z (ESI) 
428 [MNa]+, 378, 309, 149 (Found: [MNa]+, 428.1635. C20H27N3O4S requires 
[MNa]+, 428.1620). 
1H-NMR data for 253d: δH (400 MHz, CDCl3) 7.84 (2H, d, J 7.5, o-Ts), 7.39 (2H, d, 
J 7.5, m-Ts), 5.45 (1H, d, J 9.5, H-3), 4.16 (2H, s, CH2Ts), 4.02 (2H, AB quartet, J 
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11.5, H-1), 3.91 (1H, dd, J 9.5, 8.0, H-4), 4.28 (3H, s, TsMe), [1.77–1.58 and 1.45–
0.88 (11H, m, cyclohexyl)], 1.71 (3H, s, 2-Me). 
1H-NMR data for 252d: δH (400 MHz, CDCl3) 7.84 (2H, d, J 7.5, o-Ts), 7.39 (2H, d, 
J 7.5, m-Ts), 5.73 (1H, dd, J 16.0, 7.0, H-4), 5.36 (1H, d, J 16.0, H-3), 4.58 (2H, s, 
CH2Ts), 4.15–4.12 (2H, m, H-1), 4.28 (3H, s, TsMe), 2.05– 1.96 (1H, m, A-5), [1.77–
1.58 and 1.45–0.88 (10H, m, cyclohexyl)], 1.34 (3H, s, 2-Me). 
 
(E)-2-Azido-4-phenylbut-3-enyl 2-tosylacetate (252e) 
 
 
 
 
 
Allylic azide 235e (500 mg, 2.64 mmol, 1.0 equiv) was reacted according to general 
procedure M to afford (E)-2-azido-4-phenylbut-3-enyl 2-tosylacetate 252e (1.03 g, 
97%) as a colourless oil after purification over silica gel (15% EtOAc/hexane): νmax 
(film) 2109, 1747, 1598, 1328, 1151, 1085, 971, 814, 754, 695, 646 cm-1; δH (400 
MHz, CDCl3) 7.81 (2H, d, J 8.5, o-Ts), 7.40–7.28 (5H, m, Ph), 7.34 (2H, d, J 8.5, m-
Ts), 6.69 (1H, d, J 16.0, H-4), 6.04 (1H, dd, J 16.0, 7.5, H-3), 4.28–4.20 (1H, m, H-2), 
4.14 (2H, s, CH2Ts), 4.13–4.07 (2H, m, H-1), 2.42 (3H, s, TsMe); δC (101 MHz, 
CDCl3) 162.2, 145.6, 135.9 (C-4), 135.7, 135.3, 129.9, 128.8, 128.7, 128.6, 126.8 (m-
Ts), 121.7 (C-3), 67.0 (C-2), 62.2 (CH2Ts), 60.9 (C-1), 21.7 (TsMe); m/z (CI) 403 
[MNH4]+, 355, 244, 212 (Found: [MNH4]+, 403.1445. C19H19N3O4S requires 
[MNH4]+, 403.1440) (Found: C, 59.26; H, 4.16; N, 10.98. C19H19N3O4S requires C, 
59.21; H, 4.97; N, 10.90). 
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 (E)-4-Azido-2-methyl-4-phenylbut-2-enyl 2-tosylacetate (E-236f) and (Z)-4-
azido-2-methyl-4-phenylbut-2-enyl 2-tosylacetate (Z-236f) 
 
  
 
 
 
 
Allylic azide 236f (212 mg, 1.04 mmol, 1.0 equiv) was reacted according to general 
procedure M to afford a 75:25 mixture of (E)-4-azido-2-methyl-4-phenylbut-2-enyl 2-
tosylacetate E-253f and (Z)-4-azido-2-methyl-4-phenylbut-2-enyl 2-tosylacetate Z-
253f respectively (313 mg, 75%) as a colourless oil after purification over silica gel 
(25% ether/hexane). 
Data for the mixture: νmax (film) 2101, 1742, 1598, 1329, 1151, 1055, 814 cm-1; δC 
(101 MHz, CDCl3) 162.3 (Z C-1), 162.1 (E C-1), 148.5, 138.9, 138.4, 136.4, 136.0, 
135.8, 135.7, 133.6, 129.9, 129.6, 128.7, 128.6, 128.5, 128.4, 128.2, 126.4, 69.1 (E C-
1), 62.4 (Z C-1), 60.9 (E and Z CH2Ts), 55.2 (E C-4), 54.9 (Z C-4), 21.7 (E and Z 
TsMe), 20.7 (Z C-5), 20.4 (E C-5); m/z (ESI) 423 [MHNa]+, 422 [MNa]+, 417, 394, 
196, 143 (Found: [MNa]+, 422.1153. C20H21N3O4S requires [MNa]+, 422.1150). 
1H-NMR data for E-253f: δH (400 MHz, CDCl3) 7.80 (2H, d, J 8.5, m-Ts), 7.43–7.35 
(5H, m, Ph), 7.17 (2H, d, J 8.5, o-Ts), 5.72 (1H, dt, J 9.5, 1.5, H-3), 4.83 (2H, d, J 1.5, 
H-1), 4.13 (2H, s, CH2Ts), 4.05 (1H, dq, J 9.5, 6.5, H-4), 2.48 (3H, s, TsMe), 1.25 
(3H, d, J 6.5, H-5). 
1H-NMR data for Z-253f: δH (400 MHz, CDCl3) 7.77 (2H, d, J 8.5, m-Ts), 7.43–7.35 
(5H, m, Ph), 7.33 (2H, d, J 8.5, o-Ts), 5.93 (1H, d, J 9.5, H-3), 5.09 (2H, AB quartet, 
J 12.5, H-1), 4.54 (1H, dq, J 9.5, 6.5, H-4), 4.10 (2H, s, CH2Ts), 2.47 (3H, s, Z 
TsMe), 1.36 (3H, d, J 6.5, H-5). 
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(E)-2-Azido-2-methyl-4-(pyridin-2-yl)but-3-enyl 2-tosylacetate (252g) 
 
 
 
 
 
Allylic azide 235g (532 mg, 1.24 mmol, 1.0 equiv) was reacted according to general 
procedure M to afford (E)-2-azido-2-methyl-4-(pyridin-2-yl)but-3-enyl 2-tosylacetate 
252g (259 mg, 52%) as a yellow oil after purification over silica gel (30% EtOAc/5% 
TEA/hexane): νmax (film) 2106, 1748, 1586, 1329, 1151, 1085, 970, 768 cm-1; δH (400 
MHz, CDCl3) 8.61 (1H, d, J 5.0, 6-pyridyl), 7.85 (2H, d, J 8.0, o-Ts), 7.70 (1H, dt, J 
7.5, 2.0, 4-pyridyl), 7.38 (2H, d, J 8.0, m-Ts), 7.35 (1H, d, J 7.5, 3-pyridyl), 7.22 (1H, 
dd, J 7.5, 5.0, 5-pyridyl), 6.79 (1H, d, J 16.0, H-4), 6.73 (1H, d, J 16.0, H-3), 4.19 
(2H, s, CH2Ts), 4.17 (2H, d, J 2.0, H-1), 2.47 (3H, s, TsMe), 1.53 (3H, s, 2-Me); δC 
(101 MHz, CDCl3) 162.1 (C=O), 154.0 (2-pyridyl), 149.7 (6-pyridyl), 145.6, 136.8 
(4-pyridyl), 135.7, [131.8 and 131.7 (C-3) and [C-4)], 130.0 (m-Ts), 128.5 (o-Ts), 
123.0 (5-pyridyl) 122.7 (3-pyridyl), 7.05 (C-1), 63.1 (C-2), 60.9 (CH2Ts), 21.7 
(TsMe), 21.0 (2-Me); m/z (CI) 401 [MH]+, 360, 188 (Found: [MH]+, 401.1276. 
C19H20N4O4S requires [MH]+, 401.1284). 
 
1-[(3-Azido-2-ethenyloctane)sulfonyl]-4-methylbenzene (254a) 
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A 58:42 mixture of allylic azides 252a and 253a respectively (50 mg, 0.132 mmol, 
1.0 equiv) was reacted according to general procedure N to afford 1-[(3-azido-2-
ethenyloctane)sulfonyl]-4-methylbenzene 254a (38 mg, 86%, 84:16 syn:anti mixture 
of diastereomers) as a white solid after purification over silica gel (2–10% 
ether/petrol). 
An alternative one-step procedure gave 254a in a lower yield: 
N,N-bis(trimethylsilyl)acetamide (0.484 mL, 1.98 mmol, 5.0 equiv), a 58:42 mixture 
of allylic azides 252a and 253a respectively (150 mg, 0.396 mmol, 1.0 equiv) and 
potassium acetate (4 mg, 0.396 mmol, 0.1 equiv) were combined in a 0.2–0.5 mL 
microwave vial.  The vial was flushed with nitrogen, sealed and heated under 
microwave irradiation at 170 °C for two cycles of 5 min.  The reaction mixture was 
concentrated under reduced pressure and the residue was purified over silica gel (2–
10% ether/petrol) to afford 1-[(3-azido-2-ethenyloctane)sulfonyl]-4-methylbenzene 
254a (42 mg, 32%, 84:16 syn:anti mixture of diastereomers) as a white solid. 
Repeated purification over silica gel (2–10% ether/petrol) followed by 
recrystallisation (EtOAc/petrol) afforded an analytical sample of syn-254a and an 
analytical sample enriched in anti-254a. 
Data for syn-254a: m.p 72–74 °C; νmax (film) 2902, 2100, 1456, 1142, 880, 771, 706, 
670 cm-1; δH (400 MHz, CDCl3) 7.81 (2H, d, J 8.5, o-Ts), 7.39 (2H, d, J 8.5, m-Ts), 
5.60 (1H, ddd, J 17.0, 10.0, 8.5, CHCH2), 5.17 (1H, d, J 10.0, trans-CHCH2), 5.12 
(1H, d, J 17.0, cis-CHCH2), 3.70 (1H, ddd, J 8.5, 5.5, 3.0, H-3), [3.40 (1H, dd, J 14.0, 
7.0) and 3.15 (1H, dd, J 14.0, 6.0), H-1], 2.90 (1H, dddd, J 12.5, 9.5, 6.0, 3.0, H-2), 
2.48 (3H, s, TsMe), 1.62–1.31 (8H, m, H-4,5,6,7), 0.92 (3H, t, J 6.0, H-8); δC (101 
MHz, CDCl3) 144.9 (Ts), 136.9 (Ts), 133.7 (CHCH2), 130.0 (m-Ts), 128.0 (o-Ts), 
119.5 (CHCH2), 64.3 (C-3), 58.1 (C-1), 42.5 (C-2), 32.2 (C-4), 31.5 (C-5), 25.8 (C-6), 
22.5 (C-7), 21.7 (TsMe), 14.0 (C-8); m/z (CI) 353 [MNH4]+, 310, 226, 174, 152; m/z 
(CI) 353 [MNH4]+, 310, 226, 152 (Found: [MNH4]+, 353.2020. C17H25N3O2S requires 
[MNH4]+, 353.2011) (Found: C, 60.95; H, 7.47; N, 12.48. C17H25N3O2S requires C, 
60.87; H, 7.51; N, 12.53). 
NMR data for anti-254a: δH (400 MHz, CDCl3) 7.79 (2H, d, J 8.0, o-Ts), 7.38 (2H, d, 
J 8.0, m-Ts), 5.68 (1H, ddd, J 17.5, 10.0, 8.5, CHCH2), 5.17 (1H, d, J 10.0, trans-
Experimental 
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CHCH2), 5.16 (1H, d, J 17.5, cis-CHCH2), 3.41–3.36 (1H, m, H-3), [3.31 (1H, dd, J 
14.5, 3.5) and 3.20 (1H, dd, J 14.5, 9.0), H-1], 2.80–2.74 (1H, m, H-2), 2.48 (3H, s, 
TsMe), 1.63–1.28 (8H, m, H-4,5,6,7), 0.91 (3H, t, J 7.0, H-8); δC (101 MHz, CDCl3) 
144.4 (Ts), 135.9 (Ts), 135.5 (CHCH2), 129.9 (m-Ts), 128.1 (o-Ts), 118.9 (CHCH2), 
65.8 (C-3), 56.9 (C-1), 43.0 (C-2), 31.6 (C-4), 31.4 (C-5), 25.3 (C-6), 22.4 (C-7), 21.7 
(TsMe), 13.6 (C-8). 
 
1-{[3-Azido-2-(prop-1-en-2-yl)octane]sulfonyl}-4-methylbenzene (254b) 
 
 
 
  
 
A 68:32 mixture of allylic azides 253b and 252b respectively (161 mg, 0.41 mmol, 
1.0 equiv) was reacted according to general procedure O to afford 1-{[3-azido-2-
(prop-1-en-2-yl)octane]sulfonyl}-4-methylbenzene 254b (97 mg, 68%, 68:32 syn:anti 
mixture of diastereomers) as a colourless oil after purification over silica gel (15% 
ether/petrol). Further purification over silica gel (10% ether/petrol) afforded an 
analytical sample of syn-254b and an analytical sample enriched in anti-254b.  
Data for syn-254b: νmax (film) 2103, 1647, 1597, 1455, 1303, 1142, 1088, 899, 815 
cm-1; δH (400 MHz, CDCl3) 7.68 (2H, d, J 8.0, o-Ts), 7.34 (2H, d, J 8.0, m-Ts), 4.87 
(1H, t, J 1.5, trans-CMeCH2), 4.78 (1H, s, cis-CMeCH2), 3.61 (1H, dt, J 7.0, 5.0, H-
3), [3.37 (1H, dd, J 14.5, 6.5) and 3.19 (1H, dd, J 14.5, 6.5), H-1], 2.86 (1H, dt, J 6.5, 
5.0, H-2), 2.43 (3H, s, TsMe), 1.64 (3H, s, CMeCH2), 1.49–1.23 (8H, m, H-4,5,6,7), 
0.87 (3H, t, J 6.5, H-8); δC (101 MHz, CDCl3) 144.8, 141.4, 136.9, 129.9 (o-Ts), 
128.0 (m-Ts), 116.4 (CMeCH2), 64.2 (C-3), 57.1 (C-1), 44.7 (C-2), 32.3, 31.5, 26.2, 
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22.5, 21.0, 14.0 (C-8); m/z (CI) 367 [MNH4]+, 350 [MH]+, 324, 240 (Found: 
[MNH4]+, 367.2172. C18H27N3O2S requires [MNH4]+, 367.2168). 
NMR data for anti-254b: δH (400 MHz, CDCl3) 7.74 (2H, d, J 8.0, o-Ts), 7.32 (2H, d, 
J 8.0, o-Ts), 4.89 (1H, t, J 1.5, trans-CMeCH2), 4.83 (1H, s, cis-CMeCH2), [3.94 (1H, 
dd, J 14.5, 3.0) and 3.27 (1H, dd, J 14.5, 8.0), H-1], 3.17–3.12 (1H, m, H-3), 2.60 
(1H, ddd, J 10.0, 8.0, 3.0, H-2), 2.43 (3H, s, TsMe), 1.63 (3H, s, CMeCH2), 1.49–1.23 
(8H, m, H-4,5,6,7), 0.87 (3H, t, J 6.5, H-8); δC (101 MHz, CDCl3) 144.7, 141.8, 
136.8, 129.8 (o-Ts), 128.1 (m-Ts), 116.2 (CMeCH2), 64.7 (C-3), 56.2 (C-1), 45.8 (C-
2), 32.1, 31.4, 25.8, 21.6, 19.8, 14.0 (C-8). 
 
1-[2-(1-Azidoethyl)-3-methylbut-3-ene-1-sulfonyl]-4-methylbenzene (254c) 
 
 
 
  
 
A 70:30 mixture of allylic azides 253c and 252c respectively (50 mg, 0.16 mmol, 1.0 
equiv) was reacted according to general procedure N to afford 1-[2-(1-azidoethyl)-3-
methylbut-3-ene-1-sulfonyl]-4-methylbenzene 254c (36 mg, 82%, 91:9 syn:anti 
mixture of diastereomers) as a colourless oil after purification over silica gel (10% 
ether/petrol). Further purification over silica gel (10% ether/petrol) afforded an 
analytical sample of syn-254c and an analytical sample enriched in anti-254c.  
Data for syn-254c: νmax (film) 2110, 1648, 1598, 1452, 1304, 1146, 1087, 871, 693 
cm-1; δH (400 MHz, CDCl3) 7.81 (2H, d, J 8.0, o-Ts), 7.38 (2H, d, J 8.0, m-Ts), 4.95 
(1H, s, trans-CMeCH2), 4.83 (1H, s, cis-CMeCH2), 3.89 (1H, dq, J 6.5, 5.0, H-3), 
[3.40 (1H, dd, J 14.0, 6.0) and 3.25 (1H, dd, J 14.0, 7.0), H-1], 2.81 (1H, dt, J 6.0, 
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5.0, H-2), 2.48 (3H, s, TsMe), 1.70 (3H, s, CMeCH2), 1.26 (3H, d, J 6.5, H-4); δC 
(101 MHz, CDCl3) 144.8, 141.2, 136.8, 129.8 (m-Ts), 128.0 (o-Ts), 116.5 (CMeCH2), 
58.7 (C-3), 56.8 (C-1), 45.7 (C-2), 21.7 (TsMe), 21.1 (CMeCH2), 16.9 (C-4); m/z (CI), 
311 [MNH4]+, 294 [MH]+, 268  (Found: [MNH4]+, 311.1542. C14H19N3O2S requires 
[MNH4]+, 311.1542). 
NMR data for anti-254c inter alia: δH (400 MHz, CDCl3) 7.79 (2H, d, J 7.5, o-Ts), 
7.37 (2H, d, J 7.5, m-Ts), 4.87 (1H, s, trans-CMeCH2), 4.54 (1H, s, cis-CMeCH2), 
2.06–1.93 (1H, m, H-3), 1.05 (3H, d, J 7.0, H-4), δC (101 MHz, CDCl3) 129.7 (m-Ts), 
128.1 (o-Ts). 
 
1-{2-[Azido(cyclohexyl)methyl]-3-methylbut-3-ene-1-sulfonyl}-4-methylbenzene 
(254d) 
 
 
 
  
 
A 65:35 mixture of allylic azides 253d and 252d respectively (234 mg, 0.58 mmol, 
1.0 equiv) was reacted according to general procedure O to afford 1-{2-
[azido(cyclohexyl)methyl]-3-methylbut-3-ene-1-sulfonyl}-4-methylbenzene 254d (92 
mg, 44%, 82:18 syn:anti mixture of diastereomers) as a colourless gum after 
purification over silica gel (15% ether/petrol). 
Data for the mixture: νmax (film) 2100, 1646, 1597, 1449, 1302, 1143, 1087, 815, 761 
cm-1; m/z (CI) 379 [MNH4]+, 336, 240, 184, 112 (Found: [MNH4]+, 379.2170. 
C19H27N3O2S requires [MNH4]+, 379.2168). 
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NMR data for syn-254d: δH (400 MHz, CDCl3) 7.82 (2H, d, J 8.5, o-Ts), 7.39 (2H, d, 
J 8.5, m-Ts), 4.90 (1H, t, J 1.5, trans-CMeCH2), 4.85 (1H, s, cis-CMeCH2), 3.85–3.42 
(2H, m, H-1 and H-3), 3.21 (1H, dd, J 14.5, 6.0, H-1), 3.08 (1H, dt, J 7.5, 6.0, H-2), 
2.49 (3H, s, TsMe), 1.89–1.07 (11H, m, cyclohexyl), 1.67 (3H, s, CMeCH2); δC (101 
MHz, CDCl3) 144.8 (i-Ts), 141.9 (p-Ts), 129.9 (m-Ts), 128.1 (o-Ts), 116.6 
(CMeCH2), 77.2 (CMeCH2), 70.1 (C-3), 57.7 (C-1), 42.2 (C-2), 40.6, 30.5, 29.1, 26.1, 
25.8, 20.8. 
NMR data for anti-254d: δH (400 MHz, CDCl3) 7.79 (2H, d, J 8.5, o-Ts), 7.37 (2H, d, 
J 8.5, m-Ts), 4.95 (1H, t, J 1.5, trans-CMeCH2), 4.91 (1H, s, cis-CMeCH2), 3.43–3.29 
(2H, m, H-1), 3.08–3.04 (1H, m, H-3), 2.87 (1H, m, H-2), 2.48 (3H, s, TsMe), 1.89–
1.07 (11H, m, cyclohexyl), 1.70 (3H, s, CMeCH2); δC (101 MHz, CDCl3) 144.6 (i-
Ts), 136.9 (p-Ts), 129.7 (m-Ts), 128.2 (o-Ts), 115.8 (CMeCH2), 77.2 (CMeCH2), 71.5 
(C-3), 56.0 (C-1), 42.6 (C-2), 40.6, 30.8, 27.6, 25.7, 21.7, 20.0. 
 
1-{2-[Azido(phenyl)methyl]but-3-ene-1-sulfonyl}-4-methylbenzene (254e) 
 
 
 
  
 
Allylic azide 252e (213 mg, 0.55 mmol, 1.0 equiv) was reacted according to general 
procedure O to afford 1-{2-[azido(phenyl)methyl]but-3-ene-1-sulfonyl}-4-
methylbenzene 254e (36 mg, 22%, 75:25 syn:anti mixture of diastereomers) after 
purification over silica gel (10% ether/petrol). 
Data for the mixture: νmax (film) 2104, 1640, 1598, 1300, 1146, 1087, 755, 662 cm-1; 
m/z (CI) 359 [MNH4]+, 342 [MH]+, 316, 311, 266 (Found: [MNH4]+, 359.1546. 
C18H19N3O2S requires [MNH4]+, 359.1542). 
NMR data for syn-254e: δH (400 MHz, CDCl3) 7.81 (2H, d, J 8.0, o-Ts), 7.38 (2H, d, 
J 8.0, m-Ts), 7.31–7.17 (5H, m, Ph), 5.68 (1H, ddd, J 17.5, 10.0, 7.5, CHCH2), 5.38 
Ph
N3
O
O
Ts
252e
Ph
N3
Ts
syn-254e
Ph
N3
Ts
anti-254e
Experimental 
 
 
 
 224 
(1H, d, J 17.5, cis-CHCH2), 5.19 (1H, d, J 10.0, trans-CHCH2), 4.96 (1H, d, J 8.5, H-
3), [3.41 (1H, dd, J 14.5, 9.5) and 3.38 (1H, dd, J 14.5, 5.5), H-1], 3.24–3.18 (1H, m, 
H-2), 2.48 (3H, s, TsMe); δC (101 MHz, CDCl3) 144.5, 135.3, 129.9, 129.6, 129.4, 
128.0, 127.9, 127.4, 127.3, 117.3, 67.8 (C-3), 56.7 (C-1), 45.7 (C-2), 21.7 (TsMe). 
NMR data for anti-254e: δH (400 MHz, CDCl3) 7.78 (2H, d, J 8.0, o-Ts), 7.37 (2H, d, 
J 8.0, m-Ts), 7.31–7.17 (5H, m, Ph), 5.57 (1H, ddd, J 17.0, 10.0, 8.5, CHCH2), 5.10 
(1H, d, J 10.0, trans-CHCH2), 4.91 (1H, d, J 8.5, H-3), 4.85 (1H, d, J 17.0, cis-
CHCH2), [3.26 (1H, dd, J 14.5, 7.0) and 3.10 (1H, dd, J 14.5, 7.0), H-1], 3.03–2.96 
(1H, m, H-2), 2.43 (3H, s, TsMe); δC (101 MHz, CDCl3) inter alia 141.1, 133.9, 
130.0, 128.5, 119.7, 65.5 (C-3), 57.3 (C-1), 44.7 (C-2), 21.1 (TsMe). 
 
1-[2-(1-Azidoethyl)-3-phenylbut-3-ene-1-sulfonyl]-4-methylbenzene (254f) 
 
 
 
  
 
A 75:25 mixture of allylic azides E-253f and Z-253f respectively (297 mg, 0.74 
mmol, 1.0 equiv) was reacted according to general procedure N to afford 1-[2-(1-
azidoethyl)-3-phenylbut-3-ene-1-sulfonyl]-4-methylbenzene 254f (87 mg, 32%, 73:27 
syn:anti mixture of diastereomers) as a colourless oil after purification over silica gel 
(10–40% ether/hexane). 
Data for the mixture: νmax (film) 2109, 1626, 1597, 1494, 1317, 1143, 1087, 907, 815, 
779 cm-1; m/z (CI) 373 [MNH4]+, 355 [M]+, 330, 178 (Found: [MNH4]+, 373.1698. 
C19H21N3O2S requires [MNH4]+, 373.1698). 
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NMR data for syn-254f: δH (400 MHz, CDCl3) 7.82 (2H, d, J 8.0, o-Ts), 7.38–7.32 
(7H, m-Ts, CPhCH2), [5.43 (1H, s) and 5.19 (1H, s), CPhCH2], 3.94 (1H, dq, 6.5, 4.0, 
H-3), 3.63–3.42 (3H, m, H-1,2), 2.48 (3H, s, TsMe), 1.15 (3H, d, J 6.5, H-4); δC (101 
MHz, CDCl3) 145.9 (CPhCH2), 144.9, 142.0, 136.9, 130.0, 129.8, 128.6, 128.1, 
128.0, 117.0 (CPhCH2), 58.8 (C-3), 57.1 (C-1), 42.8 (C-2), 21.7 (TsMe), 16.2 (C-4). 
NMR data for anti-254f: δH (400 MHz, CDCl3) 7.75 (2H, d, J 8.0, o-Ts), 7.38–7.32 
(7H, m-Ts, CPhCH2), [5.12 (1H, s) and 5.39 (1H, s), CPhCH2], 3.63–3.42 (3H, m, H-
1,3), 3.20 (1H, ddd, J 9.0, 6.5, 3.0, H-2), 2.46 (3H, s, TsMe), 1.29 (3H, d, J 6.5, H-
4); δC (101 MHz, CDCl3) inter alia 147.1 (CPhCH2), 141.1, 128.5, 127.9, 127.0, 
126.5, 116.4 (CPhCH2), 60.3 (C-3), 57.0 (C-1), 44.7 (C-2), 21.7 (TsMe), 17.7 (C-4). 
 
(E)-2-Azido-2-methylpent-3-en-1-yl 2-(benzyloxy)acetate (265) and (E)-4-azido-
2-methylpent-2-en-1-yl 2-(benzyloxy)acetate (266) 
 
 
 
 
 
To a solution of a 64:36 mixture of allylic azides 235c and 236c respectively (82 mg, 
0.58 mmol, 1.0 equiv) in dichloromethane (2 mL) was added DCC (132 mg, 0.64 
mmol, 1.1 equiv) and DMAP (7 mg, 0.06 mmol, 0.1 equiv) at rt and the resulting 
solution was stirred for 5 min.  Benzyloxyacetic acid (91 µL, 0.64 mmol, 1.1 equiv) 
was added dropwise via syringe to give a white suspension.  After stirring for 14 h, 
the reaction mixture was filtered over Celite and the filtrate was concentrated under 
reduced pressure. Purification of the residue over silica gel (10% ether/petrol) 
afforded a 66:33 mixture of (E)-4-azido-2-methylpent-2-en-1-yl 2-(benzyloxy)acetate 
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266 and (E)-2-Azido-2-methylpent-3-en-1-yl 2-(benzyloxy)acetate 265 respectively 
(71 mg, 42%) as a colourless oil.  
Data for the mixture: νmax (film) 2104, 1757, 1452, 1243, 1192, 1127 cm-1; δC (101 
MHz, CDCl3) 170.0 (C-1), 132.2, 134.3, 134.2, 130.1, 129.6, 128.9, 128.7, 128.3, 
127.8, 73.6 (CH2), 69.7 (CH2), 69.0 (CH2), 67.3 (CH2), 67.1 (CH2), 63.4, 62.3, 54.7, 
21.7, 21.3, 20.9, 20.5, 18.1, 14.6; m/z (CI) 307 [MNH4]+, 247 (Found: [MNH4]+, 
307.1774. C15H19N3O3 requires [MNH4]+, 307.1770). 
1H-NMR data for 265: δH (400 MHz, CDCl3) 7.41–7.36 (5H, m, Ph), 5.85 (1H, dq, J 
15.5, 6.5, H-4), 5.50 (1H, d, J 15.5, H-3), 4.64 (2H, s), 4.19 (2H, s), 4.10 (2H, s), 1.41 
(3H, s, 2-Me), 1.27 (3H, d, J 6.5, H-5). 
1H-NMR data for 266: δH (400 MHz, CDCl3) 7.41–7.36 (5H, m, Ph), 5.46 (1H, d, J 
9.0, H-3), 4.68 (2H, s), 4.35 (1H, dq, J 9.0, 6.5, H-4), 4.18 (2H, s), 4.07 (2H, s), 1.78 
(3H, d, J 1.5, 2-Me), 1.28 (3H, d, J 6.5, H-5). 
 
4-Azido-3-(prop-1-enyl)-2-(benzyloxy)-pentanoic acid (267) 
 
  
 
 
  
 
To a solution of a 66:33 mixture of allylic azides 266 and 265 respectively (69 mg, 
0.24 mmol, 1.0 equiv) in THF (3.4 mL) at –95 °C was added LHMDS (0.72 mL of a 
1 M solution in THF, 0.72 mmol, 3.0 equiv) dropwise via syringe.  The resulting 
solution was stirred for 1 h and base-treated chlorotrimethylsilane (0.18 mL, 1.43 
mmol, 6.0 equiv) was added at –95 °C.  The reaction mixture was stirred at –95 °C for 
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1 h, warmed to 0 °C over 1 h and warmed to rt during 24 h.  Water (10 mL) and 
aqueous HCl (2 M, 10 mL) were added, the phases were separated and the aqueous 
layer was extracted with EtOAc (3 x 20 mL).  The combined organic extracts were 
dried (MgSO4), concentrated under reduced pressure and purified over silica gel (20% 
EtOAc/5% formic acid/petrol) to afford recovered starting material 265/266 (20 mg, 
29% 66:33 mixture) and 4-azido-3-(prop-1-enyl)-2-(benzyloxy)-pentanoic acid 267 
(44 mg, 64%, 90% BRSM, 55:23:17:5 unassigned mixture of 4 diastereomers) as a 
colourless oil: νmax (film) 3468, 2104, 1747, 1452, 1379, 1240, 1124, 1029, 743, 699 
cm-1; δH (400 MHz, CDCl3) 7.43–7.34 (20H, m, Ph), 5.02–4.13 (20H, m, OCH2, 
CMeCH2 and H-2), [4.18 (1H, dq, J 7.0, 4.5), 3.93 (1H, dq, J 10.0, 6.5), 3.86 (1H, dq, 
J 10.5, 6.5) and 3.78 (1H, dq, J 10.0, 6.5), H-4], [2.67 (1H, dd, J 10.0, 3.0), 2.59 (1H, 
dd, J 9.5, 4.5), 2.57 (1H, dd, J 9.5, 4.0) and (1H, dd, J 11.0, 4.0), H-3], [1.89 (3H, s), 
1.82 (6H, s), 1.79 (3H, s) and 1.79 (3H, s), CMeCH2], 1.30–1.22 (12H, m, H-5); δC 
(101 MHz, CDCl3) [177.0, 176.8, 176.7 and 176.4 (C-1)], 166.1, 165.2, 142.8, 142.0, 
136.9, 136.8, 136.7, 117.5, 116.7, 115.1, 79.0, 78.9, 78.8, 78.6, 73.6, 73.5, 73.2, 73.1, 
56.5, 56.2, 55.9, 55.4, 54.7, 54.6, 54.4, 54.1, 31.9, 29.7, 29.5, 29.4, 29.2, 29.1, [22.7, 
22.5, 22.0 and 21.2 (CMeCH2)], [17.9, 17.7, 17.4 and 17.2 (C-5)]; m/z (CI), 321, 307 
[MNH4]+, 288 [M–H]+, 274, 184 (Found: [MNH4]+, 307.1773. C15H19N3O3 requires 
[MNH4]+, 307.1770). 
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3.4.4 Compounds relevant to section 2.6 
 
Syn-4-azido-3-{[(4-methylbenzene)sulfonyl]methyl}nonan-2-one (syn-274) 
 
 
 
 
 
Ozone gas was passed through a stirred solution of sulfone syn-254b (24 mg, 0.07 
mmol, 1.0 equiv) in dichloromethane (2.5 mL) at –78 °C for 5 min.  The solution was 
purged with nitrogen and dimethylsulfide (0.10 mL) was added at –78 °C.  The 
solution was stirred at –78 °C for 1 h, allowed to warm to rt overnight and 
concentrated under reduced pressure. Purification of the residue over silica gel (10% 
EtOAc/petrol) afforded syn-4-azido-3-{[(4-methylbenzene)sulfonyl]methyl}nonan-2-
one syn-274 (21 mg, 88%) as a colourless oil: νmax (film) 2106, 1719, 1598, 1316, 
1148, 1087, 816 cm-1; δH (400 MHz, CDCl3) 7.80 (2H, d, J 8.0, o-Ts), 7.40 (2H, d, J 
8.0, m-Ts), [3.73 (1H, dd, J 14.0, 9.5) and 3.13 (1H, dd, J 14.0, 3.0), CH2Ts], 3.59 
(1H, dt, J 9.0, 6.5, H-4), 3.54 (1H, dt, J 9.5, 6.5, H-3), 2.49 (3H, s, TsMe), 2.35 (3H, 
s, H-1), 1.48–1.27 (8H, m, H-5,6,7,8), 0.91 (3H, t, J 7.0, H-9); δC (101 MHz, CDCl3) 
206.1 (C-2), 145.3, 136.1, 130.1 (m-Ts), 128.0 (o-Ts), 63.1 (C-4), 54.8 (CH2Ts), 49.2 
(C-3), 31.5, 31.4, 31.3 (C-1), 25.5, 22.4, 21.7 (TsMe), 13.9 (C-9);  m/z (CI) 369 
[MNH4]+, 342, 326 (Found: C, 58.00; H, 7.13; N, 11.85. C17H25N3O3S requires C, 
58.09; H, 7.17; N, 11.96). 
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Syn-4-azido-3-{[(4-methylbenzene)sulfonyl]methyl}nonan-2-one (syn-274) and 4-
azido-2-methoxy-3-{[(4-methylbenzene)sulfonyl]methyl}nonan-2-ol (275) 
 
 
 
  
 
When the above reaction was performed with a mixture of dichloromethane and 
methanol (4:1 v/v) as the solvent, syn-274 (17%) and an additional product 4-azido-2-
methoxy-3-{[(4-methylbenzene)sulfonyl]methyl}nonan-2-ol 275 (34%) was isolated as 
a colourless oil composed of a single diastereomer: νmax (film) 3392, 2105, 1598, 
1294, 1143, 815 cm-1; δH (400 MHz, CDCl3) 7.86 (2H, d, J 8.0, o-Ts), 7.41 (2H, d, J 
8.0, m-Ts), 3.65 (1H, dt, J 10.0, 3.5, H-4), [3.59 (1H, dd, J 14.5, 4.0) and 3.14 (1H, 
dd, J 14.5, 5.0) CH2Ts], 3.32 (3H, s, OMe), 3.00 (1H, dt, J 10.0, 4.0, H-3), 2.49 (3H, 
s, TsMe), 1.54 (3H, s, H-1), 1.50–1.25 (8H, m, H-5,6,7,8), 0.92 (3H, t, J 7.0, H-9); δC 
(101 MHz, CDCl3) 145.0, 136.5, 130.0 (m-Ts), 128.1 (o-Ts), 106.7 (C-2), 63.3 (C-4), 
53.3 (CH2Ts), 49.8 (OMe), 42.8 (C-3), 31.4 (C-5), 31.3 (C-6), 26.7 (C-7,8), 21.7 
(TsMe), 18.4 (C-1), 14.0 (C-9). 
 
4-Azidononan-2-one (276) 
 
 
 
 
 
To a solution of azidotrimethylsilane (3.32 mL, 25.0 mmol, 5.0 equiv) in 
dichloromethane (20 mL) was added acetic acid (1.42 mL, 25.0 mmol, 5.0 equiv) at 
rt. The solution was stirred for 20 min and 3-nonen-2-one 238b (0.70 g, 5.0 mmol, 1.0 
equiv) was added dropwise. TEA (0.14 mL, 1.0 mmol, 0.2 equiv) was then added and 
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the solution was stirred for 24 h.  The reaction mixture was passed through a silica gel 
plug (10% ether/petrol) and concentrated under reduced pressure to afford 4-
azidononan-2-one 276 (863 mg, 94%) as a colourless oil: νmax (film) 2102, 1719, 
1362, 1260 cm-1; δH (400 MHz, CDCl3) 3.90–3.83 (1H, m, H-4), [2.69 (1H, dd, J 
17.0, 8.5) and 2.57 (1H, dd, J 17.0, 5.0), H-3], 2.21 (3H, s, H-1), 1.54–1.26 (8H, m, 
H-5,6,7,8), 0.92 (3H, t, J 7.0, H-9); δC (101 MHz, CDCl3) 205.9 (C-2), 58.2 (C-4), 
48.0 (C-3), 34.4 (C-5), 31.8 (C-6), 30.6 (C-1), 25.6 (C-7), 22.5 (C-8), 14.0 (C-9); m/z 
(CI)  201 [MNH4]+, 184 [MH]+, 156 (Found: [MNH4]+, 201.1715. C9H17N3O requires 
[MNH4]+, 201.1715); in agreement with published data.202e 
 
(E)- and (Z)-4-Azidononan-2-one oxime (277) 
 
 
 
  
 
To a solution of azidoketone 276 (2.20 g, 12.0 mmol, 1.0 equiv) in acetonitrile (40 
mL) and water (10 mL) was added sodium acetate (1.48 g, 18.0 mmol, 1.50 equiv) at 
rt. The mixture was stirred for 10 min to give a homogeneous solution and 
hydroxylamine hydrochloride (0.97 g, 14.0 mmol, 1.17 equiv) was added.  The 
resulting solution was stirred at rt for 2 h and concentrated under reduced pressure to 
remove acetonitrile.  The residue was partitioned between EtOAc (50 mL) and water 
(50 mL), the phases were separated and the aqueous layer was extracted with EtOAc 
(2 x 50 mL). The combined organic layers were dried (MgSO4) and concentrated 
under reduced pressure to afford an inseparable 66:33 mixture of (E)- and (Z)-4-
azidononan-2-one oxime 277 respectively (2.23 g, 94%) as a colourless oil after 
purification over silica gel (15% ether/petrol). 
Data for the mixture: νmax (film) 3234, 2103, 1664, 1468, 1378, 1248, 961, 727; m/z 
(CI) 216 [MNH4]+, 199 [MH]+, 177 (Found: [MH]+, 199.1559. C9H18N4O requires 
[MH]+, 199.1559). 
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NMR data for E-277: δH (500 MHz, CDCl3) 8.06 (1H, s (br), OH), 3.36 (1H, dt, J 
13.0, 6.5, H-4), 2.38 (1H, d, J 6.5, H-3), 1.93 (1H, s, H-1), 1.57–1.25 (8H, m, H-
5,6,7,8), 0.89 (3H, t, J 6.5, H-9); δC (101 MHz, CDCl3) 155.5 (C-2), 59.9 (C-4), 40.7 
(C-3), 34.5, 31.5, 25.6, 22.5, 14.0 (C-9 and C-1). 
NMR data for Z-277: δH (500 MHz, CDCl3) 8.06 (1H, s (br), OH), 3.73–3.68 (1H, m, 
H-4), [2.65 (1H, dd, J 13.0, 5.0) and 2.46 (1H, dd, J 13.0, 9.5), H-3], 1.95 (1H, s, H-
1), 1.57–1.25 (8H, m, H-5,6,7,8), 0.90 (3H, t, J 6.5, H-9); δC (101 MHz, CDCl3) 155.8 
(C-2), 59.6 (C-4), 34.9, 34.5, 33.9 (C-3), 31.5, 22.5, 21.1 (C-1), 14.0 (C-9). 
 
N-(2-Azidoheptyl)acetamide (279) and  3-azido-N-methyloctanamide (280) 
 
  
 
  
 
To a solution of the oxime 277 (111 mg, 0.56 mmol, 1.0 equiv) in dichloromethane 
(3.29 mL) was added TEA (0.22 mL, 1.60 mmol, 2.85 equiv), DMAP (14 mg, 0.11 
mmol, 0.2 equiv) and p-toluenesulfonyl chloride (305 mg, 1.60 mmol, 2.85 equiv) at 
rt.  The mixture was stirred for 15 min and concentrated under reduced pressure.  The 
residue was purified over silica gel (20% ether/petrol) to remove residual p-
toluenesulfonyl chloride. Then, to a solution of the residue in IPA-water (3.29 mL, 
4:1 v/v) was added TEA (0.22 mL, 1.60 mmol, 2.85 equiv) and the mixture was 
heated to reflux at 90 °C for 3 h. The reaction mixture was cooled to rt and water (25 
mL) and EtOAc (25 mL) were added.  The phases were separated and the aqueous 
layer was extracted with EtOAc (2 x 25 mL).  The combined organic extracts were 
dried (MgSO4) and concentrated under reduced pressure. Purification of the residue 
over silica gel (50–80% EtOAc/petrol) gave an inseparable 2:1 mixture of N-(2-
azidoheptyl)acetamide 279 and 3-azido-N-methyloctanamide 280 respectively (49 
mg, 44%) as a yellow oil.  
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Data for the mixture: νmax (film) 3298, 3087, 2107, 1654, 1555, 1462, 1373, 1274 cm-
1; m/z (CI) 216 [MNH4]+, 199 [MH]+, 171, 100 (Found: [MH]+, 199.1560. C9H18N4O 
requires [MH]+, 199.1559). 
NMR data for 279: δH (400 MHz, CDCl3) 5.83 (1H, s (br), NH), [3.62 (1H, ddd, J 
13.5, 7.0, 3.5) and 3.04 (1H, ddd, 13.5, 8.5, 3.5), H-1], 3.56–3.50 (1H, m, H-2), 2.04 
(3H, s, Me), 1.59–1.28 (8H, m, H-3,4,5,6), 0.92 (3H, t, J 7.0, H-7); δC (101 MHz, 
CDCl3) 170.3 (C=O), 62.3 (C-2), 43.0 (C-1), 31.5, 32.2 (C-3), 25.6, 23.2 (Me), 22.5, 
14.0 (C-7);  
NMR data for 280: δH (400 MHz, CDCl3) 5.72 (1H, s (br), NH), 3.88 (1H, ddt, J 14.0, 
6.5, 2.5, H-3), 2.86 (3H, d, J 5.0, NHMe), [2.40 (1H, dd, J 14.0, 4.5) and 2.29 (1H, 
dd, J 14.0, 8.5), H-2], 1.59–1.28 (8H, m, H-3,4,5,6), 0.92 (3H, t, J 7.0, H-7); δC (101 
MHz, CDCl3) 170.4 (C-1), 59.6 (C-3), 41.4 (C-2), 35.5 (C-4), 32.0, 29.9, 26.6 
(NHMe), 23.0, 14.1 (C-8). 
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4.1 Crystallographic data for anti-160 
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Table 1. Crystal data and structure refinement for DC0703. 
 
Identification code DC0703 
Empirical formula C21 H22 N2 O6 
Formula weight 398.41 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54248 Å 
Crystal system, space group Monoclinic, P2(1)/n 
Unit cell dimensions a = 9.6435(2) Å α = 90° 
 b = 9.8412(2) Å β = 
91.418(2)° 
 c = 42.7551(9) Å γ = 90° 
Volume, Z 4056.37(15) Å3, 8 
Density (calculated) 1.305 Mg/m3 
Absorption coefficient 0.803 mm-1 
F(000) 1680 
Crystal colour / morphology Colourless plates 
Crystal size 0.42 x 0.24 x 0.01 mm3 
θ range for data collection 2.07 to 71.58° 
Index ranges -11<=h<=11, -10<=k<=11, -
51<=l<=52 
Reflns collected / unique 55324 / 7825 [R(int) = 0.0676] 
Reflns observed [F>4σ(F)] 4517 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.72928 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7825 / 0 / 523 
Goodness-of-fit on F2 1.041 
Final R indices [F>4σ(F)] R1 = 0.0547, wR2 = 0.1288 
R indices (all data) R1 = 0.0967, wR2 = 0.1485 
Largest diff. peak, hole 0.186, -0.229 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Table 2. Bond lengths [Å] and angles [°] for DC0703. 
 
C(1)-O(7) 1.460(3) 
C(1)-C(2) 1.501(3) 
C(2)-C(3) 1.535(3) 
C(3)-C(21) 1.502(3) 
C(3)-C(4) 1.539(3) 
C(4)-C(23) 1.515(3) 
C(4)-C(5) 1.538(4) 
C(5)-C(6) 1.514(3) 
O(7)-C(8) 1.327(3) 
C(8)-O(8) 1.209(3) 
C(8)-C(9) 1.501(3) 
C(9)-C(10) 1.379(3) 
C(9)-C(14) 1.391(3) 
C(10)-C(11) 1.380(3) 
C(11)-C(12) 1.379(3) 
C(11)-N(15) 1.468(3) 
C(12)-C(13) 1.378(3) 
C(13)-C(14) 1.379(3) 
C(13)-N(18) 1.477(3) 
N(15)-O(16) 1.222(2) 
N(15)-O(17) 1.228(2) 
N(18)-O(20) 1.228(2) 
N(18)-O(19) 1.230(2) 
C(21)-C(22) 1.304(4) 
C(23)-C(24) 1.387(3) 
C(23)-C(28) 1.389(3) 
C(24)-C(25) 1.379(3) 
C(25)-C(26) 1.380(4) 
C(26)-C(27) 1.376(3) 
C(27)-C(28) 1.380(3) 
C(1')-O(7') 1.463(3) 
C(1')-C(2') 1.505(3) 
C(2')-C(3') 1.530(4) 
C(3')-C(21') 1.502(4) 
C(3')-C(4') 1.545(3) 
C(4')-C(23') 1.512(4) 
C(4')-C(5') 1.546(4) 
C(5')-C(6') 1.512(4) 
O(7')-C(8') 1.329(3) 
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C(8')-O(8') 1.206(3) 
C(8')-C(9') 1.498(3) 
C(9')-C(10') 1.378(4) 
C(9')-C(14') 1.397(3) 
C(10')-C(11') 1.380(3) 
C(11')-C(12') 1.389(3) 
C(11')-N(15') 1.461(3) 
C(12')-C(13') 1.366(4) 
C(13')-C(14') 1.375(4) 
C(13')-N(18') 1.485(3) 
N(15')-O(17') 1.223(2) 
N(15')-O(16') 1.233(3) 
N(18')-O(19') 1.222(3) 
N(18')-O(20') 1.226(4) 
C(21')-C(22') 1.307(4) 
C(23')-C(24') 1.386(4) 
C(23')-C(28') 1.391(4) 
C(24')-C(25') 1.382(4) 
C(25')-C(26') 1.384(4) 
C(26')-C(27') 1.377(4) 
C(27')-C(28') 1.380(3) 
 
O(7)-C(1)-C(2) 106.37(18) 
C(1)-C(2)-C(3) 113.8(2) 
C(21)-C(3)-C(2) 108.4(2) 
C(21)-C(3)-C(4) 110.65(19) 
C(2)-C(3)-C(4) 112.3(2) 
C(23)-C(4)-C(5) 110.3(2) 
C(23)-C(4)-C(3) 113.39(19) 
C(5)-C(4)-C(3) 111.2(2) 
C(6)-C(5)-C(4) 113.6(2) 
C(8)-O(7)-C(1) 116.67(17) 
O(8)-C(8)-O(7) 125.5(2) 
O(8)-C(8)-C(9) 123.1(2) 
O(7)-C(8)-C(9) 111.36(19) 
C(10)-C(9)-C(14) 120.2(2) 
C(10)-C(9)-C(8) 117.8(2) 
C(14)-C(9)-C(8) 122.0(2) 
C(9)-C(10)-C(11) 119.2(2) 
C(12)-C(11)-C(10) 122.5(2) 
C(12)-C(11)-N(15) 118.68(19) 
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C(10)-C(11)-N(15) 118.86(19) 
C(13)-C(12)-C(11) 116.7(2) 
C(12)-C(13)-C(14) 123.0(2) 
C(12)-C(13)-N(18) 118.27(19) 
C(14)-C(13)-N(18) 118.7(2) 
C(13)-C(14)-C(9) 118.4(2) 
O(16)-N(15)-O(17) 124.2(2) 
O(16)-N(15)-C(11) 117.82(18) 
O(17)-N(15)-C(11) 117.93(18) 
O(20)-N(18)-O(19) 124.33(19) 
O(20)-N(18)-C(13) 117.87(19) 
O(19)-N(18)-C(13) 117.8(2) 
C(22)-C(21)-C(3) 125.9(3) 
C(24)-C(23)-C(28) 117.5(2) 
C(24)-C(23)-C(4) 121.4(2) 
C(28)-C(23)-C(4) 120.9(2) 
C(25)-C(24)-C(23) 121.0(2) 
C(24)-C(25)-C(26) 120.4(3) 
C(27)-C(26)-C(25) 119.5(2) 
C(26)-C(27)-C(28) 119.8(3) 
C(27)-C(28)-C(23) 121.7(2) 
O(7')-C(1')-C(2') 106.6(2) 
C(1')-C(2')-C(3') 114.1(2) 
C(21')-C(3')-C(2') 109.4(2) 
C(21')-C(3')-C(4') 111.3(2) 
C(2')-C(3')-C(4') 110.9(2) 
C(23')-C(4')-C(3') 113.4(2) 
C(23')-C(4')-C(5') 109.8(2) 
C(3')-C(4')-C(5') 110.8(2) 
C(6')-C(5')-C(4') 114.9(2) 
C(8')-O(7')-C(1') 116.3(2) 
O(8')-C(8')-O(7') 125.0(3) 
O(8')-C(8')-C(9') 123.2(2) 
O(7')-C(8')-C(9') 111.8(2) 
C(10')-C(9')-C(14') 120.3(3) 
C(10')-C(9')-C(8') 117.8(2) 
C(14')-C(9')-C(8') 121.9(3) 
C(9')-C(10')-C(11') 119.2(2) 
C(10')-C(11')-C(12') 121.8(3) 
C(10')-C(11')-N(15') 118.9(2) 
C(12')-C(11')-N(15') 119.3(2) 
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C(13')-C(12')-C(11') 117.5(3) 
C(12')-C(13')-C(14') 123.0(2) 
C(12')-C(13')-N(18') 118.2(3) 
C(14')-C(13')-N(18') 118.8(3) 
C(13')-C(14')-C(9') 118.3(3) 
O(17')-N(15')-O(16') 123.5(3) 
O(17')-N(15')-C(11') 118.5(2) 
O(16')-N(15')-C(11') 118.0(2) 
O(19')-N(18')-O(20') 125.3(3) 
O(19')-N(18')-C(13') 117.3(3) 
O(20')-N(18')-C(13') 117.3(3) 
C(22')-C(21')-C(3') 125.5(3) 
C(24')-C(23')-C(28') 117.5(3) 
C(24')-C(23')-C(4') 121.7(3) 
C(28')-C(23')-C(4') 120.7(2) 
C(25')-C(24')-C(23') 121.2(3) 
C(24')-C(25')-C(26') 120.4(3) 
C(27')-C(26')-C(25') 119.1(3) 
C(26')-C(27')-C(28') 120.2(3) 
C(27')-C(28')-C(23') 121.5(3) 
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4.2 Crystallographic data for syn-197 
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Table 1. Crystal data and structure refinement for DC0901. 
 
Identification code DC0901 
Empirical formula C19 H19 N3 O5 S 
Formula weight 401.43 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Triclinic, P-1 
Unit cell dimensions a = 7.0330(2) Å α = 
69.170(3)° 
 b = 11.6869(4) Å β = 
78.712(3)° 
 c = 12.9973(5) Å γ = 
82.731(3)° 
Volume, Z 977.27(6) Å3, 2 
Density (calculated) 1.364 Mg/m3 
Absorption coefficient 0.201 mm-1 
F(000) 420 
Crystal colour / morphology Yellow tabular needles 
Crystal size 0.45 x 0.24 x 0.10 mm3 
θ range for data collection 2.92 to 32.43° 
Index ranges -6<=h<=10, -16<=k<=17, -18<=l<=19 
Reflns collected / unique 12052 / 6353 [R(int) = 0.0204] 
Reflns observed [F>4σ(F)] 4267 
Absorption correction Analytical 
Max. and min. transmission 0.980 and 0.938 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6353 / 21 / 270 
Goodness-of-fit on F2 1.053 
Final R indices [F>4σ(F)] R1 = 0.0556, wR2 = 0.1351 
R indices (all data) R1 = 0.0896, wR2 = 0.1467 
Largest diff. peak, hole 0.424, -0.637 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
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Table 2. Bond lengths [Å] and angles [°] for DC0901. 
 
N(1)-C(2) 1.3805(18) 
N(1)-C(7) 1.3878(16) 
C(2)-O(2) 1.2055(18) 
C(2)-C(3) 1.5157(19) 
C(3)-C(4) 1.527(2) 
C(4)-C(19) 1.502(2) 
C(4)-C(5) 1.532(2) 
C(5)-C(6) 1.541(3) 
C(5)-S(21) 1.819(2) 
C(7)-C(12) 1.401(2) 
C(7)-C(8) 1.4095(19) 
C(8)-C(9) 1.3883(19) 
C(8)-N(13) 1.465(3) 
C(8)-N(13') 1.478(10) 
C(9)-C(10) 1.365(2) 
C(10)-C(11) 1.380(2) 
C(10)-N(16) 1.4636(18) 
C(11)-C(12) 1.3754(19) 
N(13)-O(15) 1.206(3) 
N(13)-O(14) 1.231(3) 
N(13')-O(15') 1.218(12) 
N(13')-O(14') 1.223(12) 
N(16)-O(17) 1.2162(19) 
N(16)-O(18) 1.2215(19) 
C(19)-C(20) 1.315(2) 
S(21)-C(22) 1.7751(17) 
C(22)-C(23) 1.378(3) 
C(22)-C(27) 1.390(3) 
C(23)-C(24) 1.383(3) 
C(24)-C(25) 1.383(3) 
C(25)-C(26) 1.365(3) 
C(26)-C(27) 1.395(3) 
 
C(2)-N(1)-C(7) 127.93(12) 
O(2)-C(2)-N(1) 123.64(13) 
O(2)-C(2)-C(3) 123.04(13) 
N(1)-C(2)-C(3) 113.30(13) 
C(2)-C(3)-C(4) 112.97(12) 
C(19)-C(4)-C(3) 109.77(13) 
Appendix 
 
 
 
 
 243 
C(19)-C(4)-C(5) 112.54(13) 
C(3)-C(4)-C(5) 113.22(12) 
C(4)-C(5)-C(6) 110.63(16) 
C(4)-C(5)-S(21) 114.31(12) 
C(6)-C(5)-S(21) 107.74(18) 
N(1)-C(7)-C(12) 121.63(12) 
N(1)-C(7)-C(8) 121.78(12) 
C(12)-C(7)-C(8) 116.59(12) 
C(9)-C(8)-C(7) 122.07(13) 
C(9)-C(8)-N(13) 114.55(15) 
C(7)-C(8)-N(13) 123.33(15) 
C(9)-C(8)-N(13') 118.0(5) 
C(7)-C(8)-N(13') 119.2(5) 
C(10)-C(9)-C(8) 118.38(13) 
C(9)-C(10)-C(11) 122.03(13) 
C(9)-C(10)-N(16) 119.11(13) 
C(11)-C(10)-N(16) 118.85(14) 
C(12)-C(11)-C(10) 119.16(14) 
C(11)-C(12)-C(7) 121.76(13) 
O(15)-N(13)-O(14) 121.3(2) 
O(15)-N(13)-C(8) 118.6(2) 
O(14)-N(13)-C(8) 120.1(2) 
O(15')-N(13')-O(14') 124.1(13) 
O(15')-N(13')-C(8) 117.4(9) 
O(14')-N(13')-C(8) 117.5(10) 
O(17)-N(16)-O(18) 123.44(14) 
O(17)-N(16)-C(10) 118.27(14) 
O(18)-N(16)-C(10) 118.27(14) 
C(20)-C(19)-C(4) 124.11(17) 
C(22)-S(21)-C(5) 104.50(8) 
C(23)-C(22)-C(27) 119.05(17) 
C(23)-C(22)-S(21) 118.00(13) 
C(27)-C(22)-S(21) 122.86(17) 
C(22)-C(23)-C(24) 120.81(18) 
C(23)-C(24)-C(25) 120.3(2) 
C(26)-C(25)-C(24) 119.12(18) 
C(25)-C(26)-C(27) 121.21(18) 
C(22)-C(27)-C(26) 119.5(2) 
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4.3 Crystallographic data for syn-254a 
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Table 1. Crystal data and structure refinement for DC0808. 
 
Identification code DC0808 
Empirical formula C17 H25 N3 O2 S 
Formula weight 335.46 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Monoclinic, P2(1)/n 
Unit cell dimensions a = 5.48411(17) Å α = 90° 
 b = 8.0007(2) Å β = 
90.353(3)° 
 c = 41.2338(12) Å γ = 90° 
Volume, Z 1809.17(9) Å3, 4 
Density (calculated) 1.232 Mg/m3 
Absorption coefficient 0.192 mm-1 
F(000) 720 
Crystal colour / morphology Colourless platy needles 
Crystal size 0.45 x 0.15 x 0.02 mm3 
θ range for data collection 3.91 to 31.68° 
Index ranges -8<=h<=7, -11<=k<=11, -59<=l<=59 
Reflns collected / unique 22930 / 5800 [R(int) = 0.0666] 
Reflns observed [F>4σ(F)] 4035 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.88234 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5800 / 0 / 209 
Goodness-of-fit on F2 1.212 
Final R indices [F>4σ(F)] R1 = 0.1083, wR2 = 0.1913 
R indices (all data) R1 = 0.1493, wR2 = 0.2018 
Largest diff. peak, hole 0.450, -0.793 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Table 2. Bond lengths [Å] and angles [°] for DC0808. 
 
C(1)-C(2) 1.550(4) 
C(1)-S(9) 1.772(3) 
C(2)-C(19) 1.502(5) 
C(2)-C(3) 1.531(5) 
C(3)-N(21) 1.498(4) 
C(3)-C(4) 1.524(5) 
C(4)-C(5) 1.513(5) 
C(5)-C(6) 1.539(5) 
C(6)-C(7) 1.498(6) 
C(7)-C(8) 1.515(6) 
S(9)-O(11) 1.431(3) 
S(9)-O(10) 1.438(3) 
S(9)-C(12) 1.766(3) 
C(12)-C(13) 1.383(5) 
C(12)-C(17) 1.388(5) 
C(13)-C(14) 1.387(5) 
C(14)-C(15) 1.394(5) 
C(15)-C(16) 1.380(5) 
C(15)-C(18) 1.518(5) 
C(16)-C(17) 1.393(5) 
C(19)-C(20) 1.308(6) 
N(21)-N(22) 1.225(5) 
N(22)-N(23) 1.128(5) 
 
C(2)-C(1)-S(9) 113.1(2) 
C(19)-C(2)-C(3) 112.6(3) 
C(19)-C(2)-C(1) 108.3(3) 
C(3)-C(2)-C(1) 112.5(3) 
N(21)-C(3)-C(4) 109.8(3) 
N(21)-C(3)-C(2) 107.7(3) 
C(4)-C(3)-C(2) 111.9(3) 
C(5)-C(4)-C(3) 114.5(3) 
C(4)-C(5)-C(6) 111.9(3) 
C(7)-C(6)-C(5) 114.7(3) 
C(6)-C(7)-C(8) 112.5(4) 
O(11)-S(9)-O(10) 118.62(18) 
O(11)-S(9)-C(12) 107.89(16) 
O(10)-S(9)-C(12) 108.26(15) 
O(11)-S(9)-C(1) 109.27(16) 
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O(10)-S(9)-C(1) 107.75(17) 
C(12)-S(9)-C(1) 104.11(16) 
C(13)-C(12)-C(17) 121.4(3) 
C(13)-C(12)-S(9) 119.8(3) 
C(17)-C(12)-S(9) 118.8(3) 
C(12)-C(13)-C(14) 119.0(3) 
C(13)-C(14)-C(15) 121.0(3) 
C(16)-C(15)-C(14) 118.6(3) 
C(16)-C(15)-C(18) 120.5(3) 
C(14)-C(15)-C(18) 120.9(3) 
C(15)-C(16)-C(17) 121.6(3) 
C(12)-C(17)-C(16) 118.4(3) 
C(20)-C(19)-C(2) 124.3(4) 
N(22)-N(21)-C(3) 115.1(3) 
N(23)-N(22)-N(21) 173.6(4) 
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